id	sid	tid	token	lemma	pos
bptjm-49	1	1	berkeley	berkeley	PROPN
bptjm-49	1	2	pharma	pharma	PROPN
bptjm-49	1	3	tech	tech	NOUN
bptjm-49	1	4	journal	journal	NOUN
bptjm-49	1	5	of	of	ADP
bptjm-49	1	6	medicine	medicine	NOUN
bptjm-49	1	7	correspondence	correspondence	NOUN
bptjm-49	1	8	:	:	PUNCT
bptjm-49	1	9	hasset1@gmail.com	hasset1@gmail.com	X
bptjm-49	1	10	keywords	keyword	NOUN
bptjm-49	1	11	:	:	PUNCT
bptjm-49	1	12	ptpn	ptpn	PROPN
bptjm-49	1	13	digestive	digestive	ADJ
bptjm-49	1	14	cancer	cancer	NOUN
bptjm-49	1	15	phosphatase	phosphatase	NOUN
bptjm-49	1	16	lung	lung	NOUN
bptjm-49	1	17	cancer	cancer	NOUN
bptjm-49	1	18	tumor	tumor	NOUN
bptjm-49	1	19	promoter	promoter	NOUN
bptjm-49	1	20	submitted	submit	VERB
bptjm-49	1	21	:	:	PUNCT
bptjm-49	1	22	may	may	AUX
bptjm-49	1	23	10	10	NUM
bptjm-49	1	24	,	,	PUNCT
bptjm-49	1	25	2023	2023	NUM
bptjm-49	1	26	accepted	accept	VERB
bptjm-49	1	27	:	:	PUNCT
bptjm-49	1	28	june	june	PROPN
bptjm-49	1	29	30	30	NUM
bptjm-49	1	30	,	,	PUNCT
bptjm-49	1	31	2023	2023	NUM
bptjm-49	1	32	published	publish	VERB
bptjm-49	1	33	:	:	PUNCT
bptjm-49	1	34	december	december	PROPN
bptjm-49	1	35	30	30	NUM
bptjm-49	1	36	,	,	PUNCT
bptjm-49	1	37	2023	2023	NUM
bptjm-49	1	38	full	full	ADJ
bptjm-49	1	39	open	open	ADJ
bptjm-49	1	40	access	access	NOUN
bptjm-49	1	41	creative	creative	ADJ
bptjm-49	1	42	commons	common	NOUN
bptjm-49	1	43	attribution	attribution	NOUN
bptjm-49	1	44	license	license	VERB
bptjm-49	1	45	4.0	4.0	NUM
bptjm-49	1	46	abstract	abstract	ADJ
bptjm-49	1	47	protein	protein	NOUN
bptjm-49	1	48	phosphorylation	phosphorylation	NOUN
bptjm-49	1	49	and	and	CCONJ
bptjm-49	1	50	dephosphorylation	dephosphorylation	NOUN
bptjm-49	1	51	are	be	AUX
bptjm-49	1	52	pivotal	pivotal	ADJ
bptjm-49	1	53	in	in	ADP
bptjm-49	1	54	regulating	regulate	VERB
bptjm-49	1	55	protein	protein	NOUN
bptjm-49	1	56	activity	activity	NOUN
bptjm-49	1	57	.	.	PUNCT
bptjm-49	2	1	two	two	NUM
bptjm-49	2	2	key	key	ADJ
bptjm-49	2	3	players	player	NOUN
bptjm-49	2	4	,	,	PUNCT
bptjm-49	2	5	protein	protein	NOUN
bptjm-49	2	6	tyrosine	tyrosine	NOUN
bptjm-49	2	7	kinases	kinase	NOUN
bptjm-49	2	8	and	and	CCONJ
bptjm-49	2	9	protein	protein	NOUN
bptjm-49	2	10	tyrosine	tyrosine	NOUN
bptjm-49	2	11	phosphatases	phosphatase	NOUN
bptjm-49	2	12	(	(	PUNCT
bptjm-49	2	13	ptpn	ptpn	PROPN
bptjm-49	2	14	)	)	PUNCT
bptjm-49	2	15	,	,	PUNCT
bptjm-49	2	16	especially	especially	ADV
bptjm-49	2	17	non	non	ADJ
bptjm-49	2	18	-	-	ADJ
bptjm-49	2	19	receptor	receptor	ADJ
bptjm-49	2	20	ptpns	ptpns	NOUN
bptjm-49	2	21	,	,	PUNCT
bptjm-49	2	22	exert	exert	VERB
bptjm-49	2	23	opposing	oppose	VERB
bptjm-49	2	24	influences	influence	NOUN
bptjm-49	2	25	in	in	ADP
bptjm-49	2	26	this	this	DET
bptjm-49	2	27	process	process	NOUN
bptjm-49	2	28	.	.	PUNCT
bptjm-49	3	1	while	while	SCONJ
bptjm-49	3	2	all	all	DET
bptjm-49	3	3	ptpns	ptpns	ADJ
bptjm-49	3	4	dephosphorylate	dephosphorylate	NOUN
bptjm-49	3	5	substrates	substrate	NOUN
bptjm-49	3	6	,	,	PUNCT
bptjm-49	3	7	their	their	PRON
bptjm-49	3	8	impact	impact	NOUN
bptjm-49	3	9	on	on	ADP
bptjm-49	3	10	different	different	ADJ
bptjm-49	3	11	cancers	cancer	NOUN
bptjm-49	3	12	varies	vary	VERB
bptjm-49	3	13	.	.	PUNCT
bptjm-49	4	1	some	some	DET
bptjm-49	4	2	act	act	NOUN
bptjm-49	4	3	as	as	ADP
bptjm-49	4	4	tumor	tumor	NOUN
bptjm-49	4	5	suppressors	suppressor	NOUN
bptjm-49	4	6	in	in	ADP
bptjm-49	4	7	specific	specific	ADJ
bptjm-49	4	8	cancers	cancer	NOUN
bptjm-49	4	9	,	,	PUNCT
bptjm-49	4	10	while	while	SCONJ
bptjm-49	4	11	in	in	ADP
bptjm-49	4	12	others	other	NOUN
bptjm-49	4	13	,	,	PUNCT
bptjm-49	4	14	they	they	PRON
bptjm-49	4	15	may	may	AUX
bptjm-49	4	16	function	function	VERB
bptjm-49	4	17	as	as	ADP
bptjm-49	4	18	tumor	tumor	NOUN
bptjm-49	4	19	promoters	promoter	NOUN
bptjm-49	4	20	.	.	PUNCT
bptjm-49	5	1	this	this	DET
bptjm-49	5	2	review	review	NOUN
bptjm-49	5	3	focuses	focus	VERB
bptjm-49	5	4	on	on	ADP
bptjm-49	5	5	comprehending	comprehend	VERB
bptjm-49	5	6	the	the	DET
bptjm-49	5	7	roles	role	NOUN
bptjm-49	5	8	of	of	ADP
bptjm-49	5	9	ptpns	ptpns	NOUN
bptjm-49	5	10	in	in	ADP
bptjm-49	5	11	lung	lung	NOUN
bptjm-49	5	12	and	and	CCONJ
bptjm-49	5	13	digestive	digestive	ADJ
bptjm-49	5	14	cancers	cancer	NOUN
bptjm-49	5	15	.	.	PUNCT
bptjm-49	6	1	notably	notably	ADV
bptjm-49	6	2	,	,	PUNCT
bptjm-49	6	3	lung	lung	NOUN
bptjm-49	6	4	cancer	cancer	NOUN
bptjm-49	6	5	ranks	rank	VERB
bptjm-49	6	6	as	as	ADP
bptjm-49	6	7	the	the	DET
bptjm-49	6	8	third	third	ADJ
bptjm-49	6	9	most	most	ADV
bptjm-49	6	10	common	common	ADJ
bptjm-49	6	11	cancer	cancer	NOUN
bptjm-49	6	12	in	in	ADP
bptjm-49	6	13	the	the	DET
bptjm-49	6	14	us	us	PROPN
bptjm-49	6	15	,	,	PUNCT
bptjm-49	6	16	with	with	ADP
bptjm-49	6	17	around	around	ADP
bptjm-49	6	18	200,000	200,000	NUM
bptjm-49	6	19	new	new	ADJ
bptjm-49	6	20	cases	case	NOUN
bptjm-49	6	21	reported	report	VERB
bptjm-49	6	22	annually	annually	ADV
bptjm-49	6	23	.	.	PUNCT
bptjm-49	7	1	despite	despite	SCONJ
bptjm-49	7	2	declining	decline	VERB
bptjm-49	7	3	rates	rate	NOUN
bptjm-49	7	4	in	in	ADP
bptjm-49	7	5	the	the	DET
bptjm-49	7	6	united	united	PROPN
bptjm-49	7	7	states	states	PROPN
bptjm-49	7	8	,	,	PUNCT
bptjm-49	7	9	stomach	stomach	NOUN
bptjm-49	7	10	cancer	cancer	NOUN
bptjm-49	7	11	remains	remain	VERB
bptjm-49	7	12	a	a	DET
bptjm-49	7	13	major	major	ADJ
bptjm-49	7	14	cause	cause	NOUN
bptjm-49	7	15	of	of	ADP
bptjm-49	7	16	cancer	cancer	NOUN
bptjm-49	7	17	-	-	PUNCT
bptjm-49	7	18	related	relate	VERB
bptjm-49	7	19	deaths	death	NOUN
bptjm-49	7	20	worldwide	worldwide	ADV
bptjm-49	7	21	.	.	PUNCT
bptjm-49	8	1	the	the	DET
bptjm-49	8	2	objective	objective	NOUN
bptjm-49	8	3	of	of	ADP
bptjm-49	8	4	this	this	DET
bptjm-49	8	5	review	review	NOUN
bptjm-49	8	6	article	article	NOUN
bptjm-49	8	7	is	be	AUX
bptjm-49	8	8	to	to	PART
bptjm-49	8	9	elucidate	elucidate	VERB
bptjm-49	8	10	the	the	DET
bptjm-49	8	11	functions	function	NOUN
bptjm-49	8	12	of	of	ADP
bptjm-49	8	13	ptpn1	ptpn1	NOUN
bptjm-49	8	14	,	,	PUNCT
bptjm-49	8	15	ptpn2	ptpn2	ADJ
bptjm-49	8	16	,	,	PUNCT
bptjm-49	8	17	ptpn3	ptpn3	PROPN
bptjm-49	8	18	,	,	PUNCT
bptjm-49	8	19	ptpn6	ptpn6	NOUN
bptjm-49	8	20	,	,	PUNCT
bptjm-49	8	21	ptpn11	ptpn11	NOUN
bptjm-49	8	22	,	,	PUNCT
bptjm-49	8	23	ptpn12	ptpn12	VERB
bptjm-49	8	24	,	,	PUNCT
bptjm-49	8	25	and	and	CCONJ
bptjm-49	8	26	ptpn13	ptpn13	NOUN
bptjm-49	8	27	in	in	ADP
bptjm-49	8	28	lung	lung	NOUN
bptjm-49	8	29	and/or	and/or	CCONJ
bptjm-49	8	30	digestive	digestive	ADJ
bptjm-49	8	31	cancers	cancer	NOUN
bptjm-49	8	32	.	.	PUNCT
bptjm-49	9	1	emphasis	emphasis	NOUN
bptjm-49	9	2	is	be	AUX
bptjm-49	9	3	placed	place	VERB
bptjm-49	9	4	on	on	ADP
bptjm-49	9	5	exploring	explore	VERB
bptjm-49	9	6	their	their	PRON
bptjm-49	9	7	potential	potential	NOUN
bptjm-49	9	8	as	as	ADP
bptjm-49	9	9	prognostic	prognostic	ADJ
bptjm-49	9	10	markers	marker	NOUN
bptjm-49	9	11	or	or	CCONJ
bptjm-49	9	12	therapeutic	therapeutic	ADJ
bptjm-49	9	13	targets	target	NOUN
bptjm-49	9	14	.	.	PUNCT
bptjm-49	10	1	exploring	explore	VERB
bptjm-49	10	2	the	the	DET
bptjm-49	10	3	therapeutic	therapeutic	ADJ
bptjm-49	10	4	potential	potential	NOUN
bptjm-49	10	5	of	of	ADP
bptjm-49	10	6	ptpn	ptpn	PROPN
bptjm-49	10	7	families	family	NOUN
bptjm-49	10	8	in	in	ADP
bptjm-49	10	9	lung	lung	NOUN
bptjm-49	10	10	and	and	CCONJ
bptjm-49	10	11	digestive	digestive	ADJ
bptjm-49	10	12	cancers	cancer	NOUN
bptjm-49	10	13	by	by	ADP
bptjm-49	10	14	:	:	PUNCT
bptjm-49	10	15	hasset	hasset	ADJ
bptjm-49	10	16	yishak	yishak	NOUN
bptjm-49	10	17	,	,	PUNCT
bptjm-49	10	18	kareem	kareem	PROPN
bptjm-49	10	19	halwah	halwah	PROPN
bptjm-49	10	20	,	,	PUNCT
bptjm-49	10	21	and	and	CCONJ
bptjm-49	10	22	jiyun	jiyun	VERB
bptjm-49	10	23	rhim	rhim	PROPN
bptjm-49	10	24	berkeley	berkeley	PROPN
bptjm-49	10	25	pharma	pharma	PROPN
bptjm-49	10	26	tech	tech	NOUN
bptjm-49	10	27	journal	journal	NOUN
bptjm-49	10	28	of	of	ADP
bptjm-49	10	29	medicine	medicine	NOUN
bptjm-49	10	30	|	|	ADV
bptjm-49	10	31	83	83	NUM
bptjm-49	10	32	1	1	NUM
bptjm-49	10	33	.	.	PUNCT
bptjm-49	11	1	introduction	introduction	NOUN
bptjm-49	11	2	cancer	cancer	NOUN
bptjm-49	11	3	is	be	AUX
bptjm-49	11	4	a	a	DET
bptjm-49	11	5	leading	lead	VERB
bptjm-49	11	6	cause	cause	NOUN
bptjm-49	11	7	of	of	ADP
bptjm-49	11	8	death	death	NOUN
bptjm-49	11	9	all	all	ADV
bptjm-49	11	10	over	over	ADP
bptjm-49	11	11	the	the	DET
bptjm-49	11	12	world	world	NOUN
bptjm-49	11	13	,	,	PUNCT
bptjm-49	11	14	and	and	CCONJ
bptjm-49	11	15	the	the	DET
bptjm-49	11	16	complications	complication	NOUN
bptjm-49	11	17	associated	associate	VERB
bptjm-49	11	18	with	with	ADP
bptjm-49	11	19	the	the	DET
bptjm-49	11	20	disease	disease	NOUN
bptjm-49	11	21	makes	make	VERB
bptjm-49	11	22	it	it	PRON
bptjm-49	11	23	difficult	difficult	ADJ
bptjm-49	11	24	to	to	PART
bptjm-49	11	25	efficiently	efficiently	ADV
bptjm-49	11	26	treat	treat	VERB
bptjm-49	11	27	.	.	PUNCT
bptjm-49	12	1	various	various	ADJ
bptjm-49	12	2	types	type	NOUN
bptjm-49	12	3	of	of	ADP
bptjm-49	12	4	cancer	cancer	NOUN
bptjm-49	12	5	exist	exist	NOUN
bptjm-49	12	6	,	,	PUNCT
bptjm-49	12	7	such	such	ADJ
bptjm-49	12	8	as	as	ADP
bptjm-49	12	9	lung	lung	NOUN
bptjm-49	12	10	cancer	cancer	NOUN
bptjm-49	12	11	,	,	PUNCT
bptjm-49	12	12	gastric	gastric	ADJ
bptjm-49	12	13	cancer	cancer	NOUN
bptjm-49	12	14	,	,	PUNCT
bptjm-49	12	15	breast	breast	NOUN
bptjm-49	12	16	cancer	cancer	NOUN
bptjm-49	12	17	,	,	PUNCT
bptjm-49	12	18	lymphoma	lymphoma	NOUN
bptjm-49	12	19	,	,	PUNCT
bptjm-49	12	20	prostate	prostate	NOUN
bptjm-49	12	21	cancer	cancer	NOUN
bptjm-49	12	22	,	,	PUNCT
bptjm-49	12	23	and	and	CCONJ
bptjm-49	12	24	kidney	kidney	NOUN
bptjm-49	12	25	cancer	cancer	NOUN
bptjm-49	12	26	.	.	PUNCT
bptjm-49	13	1	lung	lung	NOUN
bptjm-49	13	2	cancer	cancer	NOUN
bptjm-49	13	3	is	be	AUX
bptjm-49	13	4	the	the	DET
bptjm-49	13	5	second	second	ADJ
bptjm-49	13	6	most	most	ADV
bptjm-49	13	7	common	common	ADJ
bptjm-49	13	8	cancer	cancer	NOUN
bptjm-49	13	9	in	in	ADP
bptjm-49	13	10	the	the	DET
bptjm-49	13	11	united	united	PROPN
bptjm-49	13	12	states,1	states,1	PROPN
bptjm-49	13	13	with	with	ADP
bptjm-49	13	14	approximately	approximately	ADV
bptjm-49	13	15	80	80	NUM
bptjm-49	13	16	%	%	NOUN
bptjm-49	13	17	of	of	ADP
bptjm-49	13	18	lung	lung	NOUN
bptjm-49	13	19	cancers	cancer	NOUN
bptjm-49	13	20	being	be	AUX
bptjm-49	13	21	nonsmall	nonsmall	ADJ
bptjm-49	13	22	lung	lung	NOUN
bptjm-49	13	23	cancer	cancer	NOUN
bptjm-49	13	24	(	(	PUNCT
bptjm-49	13	25	nsclc	nsclc	NOUN
bptjm-49	13	26	)	)	PUNCT
bptjm-49	13	27	.	.	PUNCT
bptjm-49	14	1	furthermore	furthermore	ADV
bptjm-49	14	2	,	,	PUNCT
bptjm-49	14	3	lung	lung	NOUN
bptjm-49	14	4	cancer	cancer	NOUN
bptjm-49	14	5	accounts	account	VERB
bptjm-49	14	6	for	for	ADP
bptjm-49	14	7	the	the	DET
bptjm-49	14	8	greatest	great	ADJ
bptjm-49	14	9	number	number	NOUN
bptjm-49	14	10	of	of	ADP
bptjm-49	14	11	deaths	death	NOUN
bptjm-49	14	12	stemming	stem	VERB
bptjm-49	14	13	from	from	ADP
bptjm-49	14	14	cancer	cancer	NOUN
bptjm-49	14	15	in	in	ADP
bptjm-49	14	16	men	man	NOUN
bptjm-49	14	17	with	with	ADP
bptjm-49	14	18	a	a	DET
bptjm-49	14	19	5	5	NUM
bptjm-49	14	20	-	-	PUNCT
bptjm-49	14	21	year	year	NOUN
bptjm-49	14	22	survival	survival	NOUN
bptjm-49	14	23	rate	rate	NOUN
bptjm-49	14	24	ranging	range	VERB
bptjm-49	14	25	from	from	ADP
bptjm-49	14	26	10	10	NUM
bptjm-49	14	27	%	%	NOUN
bptjm-49	14	28	to	to	ADP
bptjm-49	14	29	20%.2	20%.2	PROPN
bptjm-49	14	30	digestive	digestive	ADJ
bptjm-49	14	31	cancer	cancer	NOUN
bptjm-49	14	32	encompasses	encompass	VERB
bptjm-49	14	33	different	different	ADJ
bptjm-49	14	34	types	type	NOUN
bptjm-49	14	35	of	of	ADP
bptjm-49	14	36	cancer	cancer	NOUN
bptjm-49	14	37	,	,	PUNCT
bptjm-49	14	38	such	such	ADJ
bptjm-49	14	39	as	as	ADP
bptjm-49	14	40	gastric	gastric	ADJ
bptjm-49	14	41	and	and	CCONJ
bptjm-49	14	42	colorectal	colorectal	ADJ
bptjm-49	14	43	cancer	cancer	NOUN
bptjm-49	14	44	.	.	PUNCT
bptjm-49	15	1	gastric	gastric	ADJ
bptjm-49	15	2	cancer	cancer	NOUN
bptjm-49	15	3	,	,	PUNCT
bptjm-49	15	4	also	also	ADV
bptjm-49	15	5	known	know	VERB
bptjm-49	15	6	as	as	ADP
bptjm-49	15	7	stomach	stomach	NOUN
bptjm-49	15	8	cancer	cancer	NOUN
bptjm-49	15	9	,	,	PUNCT
bptjm-49	15	10	significantly	significantly	ADV
bptjm-49	15	11	affects	affect	VERB
bptjm-49	15	12	1	1	NUM
bptjm-49	15	13	in	in	ADP
bptjm-49	15	14	96	96	NUM
bptjm-49	15	15	men	man	NOUN
bptjm-49	15	16	and	and	CCONJ
bptjm-49	15	17	1	1	NUM
bptjm-49	15	18	in	in	ADP
bptjm-49	15	19	152	152	NUM
bptjm-49	15	20	women.1	women.1	ADV
bptjm-49	15	21	known	know	VERB
bptjm-49	15	22	as	as	ADP
bptjm-49	15	23	the	the	DET
bptjm-49	15	24	fifth	fifth	ADJ
bptjm-49	15	25	most	most	ADV
bptjm-49	15	26	common	common	ADJ
bptjm-49	15	27	cancer	cancer	NOUN
bptjm-49	15	28	in	in	ADP
bptjm-49	15	29	the	the	DET
bptjm-49	15	30	world	world	NOUN
bptjm-49	15	31	,	,	PUNCT
bptjm-49	15	32	gastric	gastric	ADJ
bptjm-49	15	33	cancer	cancer	NOUN
bptjm-49	15	34	’s	’s	PART
bptjm-49	15	35	5	5	NUM
bptjm-49	15	36	-	-	PUNCT
bptjm-49	15	37	year	year	NOUN
bptjm-49	15	38	survival	survival	NOUN
bptjm-49	15	39	rate	rate	NOUN
bptjm-49	15	40	is	be	AUX
bptjm-49	15	41	32%.3	32%.3	PROPN
bptjm-49	15	42	current	current	ADJ
bptjm-49	15	43	cancer	cancer	NOUN
bptjm-49	15	44	treatments	treatment	NOUN
bptjm-49	15	45	include	include	VERB
bptjm-49	15	46	surgery	surgery	NOUN
bptjm-49	15	47	,	,	PUNCT
bptjm-49	15	48	chemotherapy	chemotherapy	NOUN
bptjm-49	15	49	,	,	PUNCT
bptjm-49	15	50	hormone	hormone	NOUN
bptjm-49	15	51	therapy	therapy	NOUN
bptjm-49	15	52	,	,	PUNCT
bptjm-49	15	53	radiation	radiation	NOUN
bptjm-49	15	54	therapy	therapy	NOUN
bptjm-49	15	55	,	,	PUNCT
bptjm-49	15	56	hyperthermia	hyperthermia	NOUN
bptjm-49	15	57	,	,	PUNCT
bptjm-49	15	58	immunotherapy	immunotherapy	NOUN
bptjm-49	15	59	,	,	PUNCT
bptjm-49	15	60	and	and	CCONJ
bptjm-49	15	61	targeted	target	VERB
bptjm-49	15	62	therapy.4,5	therapy.4,5	PROPN
bptjm-49	15	63	despite	despite	SCONJ
bptjm-49	15	64	the	the	DET
bptjm-49	15	65	variety	variety	NOUN
bptjm-49	15	66	of	of	ADP
bptjm-49	15	67	treatments	treatment	NOUN
bptjm-49	15	68	,	,	PUNCT
bptjm-49	15	69	these	these	DET
bptjm-49	15	70	treatments	treatment	NOUN
bptjm-49	15	71	are	be	AUX
bptjm-49	15	72	not	not	PART
bptjm-49	15	73	fully	fully	ADV
bptjm-49	15	74	effective	effective	ADJ
bptjm-49	15	75	as	as	SCONJ
bptjm-49	15	76	millions	million	NOUN
bptjm-49	15	77	of	of	ADP
bptjm-49	15	78	people	people	NOUN
bptjm-49	15	79	continuously	continuously	ADV
bptjm-49	15	80	die	die	VERB
bptjm-49	15	81	from	from	ADP
bptjm-49	15	82	cancer	cancer	NOUN
bptjm-49	15	83	annually	annually	ADV
bptjm-49	15	84	.	.	PUNCT
bptjm-49	16	1	thus	thus	ADV
bptjm-49	16	2	,	,	PUNCT
bptjm-49	16	3	there	there	PRON
bptjm-49	16	4	is	be	VERB
bptjm-49	16	5	a	a	DET
bptjm-49	16	6	strong	strong	ADJ
bptjm-49	16	7	drive	drive	NOUN
bptjm-49	16	8	to	to	PART
bptjm-49	16	9	develop	develop	VERB
bptjm-49	16	10	alternative	alternative	ADJ
bptjm-49	16	11	treatments	treatment	NOUN
bptjm-49	16	12	by	by	ADP
bptjm-49	16	13	exploring	explore	VERB
bptjm-49	16	14	the	the	DET
bptjm-49	16	15	molecular	molecular	ADJ
bptjm-49	16	16	mechanisms	mechanism	NOUN
bptjm-49	16	17	of	of	ADP
bptjm-49	16	18	various	various	ADJ
bptjm-49	16	19	proteins	protein	NOUN
bptjm-49	16	20	involved	involve	VERB
bptjm-49	16	21	in	in	ADP
bptjm-49	16	22	the	the	DET
bptjm-49	16	23	progression	progression	NOUN
bptjm-49	16	24	or	or	CCONJ
bptjm-49	16	25	inhibition	inhibition	NOUN
bptjm-49	16	26	of	of	ADP
bptjm-49	16	27	cancer	cancer	NOUN
bptjm-49	16	28	.	.	PUNCT
bptjm-49	17	1	1.1	1.1	NUM
bptjm-49	17	2	introduction	introduction	NOUN
bptjm-49	17	3	to	to	ADP
bptjm-49	17	4	ptpn	ptpn	NOUN
bptjm-49	17	5	with	with	ADP
bptjm-49	17	6	current	current	ADJ
bptjm-49	17	7	experimentation	experimentation	NOUN
bptjm-49	17	8	being	be	AUX
bptjm-49	17	9	conducted	conduct	VERB
bptjm-49	17	10	in	in	ADP
bptjm-49	17	11	regards	regard	NOUN
bptjm-49	17	12	to	to	ADP
bptjm-49	17	13	novel	novel	ADJ
bptjm-49	17	14	therapeutics	therapeutic	NOUN
bptjm-49	17	15	in	in	ADP
bptjm-49	17	16	lung	lung	NOUN
bptjm-49	17	17	and	and	CCONJ
bptjm-49	17	18	digestive	digestive	ADJ
bptjm-49	17	19	cancer	cancer	NOUN
bptjm-49	17	20	,	,	PUNCT
bptjm-49	17	21	this	this	DET
bptjm-49	17	22	review	review	NOUN
bptjm-49	17	23	paper	paper	NOUN
bptjm-49	17	24	explores	explore	NOUN
bptjm-49	17	25	,	,	PUNCT
bptjm-49	17	26	as	as	ADV
bptjm-49	17	27	well	well	ADV
bptjm-49	17	28	as	as	ADP
bptjm-49	17	29	summarizes	summarize	NOUN
bptjm-49	17	30	,	,	PUNCT
bptjm-49	17	31	the	the	DET
bptjm-49	17	32	existing	exist	VERB
bptjm-49	17	33	body	body	NOUN
bptjm-49	17	34	of	of	ADP
bptjm-49	17	35	scientific	scientific	ADJ
bptjm-49	17	36	literature	literature	NOUN
bptjm-49	17	37	on	on	ADP
bptjm-49	17	38	the	the	DET
bptjm-49	17	39	family	family	NOUN
bptjm-49	17	40	of	of	ADP
bptjm-49	17	41	protein	protein	NOUN
bptjm-49	17	42	phosphatases	phosphatase	NOUN
bptjm-49	17	43	known	know	VERB
bptjm-49	17	44	as	as	ADP
bptjm-49	17	45	non	non	ADJ
bptjm-49	17	46	-	-	ADJ
bptjm-49	17	47	receptor	receptor	ADJ
bptjm-49	17	48	protein	protein	NOUN
bptjm-49	17	49	tyrosine	tyrosine	NOUN
bptjm-49	17	50	phosphatases	phosphatase	NOUN
bptjm-49	17	51	(	(	PUNCT
bptjm-49	17	52	ptpn	ptpn	PROPN
bptjm-49	17	53	)	)	PUNCT
bptjm-49	17	54	.	.	PUNCT
bptjm-49	18	1	phosphorylation	phosphorylation	NOUN
bptjm-49	18	2	and	and	CCONJ
bptjm-49	18	3	dephosphorylation	dephosphorylation	NOUN
bptjm-49	18	4	are	be	AUX
bptjm-49	18	5	highly	highly	ADV
bptjm-49	18	6	used	use	VERB
bptjm-49	18	7	mechanisms	mechanism	NOUN
bptjm-49	18	8	by	by	ADP
bptjm-49	18	9	the	the	DET
bptjm-49	18	10	cell	cell	NOUN
bptjm-49	18	11	to	to	PART
bptjm-49	18	12	regulate	regulate	VERB
bptjm-49	18	13	signaling	signal	VERB
bptjm-49	18	14	within	within	ADP
bptjm-49	18	15	and	and	CCONJ
bptjm-49	18	16	between	between	ADP
bptjm-49	18	17	cells	cell	NOUN
bptjm-49	18	18	.	.	PUNCT
bptjm-49	19	1	importantly	importantly	ADV
bptjm-49	19	2	,	,	PUNCT
bptjm-49	19	3	ptpns	ptpns	NOUN
bptjm-49	19	4	affect	affect	VERB
bptjm-49	19	5	tumor	tumor	NOUN
bptjm-49	19	6	progression	progression	NOUN
bptjm-49	19	7	by	by	ADP
bptjm-49	19	8	dephosphorylating	dephosphorylate	VERB
bptjm-49	19	9	proteins	protein	NOUN
bptjm-49	19	10	in	in	ADP
bptjm-49	19	11	order	order	NOUN
bptjm-49	19	12	to	to	PART
bptjm-49	19	13	activate	activate	VERB
bptjm-49	19	14	or	or	CCONJ
bptjm-49	19	15	inhibit	inhibit	VERB
bptjm-49	19	16	potentially	potentially	ADV
bptjm-49	19	17	oncogenic	oncogenic	ADJ
bptjm-49	19	18	pathways.6	pathways.6	NOUN
bptjm-49	19	19	this	this	PRON
bptjm-49	19	20	creates	create	VERB
bptjm-49	19	21	a	a	DET
bptjm-49	19	22	strong	strong	ADJ
bptjm-49	19	23	potential	potential	NOUN
bptjm-49	19	24	for	for	SCONJ
bptjm-49	19	25	ptpn	ptpn	PROPN
bptjm-49	19	26	families	family	NOUN
bptjm-49	19	27	to	to	PART
bptjm-49	19	28	be	be	AUX
bptjm-49	19	29	used	use	VERB
bptjm-49	19	30	as	as	ADP
bptjm-49	19	31	a	a	DET
bptjm-49	19	32	prognosis	prognosis	NOUN
bptjm-49	19	33	marker	marker	NOUN
bptjm-49	19	34	and/or	and/or	CCONJ
bptjm-49	19	35	therapeutic	therapeutic	ADJ
bptjm-49	19	36	target	target	NOUN
bptjm-49	19	37	in	in	ADP
bptjm-49	19	38	treating	treat	VERB
bptjm-49	19	39	lung	lung	NOUN
bptjm-49	19	40	and	and	CCONJ
bptjm-49	19	41	digestive	digestive	ADJ
bptjm-49	19	42	tract	tract	NOUN
bptjm-49	19	43	cancers	cancer	NOUN
bptjm-49	19	44	.	.	PUNCT
bptjm-49	20	1	therefore	therefore	ADV
bptjm-49	20	2	,	,	PUNCT
bptjm-49	20	3	this	this	DET
bptjm-49	20	4	literature	literature	NOUN
bptjm-49	20	5	review	review	NOUN
bptjm-49	20	6	characterizes	characterize	VERB
bptjm-49	20	7	the	the	DET
bptjm-49	20	8	importance	importance	NOUN
bptjm-49	20	9	of	of	ADP
bptjm-49	20	10	several	several	ADJ
bptjm-49	20	11	ptpns	ptpns	NOUN
bptjm-49	20	12	,	,	PUNCT
bptjm-49	20	13	ptpn	ptpn	PROPN
bptjm-49	20	14	1	1	NUM
bptjm-49	20	15	,	,	PUNCT
bptjm-49	20	16	3	3	NUM
bptjm-49	20	17	,	,	PUNCT
bptjm-49	20	18	6	6	NUM
bptjm-49	20	19	,	,	PUNCT
bptjm-49	20	20	11	11	NUM
bptjm-49	20	21	,	,	PUNCT
bptjm-49	20	22	12	12	NUM
bptjm-49	20	23	,	,	PUNCT
bptjm-49	20	24	13	13	NUM
bptjm-49	20	25	,	,	PUNCT
bptjm-49	20	26	by	by	ADP
bptjm-49	20	27	summarizing	summarize	VERB
bptjm-49	20	28	their	their	PRON
bptjm-49	20	29	roles	role	NOUN
bptjm-49	20	30	as	as	ADP
bptjm-49	20	31	a	a	DET
bptjm-49	20	32	tumor	tumor	NOUN
bptjm-49	20	33	promoter	promoter	NOUN
bptjm-49	20	34	,	,	PUNCT
bptjm-49	20	35	tumor	tumor	NOUN
bptjm-49	20	36	suppressor	suppressor	NOUN
bptjm-49	20	37	or	or	CCONJ
bptjm-49	20	38	both	both	PRON
bptjm-49	20	39	as	as	ADV
bptjm-49	20	40	well	well	ADV
bptjm-49	20	41	as	as	ADP
bptjm-49	20	42	exploring	explore	VERB
bptjm-49	20	43	their	their	PRON
bptjm-49	20	44	molecular	molecular	ADJ
bptjm-49	20	45	mechanisms	mechanism	NOUN
bptjm-49	20	46	in	in	ADP
bptjm-49	20	47	digestive	digestive	ADJ
bptjm-49	20	48	and/or	and/or	CCONJ
bptjm-49	20	49	lung	lung	NOUN
bptjm-49	20	50	cancer	cancer	NOUN
bptjm-49	20	51	[	[	X
bptjm-49	20	52	figure	figure	NOUN
bptjm-49	20	53	1	1	NUM
bptjm-49	20	54	]	]	PUNCT
bptjm-49	20	55	.	.	PUNCT
bptjm-49	21	1	berkeley	berkeley	PROPN
bptjm-49	21	2	pharma	pharma	PROPN
bptjm-49	21	3	tech	tech	PROPN
bptjm-49	21	4	journal	journal	NOUN
bptjm-49	21	5	of	of	ADP
bptjm-49	21	6	medicine	medicine	NOUN
bptjm-49	21	7	|	|	ADV
bptjm-49	21	8	84	84	NUM
bptjm-49	21	9	figure	figure	NOUN
bptjm-49	21	10	1	1	NUM
bptjm-49	21	11	:	:	PUNCT
bptjm-49	21	12	an	an	DET
bptjm-49	21	13	overview	overview	NOUN
bptjm-49	21	14	of	of	ADP
bptjm-49	21	15	the	the	DET
bptjm-49	21	16	role	role	NOUN
bptjm-49	21	17	of	of	ADP
bptjm-49	21	18	each	each	DET
bptjm-49	21	19	ptpn	ptpn	NOUN
bptjm-49	21	20	in	in	ADP
bptjm-49	21	21	lung	lung	NOUN
bptjm-49	21	22	or	or	CCONJ
bptjm-49	21	23	digestive	digestive	ADJ
bptjm-49	21	24	cancer	cancer	NOUN
bptjm-49	21	25	.	.	PUNCT
bptjm-49	22	1	ptpns	ptpns	PROPN
bptjm-49	22	2	marked	mark	VERB
bptjm-49	22	3	in	in	ADP
bptjm-49	22	4	green	green	PROPN
bptjm-49	22	5	have	have	VERB
bptjm-49	22	6	tumor	tumor	NOUN
bptjm-49	22	7	suppressing	suppress	VERB
bptjm-49	22	8	capabilities	capability	NOUN
bptjm-49	22	9	,	,	PUNCT
bptjm-49	22	10	red	red	ADJ
bptjm-49	22	11	as	as	ADP
bptjm-49	22	12	tumor	tumor	NOUN
bptjm-49	22	13	promoting	promoting	NOUN
bptjm-49	22	14	,	,	PUNCT
bptjm-49	22	15	and	and	CCONJ
bptjm-49	22	16	orange	orange	VERB
bptjm-49	22	17	as	as	ADP
bptjm-49	22	18	having	have	VERB
bptjm-49	22	19	both	both	CCONJ
bptjm-49	22	20	tumor	tumor	NOUN
bptjm-49	22	21	suppressing	suppress	VERB
bptjm-49	22	22	and	and	CCONJ
bptjm-49	22	23	promoting	promote	VERB
bptjm-49	22	24	capabilities	capability	NOUN
bptjm-49	22	25	.	.	PUNCT
bptjm-49	23	1	2	2	X
bptjm-49	23	2	.	.	X
bptjm-49	23	3	ptpn1	ptpn1	NOUN
bptjm-49	23	4	ptp1b	ptp1b	PROPN
bptjm-49	23	5	,	,	PUNCT
bptjm-49	23	6	also	also	ADV
bptjm-49	23	7	known	know	VERB
bptjm-49	23	8	as	as	ADP
bptjm-49	23	9	protein	protein	NOUN
bptjm-49	23	10	tyrosine	tyrosine	NOUN
bptjm-49	23	11	phosphatase	phosphatase	NOUN
bptjm-49	23	12	non	non	NOUN
bptjm-49	23	13	-	-	NOUN
bptjm-49	23	14	receptor	receptor	ADJ
bptjm-49	23	15	1b	1b	NUM
bptjm-49	23	16	,	,	PUNCT
bptjm-49	23	17	is	be	AUX
bptjm-49	23	18	encoded	encode	VERB
bptjm-49	23	19	by	by	ADP
bptjm-49	23	20	the	the	DET
bptjm-49	23	21	ptpn1	ptpn1	NOUN
bptjm-49	23	22	gene	gene	NOUN
bptjm-49	23	23	.	.	PUNCT
bptjm-49	24	1	its	its	PRON
bptjm-49	24	2	uncontrolled	uncontrolled	ADJ
bptjm-49	24	3	growth	growth	NOUN
bptjm-49	24	4	is	be	AUX
bptjm-49	24	5	shown	show	VERB
bptjm-49	24	6	to	to	PART
bptjm-49	24	7	be	be	AUX
bptjm-49	24	8	correlated	correlate	VERB
bptjm-49	24	9	with	with	ADP
bptjm-49	24	10	growth	growth	NOUN
bptjm-49	24	11	of	of	ADP
bptjm-49	24	12	digestive	digestive	ADJ
bptjm-49	24	13	cancer	cancer	NOUN
bptjm-49	24	14	,	,	PUNCT
bptjm-49	24	15	demonstrating	demonstrate	VERB
bptjm-49	24	16	ptpn1b	ptpn1b	PROPN
bptjm-49	24	17	’s	’s	PART
bptjm-49	24	18	potential	potential	ADJ
bptjm-49	24	19	oncogenic	oncogenic	ADJ
bptjm-49	24	20	role	role	NOUN
bptjm-49	24	21	in	in	ADP
bptjm-49	24	22	digestive	digestive	NOUN
bptjm-49	24	23	cancer.7	cancer.7	PROPN
bptjm-49	24	24	for	for	ADP
bptjm-49	24	25	crc	crc	NOUN
bptjm-49	24	26	(	(	PUNCT
bptjm-49	24	27	colorectal	colorectal	ADJ
bptjm-49	24	28	cancer	cancer	NOUN
bptjm-49	24	29	)	)	PUNCT
bptjm-49	24	30	,	,	PUNCT
bptjm-49	24	31	ptp1b	ptp1b	PROPN
bptjm-49	24	32	was	be	AUX
bptjm-49	24	33	associated	associate	VERB
bptjm-49	24	34	with	with	ADP
bptjm-49	24	35	crc	crc	NOUN
bptjm-49	24	36	patients	patient	NOUN
bptjm-49	24	37	’	'	PUNCT
bptjm-49	24	38	low	low	ADJ
bptjm-49	24	39	overall	overall	ADJ
bptjm-49	24	40	survival	survival	NOUN
bptjm-49	24	41	;	;	PUNCT
bptjm-49	24	42	additional	additional	ADJ
bptjm-49	24	43	studies	study	NOUN
bptjm-49	24	44	also	also	ADV
bptjm-49	24	45	support	support	VERB
bptjm-49	24	46	the	the	DET
bptjm-49	24	47	relationship	relationship	NOUN
bptjm-49	24	48	of	of	ADP
bptjm-49	24	49	ptp1b	ptp1b	NOUN
bptjm-49	24	50	overexpression	overexpression	NOUN
bptjm-49	24	51	and	and	CCONJ
bptjm-49	24	52	late	late	ADJ
bptjm-49	24	53	stage	stage	NOUN
bptjm-49	24	54	tumors.8	tumors.8	PROPN
bptjm-49	24	55	therefore	therefore	ADV
bptjm-49	24	56	,	,	PUNCT
bptjm-49	24	57	ptp1b	ptp1b	NOUN
bptjm-49	24	58	expression	expression	NOUN
bptjm-49	24	59	level	level	NOUN
bptjm-49	24	60	can	can	AUX
bptjm-49	24	61	be	be	AUX
bptjm-49	24	62	utilized	utilize	VERB
bptjm-49	24	63	as	as	ADP
bptjm-49	24	64	a	a	DET
bptjm-49	24	65	possible	possible	ADJ
bptjm-49	24	66	biomarker	biomarker	NOUN
bptjm-49	24	67	for	for	ADP
bptjm-49	24	68	prognosis	prognosis	NOUN
bptjm-49	24	69	of	of	ADP
bptjm-49	24	70	late	late	ADJ
bptjm-49	24	71	stage	stage	NOUN
bptjm-49	24	72	tumors	tumor	NOUN
bptjm-49	24	73	,	,	PUNCT
bptjm-49	24	74	including	include	VERB
bptjm-49	24	75	crc.9	crc.9	NOUN
bptjm-49	24	76	2.1	2.1	NUM
bptjm-49	24	77	gastric	gastric	ADJ
bptjm-49	24	78	cancer	cancer	NOUN
bptjm-49	24	79	likewise	likewise	ADV
bptjm-49	24	80	,	,	PUNCT
bptjm-49	24	81	according	accord	VERB
bptjm-49	24	82	to	to	ADP
bptjm-49	24	83	the	the	DET
bptjm-49	24	84	rt	rt	PROPN
bptjm-49	24	85	-	-	PUNCT
bptjm-49	24	86	pcr	pcr	NOUN
bptjm-49	24	87	assay	assay	NOUN
bptjm-49	24	88	,	,	PUNCT
bptjm-49	24	89	ptp1b	ptp1b	PROPN
bptjm-49	24	90	was	be	AUX
bptjm-49	24	91	found	find	VERB
bptjm-49	24	92	to	to	PART
bptjm-49	24	93	be	be	AUX
bptjm-49	24	94	overexpressed	overexpresse	VERB
bptjm-49	24	95	in	in	ADP
bptjm-49	24	96	gastric	gastric	ADJ
bptjm-49	24	97	cancer	cancer	NOUN
bptjm-49	24	98	tissues	tissue	NOUN
bptjm-49	24	99	relative	relative	ADJ
bptjm-49	24	100	to	to	ADP
bptjm-49	24	101	normal	normal	ADJ
bptjm-49	24	102	gastric	gastric	ADJ
bptjm-49	24	103	cells	cell	NOUN
bptjm-49	24	104	.	.	PUNCT
bptjm-49	25	1	amplification	amplification	NOUN
bptjm-49	25	2	of	of	ADP
bptjm-49	25	3	ptp1b	ptp1b	PROPN
bptjm-49	25	4	was	be	AUX
bptjm-49	25	5	associated	associate	VERB
bptjm-49	25	6	with	with	ADP
bptjm-49	25	7	poor	poor	ADJ
bptjm-49	25	8	survival	survival	NOUN
bptjm-49	25	9	of	of	ADP
bptjm-49	25	10	gastric	gastric	ADJ
bptjm-49	25	11	cancer	cancer	NOUN
bptjm-49	25	12	patients.9	patients.9	NOUN
bptjm-49	25	13	therefore	therefore	ADV
bptjm-49	25	14	,	,	PUNCT
bptjm-49	25	15	the	the	DET
bptjm-49	25	16	amplification	amplification	NOUN
bptjm-49	25	17	of	of	ADP
bptjm-49	25	18	ptp1b	ptp1b	NOUN
bptjm-49	25	19	can	can	AUX
bptjm-49	25	20	be	be	AUX
bptjm-49	25	21	both	both	PRON
bptjm-49	25	22	used	use	VERB
bptjm-49	25	23	as	as	ADP
bptjm-49	25	24	a	a	DET
bptjm-49	25	25	biomarker	biomarker	NOUN
bptjm-49	25	26	for	for	ADP
bptjm-49	25	27	gastric	gastric	ADJ
bptjm-49	25	28	cancer	cancer	NOUN
bptjm-49	25	29	and	and	CCONJ
bptjm-49	25	30	indicative	indicative	ADJ
bptjm-49	25	31	for	for	ADP
bptjm-49	25	32	poor	poor	ADJ
bptjm-49	25	33	survival	survival	NOUN
bptjm-49	25	34	rate	rate	NOUN
bptjm-49	25	35	,	,	PUNCT
bptjm-49	25	36	revealing	reveal	VERB
bptjm-49	25	37	ptp1b	ptp1b	NOUN
bptjm-49	25	38	’s	’s	PART
bptjm-49	25	39	oncogenic	oncogenic	ADJ
bptjm-49	25	40	role	role	NOUN
bptjm-49	25	41	as	as	ADP
bptjm-49	25	42	a	a	DET
bptjm-49	25	43	tumor	tumor	NOUN
bptjm-49	25	44	promoter	promoter	NOUN
bptjm-49	25	45	in	in	ADP
bptjm-49	25	46	gastric	gastric	ADJ
bptjm-49	25	47	carcinogenesis.10	carcinogenesis.10	NOUN
bptjm-49	25	48	furthermore	furthermore	ADV
bptjm-49	25	49	,	,	PUNCT
bptjm-49	25	50	inhibition	inhibition	NOUN
bptjm-49	25	51	of	of	ADP
bptjm-49	25	52	ptp1b	ptp1b	NOUN
bptjm-49	25	53	in	in	ADP
bptjm-49	25	54	gastric	gastric	ADJ
bptjm-49	25	55	cells	cell	NOUN
bptjm-49	25	56	was	be	AUX
bptjm-49	25	57	associated	associate	VERB
bptjm-49	25	58	with	with	ADP
bptjm-49	25	59	hindrance	hindrance	NOUN
bptjm-49	25	60	of	of	ADP
bptjm-49	25	61	gastric	gastric	ADJ
bptjm-49	25	62	cancer	cancer	NOUN
bptjm-49	25	63	cell	cell	NOUN
bptjm-49	25	64	growth	growth	NOUN
bptjm-49	25	65	in	in	ADP
bptjm-49	25	66	both	both	PRON
bptjm-49	25	67	vitro	vitro	X
bptjm-49	25	68	and	and	CCONJ
bptjm-49	25	69	vivo	vivo	NOUN
bptjm-49	25	70	.	.	PUNCT
bptjm-49	26	1	furthermore	furthermore	ADV
bptjm-49	26	2	,	,	PUNCT
bptjm-49	26	3	its	its	PRON
bptjm-49	26	4	inhibition	inhibition	NOUN
bptjm-49	26	5	changed	change	VERB
bptjm-49	26	6	genome	genome	NOUN
bptjm-49	26	7	-	-	PUNCT
bptjm-49	26	8	wide	wide	ADJ
bptjm-49	26	9	expression	expression	NOUN
bptjm-49	26	10	of	of	ADP
bptjm-49	26	11	genes	gene	NOUN
bptjm-49	26	12	related	relate	VERB
bptjm-49	26	13	to	to	ADP
bptjm-49	26	14	cell	cell	NOUN
bptjm-49	26	15	growth	growth	NOUN
bptjm-49	26	16	;	;	PUNCT
bptjm-49	26	17	thus	thus	ADV
bptjm-49	26	18	,	,	PUNCT
bptjm-49	26	19	ptp1b	ptp1b	NOUN
bptjm-49	26	20	can	can	AUX
bptjm-49	26	21	be	be	AUX
bptjm-49	26	22	directly	directly	ADV
bptjm-49	26	23	used	use	VERB
bptjm-49	26	24	as	as	ADP
bptjm-49	26	25	cancer	cancer	NOUN
bptjm-49	26	26	therapy	therapy	NOUN
bptjm-49	26	27	to	to	PART
bptjm-49	26	28	slow	slow	VERB
bptjm-49	26	29	down	down	ADP
bptjm-49	26	30	digestive	digestive	ADJ
bptjm-49	26	31	cancer	cancer	NOUN
bptjm-49	26	32	growth.11	growth.11	NOUN
bptjm-49	26	33	despite	despite	SCONJ
bptjm-49	26	34	there	there	PRON
bptjm-49	26	35	being	be	AUX
bptjm-49	26	36	evidence	evidence	NOUN
bptjm-49	26	37	of	of	ADP
bptjm-49	26	38	ptp1b	ptp1b	NOUN
bptjm-49	26	39	functioning	function	VERB
bptjm-49	26	40	as	as	ADP
bptjm-49	26	41	a	a	DET
bptjm-49	26	42	tumor	tumor	NOUN
bptjm-49	26	43	promoter	promoter	NOUN
bptjm-49	26	44	,	,	PUNCT
bptjm-49	26	45	contrasting	contrast	VERB
bptjm-49	26	46	ideas	idea	NOUN
bptjm-49	26	47	in	in	ADP
bptjm-49	26	48	the	the	DET
bptjm-49	26	49	literature	literature	NOUN
bptjm-49	26	50	suggest	suggest	VERB
bptjm-49	26	51	it	it	PRON
bptjm-49	26	52	can	can	AUX
bptjm-49	26	53	also	also	ADV
bptjm-49	26	54	function	function	VERB
bptjm-49	26	55	as	as	ADP
bptjm-49	26	56	a	a	DET
bptjm-49	26	57	tumor	tumor	NOUN
bptjm-49	26	58	suppressor	suppressor	NOUN
bptjm-49	26	59	depending	depend	VERB
bptjm-49	26	60	on	on	ADP
bptjm-49	26	61	the	the	DET
bptjm-49	26	62	cellular	cellular	ADJ
bptjm-49	26	63	context.12	context.12	PROPN
bptjm-49	26	64	for	for	ADP
bptjm-49	26	65	example	example	NOUN
bptjm-49	26	66	,	,	PUNCT
bptjm-49	26	67	when	when	SCONJ
bptjm-49	26	68	egf	egf	PROPN
bptjm-49	26	69	(	(	PUNCT
bptjm-49	26	70	epidermal	epidermal	ADJ
bptjm-49	26	71	growth	growth	NOUN
bptjm-49	26	72	factor	factor	NOUN
bptjm-49	26	73	)	)	PUNCT
bptjm-49	26	74	binds	bind	VERB
bptjm-49	26	75	to	to	ADP
bptjm-49	26	76	its	its	PRON
bptjm-49	26	77	receptor	receptor	NOUN
bptjm-49	26	78	egfr	egfr	NOUN
bptjm-49	26	79	,	,	PUNCT
bptjm-49	26	80	it	it	PRON
bptjm-49	26	81	activates	activate	VERB
bptjm-49	26	82	the	the	DET
bptjm-49	26	83	shc	shc	PROPN
bptjm-49	26	84	-	-	PUNCT
bptjm-49	26	85	grb2	grb2	PROPN
bptjm-49	26	86	-	-	PUNCT
bptjm-49	26	87	sos	sos	PROPN
bptjm-49	26	88	interaction	interaction	NOUN
bptjm-49	26	89	.	.	PUNCT
bptjm-49	27	1	at	at	ADP
bptjm-49	27	2	the	the	DET
bptjm-49	27	3	end	end	NOUN
bptjm-49	27	4	of	of	ADP
bptjm-49	27	5	interaction	interaction	NOUN
bptjm-49	27	6	,	,	PUNCT
bptjm-49	27	7	ras	ras	PROPN
bptjm-49	27	8	activates	activate	VERB
bptjm-49	27	9	mek	mek	PROPN
bptjm-49	27	10	/	/	SYM
bptjm-49	27	11	erk	erk	PROPN
bptjm-49	27	12	pathway	pathway	PROPN
bptjm-49	27	13	’s	’s	PART
bptjm-49	27	14	raf	raf	PROPN
bptjm-49	27	15	and	and	CCONJ
bptjm-49	27	16	ends	end	VERB
bptjm-49	27	17	with	with	ADP
bptjm-49	27	18	erk	erk	PROPN
bptjm-49	27	19	berkeley	berkeley	PROPN
bptjm-49	27	20	pharma	pharma	PROPN
bptjm-49	27	21	tech	tech	NOUN
bptjm-49	27	22	journal	journal	NOUN
bptjm-49	27	23	of	of	ADP
bptjm-49	27	24	medicine	medicine	NOUN
bptjm-49	27	25	|	|	ADV
bptjm-49	27	26	85	85	NUM
bptjm-49	27	27	entering	enter	VERB
bptjm-49	27	28	the	the	DET
bptjm-49	27	29	nucleus	nucleus	NOUN
bptjm-49	27	30	to	to	PART
bptjm-49	27	31	activate	activate	VERB
bptjm-49	27	32	fgf2	fgf2	PROPN
bptjm-49	27	33	(	(	PUNCT
bptjm-49	27	34	fibroblast	fibroblast	ADJ
bptjm-49	27	35	growth	growth	NOUN
bptjm-49	27	36	factor	factor	NOUN
bptjm-49	27	37	2	2	NUM
bptjm-49	27	38	)	)	PUNCT
bptjm-49	27	39	which	which	PRON
bptjm-49	27	40	causes	cause	VERB
bptjm-49	27	41	uncontrolled	uncontrolled	ADJ
bptjm-49	27	42	growth	growth	NOUN
bptjm-49	27	43	of	of	ADP
bptjm-49	27	44	the	the	DET
bptjm-49	27	45	cancer.13	cancer.13	NOUN
bptjm-49	27	46	if	if	SCONJ
bptjm-49	27	47	ptp1b	ptp1b	NOUN
bptjm-49	27	48	does	do	AUX
bptjm-49	27	49	not	not	PART
bptjm-49	27	50	interfere	interfere	VERB
bptjm-49	27	51	in	in	ADP
bptjm-49	27	52	the	the	DET
bptjm-49	27	53	process	process	NOUN
bptjm-49	27	54	,	,	PUNCT
bptjm-49	27	55	fgf2	fgf2	PROPN
bptjm-49	27	56	promotes	promote	VERB
bptjm-49	27	57	cancer	cancer	NOUN
bptjm-49	27	58	growth	growth	NOUN
bptjm-49	27	59	.	.	PUNCT
bptjm-49	28	1	however	however	ADV
bptjm-49	28	2	,	,	PUNCT
bptjm-49	28	3	ptp1b	ptp1b	PROPN
bptjm-49	28	4	can	can	AUX
bptjm-49	28	5	inhibit	inhibit	VERB
bptjm-49	28	6	the	the	DET
bptjm-49	28	7	process	process	NOUN
bptjm-49	28	8	by	by	ADP
bptjm-49	28	9	interacting	interact	VERB
bptjm-49	28	10	at	at	ADP
bptjm-49	28	11	the	the	DET
bptjm-49	28	12	beginning	beginning	NOUN
bptjm-49	28	13	or	or	CCONJ
bptjm-49	28	14	end	end	NOUN
bptjm-49	28	15	of	of	ADP
bptjm-49	28	16	the	the	DET
bptjm-49	28	17	shc	shc	PROPN
bptjm-49	28	18	pathway	pathway	NOUN
bptjm-49	28	19	and/or	and/or	CCONJ
bptjm-49	28	20	prohibiting	prohibit	VERB
bptjm-49	28	21	the	the	DET
bptjm-49	28	22	entry	entry	NOUN
bptjm-49	28	23	of	of	ADP
bptjm-49	28	24	erk	erk	PROPN
bptjm-49	28	25	into	into	ADP
bptjm-49	28	26	the	the	DET
bptjm-49	28	27	nucleus	nucleus	PROPN
bptjm-49	28	28	ptp1b	ptp1b	PROPN
bptjm-49	28	29	’s	’s	PART
bptjm-49	28	30	inhibition	inhibition	NOUN
bptjm-49	28	31	of	of	ADP
bptjm-49	28	32	signaling	signal	VERB
bptjm-49	28	33	pathways	pathway	NOUN
bptjm-49	28	34	leads	lead	VERB
bptjm-49	28	35	to	to	PART
bptjm-49	28	36	decrease	decrease	VERB
bptjm-49	28	37	in	in	ADP
bptjm-49	28	38	cancer	cancer	NOUN
bptjm-49	28	39	growth13	growth13	NOUN
bptjm-49	29	1	[	[	X
bptjm-49	29	2	figure	figure	NOUN
bptjm-49	29	3	2	2	NUM
bptjm-49	29	4	]	]	PUNCT
bptjm-49	29	5	.	.	PUNCT
bptjm-49	30	1	figure	figure	NOUN
bptjm-49	30	2	2	2	NUM
bptjm-49	30	3	:	:	PUNCT
bptjm-49	30	4	effect	effect	NOUN
bptjm-49	30	5	of	of	ADP
bptjm-49	30	6	ptp1b	ptp1b	NOUN
bptjm-49	30	7	on	on	ADP
bptjm-49	30	8	the	the	DET
bptjm-49	30	9	pathway	pathway	NOUN
bptjm-49	30	10	of	of	ADP
bptjm-49	30	11	cancer	cancer	NOUN
bptjm-49	30	12	growth	growth	NOUN
bptjm-49	30	13	.	.	PUNCT
bptjm-49	31	1	when	when	SCONJ
bptjm-49	31	2	ptp1b	ptp1b	NOUN
bptjm-49	31	3	prohibits	prohibit	VERB
bptjm-49	31	4	shc	shc	PROPN
bptjm-49	31	5	-	-	PUNCT
bptjm-49	31	6	grb2	grb2	PROPN
bptjm-49	31	7	-	-	PUNCT
bptjm-49	31	8	sos	sos	NOUN
bptjm-49	31	9	interaction	interaction	NOUN
bptjm-49	31	10	,	,	PUNCT
bptjm-49	31	11	the	the	DET
bptjm-49	31	12	growth	growth	NOUN
bptjm-49	31	13	of	of	ADP
bptjm-49	31	14	cancer	cancer	NOUN
bptjm-49	31	15	is	be	AUX
bptjm-49	31	16	prohibited	prohibit	VERB
bptjm-49	31	17	due	due	ADP
bptjm-49	31	18	to	to	ADP
bptjm-49	31	19	a	a	DET
bptjm-49	31	20	decreased	decrease	VERB
bptjm-49	31	21	expression	expression	NOUN
bptjm-49	31	22	of	of	ADP
bptjm-49	31	23	fgf2	fgf2	PROPN
bptjm-49	31	24	.	.	PUNCT
bptjm-49	32	1	oppositely	oppositely	ADV
bptjm-49	32	2	,	,	PUNCT
bptjm-49	32	3	when	when	SCONJ
bptjm-49	32	4	ptp1b	ptp1b	NOUN
bptjm-49	32	5	does	do	AUX
bptjm-49	32	6	not	not	PART
bptjm-49	32	7	stop	stop	VERB
bptjm-49	32	8	the	the	DET
bptjm-49	32	9	pathway	pathway	NOUN
bptjm-49	32	10	,	,	PUNCT
bptjm-49	32	11	the	the	DET
bptjm-49	32	12	cancer	cancer	NOUN
bptjm-49	32	13	cells	cell	NOUN
bptjm-49	32	14	will	will	AUX
bptjm-49	32	15	be	be	AUX
bptjm-49	32	16	able	able	ADJ
bptjm-49	32	17	to	to	PART
bptjm-49	32	18	proliferate	proliferate	VERB
bptjm-49	32	19	and	and	CCONJ
bptjm-49	32	20	duplicate	duplicate	VERB
bptjm-49	32	21	itself	itself	PRON
bptjm-49	32	22	.	.	PUNCT
bptjm-49	33	1	2.2	2.2	NUM
bptjm-49	33	2	non	non	ADJ
bptjm-49	33	3	-	-	ADJ
bptjm-49	33	4	small	small	ADJ
bptjm-49	33	5	cell	cell	NOUN
bptjm-49	33	6	lung	lung	NOUN
bptjm-49	33	7	cancer	cancer	NOUN
bptjm-49	33	8	(	(	PUNCT
bptjm-49	33	9	nsclc	nsclc	NOUN
bptjm-49	33	10	)	)	PUNCT
bptjm-49	33	11	in	in	ADP
bptjm-49	33	12	regards	regard	NOUN
bptjm-49	33	13	to	to	ADP
bptjm-49	33	14	nsclc	nsclc	NOUN
bptjm-49	33	15	,	,	PUNCT
bptjm-49	33	16	ptp1b	ptp1b	NOUN
bptjm-49	33	17	levels	level	NOUN
bptjm-49	33	18	increase	increase	VERB
bptjm-49	33	19	with	with	ADP
bptjm-49	33	20	the	the	DET
bptjm-49	33	21	progression	progression	NOUN
bptjm-49	33	22	of	of	ADP
bptjm-49	33	23	the	the	DET
bptjm-49	33	24	cancer	cancer	NOUN
bptjm-49	33	25	,	,	PUNCT
bptjm-49	33	26	highlighting	highlight	VERB
bptjm-49	33	27	how	how	SCONJ
bptjm-49	33	28	increased	increase	VERB
bptjm-49	33	29	ptp1b	ptp1b	NOUN
bptjm-49	33	30	levels	level	NOUN
bptjm-49	33	31	are	be	AUX
bptjm-49	33	32	associated	associate	VERB
bptjm-49	33	33	with	with	ADP
bptjm-49	33	34	poor	poor	ADJ
bptjm-49	33	35	survival	survival	NOUN
bptjm-49	33	36	of	of	ADP
bptjm-49	33	37	patients	patient	NOUN
bptjm-49	33	38	with	with	ADP
bptjm-49	33	39	nsclc.14	nsclc.14	NOUN
bptjm-49	33	40	additionally	additionally	ADV
bptjm-49	33	41	,	,	PUNCT
bptjm-49	33	42	when	when	SCONJ
bptjm-49	33	43	ptp1b	ptp1b	NOUN
bptjm-49	33	44	expression	expression	NOUN
bptjm-49	33	45	was	be	AUX
bptjm-49	33	46	downregulated	downregulate	VERB
bptjm-49	33	47	,	,	PUNCT
bptjm-49	33	48	berkeley	berkeley	PROPN
bptjm-49	33	49	pharma	pharma	PROPN
bptjm-49	33	50	tech	tech	NOUN
bptjm-49	33	51	journal	journal	NOUN
bptjm-49	33	52	of	of	ADP
bptjm-49	33	53	medicine	medicine	NOUN
bptjm-49	33	54	|	|	ADV
bptjm-49	33	55	86	86	NUM
bptjm-49	33	56	there	there	PRON
bptjm-49	33	57	was	be	VERB
bptjm-49	33	58	a	a	DET
bptjm-49	33	59	decrease	decrease	NOUN
bptjm-49	33	60	in	in	ADP
bptjm-49	33	61	cell	cell	NOUN
bptjm-49	33	62	proliferation	proliferation	NOUN
bptjm-49	33	63	and	and	CCONJ
bptjm-49	33	64	metastasis	metastasis	NOUN
bptjm-49	33	65	in	in	ADP
bptjm-49	33	66	vitro	vitro	VERB
bptjm-49	33	67	.	.	PUNCT
bptjm-49	34	1	likewise	likewise	ADV
bptjm-49	34	2	,	,	PUNCT
bptjm-49	34	3	downregulation	downregulation	NOUN
bptjm-49	34	4	of	of	ADP
bptjm-49	34	5	ptp1b	ptp1b	NOUN
bptjm-49	34	6	in	in	ADP
bptjm-49	34	7	mice	mouse	NOUN
bptjm-49	34	8	transfected	transfecte	VERB
bptjm-49	34	9	with	with	ADP
bptjm-49	34	10	nsclc	nsclc	NOUN
bptjm-49	34	11	cells	cell	NOUN
bptjm-49	34	12	showed	show	VERB
bptjm-49	34	13	a	a	DET
bptjm-49	34	14	significant	significant	ADJ
bptjm-49	34	15	decrease	decrease	NOUN
bptjm-49	34	16	in	in	ADP
bptjm-49	34	17	tumor	tumor	NOUN
bptjm-49	34	18	size	size	NOUN
bptjm-49	34	19	compared	compare	VERB
bptjm-49	34	20	to	to	PART
bptjm-49	34	21	control	control	VERB
bptjm-49	34	22	mice	mouse	NOUN
bptjm-49	34	23	that	that	PRON
bptjm-49	34	24	had	have	VERB
bptjm-49	34	25	unaltered	unaltered	ADJ
bptjm-49	34	26	ptp1b	ptp1b	NOUN
bptjm-49	34	27	levels	level	NOUN
bptjm-49	34	28	.	.	PUNCT
bptjm-49	35	1	these	these	DET
bptjm-49	35	2	results	result	NOUN
bptjm-49	35	3	provide	provide	VERB
bptjm-49	35	4	evidence	evidence	NOUN
bptjm-49	35	5	for	for	ADP
bptjm-49	35	6	ptp1b	ptp1b	NOUN
bptjm-49	35	7	’s	’s	PART
bptjm-49	35	8	role	role	NOUN
bptjm-49	35	9	as	as	ADP
bptjm-49	35	10	a	a	DET
bptjm-49	35	11	tumor	tumor	NOUN
bptjm-49	35	12	promoter	promoter	NOUN
bptjm-49	35	13	in	in	ADP
bptjm-49	35	14	lung	lung	NOUN
bptjm-49	35	15	cancer	cancer	NOUN
bptjm-49	35	16	.	.	PUNCT
bptjm-49	36	1	mechanistically	mechanistically	ADV
bptjm-49	36	2	,	,	PUNCT
bptjm-49	36	3	ptp1b	ptp1b	PROPN
bptjm-49	36	4	activates	activate	VERB
bptjm-49	36	5	the	the	DET
bptjm-49	36	6	oncogene	oncogene	NOUN
bptjm-49	36	7	,	,	PUNCT
bptjm-49	36	8	src	src	NOUN
bptjm-49	36	9	(	(	PUNCT
bptjm-49	36	10	protooncogene	protooncogene	NOUN
bptjm-49	36	11	c	c	NOUN
bptjm-49	36	12	-	-	PUNCT
bptjm-49	36	13	src	src	NOUN
bptjm-49	36	14	)	)	PUNCT
bptjm-49	36	15	,	,	PUNCT
bptjm-49	36	16	which	which	PRON
bptjm-49	36	17	promotes	promote	VERB
bptjm-49	36	18	nsclc	nsclc	NOUN
bptjm-49	36	19	proliferation	proliferation	NOUN
bptjm-49	36	20	and	and	CCONJ
bptjm-49	36	21	metastasis	metastasis	NOUN
bptjm-49	36	22	.	.	PUNCT
bptjm-49	37	1	therefore	therefore	ADV
bptjm-49	37	2	,	,	PUNCT
bptjm-49	37	3	designing	design	VERB
bptjm-49	37	4	an	an	DET
bptjm-49	37	5	inhibitor	inhibitor	NOUN
bptjm-49	37	6	of	of	ADP
bptjm-49	37	7	ptp1b	ptp1b	NOUN
bptjm-49	37	8	could	could	AUX
bptjm-49	37	9	be	be	AUX
bptjm-49	37	10	promising	promise	VERB
bptjm-49	37	11	in	in	ADP
bptjm-49	37	12	treating	treat	VERB
bptjm-49	37	13	nsclc	nsclc	NOUN
bptjm-49	37	14	due	due	ADP
bptjm-49	37	15	to	to	ADP
bptjm-49	37	16	its	its	PRON
bptjm-49	37	17	suggested	suggested	ADJ
bptjm-49	37	18	tumor	tumor	NOUN
bptjm-49	37	19	suppressing	suppress	VERB
bptjm-49	37	20	capabilities.14	capabilities.14	PROPN
bptjm-49	37	21	in	in	ADP
bptjm-49	37	22	lung	lung	NOUN
bptjm-49	37	23	adenocarcinoma	adenocarcinoma	NOUN
bptjm-49	37	24	(	(	PUNCT
bptjm-49	37	25	luad	luad	NOUN
bptjm-49	37	26	)	)	PUNCT
bptjm-49	37	27	,	,	PUNCT
bptjm-49	37	28	ptpn1	ptpn1	NOUN
bptjm-49	37	29	is	be	AUX
bptjm-49	37	30	downregulated	downregulate	VERB
bptjm-49	37	31	according	accord	VERB
bptjm-49	37	32	to	to	ADP
bptjm-49	37	33	comprehensive	comprehensive	ADJ
bptjm-49	37	34	bioinformatics	bioinformatics	NOUN
bptjm-49	37	35	analysis	analysis	NOUN
bptjm-49	37	36	.	.	PUNCT
bptjm-49	38	1	its	its	PRON
bptjm-49	38	2	upregulation	upregulation	NOUN
bptjm-49	38	3	has	have	AUX
bptjm-49	38	4	been	be	AUX
bptjm-49	38	5	conferred	confer	VERB
bptjm-49	38	6	with	with	ADP
bptjm-49	38	7	overall	overall	ADJ
bptjm-49	38	8	higher	high	ADJ
bptjm-49	38	9	survival	survival	NOUN
bptjm-49	38	10	rates	rate	NOUN
bptjm-49	38	11	in	in	ADP
bptjm-49	38	12	patients	patient	NOUN
bptjm-49	38	13	,	,	PUNCT
bptjm-49	38	14	demonstrating	demonstrate	VERB
bptjm-49	38	15	the	the	DET
bptjm-49	38	16	overexpression	overexpression	NOUN
bptjm-49	38	17	of	of	ADP
bptjm-49	38	18	ptpn1	ptpn1	NOUN
bptjm-49	38	19	as	as	ADP
bptjm-49	38	20	a	a	DET
bptjm-49	38	21	potential	potential	ADJ
bptjm-49	38	22	therapeutic	therapeutic	ADJ
bptjm-49	38	23	target	target	NOUN
bptjm-49	38	24	for	for	ADP
bptjm-49	38	25	treating	treat	VERB
bptjm-49	38	26	luad	luad	ADJ
bptjm-49	38	27	patients	patient	NOUN
bptjm-49	38	28	.	.	PUNCT
bptjm-49	39	1	as	as	ADV
bptjm-49	39	2	well	well	ADV
bptjm-49	39	3	,	,	PUNCT
bptjm-49	39	4	decreased	decrease	VERB
bptjm-49	39	5	expression	expression	NOUN
bptjm-49	39	6	can	can	AUX
bptjm-49	39	7	be	be	AUX
bptjm-49	39	8	a	a	DET
bptjm-49	39	9	prognostic	prognostic	ADJ
bptjm-49	39	10	biomarker	biomarker	NOUN
bptjm-49	39	11	for	for	ADP
bptjm-49	39	12	lung	lung	NOUN
bptjm-49	39	13	cancer	cancer	NOUN
bptjm-49	39	14	progression.15	progression.15	NOUN
bptjm-49	39	15	3	3	NUM
bptjm-49	39	16	.	.	PUNCT
bptjm-49	39	17	ptpn2	ptpn2	VERB
bptjm-49	39	18	in	in	ADP
bptjm-49	39	19	crc	crc	NOUN
bptjm-49	39	20	tumor	tumor	NOUN
bptjm-49	39	21	cells	cell	NOUN
bptjm-49	39	22	,	,	PUNCT
bptjm-49	39	23	ptpn2	ptpn2	VERB
bptjm-49	39	24	levels	level	NOUN
bptjm-49	39	25	are	be	AUX
bptjm-49	39	26	enhanced	enhance	VERB
bptjm-49	39	27	,	,	PUNCT
bptjm-49	39	28	with	with	ADP
bptjm-49	39	29	greater	great	ADJ
bptjm-49	39	30	ptpn2	ptpn2	VERB
bptjm-49	39	31	gene	gene	NOUN
bptjm-49	39	32	expression	expression	NOUN
bptjm-49	39	33	correlated	correlate	VERB
bptjm-49	39	34	with	with	ADP
bptjm-49	39	35	reduced	reduce	VERB
bptjm-49	39	36	t	t	NOUN
bptjm-49	39	37	cell	cell	NOUN
bptjm-49	39	38	activity	activity	NOUN
bptjm-49	39	39	,	,	PUNCT
bptjm-49	39	40	recruitment	recruitment	NOUN
bptjm-49	39	41	,	,	PUNCT
bptjm-49	39	42	and	and	CCONJ
bptjm-49	39	43	cytotoxicity.16	cytotoxicity.16	NOUN
bptjm-49	39	44	it	it	PRON
bptjm-49	39	45	is	be	AUX
bptjm-49	39	46	also	also	ADV
bptjm-49	39	47	inversely	inversely	ADV
bptjm-49	39	48	correlated	correlate	VERB
bptjm-49	39	49	with	with	ADP
bptjm-49	39	50	low	low	ADJ
bptjm-49	39	51	immune	immune	ADJ
bptjm-49	39	52	checkpoint	checkpoint	NOUN
bptjm-49	39	53	molecule	molecule	NOUN
bptjm-49	39	54	expression.16	expression.16	PROPN
bptjm-49	39	55	ptpn2	ptpn2	VERB
bptjm-49	39	56	negatively	negatively	ADV
bptjm-49	39	57	regulates	regulate	VERB
bptjm-49	39	58	ifn	ifn	PROPN
bptjm-49	39	59	-	-	PUNCT
bptjm-49	39	60	γ	γ	NOUN
bptjm-49	39	61	signaling	signal	VERB
bptjm-49	39	62	,	,	PUNCT
bptjm-49	39	63	a	a	DET
bptjm-49	39	64	pathway	pathway	NOUN
bptjm-49	39	65	involved	involve	VERB
bptjm-49	39	66	in	in	ADP
bptjm-49	39	67	the	the	DET
bptjm-49	39	68	upregulation	upregulation	NOUN
bptjm-49	39	69	of	of	ADP
bptjm-49	39	70	immunity	immunity	NOUN
bptjm-49	39	71	related	relate	VERB
bptjm-49	39	72	genes	gene	NOUN
bptjm-49	39	73	,	,	PUNCT
bptjm-49	39	74	by	by	ADP
bptjm-49	39	75	dephosphorylating	dephosphorylate	VERB
bptjm-49	39	76	proteins	protein	NOUN
bptjm-49	39	77	involved	involve	VERB
bptjm-49	39	78	in	in	ADP
bptjm-49	39	79	the	the	DET
bptjm-49	39	80	signaling	signal	VERB
bptjm-49	39	81	pathway	pathway	NOUN
bptjm-49	39	82	.	.	PUNCT
bptjm-49	40	1	mouse	mouse	NOUN
bptjm-49	40	2	models	model	NOUN
bptjm-49	40	3	with	with	ADP
bptjm-49	40	4	tumors	tumor	NOUN
bptjm-49	40	5	deficient	deficient	ADJ
bptjm-49	40	6	in	in	ADP
bptjm-49	40	7	ptpn2	ptpn2	PROPN
bptjm-49	40	8	had	have	VERB
bptjm-49	40	9	increased	increase	VERB
bptjm-49	40	10	activation	activation	NOUN
bptjm-49	40	11	of	of	ADP
bptjm-49	40	12	the	the	DET
bptjm-49	40	13	ifn	ifn	PROPN
bptjm-49	40	14	-	-	PUNCT
bptjm-49	40	15	γ	γ	NOUN
bptjm-49	40	16	receptors	receptor	NOUN
bptjm-49	40	17	by	by	ADP
bptjm-49	40	18	the	the	DET
bptjm-49	40	19	cytokine	cytokine	NOUN
bptjm-49	40	20	,	,	PUNCT
bptjm-49	40	21	ifnγ	ifnγ	NOUN
bptjm-49	40	22	,	,	PUNCT
bptjm-49	40	23	which	which	PRON
bptjm-49	40	24	resulted	result	VERB
bptjm-49	40	25	in	in	ADP
bptjm-49	40	26	the	the	DET
bptjm-49	40	27	phosphorylation	phosphorylation	NOUN
bptjm-49	40	28	of	of	ADP
bptjm-49	40	29	the	the	DET
bptjm-49	40	30	signal	signal	ADJ
bptjm-49	40	31	transducer	transducer	NOUN
bptjm-49	40	32	and	and	CCONJ
bptjm-49	40	33	transcription	transcription	NOUN
bptjm-49	40	34	protein	protein	NOUN
bptjm-49	40	35	,	,	PUNCT
bptjm-49	40	36	stat1	stat1	X
bptjm-49	41	1	[	[	X
bptjm-49	41	2	figure	figure	NOUN
bptjm-49	41	3	3	3	NUM
bptjm-49	41	4	]	]	PUNCT
bptjm-49	41	5	.	.	PUNCT
bptjm-49	42	1	stat1	stat1	PROPN
bptjm-49	42	2	is	be	AUX
bptjm-49	42	3	able	able	ADJ
bptjm-49	42	4	to	to	PART
bptjm-49	42	5	homodimerize	homodimerize	VERB
bptjm-49	42	6	and	and	CCONJ
bptjm-49	42	7	enter	enter	VERB
bptjm-49	42	8	the	the	DET
bptjm-49	42	9	nucleus	nucleus	NOUN
bptjm-49	42	10	to	to	PART
bptjm-49	42	11	drive	drive	VERB
bptjm-49	42	12	transcription	transcription	NOUN
bptjm-49	42	13	of	of	ADP
bptjm-49	42	14	genes	gene	NOUN
bptjm-49	42	15	involved	involve	VERB
bptjm-49	42	16	in	in	ADP
bptjm-49	42	17	immunity	immunity	NOUN
bptjm-49	42	18	related	relate	VERB
bptjm-49	42	19	processes	process	NOUN
bptjm-49	42	20	such	such	ADJ
bptjm-49	42	21	as	as	ADP
bptjm-49	42	22	mhc-1	mhc-1	NOUN
bptjm-49	42	23	,	,	PUNCT
bptjm-49	42	24	possibly	possibly	ADV
bptjm-49	42	25	pd-1	pd-1	ADV
bptjm-49	42	26	,	,	PUNCT
bptjm-49	42	27	and	and	CCONJ
bptjm-49	42	28	others	other	NOUN
bptjm-49	43	1	[	[	PUNCT
bptjm-49	43	2	16	16	NUM
bptjm-49	43	3	-	-	SYM
bptjm-49	43	4	8	8	NUM
bptjm-49	43	5	]	]	PUNCT
bptjm-49	43	6	.	.	PUNCT
bptjm-49	44	1	this	this	DET
bptjm-49	44	2	results	result	VERB
bptjm-49	44	3	in	in	ADP
bptjm-49	44	4	the	the	DET
bptjm-49	44	5	activation	activation	NOUN
bptjm-49	44	6	of	of	ADP
bptjm-49	44	7	cd4	cd4	PROPN
bptjm-49	44	8	+	+	PROPN
bptjm-49	44	9	th1	th1	NOUN
bptjm-49	44	10	cells	cell	NOUN
bptjm-49	44	11	and	and	CCONJ
bptjm-49	44	12	increases	increase	VERB
bptjm-49	44	13	the	the	DET
bptjm-49	44	14	cytotoxicity	cytotoxicity	NOUN
bptjm-49	44	15	of	of	ADP
bptjm-49	44	16	cd8	cd8	PROPN
bptjm-49	44	17	+	+	PROPN
bptjm-49	44	18	t	t	NOUN
bptjm-49	44	19	cells	cell	NOUN
bptjm-49	44	20	,	,	PUNCT
bptjm-49	44	21	which	which	PRON
bptjm-49	44	22	inhibits	inhibit	VERB
bptjm-49	44	23	the	the	DET
bptjm-49	44	24	growth	growth	NOUN
bptjm-49	44	25	of	of	ADP
bptjm-49	44	26	the	the	DET
bptjm-49	44	27	tumor.16	tumor.16	PROPN
bptjm-49	44	28	cd4	cd4	PROPN
bptjm-49	44	29	+	+	PROPN
bptjm-49	44	30	th1	th1	NOUN
bptjm-49	44	31	cells	cell	NOUN
bptjm-49	44	32	is	be	AUX
bptjm-49	44	33	a	a	DET
bptjm-49	44	34	type	type	NOUN
bptjm-49	44	35	of	of	ADP
bptjm-49	44	36	t	t	PROPN
bptjm-49	44	37	helper	helper	NOUN
bptjm-49	44	38	cell	cell	NOUN
bptjm-49	44	39	that	that	PRON
bptjm-49	44	40	releases	release	VERB
bptjm-49	44	41	cytokines	cytokine	NOUN
bptjm-49	44	42	in	in	ADP
bptjm-49	44	43	response	response	NOUN
bptjm-49	44	44	to	to	ADP
bptjm-49	44	45	inflammation	inflammation	NOUN
bptjm-49	44	46	and	and	CCONJ
bptjm-49	44	47	is	be	AUX
bptjm-49	44	48	also	also	ADV
bptjm-49	44	49	involved	involve	VERB
bptjm-49	44	50	in	in	ADP
bptjm-49	44	51	the	the	DET
bptjm-49	44	52	activation	activation	NOUN
bptjm-49	44	53	and	and	CCONJ
bptjm-49	44	54	growth	growth	NOUN
bptjm-49	44	55	of	of	ADP
bptjm-49	44	56	cd8	cd8	PROPN
bptjm-49	44	57	+	+	PROPN
bptjm-49	44	58	t	t	NOUN
bptjm-49	44	59	cells	cell	NOUN
bptjm-49	44	60	,	,	PUNCT
bptjm-49	44	61	otherwise	otherwise	ADV
bptjm-49	44	62	known	know	VERB
bptjm-49	44	63	as	as	ADP
bptjm-49	44	64	killer	killer	PROPN
bptjm-49	44	65	t	t	PROPN
bptjm-49	44	66	-	-	PUNCT
bptjm-49	44	67	cells	cell	NOUN
bptjm-49	44	68	.	.	PUNCT
bptjm-49	45	1	therefore	therefore	ADV
bptjm-49	45	2	,	,	PUNCT
bptjm-49	45	3	tumors	tumor	NOUN
bptjm-49	45	4	deficient	deficient	ADJ
bptjm-49	45	5	in	in	ADP
bptjm-49	45	6	ptpn2	ptpn2	PROPN
bptjm-49	45	7	have	have	AUX
bptjm-49	45	8	increased	increase	VERB
bptjm-49	45	9	ifn	ifn	PROPN
bptjm-49	45	10	-	-	PUNCT
bptjm-49	45	11	γ	γ	NOUN
bptjm-49	45	12	signaling	signal	VERB
bptjm-49	45	13	,	,	PUNCT
bptjm-49	45	14	which	which	PRON
bptjm-49	45	15	results	result	VERB
bptjm-49	45	16	in	in	ADP
bptjm-49	45	17	a	a	DET
bptjm-49	45	18	significant	significant	ADJ
bptjm-49	45	19	reduction	reduction	NOUN
bptjm-49	45	20	of	of	ADP
bptjm-49	45	21	tumor	tumor	NOUN
bptjm-49	45	22	size	size	NOUN
bptjm-49	45	23	as	as	ADV
bptjm-49	45	24	well	well	ADV
bptjm-49	45	25	as	as	ADP
bptjm-49	45	26	greater	great	ADJ
bptjm-49	45	27	mrna	mrna	NOUN
bptjm-49	45	28	expression	expression	NOUN
bptjm-49	45	29	of	of	ADP
bptjm-49	45	30	chemokines	chemokine	NOUN
bptjm-49	45	31	,	,	PUNCT
bptjm-49	45	32	like	like	ADP
bptjm-49	45	33	cxcl9/10/11	cxcl9/10/11	NOUN
bptjm-49	45	34	and	and	CCONJ
bptjm-49	45	35	ccl5.16	ccl5.16	PROPN
bptjm-49	45	36	this	this	PRON
bptjm-49	45	37	suggests	suggest	VERB
bptjm-49	45	38	that	that	SCONJ
bptjm-49	45	39	the	the	DET
bptjm-49	45	40	inhibition	inhibition	NOUN
bptjm-49	45	41	of	of	ADP
bptjm-49	45	42	ptpn2	ptpn2	VERB
bptjm-49	45	43	through	through	ADP
bptjm-49	45	44	a	a	DET
bptjm-49	45	45	small	small	ADJ
bptjm-49	45	46	molecule	molecule	NOUN
bptjm-49	45	47	might	might	AUX
bptjm-49	45	48	prove	prove	VERB
bptjm-49	45	49	to	to	PART
bptjm-49	45	50	be	be	AUX
bptjm-49	45	51	an	an	DET
bptjm-49	45	52	effective	effective	ADJ
bptjm-49	45	53	potential	potential	ADJ
bptjm-49	45	54	therapeutic	therapeutic	ADJ
bptjm-49	45	55	drug	drug	NOUN
bptjm-49	45	56	.	.	PUNCT
bptjm-49	46	1	while	while	SCONJ
bptjm-49	46	2	additional	additional	ADJ
bptjm-49	46	3	experimentation	experimentation	NOUN
bptjm-49	46	4	would	would	AUX
bptjm-49	46	5	need	need	VERB
bptjm-49	46	6	to	to	PART
bptjm-49	46	7	be	be	AUX
bptjm-49	46	8	conducted	conduct	VERB
bptjm-49	46	9	to	to	PART
bptjm-49	46	10	better	well	ADV
bptjm-49	46	11	understand	understand	VERB
bptjm-49	46	12	the	the	DET
bptjm-49	46	13	kinetics	kinetic	NOUN
bptjm-49	46	14	involved	involve	VERB
bptjm-49	46	15	with	with	ADP
bptjm-49	46	16	the	the	DET
bptjm-49	46	17	inhibitors	inhibitor	NOUN
bptjm-49	46	18	,	,	PUNCT
bptjm-49	46	19	a	a	DET
bptjm-49	46	20	recent	recent	ADJ
bptjm-49	46	21	paper	paper	NOUN
bptjm-49	46	22	by	by	ADP
bptjm-49	46	23	zhu	zhu	PROPN
bptjm-49	46	24	et	et	PROPN
bptjm-49	46	25	al.19	al.19	PROPN
bptjm-49	46	26	has	have	AUX
bptjm-49	46	27	identified	identify	VERB
bptjm-49	46	28	various	various	ADJ
bptjm-49	46	29	small	small	ADJ
bptjm-49	46	30	noncytotoxic	noncytotoxic	ADV
bptjm-49	46	31	molecule	molecule	ADJ
bptjm-49	46	32	inhibitors	inhibitor	NOUN
bptjm-49	46	33	that	that	PRON
bptjm-49	46	34	were	be	AUX
bptjm-49	46	35	able	able	ADJ
bptjm-49	46	36	to	to	PART
bptjm-49	46	37	inhibit	inhibit	VERB
bptjm-49	46	38	ptpn2	ptpn2	VERB
bptjm-49	46	39	.	.	PUNCT
bptjm-49	47	1	this	this	PRON
bptjm-49	47	2	resulted	result	VERB
bptjm-49	47	3	in	in	ADP
bptjm-49	47	4	successful	successful	ADJ
bptjm-49	47	5	upregulation	upregulation	NOUN
bptjm-49	47	6	berkeley	berkeley	PROPN
bptjm-49	47	7	pharma	pharma	PROPN
bptjm-49	47	8	tech	tech	NOUN
bptjm-49	47	9	journal	journal	NOUN
bptjm-49	47	10	of	of	ADP
bptjm-49	47	11	medicine	medicine	NOUN
bptjm-49	47	12	|	|	ADV
bptjm-49	47	13	87	87	NUM
bptjm-49	47	14	of	of	ADP
bptjm-49	47	15	genes	gene	NOUN
bptjm-49	47	16	involved	involve	VERB
bptjm-49	47	17	in	in	ADP
bptjm-49	47	18	ifn	ifn	PROPN
bptjm-49	47	19	-	-	PUNCT
bptjm-49	47	20	γ	γ	NOUN
bptjm-49	47	21	signaling	signal	VERB
bptjm-49	47	22	,	,	PUNCT
bptjm-49	47	23	and	and	CCONJ
bptjm-49	47	24	the	the	DET
bptjm-49	47	25	sensitization	sensitization	NOUN
bptjm-49	47	26	of	of	ADP
bptjm-49	47	27	the	the	DET
bptjm-49	47	28	crc	crc	NOUN
bptjm-49	47	29	tumor	tumor	NOUN
bptjm-49	47	30	to	to	ADP
bptjm-49	47	31	treatment	treatment	NOUN
bptjm-49	47	32	.	.	PUNCT
bptjm-49	48	1	3.1	3.1	NUM
bptjm-49	48	2	kras	kra	NOUN
bptjm-49	48	3	gene	gene	NOUN
bptjm-49	48	4	approximately	approximately	ADV
bptjm-49	48	5	40	40	NUM
bptjm-49	48	6	%	%	NOUN
bptjm-49	48	7	of	of	ADP
bptjm-49	48	8	patients	patient	NOUN
bptjm-49	48	9	with	with	ADP
bptjm-49	48	10	crc	crc	NOUN
bptjm-49	48	11	have	have	VERB
bptjm-49	48	12	a	a	DET
bptjm-49	48	13	missense	missense	NOUN
bptjm-49	48	14	mutation	mutation	NOUN
bptjm-49	48	15	in	in	ADP
bptjm-49	48	16	the	the	DET
bptjm-49	48	17	kras	kra	NOUN
bptjm-49	48	18	(	(	PUNCT
bptjm-49	48	19	kirsten	kirsten	ADJ
bptjm-49	48	20	rat	rat	NOUN
bptjm-49	48	21	sarcoma	sarcoma	NOUN
bptjm-49	48	22	viral	viral	ADJ
bptjm-49	48	23	oncogene	oncogene	NOUN
bptjm-49	48	24	homologue	homologue	NOUN
bptjm-49	48	25	)	)	PUNCT
bptjm-49	49	1	gene.20	gene.20	NOUN
bptjm-49	49	2	those	those	PRON
bptjm-49	49	3	with	with	ADP
bptjm-49	49	4	the	the	DET
bptjm-49	49	5	mutation	mutation	NOUN
bptjm-49	49	6	in	in	ADP
bptjm-49	49	7	the	the	DET
bptjm-49	49	8	kras	kras	PROPN
bptjm-49	49	9	gene	gene	NOUN
bptjm-49	49	10	tend	tend	VERB
bptjm-49	49	11	to	to	PART
bptjm-49	49	12	have	have	VERB
bptjm-49	49	13	a	a	DET
bptjm-49	49	14	relatively	relatively	ADV
bptjm-49	49	15	poorer	poor	ADJ
bptjm-49	49	16	prognosis	prognosis	NOUN
bptjm-49	49	17	compared	compare	VERB
bptjm-49	49	18	to	to	ADP
bptjm-49	49	19	crc	crc	NOUN
bptjm-49	49	20	patients	patient	NOUN
bptjm-49	49	21	with	with	ADP
bptjm-49	49	22	wild	wild	ADJ
bptjm-49	49	23	type	type	NOUN
bptjm-49	49	24	kras.20	kras.20	PROPN
bptjm-49	49	25	kras	kras	PROPN
bptjm-49	49	26	encodes	encodes	PROPN
bptjm-49	49	27	for	for	ADP
bptjm-49	49	28	the	the	DET
bptjm-49	49	29	protein	protein	NOUN
bptjm-49	49	30	k	k	NOUN
bptjm-49	49	31	-	-	PUNCT
bptjm-49	49	32	ras	ras	NOUN
bptjm-49	49	33	,	,	PUNCT
bptjm-49	49	34	which	which	PRON
bptjm-49	49	35	is	be	AUX
bptjm-49	49	36	part	part	NOUN
bptjm-49	49	37	of	of	ADP
bptjm-49	49	38	the	the	DET
bptjm-49	49	39	signaling	signal	VERB
bptjm-49	49	40	pathway	pathway	NOUN
bptjm-49	49	41	of	of	ADP
bptjm-49	49	42	ras	ras	PROPN
bptjm-49	49	43	/	/	SYM
bptjm-49	49	44	mapk	mapk	NOUN
bptjm-49	49	45	,	,	PUNCT
bptjm-49	49	46	a	a	DET
bptjm-49	49	47	pathway	pathway	NOUN
bptjm-49	49	48	that	that	PRON
bptjm-49	49	49	induces	induce	VERB
bptjm-49	49	50	cellular	cellular	ADJ
bptjm-49	49	51	proliferation	proliferation	NOUN
bptjm-49	49	52	,	,	PUNCT
bptjm-49	49	53	migration	migration	NOUN
bptjm-49	49	54	,	,	PUNCT
bptjm-49	49	55	and	and	CCONJ
bptjm-49	49	56	cell	cell	NOUN
bptjm-49	49	57	growth	growth	NOUN
bptjm-49	49	58	.	.	PUNCT
bptjm-49	50	1	mutations	mutation	NOUN
bptjm-49	50	2	in	in	ADP
bptjm-49	50	3	kras	kra	NOUN
bptjm-49	50	4	are	be	AUX
bptjm-49	50	5	thought	think	VERB
bptjm-49	50	6	to	to	PART
bptjm-49	50	7	be	be	AUX
bptjm-49	50	8	the	the	DET
bptjm-49	50	9	most	most	ADV
bptjm-49	50	10	common	common	ADJ
bptjm-49	50	11	oncogenic	oncogenic	ADJ
bptjm-49	50	12	gene	gene	NOUN
bptjm-49	50	13	driver	driver	NOUN
bptjm-49	50	14	in	in	ADP
bptjm-49	50	15	human	human	ADJ
bptjm-49	50	16	cancer	cancer	NOUN
bptjm-49	50	17	,	,	PUNCT
bptjm-49	50	18	especially	especially	ADV
bptjm-49	50	19	in	in	ADP
bptjm-49	50	20	pancreatic	pancreatic	ADJ
bptjm-49	50	21	cancer	cancer	NOUN
bptjm-49	50	22	,	,	PUNCT
bptjm-49	50	23	crc	crc	NOUN
bptjm-49	50	24	,	,	PUNCT
bptjm-49	50	25	and	and	CCONJ
bptjm-49	50	26	nsclc.21	nsclc.21	NOUN
bptjm-49	50	27	these	these	DET
bptjm-49	50	28	mutations	mutation	NOUN
bptjm-49	50	29	lead	lead	VERB
bptjm-49	50	30	to	to	ADP
bptjm-49	50	31	a	a	DET
bptjm-49	50	32	continued	continue	VERB
bptjm-49	50	33	active	active	ADJ
bptjm-49	50	34	state	state	NOUN
bptjm-49	50	35	of	of	ADP
bptjm-49	50	36	kras	kra	NOUN
bptjm-49	50	37	that	that	PRON
bptjm-49	50	38	result	result	VERB
bptjm-49	50	39	in	in	ADP
bptjm-49	50	40	continuous	continuous	ADJ
bptjm-49	50	41	proliferation	proliferation	NOUN
bptjm-49	50	42	of	of	ADP
bptjm-49	50	43	tumor	tumor	NOUN
bptjm-49	50	44	cells	cell	NOUN
bptjm-49	50	45	by	by	ADP
bptjm-49	50	46	upregulating	upregulate	VERB
bptjm-49	50	47	the	the	DET
bptjm-49	50	48	ras	ras	PROPN
bptjm-49	50	49	/	/	SYM
bptjm-49	50	50	mapk	mapk	NOUN
bptjm-49	50	51	pathway	pathway	NOUN
bptjm-49	50	52	.	.	PUNCT
bptjm-49	51	1	ptpn2	ptpn2	VERB
bptjm-49	51	2	has	have	AUX
bptjm-49	51	3	been	be	AUX
bptjm-49	51	4	identified	identify	VERB
bptjm-49	51	5	as	as	ADP
bptjm-49	51	6	a	a	DET
bptjm-49	51	7	key	key	ADJ
bptjm-49	51	8	regulator	regulator	NOUN
bptjm-49	51	9	of	of	ADP
bptjm-49	51	10	kras	kras	PROPN
bptjm-49	51	11	due	due	ADP
bptjm-49	51	12	to	to	ADP
bptjm-49	51	13	its	its	PRON
bptjm-49	51	14	ability	ability	NOUN
bptjm-49	51	15	to	to	PART
bptjm-49	51	16	dephosphorylate	dephosphorylate	VERB
bptjm-49	51	17	kras	kras	PROPN
bptjm-49	51	18	,	,	PUNCT
bptjm-49	51	19	activating	activate	VERB
bptjm-49	51	20	the	the	DET
bptjm-49	51	21	kras	kra	NOUN
bptjm-49	51	22	-	-	PUNCT
bptjm-49	51	23	mediated	mediate	VERB
bptjm-49	51	24	mapk	mapk	NOUN
bptjm-49	51	25	pathway.22	pathway.22	NOUN
bptjm-49	51	26	therefore	therefore	ADV
bptjm-49	51	27	,	,	PUNCT
bptjm-49	51	28	it	it	PRON
bptjm-49	51	29	is	be	AUX
bptjm-49	51	30	hypothesized	hypothesize	VERB
bptjm-49	51	31	that	that	SCONJ
bptjm-49	51	32	inhibition	inhibition	NOUN
bptjm-49	51	33	of	of	ADP
bptjm-49	51	34	ptpn2	ptpn2	VERB
bptjm-49	51	35	could	could	AUX
bptjm-49	51	36	suppress	suppress	VERB
bptjm-49	51	37	cancer	cancer	NOUN
bptjm-49	51	38	by	by	ADP
bptjm-49	51	39	no	no	ADV
bptjm-49	51	40	longer	long	ADV
bptjm-49	51	41	activating	activate	VERB
bptjm-49	51	42	kras	kra	NOUN
bptjm-49	51	43	,	,	PUNCT
bptjm-49	51	44	presenting	present	VERB
bptjm-49	51	45	itself	itself	PRON
bptjm-49	51	46	to	to	PART
bptjm-49	51	47	be	be	AUX
bptjm-49	51	48	a	a	DET
bptjm-49	51	49	novel	novel	ADJ
bptjm-49	51	50	therapeutic	therapeutic	ADJ
bptjm-49	51	51	target.22	target.22	NOUN
bptjm-49	51	52	figure	figure	NOUN
bptjm-49	51	53	3	3	NUM
bptjm-49	51	54	:	:	PUNCT
bptjm-49	51	55	ifn	ifn	PROPN
bptjm-49	51	56	-	-	PUNCT
bptjm-49	51	57	γ	γ	NOUN
bptjm-49	51	58	signaling	signal	VERB
bptjm-49	51	59	pathway	pathway	NOUN
bptjm-49	51	60	in	in	ADP
bptjm-49	51	61	ptpn2	ptpn2	VERB
bptjm-49	51	62	deficient	deficient	ADJ
bptjm-49	51	63	tumor	tumor	NOUN
bptjm-49	51	64	cell	cell	NOUN
bptjm-49	51	65	.	.	PUNCT
bptjm-49	52	1	stat1	stat1	PROPN
bptjm-49	52	2	remains	remain	VERB
bptjm-49	52	3	phosphorylated	phosphorylate	VERB
bptjm-49	52	4	and	and	CCONJ
bptjm-49	52	5	homodimerizes	homodimerize	NOUN
bptjm-49	52	6	in	in	ADP
bptjm-49	52	7	order	order	NOUN
bptjm-49	52	8	to	to	PART
bptjm-49	52	9	enter	enter	VERB
bptjm-49	52	10	the	the	DET
bptjm-49	52	11	nucleus	nucleus	NOUN
bptjm-49	52	12	and	and	CCONJ
bptjm-49	52	13	induce	induce	VERB
bptjm-49	52	14	the	the	DET
bptjm-49	52	15	transcription	transcription	NOUN
bptjm-49	52	16	of	of	ADP
bptjm-49	52	17	immune	immune	ADJ
bptjm-49	52	18	related	relate	VERB
bptjm-49	52	19	genes	gene	NOUN
bptjm-49	52	20	.	.	PUNCT
bptjm-49	53	1	this	this	PRON
bptjm-49	53	2	ultimately	ultimately	ADV
bptjm-49	53	3	leads	lead	VERB
bptjm-49	53	4	to	to	ADP
bptjm-49	53	5	an	an	DET
bptjm-49	53	6	increase	increase	NOUN
bptjm-49	53	7	in	in	ADP
bptjm-49	53	8	chemokines	chemokine	NOUN
bptjm-49	53	9	as	as	ADV
bptjm-49	53	10	well	well	ADV
bptjm-49	53	11	as	as	ADP
bptjm-49	53	12	cd8	cd8	PROPN
bptjm-49	53	13	+	+	NOUN
bptjm-49	53	14	cells	cell	NOUN
bptjm-49	53	15	that	that	PRON
bptjm-49	53	16	reduce	reduce	VERB
bptjm-49	53	17	the	the	DET
bptjm-49	53	18	size	size	NOUN
bptjm-49	53	19	of	of	ADP
bptjm-49	53	20	the	the	DET
bptjm-49	53	21	tumor	tumor	NOUN
bptjm-49	53	22	.	.	PUNCT
bptjm-49	54	1	berkeley	berkeley	PROPN
bptjm-49	54	2	pharma	pharma	PROPN
bptjm-49	54	3	tech	tech	PROPN
bptjm-49	54	4	journal	journal	NOUN
bptjm-49	54	5	of	of	ADP
bptjm-49	54	6	medicine	medicine	NOUN
bptjm-49	54	7	|	|	ADV
bptjm-49	54	8	88	88	NUM
bptjm-49	54	9	4	4	NUM
bptjm-49	54	10	.	.	PUNCT
bptjm-49	54	11	ptpn3	ptpn3	PROPN
bptjm-49	54	12	nonsense	nonsense	NOUN
bptjm-49	54	13	and	and	CCONJ
bptjm-49	54	14	frameshift	frameshift	ADJ
bptjm-49	54	15	mutations	mutation	NOUN
bptjm-49	54	16	in	in	ADP
bptjm-49	54	17	ptpn3	ptpn3	PROPN
bptjm-49	54	18	that	that	PRON
bptjm-49	54	19	hinder	hinder	VERB
bptjm-49	54	20	its	its	PRON
bptjm-49	54	21	phosphatase	phosphatase	NOUN
bptjm-49	54	22	activity	activity	NOUN
bptjm-49	54	23	have	have	AUX
bptjm-49	54	24	been	be	AUX
bptjm-49	54	25	found	find	VERB
bptjm-49	54	26	in	in	ADP
bptjm-49	54	27	lung	lung	NOUN
bptjm-49	54	28	cancer	cancer	NOUN
bptjm-49	54	29	tissue.23	tissue.23	PROPN
bptjm-49	54	30	consequently	consequently	ADV
bptjm-49	54	31	,	,	PUNCT
bptjm-49	54	32	overexpression	overexpression	NOUN
bptjm-49	54	33	of	of	ADP
bptjm-49	54	34	ptpn3	ptpn3	PROPN
bptjm-49	54	35	results	result	NOUN
bptjm-49	54	36	in	in	ADP
bptjm-49	54	37	reduced	reduced	ADJ
bptjm-49	54	38	lung	lung	NOUN
bptjm-49	54	39	cancer	cancer	NOUN
bptjm-49	54	40	cell	cell	NOUN
bptjm-49	54	41	growth	growth	NOUN
bptjm-49	54	42	and	and	CCONJ
bptjm-49	54	43	migration	migration	NOUN
bptjm-49	54	44	,	,	PUNCT
bptjm-49	54	45	indicating	indicate	VERB
bptjm-49	54	46	that	that	SCONJ
bptjm-49	54	47	it	it	PRON
bptjm-49	54	48	might	might	AUX
bptjm-49	54	49	have	have	VERB
bptjm-49	54	50	tumor	tumor	NOUN
bptjm-49	54	51	suppressor	suppressor	NOUN
bptjm-49	54	52	capabilities.24,25	capabilities.24,25	NOUN
bptjm-49	54	53	ptpn3	ptpn3	PROPN
bptjm-49	54	54	is	be	AUX
bptjm-49	54	55	capable	capable	ADJ
bptjm-49	54	56	of	of	ADP
bptjm-49	54	57	suppressing	suppress	VERB
bptjm-49	54	58	lung	lung	NOUN
bptjm-49	54	59	cancer	cancer	NOUN
bptjm-49	54	60	cell	cell	NOUN
bptjm-49	54	61	invasion	invasion	NOUN
bptjm-49	54	62	by	by	ADP
bptjm-49	54	63	dephosphorylating	dephosphorylate	VERB
bptjm-49	54	64	the	the	DET
bptjm-49	54	65	protein	protein	NOUN
bptjm-49	54	66	,	,	PUNCT
bptjm-49	54	67	src	src	NOUN
bptjm-49	54	68	,	,	PUNCT
bptjm-49	54	69	at	at	ADP
bptjm-49	54	70	tyr416	tyr416	PROPN
bptjm-49	54	71	,	,	PUNCT
bptjm-49	54	72	which	which	PRON
bptjm-49	54	73	inhibits	inhibit	VERB
bptjm-49	54	74	srcmediated	srcmediate	VERB
bptjm-49	54	75	phosphorylation	phosphorylation	NOUN
bptjm-49	54	76	of	of	ADP
bptjm-49	54	77	tyr652	tyr652	PROPN
bptjm-49	54	78	on	on	ADP
bptjm-49	54	79	another	another	DET
bptjm-49	54	80	protein	protein	NOUN
bptjm-49	54	81	known	know	VERB
bptjm-49	54	82	as	as	ADP
bptjm-49	54	83	dishevelled	dishevel	VERB
bptjm-49	54	84	associated	associated	ADJ
bptjm-49	54	85	activator	activator	NOUN
bptjm-49	54	86	of	of	ADP
bptjm-49	54	87	morphogenesis	morphogenesis	NOUN
bptjm-49	54	88	1	1	NUM
bptjm-49	54	89	(	(	PUNCT
bptjm-49	54	90	daam1).24	daam1).24	NOUN
bptjm-49	54	91	tyrosine	tyrosine	NOUN
bptjm-49	54	92	phosphorylation	phosphorylation	NOUN
bptjm-49	54	93	of	of	ADP
bptjm-49	54	94	daam	daam	PROPN
bptjm-49	54	95	1	1	NUM
bptjm-49	54	96	at	at	ADP
bptjm-49	54	97	tyr652	tyr652	PROPN
bptjm-49	54	98	by	by	ADP
bptjm-49	54	99	src	src	NOUN
bptjm-49	54	100	is	be	AUX
bptjm-49	54	101	needed	need	VERB
bptjm-49	54	102	for	for	SCONJ
bptjm-49	54	103	daam1	daam1	NOUN
bptjm-49	54	104	dimerization.24	dimerization.24	VERB
bptjm-49	54	105	in	in	ADP
bptjm-49	54	106	the	the	DET
bptjm-49	54	107	absence	absence	NOUN
bptjm-49	54	108	of	of	ADP
bptjm-49	54	109	ptpn3	ptpn3	PROPN
bptjm-49	54	110	,	,	PUNCT
bptjm-49	54	111	daam1	daam1	PROPN
bptjm-49	54	112	is	be	AUX
bptjm-49	54	113	able	able	ADJ
bptjm-49	54	114	to	to	PART
bptjm-49	54	115	dimerize	dimerize	VERB
bptjm-49	54	116	,	,	PUNCT
bptjm-49	54	117	leading	lead	VERB
bptjm-49	54	118	to	to	ADP
bptjm-49	54	119	long	long	ADJ
bptjm-49	54	120	and	and	CCONJ
bptjm-49	54	121	thick	thick	ADJ
bptjm-49	54	122	actin	actin	NOUN
bptjm-49	54	123	,	,	PUNCT
bptjm-49	54	124	which	which	PRON
bptjm-49	54	125	improves	improve	VERB
bptjm-49	54	126	cancer	cancer	NOUN
bptjm-49	54	127	cell	cell	NOUN
bptjm-49	54	128	migration	migration	NOUN
bptjm-49	54	129	.	.	PUNCT
bptjm-49	55	1	ptpn3	ptpn3	PROPN
bptjm-49	55	2	knockdown	knockdown	NOUN
bptjm-49	55	3	cells	cell	NOUN
bptjm-49	55	4	moved	move	VERB
bptjm-49	55	5	30	30	NUM
bptjm-49	55	6	%	%	NOUN
bptjm-49	55	7	faster	fast	ADV
bptjm-49	55	8	than	than	ADP
bptjm-49	55	9	the	the	DET
bptjm-49	55	10	control	control	NOUN
bptjm-49	55	11	which	which	PRON
bptjm-49	55	12	had	have	VERB
bptjm-49	55	13	normal	normal	ADJ
bptjm-49	55	14	expression	expression	NOUN
bptjm-49	55	15	of	of	ADP
bptjm-49	55	16	ptpn3.24	ptpn3.24	NOUN
bptjm-49	55	17	4.1	4.1	NUM
bptjm-49	55	18	egfr	egfr	NOUN
bptjm-49	55	19	additionally	additionally	ADV
bptjm-49	55	20	,	,	PUNCT
bptjm-49	55	21	ptpn3	ptpn3	PROPN
bptjm-49	55	22	is	be	AUX
bptjm-49	55	23	able	able	ADJ
bptjm-49	55	24	to	to	PART
bptjm-49	55	25	target	target	VERB
bptjm-49	55	26	egfr	egfr	NOUN
bptjm-49	55	27	for	for	ADP
bptjm-49	55	28	lysosomal	lysosomal	ADJ
bptjm-49	55	29	degradation	degradation	NOUN
bptjm-49	55	30	inhibiting	inhibit	VERB
bptjm-49	55	31	proliferation	proliferation	NOUN
bptjm-49	55	32	of	of	ADP
bptjm-49	55	33	cancer	cancer	NOUN
bptjm-49	55	34	cells	cell	NOUN
bptjm-49	55	35	.	.	PUNCT
bptjm-49	56	1	ptpn3	ptpn3	PROPN
bptjm-49	56	2	is	be	AUX
bptjm-49	56	3	capable	capable	ADJ
bptjm-49	56	4	of	of	ADP
bptjm-49	56	5	dephosphorylating	dephosphorylate	VERB
bptjm-49	56	6	eps	eps	X
bptjm-49	56	7	15	15	NUM
bptjm-49	56	8	,	,	PUNCT
bptjm-49	56	9	which	which	PRON
bptjm-49	56	10	promotes	promote	VERB
bptjm-49	56	11	the	the	DET
bptjm-49	56	12	endocytosis	endocytosis	NOUN
bptjm-49	56	13	of	of	ADP
bptjm-49	56	14	egfr	egfr	NOUN
bptjm-49	56	15	,	,	PUNCT
bptjm-49	56	16	given	give	VERB
bptjm-49	56	17	that	that	DET
bptjm-49	56	18	egfr	egfr	NOUN
bptjm-49	56	19	is	be	AUX
bptjm-49	56	20	bound	bind	VERB
bptjm-49	56	21	to	to	ADP
bptjm-49	56	22	its	its	PRON
bptjm-49	56	23	ligand	ligand	NOUN
bptjm-49	56	24	,	,	PUNCT
bptjm-49	56	25	egf.25	egf.25	VERB
bptjm-49	56	26	when	when	SCONJ
bptjm-49	56	27	egfr	egfr	PROPN
bptjm-49	56	28	is	be	AUX
bptjm-49	56	29	internalized	internalize	VERB
bptjm-49	56	30	via	via	ADP
bptjm-49	56	31	lipid	lipid	NOUN
bptjm-49	56	32	raft	raft	NOUN
bptjm-49	56	33	-	-	PUNCT
bptjm-49	56	34	mediated	mediate	VERB
bptjm-49	56	35	endocytosis	endocytosis	NOUN
bptjm-49	56	36	,	,	PUNCT
bptjm-49	56	37	it	it	PRON
bptjm-49	56	38	is	be	AUX
bptjm-49	56	39	either	either	CCONJ
bptjm-49	56	40	recycled	recycle	VERB
bptjm-49	56	41	back	back	ADV
bptjm-49	56	42	to	to	ADP
bptjm-49	56	43	the	the	DET
bptjm-49	56	44	cell	cell	NOUN
bptjm-49	56	45	surface	surface	NOUN
bptjm-49	56	46	,	,	PUNCT
bptjm-49	56	47	targeted	target	VERB
bptjm-49	56	48	to	to	ADP
bptjm-49	56	49	the	the	DET
bptjm-49	56	50	lysosome	lysosome	NOUN
bptjm-49	56	51	for	for	ADP
bptjm-49	56	52	degradation	degradation	NOUN
bptjm-49	56	53	,	,	PUNCT
bptjm-49	56	54	or	or	CCONJ
bptjm-49	56	55	internalized	internalize	VERB
bptjm-49	56	56	to	to	ADP
bptjm-49	56	57	subcellular	subcellular	ADJ
bptjm-49	56	58	compartments.25	compartments.25	NOUN
bptjm-49	56	59	thus	thus	ADV
bptjm-49	56	60	,	,	PUNCT
bptjm-49	56	61	since	since	SCONJ
bptjm-49	56	62	ptpn3	ptpn3	PROPN
bptjm-49	56	63	is	be	AUX
bptjm-49	56	64	capable	capable	ADJ
bptjm-49	56	65	of	of	ADP
bptjm-49	56	66	causing	cause	VERB
bptjm-49	56	67	egfr	egfr	NOUN
bptjm-49	56	68	to	to	PART
bptjm-49	56	69	be	be	AUX
bptjm-49	56	70	degraded	degrade	VERB
bptjm-49	56	71	via	via	ADP
bptjm-49	56	72	its	its	PRON
bptjm-49	56	73	effects	effect	NOUN
bptjm-49	56	74	on	on	ADP
bptjm-49	56	75	eps	eps	PROPN
bptjm-49	56	76	15	15	NUM
bptjm-49	56	77	,	,	PUNCT
bptjm-49	56	78	ptpn3	ptpn3	NOUN
bptjm-49	56	79	functions	function	NOUN
bptjm-49	56	80	as	as	ADP
bptjm-49	56	81	a	a	DET
bptjm-49	56	82	tumor	tumor	NOUN
bptjm-49	56	83	suppressor	suppressor	NOUN
bptjm-49	56	84	.	.	PUNCT
bptjm-49	57	1	overexpression	overexpression	NOUN
bptjm-49	57	2	of	of	ADP
bptjm-49	57	3	ptpn3	ptpn3	PROPN
bptjm-49	57	4	resulted	result	VERB
bptjm-49	57	5	in	in	ADP
bptjm-49	57	6	a	a	DET
bptjm-49	57	7	decrease	decrease	NOUN
bptjm-49	57	8	of	of	ADP
bptjm-49	57	9	egfr	egfr	ADJ
bptjm-49	57	10	levels	level	NOUN
bptjm-49	57	11	when	when	SCONJ
bptjm-49	57	12	stimulated	stimulate	VERB
bptjm-49	57	13	by	by	ADP
bptjm-49	57	14	egf.25	egf.25	PROPN
bptjm-49	57	15	this	this	DET
bptjm-49	57	16	confirmed	confirm	VERB
bptjm-49	57	17	dephosphorylation	dephosphorylation	NOUN
bptjm-49	57	18	of	of	ADP
bptjm-49	57	19	eps15	eps15	PROPN
bptjm-49	57	20	by	by	ADP
bptjm-49	57	21	ptpn3	ptpn3	PROPN
bptjm-49	57	22	is	be	AUX
bptjm-49	57	23	capable	capable	ADJ
bptjm-49	57	24	of	of	ADP
bptjm-49	57	25	suppressing	suppress	VERB
bptjm-49	57	26	tumor	tumor	NOUN
bptjm-49	57	27	growth	growth	NOUN
bptjm-49	57	28	.	.	PUNCT
bptjm-49	58	1	5	5	X
bptjm-49	58	2	.	.	X
bptjm-49	58	3	ptpn6	ptpn6	NOUN
bptjm-49	58	4	5.1	5.1	NUM
bptjm-49	58	5	crc	crc	NOUN
bptjm-49	58	6	tissue	tissue	NOUN
bptjm-49	58	7	ptpn6	ptpn6	PROPN
bptjm-49	58	8	was	be	AUX
bptjm-49	58	9	highly	highly	ADV
bptjm-49	58	10	expressed	express	VERB
bptjm-49	58	11	in	in	ADP
bptjm-49	58	12	crc	crc	NOUN
bptjm-49	58	13	tissue	tissue	NOUN
bptjm-49	58	14	as	as	SCONJ
bptjm-49	58	15	demonstrated	demonstrate	VERB
bptjm-49	58	16	by	by	ADP
bptjm-49	58	17	qpcr	qpcr	ADV
bptjm-49	58	18	,	,	PUNCT
bptjm-49	58	19	cck-8	cck-8	X
bptjm-49	58	20	,	,	PUNCT
bptjm-49	58	21	clone	clone	NOUN
bptjm-49	58	22	formation	formation	NOUN
bptjm-49	58	23	assay	assay	VERB
bptjm-49	58	24	,	,	PUNCT
bptjm-49	58	25	and	and	CCONJ
bptjm-49	58	26	other	other	ADJ
bptjm-49	58	27	assessments.26	assessments.26	VERB
bptjm-49	58	28	the	the	DET
bptjm-49	58	29	overexpression	overexpression	NOUN
bptjm-49	58	30	of	of	ADP
bptjm-49	58	31	ptpn6	ptpn6	NOUN
bptjm-49	58	32	in	in	ADP
bptjm-49	58	33	malignant	malignant	ADJ
bptjm-49	58	34	colon	colon	NOUN
bptjm-49	58	35	cancer	cancer	NOUN
bptjm-49	58	36	cells	cell	NOUN
bptjm-49	58	37	was	be	AUX
bptjm-49	58	38	associated	associate	VERB
bptjm-49	58	39	with	with	ADP
bptjm-49	58	40	poor	poor	ADJ
bptjm-49	58	41	prognosis	prognosis	NOUN
bptjm-49	58	42	in	in	ADP
bptjm-49	58	43	colon	colon	NOUN
bptjm-49	58	44	cancer	cancer	NOUN
bptjm-49	58	45	patients	patient	NOUN
bptjm-49	58	46	.	.	PUNCT
bptjm-49	59	1	conversely	conversely	ADV
bptjm-49	59	2	,	,	PUNCT
bptjm-49	59	3	the	the	DET
bptjm-49	59	4	inhibition	inhibition	NOUN
bptjm-49	59	5	of	of	ADP
bptjm-49	59	6	ptpn6	ptpn6	NOUN
bptjm-49	59	7	restrained	restrained	ADJ
bptjm-49	59	8	migration	migration	NOUN
bptjm-49	59	9	,	,	PUNCT
bptjm-49	59	10	invasion	invasion	NOUN
bptjm-49	59	11	,	,	PUNCT
bptjm-49	59	12	and	and	CCONJ
bptjm-49	59	13	clonogenics	clonogenic	NOUN
bptjm-49	59	14	of	of	ADP
bptjm-49	59	15	crc	crc	NOUN
bptjm-49	59	16	tissues.26	tissues.26	PROPN
bptjm-49	59	17	therefore	therefore	ADV
bptjm-49	59	18	,	,	PUNCT
bptjm-49	59	19	ptpn6	ptpn6	NOUN
bptjm-49	59	20	amplification	amplification	NOUN
bptjm-49	59	21	can	can	AUX
bptjm-49	59	22	potentially	potentially	ADV
bptjm-49	59	23	be	be	AUX
bptjm-49	59	24	used	use	VERB
bptjm-49	59	25	as	as	ADP
bptjm-49	59	26	a	a	DET
bptjm-49	59	27	biomarker	biomarker	NOUN
bptjm-49	59	28	for	for	ADP
bptjm-49	59	29	crc	crc	NOUN
bptjm-49	59	30	and	and	CCONJ
bptjm-49	59	31	its	its	PRON
bptjm-49	59	32	progression	progression	NOUN
bptjm-49	59	33	.	.	PUNCT
bptjm-49	60	1	ptpn	ptpn	PROPN
bptjm-49	60	2	6	6	NUM
bptjm-49	60	3	is	be	AUX
bptjm-49	60	4	a	a	DET
bptjm-49	60	5	possible	possible	ADJ
bptjm-49	60	6	tumor	tumor	NOUN
bptjm-49	60	7	promoter	promoter	NOUN
bptjm-49	60	8	due	due	ADP
bptjm-49	60	9	to	to	ADP
bptjm-49	60	10	its	its	PRON
bptjm-49	60	11	ability	ability	NOUN
bptjm-49	60	12	to	to	PART
bptjm-49	60	13	promote	promote	VERB
bptjm-49	60	14	proliferation	proliferation	NOUN
bptjm-49	60	15	and	and	CCONJ
bptjm-49	60	16	migration	migration	NOUN
bptjm-49	60	17	of	of	ADP
bptjm-49	60	18	tumor	tumor	NOUN
bptjm-49	60	19	cells	cell	NOUN
bptjm-49	60	20	.	.	PUNCT
bptjm-49	61	1	additionally	additionally	ADV
bptjm-49	61	2	,	,	PUNCT
bptjm-49	61	3	ptpn6	ptpn6	PROPN
bptjm-49	61	4	interacts	interact	VERB
bptjm-49	61	5	with	with	ADP
bptjm-49	61	6	egfr	egfr	NOUN
bptjm-49	61	7	,	,	PUNCT
bptjm-49	61	8	a	a	DET
bptjm-49	61	9	receptor	receptor	NOUN
bptjm-49	61	10	known	know	VERB
bptjm-49	61	11	to	to	PART
bptjm-49	61	12	induce	induce	VERB
bptjm-49	61	13	pathways	pathway	NOUN
bptjm-49	61	14	berkeley	berkeley	PROPN
bptjm-49	61	15	pharma	pharma	PROPN
bptjm-49	61	16	tech	tech	NOUN
bptjm-49	61	17	journal	journal	NOUN
bptjm-49	61	18	of	of	ADP
bptjm-49	61	19	medicine	medicine	NOUN
bptjm-49	61	20	|	|	ADV
bptjm-49	61	21	89	89	NUM
bptjm-49	61	22	involved	involve	VERB
bptjm-49	61	23	in	in	ADP
bptjm-49	61	24	proliferation	proliferation	NOUN
bptjm-49	61	25	,	,	PUNCT
bptjm-49	61	26	migration	migration	NOUN
bptjm-49	61	27	,	,	PUNCT
bptjm-49	61	28	and	and	CCONJ
bptjm-49	61	29	adhesion	adhesion	NOUN
bptjm-49	61	30	.	.	PUNCT
bptjm-49	62	1	increased	increase	VERB
bptjm-49	62	2	expression	expression	NOUN
bptjm-49	62	3	of	of	ADP
bptjm-49	62	4	both	both	DET
bptjm-49	62	5	ptpn6	ptpn6	NOUN
bptjm-49	62	6	and	and	CCONJ
bptjm-49	62	7	egfr	egfr	NOUN
bptjm-49	62	8	resulted	result	VERB
bptjm-49	62	9	in	in	ADP
bptjm-49	62	10	the	the	DET
bptjm-49	62	11	greatest	great	ADJ
bptjm-49	62	12	cancerous	cancerous	ADJ
bptjm-49	62	13	proliferation	proliferation	NOUN
bptjm-49	62	14	as	as	SCONJ
bptjm-49	62	15	compared	compare	VERB
bptjm-49	62	16	to	to	ADP
bptjm-49	62	17	cells	cell	NOUN
bptjm-49	62	18	with	with	ADP
bptjm-49	62	19	only	only	ADJ
bptjm-49	62	20	ptpn6	ptpn6	NOUN
bptjm-49	62	21	or	or	CCONJ
bptjm-49	62	22	egfr	egfr	NOUN
bptjm-49	62	23	overexpressed	overexpresse	VERB
bptjm-49	62	24	.	.	PUNCT
bptjm-49	63	1	thus	thus	ADV
bptjm-49	63	2	,	,	PUNCT
bptjm-49	63	3	either	either	CCONJ
bptjm-49	63	4	targeting	target	VERB
bptjm-49	63	5	ptpn6	ptpn6	NOUN
bptjm-49	63	6	or	or	CCONJ
bptjm-49	63	7	the	the	DET
bptjm-49	63	8	ptpn6	ptpn6	NOUN
bptjm-49	63	9	-	-	PUNCT
bptjm-49	63	10	egfr	egfr	NOUN
bptjm-49	63	11	complex	complex	NOUN
bptjm-49	63	12	with	with	ADP
bptjm-49	63	13	an	an	DET
bptjm-49	63	14	inhibitor	inhibitor	NOUN
bptjm-49	63	15	could	could	AUX
bptjm-49	63	16	be	be	AUX
bptjm-49	63	17	a	a	DET
bptjm-49	63	18	potential	potential	ADJ
bptjm-49	63	19	therapeutic	therapeutic	NOUN
bptjm-49	63	20	.	.	PUNCT
bptjm-49	64	1	however	however	ADV
bptjm-49	64	2	,	,	PUNCT
bptjm-49	64	3	other	other	ADJ
bptjm-49	64	4	research	research	NOUN
bptjm-49	64	5	suggests	suggest	VERB
bptjm-49	64	6	ptpn6	ptpn6	NOUN
bptjm-49	64	7	might	might	AUX
bptjm-49	64	8	have	have	VERB
bptjm-49	64	9	tumor	tumor	NOUN
bptjm-49	64	10	suppressing	suppress	VERB
bptjm-49	64	11	capabilities	capability	NOUN
bptjm-49	64	12	by	by	ADP
bptjm-49	64	13	decreasing	decrease	VERB
bptjm-49	64	14	the	the	DET
bptjm-49	64	15	levels	level	NOUN
bptjm-49	64	16	of	of	ADP
bptjm-49	64	17	the	the	DET
bptjm-49	64	18	protein	protein	NOUN
bptjm-49	64	19	sp1	sp1	NOUN
bptjm-49	64	20	(	(	PUNCT
bptjm-49	64	21	specificity	specificity	NOUN
bptjm-49	64	22	protein	protein	NOUN
bptjm-49	64	23	1	1	NUM
bptjm-49	64	24	)	)	PUNCT
bptjm-49	64	25	.	.	PUNCT
bptjm-49	65	1	mapk	mapk	NOUN
bptjm-49	65	2	pathway	pathway	NOUN
bptjm-49	65	3	is	be	AUX
bptjm-49	65	4	typically	typically	ADV
bptjm-49	65	5	activated	activate	VERB
bptjm-49	65	6	by	by	ADP
bptjm-49	65	7	sp1	sp1	NOUN
bptjm-49	65	8	;	;	PUNCT
bptjm-49	65	9	however	however	ADV
bptjm-49	65	10	,	,	PUNCT
bptjm-49	65	11	due	due	ADP
bptjm-49	65	12	to	to	ADP
bptjm-49	65	13	ptpn6	ptpn6	NOUN
bptjm-49	65	14	’s	’s	PART
bptjm-49	65	15	inhibition	inhibition	NOUN
bptjm-49	65	16	of	of	ADP
bptjm-49	65	17	sp1	sp1	NOUN
bptjm-49	65	18	,	,	PUNCT
bptjm-49	65	19	mapk	mapk	NOUN
bptjm-49	65	20	pathway	pathway	NOUN
bptjm-49	65	21	is	be	AUX
bptjm-49	65	22	consequently	consequently	ADV
bptjm-49	65	23	suppressed	suppress	VERB
bptjm-49	65	24	.	.	PUNCT
bptjm-49	66	1	ptpn6	ptpn6	NOUN
bptjm-49	66	2	inhibition	inhibition	NOUN
bptjm-49	66	3	promotes	promote	VERB
bptjm-49	66	4	enhanced	enhance	VERB
bptjm-49	66	5	chemosensitivity	chemosensitivity	NOUN
bptjm-49	66	6	within	within	ADP
bptjm-49	66	7	crc	crc	NOUN
bptjm-49	66	8	cells	cell	NOUN
bptjm-49	66	9	.	.	PUNCT
bptjm-49	67	1	yet	yet	ADV
bptjm-49	67	2	,	,	PUNCT
bptjm-49	67	3	more	more	ADJ
bptjm-49	67	4	research	research	NOUN
bptjm-49	67	5	needs	need	VERB
bptjm-49	67	6	to	to	PART
bptjm-49	67	7	be	be	AUX
bptjm-49	67	8	conducted	conduct	VERB
bptjm-49	67	9	in	in	ADP
bptjm-49	67	10	order	order	NOUN
bptjm-49	67	11	to	to	PART
bptjm-49	67	12	further	far	ADV
bptjm-49	67	13	understand	understand	VERB
bptjm-49	67	14	the	the	DET
bptjm-49	67	15	various	various	ADJ
bptjm-49	67	16	effects	effect	NOUN
bptjm-49	67	17	of	of	ADP
bptjm-49	67	18	ptpn6	ptpn6	NOUN
bptjm-49	67	19	within	within	ADP
bptjm-49	67	20	crc.27	crc.27	PROPN
bptjm-49	67	21	6	6	NUM
bptjm-49	67	22	.	.	PUNCT
bptjm-49	67	23	ptpn11	ptpn11	NOUN
bptjm-49	67	24	6.1	6.1	NUM
bptjm-49	67	25	shp2	shp2	NOUN
bptjm-49	67	26	ptpn11	ptpn11	NOUN
bptjm-49	67	27	is	be	AUX
bptjm-49	67	28	a	a	DET
bptjm-49	67	29	gene	gene	NOUN
bptjm-49	67	30	that	that	PRON
bptjm-49	67	31	encodes	encode	NOUN
bptjm-49	67	32	for	for	ADP
bptjm-49	67	33	shp2	shp2	NOUN
bptjm-49	67	34	,	,	PUNCT
bptjm-49	67	35	a	a	DET
bptjm-49	67	36	protein	protein	NOUN
bptjm-49	67	37	consisting	consist	VERB
bptjm-49	67	38	of	of	ADP
bptjm-49	67	39	two	two	NUM
bptjm-49	67	40	n	n	CCONJ
bptjm-49	67	41	-	-	PUNCT
bptjm-49	67	42	terminal	terminal	ADJ
bptjm-49	67	43	src	src	NOUN
bptjm-49	67	44	homology	homology	NOUN
bptjm-49	67	45	(	(	PUNCT
bptjm-49	67	46	sh2	sh2	NOUN
bptjm-49	67	47	)	)	PUNCT
bptjm-49	67	48	domains	domain	NOUN
bptjm-49	67	49	,	,	PUNCT
bptjm-49	67	50	a	a	DET
bptjm-49	67	51	catalytic	catalytic	ADJ
bptjm-49	67	52	ptp	ptp	NOUN
bptjm-49	67	53	domain	domain	NOUN
bptjm-49	67	54	,	,	PUNCT
bptjm-49	67	55	and	and	CCONJ
bptjm-49	67	56	a	a	DET
bptjm-49	67	57	cterminal	cterminal	ADJ
bptjm-49	67	58	tail	tail	NOUN
bptjm-49	67	59	with	with	ADP
bptjm-49	67	60	tyrosyl	tyrosyl	ADJ
bptjm-49	67	61	phosphorylation	phosphorylation	NOUN
bptjm-49	67	62	sites.28	sites.28	NOUN
bptjm-49	67	63	shp2	shp2	NOUN
bptjm-49	67	64	/	/	SYM
bptjm-49	67	65	ptpn11	ptpn11	NOUN
bptjm-49	67	66	is	be	AUX
bptjm-49	67	67	involved	involve	VERB
bptjm-49	67	68	in	in	ADP
bptjm-49	67	69	promoting	promote	VERB
bptjm-49	67	70	signaling	signal	VERB
bptjm-49	67	71	pathways	pathway	NOUN
bptjm-49	67	72	such	such	ADJ
bptjm-49	67	73	as	as	ADP
bptjm-49	67	74	ras	ras	PROPN
bptjm-49	67	75	/	/	SYM
bptjm-49	67	76	erk	erk	PROPN
bptjm-49	67	77	,	,	PUNCT
bptjm-49	67	78	ras	ras	PROPN
bptjm-49	67	79	/	/	SYM
bptjm-49	67	80	mapk	mapk	PROPN
bptjm-49	67	81	,	,	PUNCT
bptjm-49	67	82	jak	jak	PROPN
bptjm-49	67	83	/	/	SYM
bptjm-49	67	84	stat	stat	PROPN
bptjm-49	67	85	,	,	PUNCT
bptjm-49	67	86	as	as	ADV
bptjm-49	67	87	well	well	ADV
bptjm-49	67	88	as	as	ADP
bptjm-49	67	89	kras	kra	NOUN
bptjm-49	67	90	signaling	signal	VERB
bptjm-49	67	91	within	within	ADP
bptjm-49	67	92	the	the	DET
bptjm-49	67	93	tumor	tumor	NOUN
bptjm-49	67	94	microenvironment.28	microenvironment.28	NOUN
bptjm-49	67	95	increased	increase	VERB
bptjm-49	67	96	expression	expression	NOUN
bptjm-49	67	97	of	of	ADP
bptjm-49	67	98	shp2	shp2	NOUN
bptjm-49	67	99	/	/	SYM
bptjm-49	67	100	ptpn11	ptpn11	NOUN
bptjm-49	67	101	is	be	AUX
bptjm-49	67	102	associated	associate	VERB
bptjm-49	67	103	with	with	ADP
bptjm-49	67	104	a	a	DET
bptjm-49	67	105	5.34	5.34	NUM
bptjm-49	67	106	fold	fold	NOUN
bptjm-49	67	107	increase	increase	NOUN
bptjm-49	67	108	in	in	ADP
bptjm-49	67	109	risk	risk	NOUN
bptjm-49	67	110	for	for	ADP
bptjm-49	67	111	gastric	gastric	ADJ
bptjm-49	67	112	cancer	cancer	NOUN
bptjm-49	67	113	and	and	CCONJ
bptjm-49	67	114	a	a	DET
bptjm-49	67	115	2.95	2.95	NUM
bptjm-49	67	116	fold	fold	NOUN
bptjm-49	67	117	increase	increase	NOUN
bptjm-49	67	118	in	in	ADP
bptjm-49	67	119	risk	risk	NOUN
bptjm-49	67	120	for	for	ADP
bptjm-49	67	121	lung	lung	NOUN
bptjm-49	67	122	cancer.29	cancer.29	NOUN
bptjm-49	67	123	furthermore	furthermore	ADV
bptjm-49	67	124	,	,	PUNCT
bptjm-49	67	125	other	other	ADJ
bptjm-49	67	126	studies	study	NOUN
bptjm-49	67	127	have	have	AUX
bptjm-49	67	128	found	find	VERB
bptjm-49	67	129	shp2	shp2	NOUN
bptjm-49	67	130	to	to	PART
bptjm-49	67	131	be	be	AUX
bptjm-49	67	132	highly	highly	ADV
bptjm-49	67	133	expressed	express	VERB
bptjm-49	67	134	in	in	ADP
bptjm-49	67	135	60.78	60.78	NUM
bptjm-49	67	136	%	%	NOUN
bptjm-49	67	137	of	of	ADP
bptjm-49	67	138	gastric	gastric	ADJ
bptjm-49	67	139	cancer	cancer	NOUN
bptjm-49	67	140	and	and	CCONJ
bptjm-49	67	141	70	70	NUM
bptjm-49	67	142	%	%	NOUN
bptjm-49	67	143	of	of	ADP
bptjm-49	67	144	nsclc	nsclc	NOUN
bptjm-49	67	145	tissue	tissue	NOUN
bptjm-49	67	146	samples.29	samples.29	PROPN
bptjm-49	67	147	patients	patient	NOUN
bptjm-49	67	148	infected	infect	VERB
bptjm-49	67	149	with	with	ADP
bptjm-49	67	150	helicobacter	helicobacter	NOUN
bptjm-49	67	151	pylori	pylori	NOUN
bptjm-49	67	152	are	be	AUX
bptjm-49	67	153	at	at	ADP
bptjm-49	67	154	a	a	DET
bptjm-49	67	155	greater	great	ADJ
bptjm-49	67	156	risk	risk	NOUN
bptjm-49	67	157	for	for	ADP
bptjm-49	67	158	gastric	gastric	ADJ
bptjm-49	67	159	cancer.30	cancer.30	NOUN
bptjm-49	67	160	a	a	DET
bptjm-49	67	161	virulence	virulence	NOUN
bptjm-49	67	162	factor	factor	NOUN
bptjm-49	67	163	of	of	ADP
bptjm-49	67	164	h.	h.	PROPN
bptjm-49	67	165	pylori	pylori	NOUN
bptjm-49	67	166	known	know	VERB
bptjm-49	67	167	as	as	ADP
bptjm-49	67	168	cytotoxin	cytotoxin	NOUN
bptjm-49	67	169	associated	associate	VERB
bptjm-49	67	170	antigen	antigen	ADV
bptjm-49	67	171	(	(	PUNCT
bptjm-49	67	172	caga	caga	NOUN
bptjm-49	67	173	)	)	PUNCT
bptjm-49	67	174	is	be	AUX
bptjm-49	67	175	able	able	ADJ
bptjm-49	67	176	to	to	PART
bptjm-49	67	177	interact	interact	VERB
bptjm-49	67	178	with	with	ADP
bptjm-49	67	179	the	the	DET
bptjm-49	67	180	epithelial	epithelial	ADJ
bptjm-49	67	181	gastric	gastric	ADJ
bptjm-49	67	182	cells	cell	NOUN
bptjm-49	67	183	,	,	PUNCT
bptjm-49	67	184	leading	lead	VERB
bptjm-49	67	185	to	to	ADP
bptjm-49	67	186	the	the	DET
bptjm-49	67	187	src	src	NOUN
bptjm-49	67	188	-	-	PUNCT
bptjm-49	67	189	dependent	dependent	ADJ
bptjm-49	67	190	tyrosine	tyrosine	NOUN
bptjm-49	67	191	phosphorylation	phosphorylation	NOUN
bptjm-49	67	192	of	of	ADP
bptjm-49	67	193	caga.30	caga.30	NOUN
bptjm-49	67	194	the	the	DET
bptjm-49	67	195	phosphorylated	phosphorylate	VERB
bptjm-49	67	196	caga	caga	NOUN
bptjm-49	67	197	binds	bind	VERB
bptjm-49	67	198	with	with	ADP
bptjm-49	67	199	shp2	shp2	NOUN
bptjm-49	67	200	,	,	PUNCT
bptjm-49	67	201	forming	form	VERB
bptjm-49	67	202	a	a	DET
bptjm-49	67	203	complex	complex	NOUN
bptjm-49	67	204	that	that	PRON
bptjm-49	67	205	allows	allow	VERB
bptjm-49	67	206	for	for	ADP
bptjm-49	67	207	the	the	DET
bptjm-49	67	208	transition	transition	NOUN
bptjm-49	67	209	of	of	ADP
bptjm-49	67	210	shp2	shp2	NOUN
bptjm-49	67	211	into	into	ADP
bptjm-49	67	212	its	its	PRON
bptjm-49	67	213	active	active	ADJ
bptjm-49	67	214	form	form	NOUN
bptjm-49	67	215	.	.	PUNCT
bptjm-49	68	1	in	in	ADP
bptjm-49	68	2	its	its	PRON
bptjm-49	68	3	active	active	ADJ
bptjm-49	68	4	form	form	NOUN
bptjm-49	68	5	,	,	PUNCT
bptjm-49	68	6	shp2	shp2	NOUN
bptjm-49	68	7	is	be	AUX
bptjm-49	68	8	capable	capable	ADJ
bptjm-49	68	9	of	of	ADP
bptjm-49	68	10	inducing	induce	VERB
bptjm-49	68	11	oncogenic	oncogenic	ADJ
bptjm-49	68	12	properties	property	NOUN
bptjm-49	68	13	,	,	PUNCT
bptjm-49	68	14	such	such	ADJ
bptjm-49	68	15	as	as	ADP
bptjm-49	68	16	neoplasia	neoplasia	NOUN
bptjm-49	68	17	,	,	PUNCT
bptjm-49	68	18	gastric	gastric	ADJ
bptjm-49	68	19	atrophy	atrophy	NOUN
bptjm-49	68	20	,	,	PUNCT
bptjm-49	68	21	and	and	CCONJ
bptjm-49	68	22	increased	increase	VERB
bptjm-49	68	23	migration	migration	NOUN
bptjm-49	68	24	of	of	ADP
bptjm-49	68	25	gastric	gastric	ADJ
bptjm-49	68	26	epithelial	epithelial	ADJ
bptjm-49	68	27	cells.30	cells.30	NOUN
bptjm-49	68	28	in	in	ADP
bptjm-49	68	29	contrast	contrast	NOUN
bptjm-49	68	30	,	,	PUNCT
bptjm-49	68	31	in	in	ADP
bptjm-49	68	32	many	many	ADJ
bptjm-49	68	33	cases	case	NOUN
bptjm-49	68	34	of	of	ADP
bptjm-49	68	35	lung	lung	NOUN
bptjm-49	68	36	cancer	cancer	NOUN
bptjm-49	68	37	,	,	PUNCT
bptjm-49	68	38	a	a	DET
bptjm-49	68	39	missense	missense	NOUN
bptjm-49	68	40	mutation	mutation	NOUN
bptjm-49	68	41	in	in	ADP
bptjm-49	68	42	the	the	DET
bptjm-49	68	43	ptpn11	ptpn11	NOUN
bptjm-49	68	44	gene	gene	NOUN
bptjm-49	68	45	leads	lead	VERB
bptjm-49	68	46	to	to	ADP
bptjm-49	68	47	a	a	DET
bptjm-49	68	48	dysfunctional	dysfunctional	ADJ
bptjm-49	68	49	shp2	shp2	NOUN
bptjm-49	68	50	protein	protein	NOUN
bptjm-49	68	51	that	that	PRON
bptjm-49	68	52	results	result	VERB
bptjm-49	68	53	in	in	ADP
bptjm-49	68	54	inappropriate	inappropriate	ADJ
bptjm-49	68	55	activation	activation	NOUN
bptjm-49	68	56	of	of	ADP
bptjm-49	68	57	various	various	ADJ
bptjm-49	68	58	signal	signal	ADJ
bptjm-49	68	59	transduction	transduction	NOUN
bptjm-49	68	60	pathways.31	pathways.31	NOUN
bptjm-49	68	61	due	due	ADP
bptjm-49	68	62	to	to	ADP
bptjm-49	68	63	the	the	DET
bptjm-49	68	64	proto	proto	NOUN
bptjm-49	68	65	-	-	ADJ
bptjm-49	68	66	oncogenic	oncogenic	ADJ
bptjm-49	68	67	nature	nature	NOUN
bptjm-49	68	68	of	of	ADP
bptjm-49	68	69	ptpn11	ptpn11	NOUN
bptjm-49	68	70	,	,	PUNCT
bptjm-49	68	71	various	various	ADJ
bptjm-49	68	72	strides	stride	NOUN
bptjm-49	68	73	have	have	AUX
bptjm-49	68	74	been	be	AUX
bptjm-49	68	75	made	make	VERB
bptjm-49	68	76	in	in	ADP
bptjm-49	68	77	developing	develop	VERB
bptjm-49	68	78	small	small	ADJ
bptjm-49	68	79	molecule	molecule	NOUN
bptjm-49	68	80	inhibitors	inhibitor	NOUN
bptjm-49	68	81	which	which	PRON
bptjm-49	68	82	are	be	AUX
bptjm-49	68	83	capable	capable	ADJ
bptjm-49	68	84	of	of	ADP
bptjm-49	68	85	binding	bind	VERB
bptjm-49	68	86	to	to	ADP
bptjm-49	68	87	the	the	DET
bptjm-49	68	88	catalytic	catalytic	ADJ
bptjm-49	68	89	site	site	NOUN
bptjm-49	68	90	of	of	ADP
bptjm-49	68	91	shp2	shp2	NOUN
bptjm-49	68	92	.	.	PUNCT
bptjm-49	69	1	one	one	NUM
bptjm-49	69	2	potential	potential	ADJ
bptjm-49	69	3	inhibitor	inhibitor	NOUN
bptjm-49	69	4	,	,	PUNCT
bptjm-49	69	5	shp099	shp099	PROPN
bptjm-49	69	6	,	,	PUNCT
bptjm-49	69	7	is	be	AUX
bptjm-49	69	8	able	able	ADJ
bptjm-49	69	9	to	to	PART
bptjm-49	69	10	bind	bind	VERB
bptjm-49	69	11	to	to	ADP
bptjm-49	69	12	the	the	DET
bptjm-49	69	13	n	n	CCONJ
bptjm-49	69	14	-	-	PUNCT
bptjm-49	69	15	terminal	terminal	ADJ
bptjm-49	69	16	,	,	PUNCT
bptjm-49	69	17	cberkeley	cberkeley	PROPN
bptjm-49	69	18	pharma	pharma	PROPN
bptjm-49	69	19	tech	tech	NOUN
bptjm-49	69	20	journal	journal	NOUN
bptjm-49	69	21	of	of	ADP
bptjm-49	69	22	medicine	medicine	NOUN
bptjm-49	69	23	|	|	ADV
bptjm-49	69	24	90	90	NUM
bptjm-49	69	25	terminal	terminal	ADJ
bptjm-49	69	26	and	and	CCONJ
bptjm-49	69	27	ptp	ptp	PROPN
bptjm-49	69	28	domain	domain	NOUN
bptjm-49	69	29	on	on	ADP
bptjm-49	69	30	shp2	shp2	NOUN
bptjm-49	69	31	,	,	PUNCT
bptjm-49	69	32	resulting	result	VERB
bptjm-49	69	33	in	in	ADP
bptjm-49	69	34	increased	increase	VERB
bptjm-49	69	35	immune	immune	ADJ
bptjm-49	69	36	system	system	NOUN
bptjm-49	69	37	activity	activity	NOUN
bptjm-49	69	38	such	such	ADJ
bptjm-49	69	39	as	as	ADP
bptjm-49	69	40	greater	great	ADJ
bptjm-49	69	41	ifn	ifn	NOUN
bptjm-49	69	42	-	-	PUNCT
bptjm-49	69	43	γ	γ	NOUN
bptjm-49	69	44	signaling	signal	VERB
bptjm-49	69	45	.	.	PUNCT
bptjm-49	70	1	this	this	PRON
bptjm-49	70	2	induced	induce	VERB
bptjm-49	70	3	greater	great	ADJ
bptjm-49	70	4	transcription	transcription	NOUN
bptjm-49	70	5	of	of	ADP
bptjm-49	70	6	cytotoxic	cytotoxic	ADJ
bptjm-49	70	7	tcell	tcell	NOUN
bptjm-49	70	8	related	relate	VERB
bptjm-49	70	9	genes	gene	NOUN
bptjm-49	70	10	within	within	ADP
bptjm-49	70	11	a	a	DET
bptjm-49	70	12	mice	mice	NOUN
bptjm-49	70	13	model	model	NOUN
bptjm-49	70	14	for	for	ADP
bptjm-49	70	15	lung	lung	NOUN
bptjm-49	70	16	cancer	cancer	NOUN
bptjm-49	70	17	treatment.31	treatment.31	PROPN
bptjm-49	70	18	while	while	SCONJ
bptjm-49	70	19	most	most	ADJ
bptjm-49	70	20	of	of	ADP
bptjm-49	70	21	shp2	shp2	NOUN
bptjm-49	70	22	inhibitors	inhibitor	NOUN
bptjm-49	70	23	are	be	AUX
bptjm-49	70	24	in	in	ADP
bptjm-49	70	25	the	the	DET
bptjm-49	70	26	preclinical	preclinical	ADJ
bptjm-49	70	27	study	study	NOUN
bptjm-49	70	28	stages	stage	NOUN
bptjm-49	70	29	,	,	PUNCT
bptjm-49	70	30	the	the	DET
bptjm-49	70	31	potential	potential	NOUN
bptjm-49	70	32	of	of	ADP
bptjm-49	70	33	ptpn11	ptpn11	NOUN
bptjm-49	70	34	as	as	ADP
bptjm-49	70	35	a	a	DET
bptjm-49	70	36	therapeutic	therapeutic	ADJ
bptjm-49	70	37	drug	drug	NOUN
bptjm-49	70	38	target	target	NOUN
bptjm-49	70	39	is	be	AUX
bptjm-49	70	40	a	a	DET
bptjm-49	70	41	promising	promising	ADJ
bptjm-49	70	42	prospect	prospect	NOUN
bptjm-49	70	43	in	in	ADP
bptjm-49	70	44	treating	treat	VERB
bptjm-49	70	45	many	many	ADJ
bptjm-49	70	46	types	type	NOUN
bptjm-49	70	47	of	of	ADP
bptjm-49	70	48	cancers	cancer	NOUN
bptjm-49	70	49	,	,	PUNCT
bptjm-49	70	50	including	include	VERB
bptjm-49	70	51	gastric	gastric	ADJ
bptjm-49	70	52	and	and	CCONJ
bptjm-49	70	53	lung	lung	NOUN
bptjm-49	70	54	cancer	cancer	NOUN
bptjm-49	70	55	.	.	PUNCT
bptjm-49	71	1	7	7	X
bptjm-49	71	2	.	.	X
bptjm-49	71	3	ptpn12	ptpn12	NOUN
bptjm-49	71	4	ptpn12	ptpn12	PROPN
bptjm-49	71	5	is	be	AUX
bptjm-49	71	6	a	a	DET
bptjm-49	71	7	tumor	tumor	NOUN
bptjm-49	71	8	suppressor	suppressor	NOUN
bptjm-49	71	9	that	that	PRON
bptjm-49	71	10	normally	normally	ADV
bptjm-49	71	11	has	have	VERB
bptjm-49	71	12	an	an	DET
bptjm-49	71	13	inhibitory	inhibitory	ADJ
bptjm-49	71	14	effect	effect	NOUN
bptjm-49	71	15	on	on	ADP
bptjm-49	71	16	the	the	DET
bptjm-49	71	17	ras	ras	PROPN
bptjm-49	71	18	/	/	SYM
bptjm-49	71	19	mek	mek	PROPN
bptjm-49	71	20	/	/	SYM
bptjm-49	71	21	erk	erk	PROPN
bptjm-49	71	22	signaling	signal	VERB
bptjm-49	71	23	by	by	ADP
bptjm-49	71	24	dephosphorylating	dephosphorylate	VERB
bptjm-49	71	25	the	the	DET
bptjm-49	71	26	protein	protein	NOUN
bptjm-49	71	27	shc.32	shc.32	NOUN
bptjm-49	71	28	however	however	ADV
bptjm-49	71	29	,	,	PUNCT
bptjm-49	71	30	it	it	PRON
bptjm-49	71	31	was	be	AUX
bptjm-49	71	32	hypothesized	hypothesize	VERB
bptjm-49	71	33	that	that	SCONJ
bptjm-49	71	34	a	a	DET
bptjm-49	71	35	missense	missense	NOUN
bptjm-49	71	36	mutation	mutation	NOUN
bptjm-49	71	37	in	in	ADP
bptjm-49	71	38	ptpn12	ptpn12	NOUN
bptjm-49	71	39	would	would	AUX
bptjm-49	71	40	leave	leave	VERB
bptjm-49	71	41	shc	shc	PROPN
bptjm-49	71	42	phosphorylated	phosphorylate	VERB
bptjm-49	71	43	,	,	PUNCT
bptjm-49	71	44	resulting	result	VERB
bptjm-49	71	45	in	in	ADP
bptjm-49	71	46	hallmarks	hallmark	NOUN
bptjm-49	71	47	of	of	ADP
bptjm-49	71	48	cancer	cancer	NOUN
bptjm-49	71	49	,	,	PUNCT
bptjm-49	71	50	such	such	ADJ
bptjm-49	71	51	as	as	ADP
bptjm-49	71	52	cellular	cellular	ADJ
bptjm-49	71	53	proliferation	proliferation	NOUN
bptjm-49	71	54	and	and	CCONJ
bptjm-49	71	55	increased	increase	VERB
bptjm-49	71	56	migration.33	migration.33	NOUN
bptjm-49	71	57	for	for	ADP
bptjm-49	71	58	example	example	NOUN
bptjm-49	71	59	,	,	PUNCT
bptjm-49	71	60	researchers	researcher	NOUN
bptjm-49	71	61	identified	identify	VERB
bptjm-49	71	62	that	that	SCONJ
bptjm-49	71	63	a	a	DET
bptjm-49	71	64	variant	variant	NOUN
bptjm-49	71	65	of	of	ADP
bptjm-49	71	66	ptpn12	ptpn12	NOUN
bptjm-49	71	67	(	(	PUNCT
bptjm-49	71	68	rs3750050	rs3750050	PROPN
bptjm-49	71	69	g	g	PROPN
bptjm-49	71	70	allele	allele	PROPN
bptjm-49	71	71	)	)	PUNCT
bptjm-49	71	72	increased	increase	VERB
bptjm-49	71	73	the	the	DET
bptjm-49	71	74	risk	risk	NOUN
bptjm-49	71	75	of	of	ADP
bptjm-49	71	76	crc	crc	NOUN
bptjm-49	71	77	by	by	ADP
bptjm-49	71	78	19%.33	19%.33	NUM
bptjm-49	71	79	conversely	conversely	ADV
bptjm-49	71	80	,	,	PUNCT
bptjm-49	71	81	upregulation	upregulation	NOUN
bptjm-49	71	82	of	of	ADP
bptjm-49	71	83	ptpn12	ptpn12	NOUN
bptjm-49	71	84	has	have	AUX
bptjm-49	71	85	been	be	AUX
bptjm-49	71	86	correlated	correlate	VERB
bptjm-49	71	87	with	with	ADP
bptjm-49	71	88	incidences	incidence	NOUN
bptjm-49	71	89	of	of	ADP
bptjm-49	71	90	esophageal	esophageal	ADJ
bptjm-49	71	91	carcinoma	carcinoma	NOUN
bptjm-49	71	92	,	,	PUNCT
bptjm-49	71	93	stomach	stomach	NOUN
bptjm-49	71	94	adenocarcinoma	adenocarcinoma	NOUN
bptjm-49	71	95	and	and	CCONJ
bptjm-49	71	96	colorectal	colorectal	ADJ
bptjm-49	71	97	cancer	cancer	NOUN
bptjm-49	71	98	,	,	PUNCT
bptjm-49	71	99	making	make	VERB
bptjm-49	71	100	it	it	PRON
bptjm-49	71	101	a	a	DET
bptjm-49	71	102	highly	highly	ADV
bptjm-49	71	103	favorable	favorable	ADJ
bptjm-49	71	104	candidate	candidate	NOUN
bptjm-49	71	105	for	for	ADP
bptjm-49	71	106	biomarker.34	biomarker.34	NOUN
bptjm-49	71	107	the	the	DET
bptjm-49	71	108	researchers	researcher	NOUN
bptjm-49	71	109	acknowledge	acknowledge	VERB
bptjm-49	71	110	that	that	SCONJ
bptjm-49	71	111	these	these	DET
bptjm-49	71	112	findings	finding	NOUN
bptjm-49	71	113	are	be	AUX
bptjm-49	71	114	seemingly	seemingly	ADV
bptjm-49	71	115	in	in	ADP
bptjm-49	71	116	contradiction	contradiction	NOUN
bptjm-49	71	117	with	with	ADP
bptjm-49	71	118	previous	previous	ADJ
bptjm-49	71	119	literature	literature	NOUN
bptjm-49	71	120	that	that	PRON
bptjm-49	71	121	suggests	suggest	VERB
bptjm-49	71	122	ptpn12	ptpn12	VERB
bptjm-49	71	123	to	to	PART
bptjm-49	71	124	have	have	VERB
bptjm-49	71	125	tumor	tumor	NOUN
bptjm-49	71	126	suppressing	suppress	VERB
bptjm-49	71	127	capabilities.34	capabilities.34	NOUN
bptjm-49	71	128	another	another	DET
bptjm-49	71	129	study	study	NOUN
bptjm-49	71	130	showed	show	VERB
bptjm-49	71	131	that	that	SCONJ
bptjm-49	71	132	ptpn12	ptpn12	NOUN
bptjm-49	71	133	might	might	AUX
bptjm-49	71	134	be	be	AUX
bptjm-49	71	135	a	a	DET
bptjm-49	71	136	favorable	favorable	ADJ
bptjm-49	71	137	prognosis	prognosis	NOUN
bptjm-49	71	138	marker	marker	NOUN
bptjm-49	71	139	for	for	ADP
bptjm-49	71	140	nsclc	nsclc	NOUN
bptjm-49	71	141	in	in	ADP
bptjm-49	71	142	patients	patient	NOUN
bptjm-49	71	143	due	due	ADP
bptjm-49	71	144	to	to	ADP
bptjm-49	71	145	higher	high	ADJ
bptjm-49	71	146	expression	expression	NOUN
bptjm-49	71	147	levels	level	NOUN
bptjm-49	71	148	associated	associate	VERB
bptjm-49	71	149	with	with	ADP
bptjm-49	71	150	higher	high	ADJ
bptjm-49	71	151	5	5	NUM
bptjm-49	71	152	-	-	PUNCT
bptjm-49	71	153	year	year	NOUN
bptjm-49	71	154	survival	survival	NOUN
bptjm-49	71	155	rates	rate	NOUN
bptjm-49	71	156	,	,	PUNCT
bptjm-49	71	157	especially	especially	ADV
bptjm-49	71	158	within	within	ADP
bptjm-49	71	159	the	the	DET
bptjm-49	71	160	subgroup	subgroup	NOUN
bptjm-49	71	161	with	with	ADP
bptjm-49	71	162	non	non	ADJ
bptjm-49	71	163	-	-	ADJ
bptjm-49	71	164	squamous	squamous	ADJ
bptjm-49	71	165	cell	cell	NOUN
bptjm-49	71	166	carcinoma.35	carcinoma.35	NOUN
bptjm-49	71	167	due	due	ADP
bptjm-49	71	168	to	to	ADP
bptjm-49	71	169	the	the	DET
bptjm-49	71	170	non	non	ADJ
bptjm-49	71	171	-	-	ADJ
bptjm-49	71	172	definitive	definitive	ADJ
bptjm-49	71	173	role	role	NOUN
bptjm-49	71	174	of	of	ADP
bptjm-49	71	175	ptpn12	ptpn12	NOUN
bptjm-49	71	176	,	,	PUNCT
bptjm-49	71	177	further	further	ADJ
bptjm-49	71	178	research	research	NOUN
bptjm-49	71	179	still	still	ADV
bptjm-49	71	180	needs	need	VERB
bptjm-49	71	181	to	to	PART
bptjm-49	71	182	be	be	AUX
bptjm-49	71	183	conducted.33	conducted.33	NOUN
bptjm-49	71	184	-	-	PUNCT
bptjm-49	71	185	35	35	NUM
bptjm-49	71	186	8	8	NUM
bptjm-49	71	187	.	.	PUNCT
bptjm-49	72	1	ptpn13	ptpn13	VERB
bptjm-49	72	2	like	like	SCONJ
bptjm-49	72	3	many	many	ADJ
bptjm-49	72	4	of	of	ADP
bptjm-49	72	5	the	the	DET
bptjm-49	72	6	other	other	ADJ
bptjm-49	72	7	ptpns	ptpns	NOUN
bptjm-49	72	8	previously	previously	ADV
bptjm-49	72	9	discussed	discuss	VERB
bptjm-49	72	10	,	,	PUNCT
bptjm-49	72	11	ptpn13	ptpn13	NOUN
bptjm-49	72	12	has	have	AUX
bptjm-49	72	13	been	be	AUX
bptjm-49	72	14	shown	show	VERB
bptjm-49	72	15	to	to	PART
bptjm-49	72	16	have	have	VERB
bptjm-49	72	17	both	both	PRON
bptjm-49	72	18	tumor	tumor	NOUN
bptjm-49	72	19	suppressive	suppressive	NOUN
bptjm-49	72	20	and	and	CCONJ
bptjm-49	72	21	tumor	tumor	NOUN
bptjm-49	72	22	promoting	promote	VERB
bptjm-49	72	23	roles	role	NOUN
bptjm-49	72	24	depending	depend	VERB
bptjm-49	72	25	on	on	ADP
bptjm-49	72	26	the	the	DET
bptjm-49	72	27	cancer	cancer	NOUN
bptjm-49	73	1	being	be	AUX
bptjm-49	73	2	examined.36	examined.36	VERB
bptjm-49	73	3	ptpn13	ptpn13	NOUN
bptjm-49	73	4	was	be	AUX
bptjm-49	73	5	shown	show	VERB
bptjm-49	73	6	to	to	PART
bptjm-49	73	7	act	act	VERB
bptjm-49	73	8	as	as	ADP
bptjm-49	73	9	a	a	DET
bptjm-49	73	10	tumor	tumor	NOUN
bptjm-49	73	11	suppressor	suppressor	NOUN
bptjm-49	73	12	in	in	ADP
bptjm-49	73	13	breast	breast	NOUN
bptjm-49	73	14	cancer37	cancer37	NOUN
bptjm-49	73	15	and	and	CCONJ
bptjm-49	73	16	high	high	ADJ
bptjm-49	73	17	grade	grade	NOUN
bptjm-49	73	18	serous	serous	ADJ
bptjm-49	73	19	ovarian	ovarian	ADJ
bptjm-49	73	20	carcinoma.38	carcinoma.38	NOUN
bptjm-49	73	21	likewise	likewise	ADV
bptjm-49	73	22	,	,	PUNCT
bptjm-49	73	23	in	in	ADP
bptjm-49	73	24	lung	lung	NOUN
bptjm-49	73	25	cancer	cancer	NOUN
bptjm-49	73	26	,	,	PUNCT
bptjm-49	73	27	ptpn13	ptpn13	NOUN
bptjm-49	73	28	has	have	AUX
bptjm-49	73	29	been	be	AUX
bptjm-49	73	30	shown	show	VERB
bptjm-49	73	31	to	to	PART
bptjm-49	73	32	have	have	VERB
bptjm-49	73	33	tumor	tumor	NOUN
bptjm-49	73	34	suppressor	suppressor	NOUN
bptjm-49	73	35	capabilities	capability	NOUN
bptjm-49	73	36	by	by	ADP
bptjm-49	73	37	acting	act	VERB
bptjm-49	73	38	on	on	ADP
bptjm-49	73	39	various	various	ADJ
bptjm-49	73	40	pathways.38	pathways.38	NOUN
bptjm-49	73	41	-	-	PUNCT
bptjm-49	73	42	42	42	NUM
bptjm-49	73	43	ptpn13	ptpn13	NOUN
bptjm-49	73	44	is	be	AUX
bptjm-49	73	45	downregulated	downregulate	VERB
bptjm-49	73	46	in	in	ADP
bptjm-49	73	47	lung	lung	NOUN
bptjm-49	73	48	cancer	cancer	NOUN
bptjm-49	73	49	mainly	mainly	ADV
bptjm-49	73	50	due	due	ADP
bptjm-49	73	51	to	to	ADP
bptjm-49	73	52	a	a	DET
bptjm-49	73	53	loss	loss	NOUN
bptjm-49	73	54	of	of	ADP
bptjm-49	73	55	at	at	ADV
bptjm-49	73	56	least	least	ADV
bptjm-49	73	57	one	one	NUM
bptjm-49	73	58	copy	copy	NOUN
bptjm-49	73	59	of	of	ADP
bptjm-49	73	60	the	the	DET
bptjm-49	73	61	ptpn13	ptpn13	NOUN
bptjm-49	73	62	locus	locus	NOUN
bptjm-49	73	63	at	at	ADP
bptjm-49	73	64	chromosome	chromosome	NOUN
bptjm-49	73	65	4q.40	4q.40	NUM
bptjm-49	73	66	40	40	NUM
bptjm-49	73	67	%	%	NOUN
bptjm-49	73	68	of	of	ADP
bptjm-49	73	69	cases	case	NOUN
bptjm-49	73	70	are	be	AUX
bptjm-49	73	71	not	not	PART
bptjm-49	73	72	accounted	account	VERB
bptjm-49	73	73	for	for	ADP
bptjm-49	73	74	by	by	ADP
bptjm-49	73	75	this	this	DET
bptjm-49	73	76	mechanism	mechanism	NOUN
bptjm-49	73	77	,	,	PUNCT
bptjm-49	73	78	however	however	ADV
bptjm-49	73	79	,	,	PUNCT
bptjm-49	73	80	and	and	CCONJ
bptjm-49	73	81	further	further	ADJ
bptjm-49	73	82	research	research	NOUN
bptjm-49	73	83	is	be	AUX
bptjm-49	73	84	needed	need	VERB
bptjm-49	73	85	to	to	PART
bptjm-49	73	86	understand	understand	VERB
bptjm-49	73	87	how	how	SCONJ
bptjm-49	73	88	it	it	PRON
bptjm-49	73	89	is	be	AUX
bptjm-49	73	90	downregulated	downregulate	VERB
bptjm-49	73	91	in	in	ADP
bptjm-49	73	92	those	those	DET
bptjm-49	73	93	cases.40	cases.40	PROPN
bptjm-49	73	94	various	various	ADJ
bptjm-49	73	95	studies	study	NOUN
bptjm-49	73	96	have	have	AUX
bptjm-49	73	97	shown	show	VERB
bptjm-49	73	98	that	that	SCONJ
bptjm-49	73	99	ptpn13	ptpn13	PROPN
bptjm-49	73	100	berkeley	berkeley	PROPN
bptjm-49	73	101	pharma	pharma	PROPN
bptjm-49	73	102	tech	tech	NOUN
bptjm-49	73	103	journal	journal	NOUN
bptjm-49	73	104	of	of	ADP
bptjm-49	73	105	medicine	medicine	NOUN
bptjm-49	73	106	|	|	ADV
bptjm-49	73	107	91	91	NUM
bptjm-49	73	108	downregulation	downregulation	NOUN
bptjm-49	73	109	results	result	NOUN
bptjm-49	73	110	in	in	ADP
bptjm-49	73	111	increased	increase	VERB
bptjm-49	73	112	proliferation	proliferation	NOUN
bptjm-49	73	113	of	of	ADP
bptjm-49	73	114	nsclc	nsclc	NOUN
bptjm-49	73	115	[	[	X
bptjm-49	73	116	39	39	NUM
bptjm-49	73	117	-	-	SYM
bptjm-49	73	118	41	41	NUM
bptjm-49	73	119	]	]	PUNCT
bptjm-49	73	120	in	in	ADP
bptjm-49	73	121	addition	addition	NOUN
bptjm-49	73	122	to	to	ADP
bptjm-49	73	123	greater	great	ADJ
bptjm-49	73	124	tumor	tumor	NOUN
bptjm-49	73	125	cell	cell	NOUN
bptjm-49	73	126	size.40	size.40	NOUN
bptjm-49	73	127	to	to	PART
bptjm-49	73	128	further	far	ADV
bptjm-49	73	129	confirm	confirm	VERB
bptjm-49	73	130	the	the	DET
bptjm-49	73	131	role	role	NOUN
bptjm-49	73	132	of	of	ADP
bptjm-49	73	133	ptpn13	ptpn13	NOUN
bptjm-49	73	134	,	,	PUNCT
bptjm-49	73	135	ptpn13	ptpn13	NOUN
bptjm-49	73	136	expression	expression	NOUN
bptjm-49	73	137	was	be	AUX
bptjm-49	73	138	restored	restore	VERB
bptjm-49	73	139	to	to	ADP
bptjm-49	73	140	ptpn13	ptpn13	VERB
bptjm-49	73	141	knockdown	knockdown	NOUN
bptjm-49	73	142	cells	cell	NOUN
bptjm-49	73	143	and	and	CCONJ
bptjm-49	73	144	this	this	PRON
bptjm-49	73	145	resulted	result	VERB
bptjm-49	73	146	in	in	ADP
bptjm-49	73	147	slower	slow	ADJ
bptjm-49	73	148	proliferation	proliferation	NOUN
bptjm-49	73	149	of	of	ADP
bptjm-49	73	150	nsclc.40	nsclc.40	PROPN
bptjm-49	73	151	ptpn13	ptpn13	PROPN
bptjm-49	73	152	’s	’s	PART
bptjm-49	73	153	tumor	tumor	NOUN
bptjm-49	73	154	suppressing	suppress	VERB
bptjm-49	73	155	capabilities	capability	NOUN
bptjm-49	73	156	stem	stem	VERB
bptjm-49	73	157	from	from	ADP
bptjm-49	73	158	it	it	PRON
bptjm-49	73	159	inhibiting	inhibit	VERB
bptjm-49	73	160	various	various	ADJ
bptjm-49	73	161	oncogenic	oncogenic	ADJ
bptjm-49	73	162	pathways	pathway	NOUN
bptjm-49	73	163	.	.	PUNCT
bptjm-49	74	1	this	this	PRON
bptjm-49	74	2	is	be	AUX
bptjm-49	74	3	explored	explore	VERB
bptjm-49	74	4	through	through	ADP
bptjm-49	74	5	the	the	DET
bptjm-49	74	6	use	use	NOUN
bptjm-49	74	7	of	of	ADP
bptjm-49	74	8	micrornas	microrna	NOUN
bptjm-49	74	9	which	which	PRON
bptjm-49	74	10	are	be	AUX
bptjm-49	74	11	known	know	VERB
bptjm-49	74	12	to	to	PART
bptjm-49	74	13	have	have	VERB
bptjm-49	74	14	different	different	ADJ
bptjm-49	74	15	effects	effect	NOUN
bptjm-49	74	16	on	on	ADP
bptjm-49	74	17	luad	luad	ADJ
bptjm-49	74	18	proliferation	proliferation	NOUN
bptjm-49	74	19	.	.	PUNCT
bptjm-49	75	1	for	for	ADP
bptjm-49	75	2	example	example	NOUN
bptjm-49	75	3	,	,	PUNCT
bptjm-49	75	4	mir-36143	mir-36143	NOUN
bptjm-49	75	5	and	and	CCONJ
bptjm-49	75	6	mir-34044	mir-34044	NOUN
bptjm-49	75	7	inhibit	inhibit	VERB
bptjm-49	75	8	luad	luad	NOUN
bptjm-49	75	9	cell	cell	NOUN
bptjm-49	75	10	growth	growth	NOUN
bptjm-49	75	11	while	while	SCONJ
bptjm-49	75	12	mir-48345	mir-48345	NOUN
bptjm-49	75	13	and	and	CCONJ
bptjm-49	75	14	mir-22446	mir-22446	NOUN
bptjm-49	75	15	promote	promote	VERB
bptjm-49	75	16	luad	luad	ADJ
bptjm-49	75	17	cell	cell	NOUN
bptjm-49	75	18	growth	growth	NOUN
bptjm-49	75	19	.	.	PUNCT
bptjm-49	76	1	microrna-30e-5p	microrna-30e-5p	PROPN
bptjm-49	76	2	(	(	PUNCT
bptjm-49	76	3	mir-30e	mir-30e	NUM
bptjm-49	76	4	)	)	PUNCT
bptjm-49	76	5	is	be	AUX
bptjm-49	76	6	of	of	ADP
bptjm-49	76	7	interest	interest	NOUN
bptjm-49	76	8	to	to	ADP
bptjm-49	76	9	this	this	DET
bptjm-49	76	10	review	review	NOUN
bptjm-49	76	11	paper	paper	NOUN
bptjm-49	76	12	due	due	ADP
bptjm-49	76	13	to	to	ADP
bptjm-49	76	14	its	its	PRON
bptjm-49	76	15	ability	ability	NOUN
bptjm-49	76	16	to	to	PART
bptjm-49	76	17	downregulate	downregulate	VERB
bptjm-49	76	18	ptpn13	ptpn13	NOUN
bptjm-49	77	1	[	[	X
bptjm-49	77	2	figure	figure	NOUN
bptjm-49	77	3	4b	4b	X
bptjm-49	77	4	]	]	PUNCT
bptjm-49	77	5	.	.	PUNCT
bptjm-49	78	1	knockdown	knockdown	NOUN
bptjm-49	78	2	of	of	ADP
bptjm-49	78	3	mir-30e	mir-30e	NUM
bptjm-49	78	4	suppresses	suppress	VERB
bptjm-49	78	5	luad	luad	ADJ
bptjm-49	78	6	growth	growth	NOUN
bptjm-49	78	7	,	,	PUNCT
bptjm-49	78	8	suggesting	suggest	VERB
bptjm-49	78	9	that	that	SCONJ
bptjm-49	78	10	the	the	DET
bptjm-49	78	11	presence	presence	NOUN
bptjm-49	78	12	of	of	ADP
bptjm-49	78	13	mir-30e	mir-30e	NUM
bptjm-49	78	14	is	be	AUX
bptjm-49	78	15	indicative	indicative	ADJ
bptjm-49	78	16	of	of	ADP
bptjm-49	78	17	poor	poor	ADJ
bptjm-49	78	18	prognosis.39	prognosis.39	NOUN
bptjm-49	78	19	upregulation	upregulation	NOUN
bptjm-49	78	20	of	of	ADP
bptjm-49	78	21	ptpn13	ptpn13	NOUN
bptjm-49	78	22	counteracts	counteract	VERB
bptjm-49	78	23	the	the	DET
bptjm-49	78	24	tumor	tumor	NOUN
bptjm-49	78	25	promoting	promote	VERB
bptjm-49	78	26	effects	effect	NOUN
bptjm-49	78	27	of	of	ADP
bptjm-49	78	28	mir-30e	mir-30e	NUM
bptjm-49	78	29	by	by	ADP
bptjm-49	78	30	inhibiting	inhibit	VERB
bptjm-49	78	31	egfr	egfr	NOUN
bptjm-49	78	32	/	/	SYM
bptjm-49	78	33	akt	akt	PROPN
bptjm-49	78	34	signaling.39	signaling.39	PROPN
bptjm-49	78	35	ptpn13	ptpn13	PROPN
bptjm-49	78	36	was	be	AUX
bptjm-49	78	37	also	also	ADV
bptjm-49	78	38	shown	show	VERB
bptjm-49	78	39	to	to	PART
bptjm-49	78	40	inhibit	inhibit	VERB
bptjm-49	78	41	the	the	DET
bptjm-49	78	42	src	src	PROPN
bptjm-49	78	43	/	/	SYM
bptjm-49	78	44	erk	erk	PROPN
bptjm-49	78	45	/	/	SYM
bptjm-49	78	46	yap1	yap1	NOUN
bptjm-49	78	47	signaling	signal	VERB
bptjm-49	78	48	pathway	pathway	NOUN
bptjm-49	78	49	,	,	PUNCT
bptjm-49	78	50	further	far	ADV
bptjm-49	78	51	contributing	contribute	VERB
bptjm-49	78	52	to	to	ADP
bptjm-49	78	53	its	its	PRON
bptjm-49	78	54	tumor	tumor	NOUN
bptjm-49	78	55	suppressive	suppressive	ADJ
bptjm-49	78	56	properties	property	NOUN
bptjm-49	78	57	in	in	ADP
bptjm-49	78	58	lung	lung	NOUN
bptjm-49	78	59	cancer	cancer	NOUN
bptjm-49	78	60	.	.	PUNCT
bptjm-49	79	1	yap1	yap1	PROPN
bptjm-49	79	2	promotes	promote	VERB
bptjm-49	79	3	the	the	DET
bptjm-49	79	4	proliferation	proliferation	NOUN
bptjm-49	79	5	of	of	ADP
bptjm-49	79	6	nsclc	nsclc	NOUN
bptjm-49	79	7	cells	cell	NOUN
bptjm-49	79	8	,	,	PUNCT
bptjm-49	79	9	classifying	classify	VERB
bptjm-49	79	10	it	it	PRON
bptjm-49	79	11	as	as	ADP
bptjm-49	79	12	an	an	DET
bptjm-49	79	13	oncoprotein.42,47	oncoprotein.42,47	ADJ
bptjm-49	79	14	yap1	yap1	NOUN
bptjm-49	79	15	has	have	AUX
bptjm-49	79	16	also	also	ADV
bptjm-49	79	17	been	be	AUX
bptjm-49	79	18	shown	show	VERB
bptjm-49	79	19	to	to	PART
bptjm-49	79	20	activate	activate	VERB
bptjm-49	79	21	the	the	DET
bptjm-49	79	22	mek	mek	PROPN
bptjm-49	79	23	/	/	SYM
bptjm-49	79	24	erk	erk	PROPN
bptjm-49	79	25	pathway	pathway	NOUN
bptjm-49	79	26	by	by	ADP
bptjm-49	79	27	promoting	promote	VERB
bptjm-49	79	28	the	the	DET
bptjm-49	79	29	expression	expression	NOUN
bptjm-49	79	30	of	of	ADP
bptjm-49	79	31	fgf239	fgf239	NOUN
bptjm-49	79	32	[	[	X
bptjm-49	79	33	figure	figure	NOUN
bptjm-49	79	34	4a	4a	NOUN
bptjm-49	79	35	]	]	PUNCT
bptjm-49	79	36	.	.	PUNCT
bptjm-49	80	1	nuclear	nuclear	ADJ
bptjm-49	80	2	yap1	yap1	PROPN
bptjm-49	80	3	levels	level	NOUN
bptjm-49	80	4	were	be	AUX
bptjm-49	80	5	increased	increase	VERB
bptjm-49	80	6	in	in	ADP
bptjm-49	80	7	ptpn13	ptpn13	NOUN
bptjm-49	80	8	knockdown	knockdown	NOUN
bptjm-49	80	9	cells	cell	NOUN
bptjm-49	80	10	,	,	PUNCT
bptjm-49	80	11	indicating	indicate	VERB
bptjm-49	80	12	that	that	SCONJ
bptjm-49	80	13	ptpn13	ptpn13	NOUN
bptjm-49	80	14	might	might	AUX
bptjm-49	80	15	act	act	VERB
bptjm-49	80	16	to	to	PART
bptjm-49	80	17	inhibit	inhibit	VERB
bptjm-49	80	18	yap1	yap1	PROPN
bptjm-49	80	19	.	.	PUNCT
bptjm-49	81	1	it	it	PRON
bptjm-49	81	2	is	be	AUX
bptjm-49	81	3	also	also	ADV
bptjm-49	81	4	thought	think	VERB
bptjm-49	81	5	that	that	SCONJ
bptjm-49	81	6	yap1	yap1	NOUN
bptjm-49	81	7	could	could	AUX
bptjm-49	81	8	be	be	AUX
bptjm-49	81	9	upregulated	upregulate	VERB
bptjm-49	81	10	via	via	ADP
bptjm-49	81	11	the	the	DET
bptjm-49	81	12	mek	mek	PROPN
bptjm-49	81	13	/	/	SYM
bptjm-49	81	14	erk	erk	PROPN
bptjm-49	81	15	pathway	pathway	NOUN
bptjm-49	81	16	when	when	SCONJ
bptjm-49	81	17	ptpn13	ptpn13	NOUN
bptjm-49	81	18	is	be	AUX
bptjm-49	81	19	suppressed.42	suppressed.42	NOUN
bptjm-49	81	20	thus	thus	ADV
bptjm-49	81	21	,	,	PUNCT
bptjm-49	81	22	another	another	DET
bptjm-49	81	23	pathway	pathway	NOUN
bptjm-49	81	24	by	by	ADP
bptjm-49	81	25	which	which	DET
bptjm-49	81	26	ptpn13	ptpn13	NOUN
bptjm-49	81	27	acts	act	VERB
bptjm-49	81	28	as	as	ADP
bptjm-49	81	29	a	a	DET
bptjm-49	81	30	tumor	tumor	NOUN
bptjm-49	81	31	suppressor	suppressor	NOUN
bptjm-49	81	32	is	be	AUX
bptjm-49	81	33	by	by	ADP
bptjm-49	81	34	inhibiting	inhibit	VERB
bptjm-49	81	35	the	the	DET
bptjm-49	81	36	mek	mek	PROPN
bptjm-49	81	37	/	/	SYM
bptjm-49	81	38	erk	erk	PROPN
bptjm-49	81	39	pathway	pathway	NOUN
bptjm-49	81	40	,	,	PUNCT
bptjm-49	81	41	which	which	PRON
bptjm-49	81	42	suppresses	suppress	VERB
bptjm-49	81	43	the	the	DET
bptjm-49	81	44	upregulation	upregulation	NOUN
bptjm-49	81	45	of	of	ADP
bptjm-49	81	46	yap1	yap1	PROPN
bptjm-49	81	47	.	.	PUNCT
bptjm-49	82	1	various	various	ADJ
bptjm-49	82	2	cancers	cancer	NOUN
bptjm-49	82	3	,	,	PUNCT
bptjm-49	82	4	including	include	VERB
bptjm-49	82	5	lung	lung	NOUN
bptjm-49	82	6	cancer	cancer	NOUN
bptjm-49	82	7	,	,	PUNCT
bptjm-49	82	8	have	have	AUX
bptjm-49	82	9	been	be	AUX
bptjm-49	82	10	shown	show	VERB
bptjm-49	82	11	to	to	PART
bptjm-49	82	12	have	have	VERB
bptjm-49	82	13	higher	high	ADJ
bptjm-49	82	14	than	than	ADP
bptjm-49	82	15	normal	normal	ADJ
bptjm-49	82	16	levels	level	NOUN
bptjm-49	82	17	of	of	ADP
bptjm-49	82	18	her2	her2	PROPN
bptjm-49	82	19	,	,	PUNCT
bptjm-49	82	20	indicating	indicate	VERB
bptjm-49	82	21	that	that	SCONJ
bptjm-49	82	22	upregulation	upregulation	NOUN
bptjm-49	82	23	of	of	ADP
bptjm-49	82	24	her2	her2	PROPN
bptjm-49	82	25	leads	lead	VERB
bptjm-49	82	26	to	to	ADP
bptjm-49	82	27	tumor	tumor	NOUN
bptjm-49	82	28	growth	growth	NOUN
bptjm-49	82	29	and	and	CCONJ
bptjm-49	82	30	poor	poor	ADJ
bptjm-49	82	31	prognosis	prognosis	NOUN
bptjm-49	82	32	.	.	PUNCT
bptjm-49	83	1	ptpn13	ptpn13	NOUN
bptjm-49	83	2	downregulates	downregulate	NOUN
bptjm-49	83	3	her2	her2	VERB
bptjm-49	83	4	activity	activity	NOUN
bptjm-49	83	5	by	by	ADP
bptjm-49	83	6	dephosphorylating	dephosphorylate	VERB
bptjm-49	83	7	the	the	DET
bptjm-49	83	8	cytoplasmic	cytoplasmic	ADJ
bptjm-49	83	9	domain	domain	NOUN
bptjm-49	83	10	of	of	ADP
bptjm-49	83	11	her2	her2	PROPN
bptjm-49	83	12	,	,	PUNCT
bptjm-49	83	13	possibly	possibly	ADV
bptjm-49	83	14	decreasing	decrease	VERB
bptjm-49	83	15	the	the	DET
bptjm-49	83	16	metastasis	metastasis	NOUN
bptjm-49	83	17	associated	associate	VERB
bptjm-49	83	18	with	with	ADP
bptjm-49	83	19	her2	her2	PROPN
bptjm-49	83	20	-	-	PUNCT
bptjm-49	83	21	overactive	overactive	ADJ
bptjm-49	83	22	nsclc	nsclc	NOUN
bptjm-49	83	23	tumor	tumor	NOUN
bptjm-49	83	24	cells.41	cells.41	PROPN
bptjm-49	83	25	ptpn13	ptpn13	NOUN
bptjm-49	83	26	was	be	AUX
bptjm-49	83	27	also	also	ADV
bptjm-49	83	28	found	find	VERB
bptjm-49	83	29	to	to	PART
bptjm-49	83	30	dephosphorylate	dephosphorylate	VERB
bptjm-49	83	31	egfr.40	egfr.40	ADJ
bptjm-49	83	32	downregulation	downregulation	NOUN
bptjm-49	83	33	of	of	ADP
bptjm-49	83	34	ptpn13	ptpn13	NOUN
bptjm-49	83	35	increased	increase	VERB
bptjm-49	83	36	egf	egf	PROPN
bptjm-49	83	37	-	-	PUNCT
bptjm-49	83	38	stimulated	stimulate	VERB
bptjm-49	83	39	egfr	egfr	NOUN
bptjm-49	83	40	and	and	CCONJ
bptjm-49	83	41	her2	her2	PROPN
bptjm-49	83	42	phosphorylation	phosphorylation	NOUN
bptjm-49	83	43	,	,	PUNCT
bptjm-49	83	44	leading	lead	VERB
bptjm-49	83	45	to	to	ADP
bptjm-49	83	46	increased	increase	VERB
bptjm-49	83	47	activation	activation	NOUN
bptjm-49	83	48	of	of	ADP
bptjm-49	83	49	mapk	mapk	NOUN
bptjm-49	83	50	and	and	CCONJ
bptjm-49	83	51	akt	akt	PROPN
bptjm-49	83	52	dependent	dependent	ADJ
bptjm-49	83	53	pathways.40	pathways.40	PROPN
bptjm-49	83	54	berkeley	berkeley	PROPN
bptjm-49	83	55	pharma	pharma	PROPN
bptjm-49	83	56	tech	tech	PROPN
bptjm-49	83	57	journal	journal	NOUN
bptjm-49	83	58	of	of	ADP
bptjm-49	83	59	medicine	medicine	NOUN
bptjm-49	83	60	|	|	ADV
bptjm-49	83	61	92	92	NUM
bptjm-49	83	62	figure	figure	NOUN
bptjm-49	83	63	4	4	NUM
bptjm-49	83	64	:	:	PUNCT
bptjm-49	83	65	overview	overview	NOUN
bptjm-49	83	66	of	of	ADP
bptjm-49	83	67	ptpn13	ptpn13	NOUN
bptjm-49	83	68	’s	’s	PART
bptjm-49	83	69	effect	effect	NOUN
bptjm-49	83	70	on	on	ADP
bptjm-49	83	71	various	various	ADJ
bptjm-49	83	72	pathways	pathway	NOUN
bptjm-49	83	73	.	.	PUNCT
bptjm-49	84	1	ptpn13	ptpn13	NOUN
bptjm-49	84	2	has	have	AUX
bptjm-49	84	3	been	be	AUX
bptjm-49	84	4	shown	show	VERB
bptjm-49	84	5	to	to	PART
bptjm-49	84	6	work	work	VERB
bptjm-49	84	7	by	by	ADP
bptjm-49	84	8	affecting	affect	VERB
bptjm-49	84	9	the	the	DET
bptjm-49	84	10	mek	mek	PROPN
bptjm-49	84	11	/	/	SYM
bptjm-49	84	12	erk	erk	PROPN
bptjm-49	84	13	pathway	pathway	NOUN
bptjm-49	84	14	in	in	ADP
bptjm-49	84	15	different	different	ADJ
bptjm-49	84	16	ways	way	NOUN
bptjm-49	84	17	.	.	PUNCT
bptjm-49	85	1	a	a	DET
bptjm-49	85	2	)	)	PUNCT
bptjm-49	85	3	ptpn13	ptpn13	NOUN
bptjm-49	85	4	can	can	AUX
bptjm-49	85	5	downregulate	downregulate	VERB
bptjm-49	85	6	egfr	egfr	NOUN
bptjm-49	85	7	and	and	CCONJ
bptjm-49	85	8	her2	her2	VERB
bptjm-49	85	9	receptors	receptor	NOUN
bptjm-49	85	10	by	by	ADP
bptjm-49	85	11	dephosphorylating	dephosphorylate	VERB
bptjm-49	85	12	them	they	PRON
bptjm-49	85	13	[	[	X
bptjm-49	85	14	40	40	NUM
bptjm-49	85	15	]	]	PUNCT
bptjm-49	85	16	.	.	PUNCT
bptjm-49	86	1	yap1	yap1	PROPN
bptjm-49	86	2	levels	level	NOUN
bptjm-49	86	3	decrease	decrease	VERB
bptjm-49	86	4	in	in	ADP
bptjm-49	86	5	the	the	DET
bptjm-49	86	6	presence	presence	NOUN
bptjm-49	86	7	of	of	ADP
bptjm-49	86	8	ptpn13	ptpn13	NOUN
bptjm-49	86	9	,	,	PUNCT
bptjm-49	86	10	which	which	PRON
bptjm-49	86	11	could	could	AUX
bptjm-49	86	12	be	be	AUX
bptjm-49	86	13	due	due	ADJ
bptjm-49	86	14	to	to	ADP
bptjm-49	86	15	ptpn13	ptpn13	VERB
bptjm-49	86	16	inhibiting	inhibit	VERB
bptjm-49	86	17	the	the	DET
bptjm-49	86	18	mek/	mek/	PROPN
bptjm-49	86	19	erk	erk	PROPN
bptjm-49	86	20	pathway	pathway	NOUN
bptjm-49	86	21	.	.	PUNCT
bptjm-49	87	1	b	b	X
bptjm-49	87	2	)	)	PUNCT
bptjm-49	87	3	mir-30e	mir-30e	NUM
bptjm-49	87	4	is	be	AUX
bptjm-49	87	5	capable	capable	ADJ
bptjm-49	87	6	of	of	ADP
bptjm-49	87	7	downregulating	downregulating	NOUN
bptjm-49	87	8	ptpn13	ptpn13	NOUN
bptjm-49	87	9	,	,	PUNCT
bptjm-49	87	10	resulting	result	VERB
bptjm-49	87	11	in	in	ADP
bptjm-49	87	12	increased	increase	VERB
bptjm-49	87	13	cell	cell	NOUN
bptjm-49	87	14	growth	growth	NOUN
bptjm-49	87	15	in	in	ADP
bptjm-49	87	16	luad	luad	NOUN
bptjm-49	87	17	by	by	ADP
bptjm-49	87	18	promoting	promote	VERB
bptjm-49	87	19	egfr	egfr	ADJ
bptjm-49	87	20	/	/	SYM
bptjm-49	87	21	akt	akt	PROPN
bptjm-49	87	22	signaling	signal	VERB
bptjm-49	87	23	.	.	PUNCT
bptjm-49	88	1	9	9	X
bptjm-49	88	2	.	.	X
bptjm-49	88	3	current	current	ADJ
bptjm-49	88	4	clinical	clinical	ADJ
bptjm-49	88	5	trials	trial	NOUN
bptjm-49	88	6	there	there	PRON
bptjm-49	88	7	are	be	VERB
bptjm-49	88	8	ongoing	ongoing	ADJ
bptjm-49	88	9	clinical	clinical	ADJ
bptjm-49	88	10	trials	trial	NOUN
bptjm-49	88	11	exploring	explore	VERB
bptjm-49	88	12	the	the	DET
bptjm-49	88	13	efficacy	efficacy	NOUN
bptjm-49	88	14	of	of	ADP
bptjm-49	88	15	small	small	ADJ
bptjm-49	88	16	molecule	molecule	NOUN
bptjm-49	88	17	inhibitors	inhibitor	NOUN
bptjm-49	88	18	on	on	ADP
bptjm-49	88	19	ptpn11	ptpn11	NOUN
bptjm-49	88	20	,	,	PUNCT
bptjm-49	88	21	like	like	ADP
bptjm-49	88	22	jab-3068	jab-3068	NOUN
bptjm-49	88	23	and	and	CCONJ
bptjm-49	88	24	jab-3312	jab-3312	NOUN
bptjm-49	88	25	,	,	PUNCT
bptjm-49	88	26	in	in	ADP
bptjm-49	88	27	patients	patient	NOUN
bptjm-49	88	28	with	with	ADP
bptjm-49	88	29	advanced	advanced	ADJ
bptjm-49	88	30	solid	solid	ADJ
bptjm-49	88	31	tumors	tumor	NOUN
bptjm-49	88	32	.	.	PUNCT
bptjm-49	89	1	it	it	PRON
bptjm-49	89	2	is	be	AUX
bptjm-49	89	3	hypothesized	hypothesize	VERB
bptjm-49	89	4	that	that	SCONJ
bptjm-49	89	5	these	these	DET
bptjm-49	89	6	small	small	ADJ
bptjm-49	89	7	molecules	molecule	NOUN
bptjm-49	89	8	will	will	AUX
bptjm-49	89	9	prevent	prevent	VERB
bptjm-49	89	10	various	various	ADJ
bptjm-49	89	11	oncogenic	oncogenic	ADJ
bptjm-49	89	12	phenotypes	phenotype	NOUN
bptjm-49	89	13	associated	associate	VERB
bptjm-49	89	14	with	with	ADP
bptjm-49	89	15	hyperactivation	hyperactivation	NOUN
bptjm-49	89	16	of	of	ADP
bptjm-49	89	17	shp2	shp2	NOUN
bptjm-49	89	18	mediated	mediate	VERB
bptjm-49	89	19	signal	signal	NOUN
bptjm-49	89	20	transduction	transduction	NOUN
bptjm-49	89	21	pathways	pathway	NOUN
bptjm-49	89	22	.	.	PUNCT
bptjm-49	90	1	jab-3068	jab-3068	PROPN
bptjm-49	90	2	is	be	AUX
bptjm-49	90	3	currently	currently	ADV
bptjm-49	90	4	in	in	ADP
bptjm-49	90	5	phase	phase	NOUN
bptjm-49	90	6	1/2a	1/2a	NUM
bptjm-49	90	7	and	and	CCONJ
bptjm-49	90	8	is	be	AUX
bptjm-49	90	9	recruiting	recruit	VERB
bptjm-49	90	10	patients	patient	NOUN
bptjm-49	90	11	with	with	ADP
bptjm-49	90	12	advanced	advanced	ADJ
bptjm-49	90	13	solid	solid	ADJ
bptjm-49	90	14	tumors	tumor	NOUN
bptjm-49	90	15	of	of	ADP
bptjm-49	90	16	nsclc	nsclc	NOUN
bptjm-49	90	17	,	,	PUNCT
bptjm-49	90	18	head	head	NOUN
bptjm-49	90	19	and	and	CCONJ
bptjm-49	90	20	neck	neck	NOUN
bptjm-49	90	21	cancer	cancer	NOUN
bptjm-49	90	22	,	,	PUNCT
bptjm-49	90	23	esophageal	esophageal	ADJ
bptjm-49	90	24	cancer	cancer	NOUN
bptjm-49	90	25	,	,	PUNCT
bptjm-49	90	26	and	and	CCONJ
bptjm-49	90	27	other	other	ADJ
bptjm-49	90	28	metastatic	metastatic	ADJ
bptjm-49	90	29	solid	solid	ADJ
bptjm-49	90	30	tumors.49	tumors.49	NOUN
bptjm-49	90	31	the	the	DET
bptjm-49	90	32	experiment	experiment	NOUN
bptjm-49	90	33	will	will	AUX
bptjm-49	90	34	consist	consist	VERB
bptjm-49	90	35	of	of	ADP
bptjm-49	90	36	oral	oral	ADJ
bptjm-49	90	37	administration	administration	NOUN
bptjm-49	90	38	of	of	ADP
bptjm-49	90	39	jab-3068	jab-3068	NOUN
bptjm-49	90	40	every	every	DET
bptjm-49	90	41	morning	morning	NOUN
bptjm-49	90	42	after	after	ADP
bptjm-49	90	43	a	a	DET
bptjm-49	90	44	six	six	NUM
bptjm-49	90	45	hour	hour	NOUN
bptjm-49	90	46	fast.49	fast.49	ADP
bptjm-49	90	47	a	a	DET
bptjm-49	90	48	pharmacokinetics	pharmacokinetic	NOUN
bptjm-49	90	49	(	(	PUNCT
bptjm-49	90	50	pk	pk	NOUN
bptjm-49	90	51	)	)	PUNCT
bptjm-49	90	52	analysis	analysis	NOUN
bptjm-49	90	53	will	will	AUX
bptjm-49	90	54	be	be	AUX
bptjm-49	90	55	taken	take	VERB
bptjm-49	90	56	which	which	PRON
bptjm-49	90	57	will	will	AUX
bptjm-49	90	58	be	be	AUX
bptjm-49	90	59	used	use	VERB
bptjm-49	90	60	to	to	PART
bptjm-49	90	61	monitor	monitor	VERB
bptjm-49	90	62	the	the	DET
bptjm-49	90	63	drug	drug	NOUN
bptjm-49	90	64	as	as	SCONJ
bptjm-49	90	65	it	it	PRON
bptjm-49	90	66	reacts	react	VERB
bptjm-49	90	67	with	with	ADP
bptjm-49	90	68	the	the	DET
bptjm-49	90	69	body	body	NOUN
bptjm-49	90	70	.	.	PUNCT
bptjm-49	91	1	similarly	similarly	ADV
bptjm-49	91	2	,	,	PUNCT
bptjm-49	91	3	the	the	DET
bptjm-49	91	4	small	small	ADJ
bptjm-49	91	5	molecule	molecule	NOUN
bptjm-49	91	6	inhibitor	inhibitor	NOUN
bptjm-49	91	7	jab-3312	jab-3312	NOUN
bptjm-49	91	8	is	be	AUX
bptjm-49	91	9	in	in	ADP
bptjm-49	91	10	phase	phase	NOUN
bptjm-49	91	11	1	1	NUM
bptjm-49	91	12	study	study	NOUN
bptjm-49	91	13	and	and	CCONJ
bptjm-49	91	14	is	be	AUX
bptjm-49	91	15	also	also	ADV
bptjm-49	91	16	recruiting	recruit	VERB
bptjm-49	91	17	patients	patient	NOUN
bptjm-49	91	18	with	with	ADP
bptjm-49	91	19	advanced	advanced	ADJ
bptjm-49	91	20	solid	solid	ADJ
bptjm-49	91	21	tumors	tumor	NOUN
bptjm-49	91	22	of	of	ADP
bptjm-49	91	23	nsclc	nsclc	NOUN
bptjm-49	91	24	,	,	PUNCT
bptjm-49	91	25	crc	crc	NOUN
bptjm-49	91	26	,	,	PUNCT
bptjm-49	91	27	pancreatic	pancreatic	ADJ
bptjm-49	91	28	ductal	ductal	ADJ
bptjm-49	91	29	carcinoma	carcinoma	NOUN
bptjm-49	91	30	,	,	PUNCT
bptjm-49	91	31	esophageal	esophageal	ADJ
bptjm-49	91	32	squamous	squamous	ADJ
bptjm-49	91	33	cell	cell	NOUN
bptjm-49	91	34	carcinoma	carcinoma	NOUN
bptjm-49	91	35	,	,	PUNCT
bptjm-49	91	36	head	head	NOUN
bptjm-49	91	37	and	and	CCONJ
bptjm-49	91	38	neck	neck	VERB
bptjm-49	91	39	squamous	squamous	ADJ
bptjm-49	91	40	cell	cell	NOUN
bptjm-49	91	41	carcinoma	carcinoma	NOUN
bptjm-49	91	42	,	,	PUNCT
bptjm-49	91	43	breast	breast	NOUN
bptjm-49	91	44	cancer	cancer	NOUN
bptjm-49	91	45	,	,	PUNCT
bptjm-49	91	46	and	and	CCONJ
bptjm-49	91	47	other	other	ADJ
bptjm-49	91	48	solid	solid	ADJ
bptjm-49	91	49	tumors	tumor	NOUN
bptjm-49	91	50	.	.	PUNCT
bptjm-49	92	1	the	the	DET
bptjm-49	92	2	experiment	experiment	NOUN
bptjm-49	92	3	will	will	AUX
bptjm-49	92	4	consist	consist	VERB
bptjm-49	92	5	of	of	ADP
bptjm-49	92	6	daily	daily	ADJ
bptjm-49	92	7	oral	oral	ADJ
bptjm-49	92	8	administration	administration	NOUN
bptjm-49	92	9	of	of	ADP
bptjm-49	92	10	the	the	DET
bptjm-49	92	11	drug	drug	NOUN
bptjm-49	92	12	in	in	ADP
bptjm-49	92	13	treatment	treatment	NOUN
bptjm-49	92	14	cycles	cycle	NOUN
bptjm-49	92	15	of	of	ADP
bptjm-49	92	16	21	21	NUM
bptjm-49	92	17	days.50	days.50	NOUN
bptjm-49	92	18	9.1	9.1	NUM
bptjm-49	92	19	matched	match	VERB
bptjm-49	92	20	targeted	target	VERB
bptjm-49	92	21	therapy	therapy	NOUN
bptjm-49	92	22	another	another	DET
bptjm-49	92	23	ongoing	ongoing	ADJ
bptjm-49	92	24	clinical	clinical	ADJ
bptjm-49	92	25	trial	trial	NOUN
bptjm-49	92	26	is	be	AUX
bptjm-49	92	27	utilizing	utilize	VERB
bptjm-49	92	28	matched	match	VERB
bptjm-49	92	29	targeted	target	VERB
bptjm-49	92	30	therapy	therapy	NOUN
bptjm-49	92	31	(	(	PUNCT
bptjm-49	92	32	mtt	mtt	NOUN
bptjm-49	92	33	)	)	PUNCT
bptjm-49	92	34	in	in	ADP
bptjm-49	92	35	order	order	NOUN
bptjm-49	92	36	to	to	PART
bptjm-49	92	37	test	test	VERB
bptjm-49	92	38	the	the	DET
bptjm-49	92	39	efficacy	efficacy	NOUN
bptjm-49	92	40	of	of	ADP
bptjm-49	92	41	trametinib	trametinib	NOUN
bptjm-49	92	42	on	on	ADP
bptjm-49	92	43	ptpn11	ptpn11	NOUN
bptjm-49	92	44	and	and	CCONJ
bptjm-49	92	45	other	other	ADJ
bptjm-49	92	46	proteins	protein	NOUN
bptjm-49	92	47	involved	involve	VERB
bptjm-49	92	48	in	in	ADP
bptjm-49	92	49	berkeley	berkeley	PROPN
bptjm-49	92	50	pharma	pharma	PROPN
bptjm-49	92	51	tech	tech	NOUN
bptjm-49	92	52	journal	journal	NOUN
bptjm-49	92	53	of	of	ADP
bptjm-49	92	54	medicine	medicine	NOUN
bptjm-49	93	1	|	|	ADV
bptjm-49	94	1	93	93	NUM
bptjm-49	94	2	cancer	cancer	NOUN
bptjm-49	94	3	progression	progression	NOUN
bptjm-49	94	4	.	.	PUNCT
bptjm-49	95	1	specifically	specifically	ADV
bptjm-49	95	2	,	,	PUNCT
bptjm-49	95	3	trametinib	trametinib	NOUN
bptjm-49	95	4	is	be	AUX
bptjm-49	95	5	a	a	DET
bptjm-49	95	6	kinase	kinase	ADJ
bptjm-49	95	7	inhibitor	inhibitor	NOUN
bptjm-49	95	8	that	that	PRON
bptjm-49	95	9	blocks	block	VERB
bptjm-49	95	10	the	the	DET
bptjm-49	95	11	abnormal	abnormal	ADJ
bptjm-49	95	12	protein	protein	NOUN
bptjm-49	95	13	signals	signal	NOUN
bptjm-49	95	14	that	that	PRON
bptjm-49	95	15	cause	cause	VERB
bptjm-49	95	16	cancer	cancer	NOUN
bptjm-49	95	17	cell	cell	NOUN
bptjm-49	95	18	multiplication	multiplication	NOUN
bptjm-49	95	19	.	.	PUNCT
bptjm-49	96	1	the	the	DET
bptjm-49	96	2	drug	drug	NOUN
bptjm-49	96	3	will	will	AUX
bptjm-49	96	4	be	be	AUX
bptjm-49	96	5	consumed	consume	VERB
bptjm-49	96	6	orally	orally	ADV
bptjm-49	96	7	with	with	ADP
bptjm-49	96	8	two	two	NUM
bptjm-49	96	9	mg	mg	NOUN
bptjm-49	96	10	per	per	ADP
bptjm-49	96	11	day	day	NOUN
bptjm-49	96	12	.	.	PUNCT
bptjm-49	97	1	the	the	DET
bptjm-49	97	2	trials	trial	NOUN
bptjm-49	97	3	are	be	AUX
bptjm-49	97	4	expected	expect	VERB
bptjm-49	97	5	to	to	PART
bptjm-49	97	6	be	be	AUX
bptjm-49	97	7	completed	complete	VERB
bptjm-49	97	8	by	by	ADP
bptjm-49	97	9	2026	2026	NUM
bptjm-49	97	10	.	.	PUNCT
bptjm-49	98	1	some	some	DET
bptjm-49	98	2	measures	measure	NOUN
bptjm-49	98	3	that	that	PRON
bptjm-49	98	4	researchers	researcher	NOUN
bptjm-49	98	5	will	will	AUX
bptjm-49	98	6	be	be	AUX
bptjm-49	98	7	noting	note	VERB
bptjm-49	98	8	are	be	AUX
bptjm-49	98	9	short	short	ADJ
bptjm-49	98	10	-	-	PUNCT
bptjm-49	98	11	term	term	NOUN
bptjm-49	98	12	and	and	CCONJ
bptjm-49	98	13	long	long	ADJ
bptjm-49	98	14	-	-	PUNCT
bptjm-49	98	15	term	term	NOUN
bptjm-49	98	16	progression	progression	NOUN
bptjm-49	98	17	,	,	PUNCT
bptjm-49	98	18	duration	duration	NOUN
bptjm-49	98	19	of	of	ADP
bptjm-49	98	20	response	response	NOUN
bptjm-49	98	21	,	,	PUNCT
bptjm-49	98	22	survival	survival	NOUN
bptjm-49	98	23	,	,	PUNCT
bptjm-49	98	24	adverse	adverse	ADJ
bptjm-49	98	25	effects	effect	NOUN
bptjm-49	98	26	,	,	PUNCT
bptjm-49	98	27	and	and	CCONJ
bptjm-49	98	28	more.51	more.51	NOUN
bptjm-49	98	29	10	10	NUM
bptjm-49	98	30	.	.	PUNCT
bptjm-49	99	1	future	future	ADJ
bptjm-49	99	2	directions	direction	NOUN
bptjm-49	99	3	&	&	CCONJ
bptjm-49	99	4	conclusion	conclusion	NOUN
bptjm-49	99	5	this	this	DET
bptjm-49	99	6	article	article	NOUN
bptjm-49	99	7	provided	provide	VERB
bptjm-49	99	8	a	a	DET
bptjm-49	99	9	review	review	NOUN
bptjm-49	99	10	of	of	ADP
bptjm-49	99	11	various	various	ADJ
bptjm-49	99	12	ptpn	ptpn	NOUN
bptjm-49	99	13	protein	protein	NOUN
bptjm-49	99	14	families	family	NOUN
bptjm-49	99	15	in	in	ADP
bptjm-49	99	16	regards	regard	NOUN
bptjm-49	99	17	to	to	ADP
bptjm-49	99	18	lung	lung	NOUN
bptjm-49	99	19	and	and	CCONJ
bptjm-49	99	20	digestive	digestive	ADJ
bptjm-49	99	21	cancer	cancer	NOUN
bptjm-49	99	22	with	with	ADP
bptjm-49	99	23	the	the	DET
bptjm-49	99	24	goal	goal	NOUN
bptjm-49	99	25	of	of	ADP
bptjm-49	99	26	providing	provide	VERB
bptjm-49	99	27	researchers	researcher	NOUN
bptjm-49	99	28	foundational	foundational	ADJ
bptjm-49	99	29	information	information	NOUN
bptjm-49	99	30	in	in	ADP
bptjm-49	99	31	their	their	PRON
bptjm-49	99	32	efforts	effort	NOUN
bptjm-49	99	33	to	to	PART
bptjm-49	99	34	develop	develop	VERB
bptjm-49	99	35	therapeutics	therapeutic	NOUN
bptjm-49	99	36	that	that	PRON
bptjm-49	99	37	target	target	VERB
bptjm-49	99	38	ptpns	ptpns	NOUN
bptjm-49	99	39	.	.	PUNCT
bptjm-49	100	1	many	many	ADJ
bptjm-49	100	2	studies	study	NOUN
bptjm-49	100	3	have	have	AUX
bptjm-49	100	4	investigated	investigate	VERB
bptjm-49	100	5	the	the	DET
bptjm-49	100	6	roles	role	NOUN
bptjm-49	100	7	of	of	ADP
bptjm-49	100	8	ptpns	ptpns	NOUN
bptjm-49	100	9	in	in	ADP
bptjm-49	100	10	tumor	tumor	NOUN
bptjm-49	100	11	progression	progression	NOUN
bptjm-49	100	12	,	,	PUNCT
bptjm-49	100	13	outlining	outline	VERB
bptjm-49	100	14	how	how	SCONJ
bptjm-49	100	15	ptpns	ptpns	ADJ
bptjm-49	100	16	act	act	NOUN
bptjm-49	100	17	on	on	ADP
bptjm-49	100	18	different	different	ADJ
bptjm-49	100	19	pathways	pathway	NOUN
bptjm-49	100	20	and	and	CCONJ
bptjm-49	100	21	thus	thus	ADV
bptjm-49	100	22	affect	affect	VERB
bptjm-49	100	23	tumor	tumor	NOUN
bptjm-49	100	24	progression	progression	NOUN
bptjm-49	100	25	differently	differently	ADV
bptjm-49	100	26	.	.	PUNCT
bptjm-49	101	1	this	this	DET
bptjm-49	101	2	review	review	NOUN
bptjm-49	101	3	paper	paper	NOUN
bptjm-49	101	4	focuses	focus	VERB
bptjm-49	101	5	on	on	ADP
bptjm-49	101	6	the	the	DET
bptjm-49	101	7	molecular	molecular	ADJ
bptjm-49	101	8	mechanisms	mechanism	NOUN
bptjm-49	101	9	that	that	PRON
bptjm-49	101	10	underlie	underlie	VERB
bptjm-49	101	11	the	the	DET
bptjm-49	101	12	effects	effect	NOUN
bptjm-49	101	13	of	of	ADP
bptjm-49	101	14	ptpns	ptpns	NOUN
bptjm-49	101	15	,	,	PUNCT
bptjm-49	101	16	as	as	SCONJ
bptjm-49	101	17	it	it	PRON
bptjm-49	101	18	could	could	AUX
bptjm-49	101	19	aid	aid	VERB
bptjm-49	101	20	in	in	ADP
bptjm-49	101	21	determining	determine	VERB
bptjm-49	101	22	if	if	SCONJ
bptjm-49	101	23	ptpn	ptpn	PROPN
bptjm-49	101	24	therapeutics	therapeutic	NOUN
bptjm-49	101	25	are	be	AUX
bptjm-49	101	26	worth	worth	ADJ
bptjm-49	101	27	exploring	explore	VERB
bptjm-49	101	28	.	.	PUNCT
bptjm-49	102	1	many	many	ADJ
bptjm-49	102	2	of	of	ADP
bptjm-49	102	3	these	these	DET
bptjm-49	102	4	ptpns	ptpns	NOUN
bptjm-49	102	5	can	can	AUX
bptjm-49	102	6	be	be	AUX
bptjm-49	102	7	used	use	VERB
bptjm-49	102	8	as	as	ADP
bptjm-49	102	9	biomarkers	biomarker	NOUN
bptjm-49	102	10	and/or	and/or	CCONJ
bptjm-49	102	11	prognosis	prognosis	NOUN
bptjm-49	102	12	markers	marker	NOUN
bptjm-49	102	13	as	as	SCONJ
bptjm-49	102	14	overexpression	overexpression	NOUN
bptjm-49	102	15	or	or	CCONJ
bptjm-49	102	16	underexpression	underexpression	NOUN
bptjm-49	102	17	of	of	ADP
bptjm-49	102	18	certain	certain	ADJ
bptjm-49	102	19	ptpns	ptpns	NOUN
bptjm-49	102	20	are	be	AUX
bptjm-49	102	21	associated	associate	VERB
bptjm-49	102	22	with	with	ADP
bptjm-49	102	23	each	each	DET
bptjm-49	102	24	cancer	cancer	NOUN
bptjm-49	103	1	[	[	X
bptjm-49	103	2	figure	figure	NOUN
bptjm-49	103	3	5	5	NUM
bptjm-49	103	4	]	]	PUNCT
bptjm-49	103	5	.	.	PUNCT
bptjm-49	104	1	in	in	ADP
bptjm-49	104	2	regards	regard	NOUN
bptjm-49	104	3	to	to	ADP
bptjm-49	104	4	digestive	digestive	ADJ
bptjm-49	104	5	cancer	cancer	NOUN
bptjm-49	104	6	,	,	PUNCT
bptjm-49	104	7	ptpn2	ptpn2	VERB
bptjm-49	104	8	and	and	CCONJ
bptjm-49	104	9	ptpn11	ptpn11	NOUN
bptjm-49	104	10	were	be	AUX
bptjm-49	104	11	shown	show	VERB
bptjm-49	104	12	to	to	PART
bptjm-49	104	13	have	have	VERB
bptjm-49	104	14	tumor	tumor	NOUN
bptjm-49	104	15	promoting	promote	VERB
bptjm-49	104	16	capabilities	capability	NOUN
bptjm-49	104	17	while	while	SCONJ
bptjm-49	104	18	ptp1b	ptp1b	NOUN
bptjm-49	104	19	,	,	PUNCT
bptjm-49	104	20	ptpn6	ptpn6	NOUN
bptjm-49	104	21	,	,	PUNCT
bptjm-49	104	22	and	and	CCONJ
bptjm-49	104	23	ptpn12	ptpn12	NOUN
bptjm-49	104	24	were	be	AUX
bptjm-49	104	25	shown	show	VERB
bptjm-49	104	26	to	to	PART
bptjm-49	104	27	have	have	VERB
bptjm-49	104	28	both	both	PRON
bptjm-49	104	29	tumor	tumor	NOUN
bptjm-49	104	30	promoting	promote	VERB
bptjm-49	104	31	and	and	CCONJ
bptjm-49	104	32	tumor	tumor	NOUN
bptjm-49	104	33	suppressing	suppress	VERB
bptjm-49	104	34	capabilities	capability	NOUN
bptjm-49	104	35	.	.	PUNCT
bptjm-49	105	1	in	in	ADP
bptjm-49	105	2	lung	lung	NOUN
bptjm-49	105	3	cancer	cancer	NOUN
bptjm-49	105	4	,	,	PUNCT
bptjm-49	105	5	ptpn3	ptpn3	PROPN
bptjm-49	105	6	,	,	PUNCT
bptjm-49	105	7	ptpn12	ptpn12	VERB
bptjm-49	105	8	,	,	PUNCT
bptjm-49	105	9	and	and	CCONJ
bptjm-49	105	10	ptpn13	ptpn13	NOUN
bptjm-49	105	11	were	be	AUX
bptjm-49	105	12	shown	show	VERB
bptjm-49	105	13	to	to	PART
bptjm-49	105	14	have	have	VERB
bptjm-49	105	15	tumor	tumor	NOUN
bptjm-49	105	16	suppressing	suppress	VERB
bptjm-49	105	17	capabilities	capability	NOUN
bptjm-49	105	18	while	while	SCONJ
bptjm-49	105	19	ptpn11	ptpn11	NOUN
bptjm-49	105	20	had	have	VERB
bptjm-49	105	21	tumor	tumor	NOUN
bptjm-49	105	22	promoting	promote	VERB
bptjm-49	105	23	capabilities	capability	NOUN
bptjm-49	105	24	.	.	PUNCT
bptjm-49	106	1	ptp1b	ptp1b	NOUN
bptjm-49	106	2	was	be	AUX
bptjm-49	106	3	seen	see	VERB
bptjm-49	106	4	to	to	PART
bptjm-49	106	5	have	have	VERB
bptjm-49	106	6	both	both	PRON
bptjm-49	106	7	tumor	tumor	NOUN
bptjm-49	106	8	suppressing	suppress	VERB
bptjm-49	106	9	and	and	CCONJ
bptjm-49	106	10	tumor	tumor	NOUN
bptjm-49	106	11	promoting	promote	VERB
bptjm-49	106	12	capabilities	capability	NOUN
bptjm-49	106	13	depending	depend	VERB
bptjm-49	106	14	on	on	ADP
bptjm-49	106	15	the	the	DET
bptjm-49	106	16	cellular	cellular	ADJ
bptjm-49	106	17	substrate	substrate	NOUN
bptjm-49	106	18	.	.	PUNCT
bptjm-49	107	1	given	give	VERB
bptjm-49	107	2	these	these	DET
bptjm-49	107	3	ptpns	ptpns	NOUN
bptjm-49	107	4	and	and	CCONJ
bptjm-49	107	5	their	their	PRON
bptjm-49	107	6	varying	vary	VERB
bptjm-49	107	7	effects	effect	NOUN
bptjm-49	107	8	on	on	ADP
bptjm-49	107	9	each	each	DET
bptjm-49	107	10	cancer	cancer	NOUN
bptjm-49	107	11	,	,	PUNCT
bptjm-49	107	12	therapeutic	therapeutic	ADJ
bptjm-49	107	13	targets	target	NOUN
bptjm-49	107	14	that	that	PRON
bptjm-49	107	15	act	act	VERB
bptjm-49	107	16	to	to	ADP
bptjm-49	107	17	either	either	CCONJ
bptjm-49	107	18	promote	promote	VERB
bptjm-49	107	19	or	or	CCONJ
bptjm-49	107	20	suppress	suppress	VERB
bptjm-49	107	21	various	various	ADJ
bptjm-49	107	22	ptpn	ptpn	NOUN
bptjm-49	107	23	have	have	VERB
bptjm-49	107	24	great	great	ADJ
bptjm-49	107	25	potential	potential	NOUN
bptjm-49	107	26	for	for	ADP
bptjm-49	107	27	cancer	cancer	NOUN
bptjm-49	107	28	treatment	treatment	NOUN
bptjm-49	107	29	.	.	PUNCT
bptjm-49	108	1	to	to	PART
bptjm-49	108	2	suppress	suppress	VERB
bptjm-49	108	3	ptpns	ptpns	NOUN
bptjm-49	108	4	with	with	ADP
bptjm-49	108	5	tumor	tumor	NOUN
bptjm-49	108	6	promoting	promote	VERB
bptjm-49	108	7	capabilities	capability	NOUN
bptjm-49	108	8	,	,	PUNCT
bptjm-49	108	9	researchers	researcher	NOUN
bptjm-49	108	10	could	could	AUX
bptjm-49	108	11	look	look	VERB
bptjm-49	108	12	into	into	ADP
bptjm-49	108	13	developing	develop	VERB
bptjm-49	108	14	inhibitors	inhibitor	NOUN
bptjm-49	108	15	that	that	PRON
bptjm-49	108	16	bind	bind	VERB
bptjm-49	108	17	to	to	ADP
bptjm-49	108	18	the	the	DET
bptjm-49	108	19	ptpn	ptpn	PROPN
bptjm-49	108	20	proteins	protein	NOUN
bptjm-49	108	21	.	.	PUNCT
bptjm-49	109	1	in	in	ADP
bptjm-49	109	2	contrast	contrast	NOUN
bptjm-49	109	3	,	,	PUNCT
bptjm-49	109	4	in	in	ADP
bptjm-49	109	5	order	order	NOUN
bptjm-49	109	6	to	to	PART
bptjm-49	109	7	promote	promote	VERB
bptjm-49	109	8	ptpns	ptpns	NOUN
bptjm-49	109	9	with	with	ADP
bptjm-49	109	10	tumor	tumor	NOUN
bptjm-49	109	11	suppressing	suppress	VERB
bptjm-49	109	12	capabilities	capability	NOUN
bptjm-49	109	13	,	,	PUNCT
bptjm-49	109	14	researchers	researcher	NOUN
bptjm-49	109	15	could	could	AUX
bptjm-49	109	16	look	look	VERB
bptjm-49	109	17	at	at	ADP
bptjm-49	109	18	developing	develop	VERB
bptjm-49	109	19	transcription	transcription	NOUN
bptjm-49	109	20	factors	factor	NOUN
bptjm-49	109	21	that	that	PRON
bptjm-49	109	22	enhance	enhance	VERB
bptjm-49	109	23	ptpn	ptpn	PROPN
bptjm-49	109	24	gene	gene	NOUN
bptjm-49	109	25	expression	expression	NOUN
bptjm-49	109	26	.	.	PUNCT
bptjm-49	110	1	therefore	therefore	ADV
bptjm-49	110	2	,	,	PUNCT
bptjm-49	110	3	additional	additional	ADJ
bptjm-49	110	4	clinical	clinical	ADJ
bptjm-49	110	5	trials	trial	NOUN
bptjm-49	110	6	and	and	CCONJ
bptjm-49	110	7	research	research	NOUN
bptjm-49	110	8	need	need	VERB
bptjm-49	110	9	to	to	PART
bptjm-49	110	10	be	be	AUX
bptjm-49	110	11	conducted	conduct	VERB
bptjm-49	110	12	in	in	ADP
bptjm-49	110	13	order	order	NOUN
bptjm-49	110	14	to	to	PART
bptjm-49	110	15	better	well	ADV
bptjm-49	110	16	understand	understand	VERB
bptjm-49	110	17	how	how	SCONJ
bptjm-49	110	18	to	to	PART
bptjm-49	110	19	mechanistically	mechanistically	ADV
bptjm-49	110	20	target	target	VERB
bptjm-49	110	21	ptpns	ptpns	NOUN
bptjm-49	110	22	to	to	PART
bptjm-49	110	23	develop	develop	VERB
bptjm-49	110	24	effective	effective	ADJ
bptjm-49	110	25	treatments	treatment	NOUN
bptjm-49	110	26	for	for	ADP
bptjm-49	110	27	lung	lung	NOUN
bptjm-49	110	28	and	and	CCONJ
bptjm-49	110	29	digestive	digestive	ADJ
bptjm-49	110	30	cancer	cancer	NOUN
bptjm-49	110	31	.	.	PUNCT
bptjm-49	111	1	berkeley	berkeley	PROPN
bptjm-49	111	2	pharma	pharma	PROPN
bptjm-49	111	3	tech	tech	PROPN
bptjm-49	111	4	journal	journal	NOUN
bptjm-49	111	5	of	of	ADP
bptjm-49	111	6	medicine	medicine	NOUN
bptjm-49	111	7	|	|	ADV
bptjm-49	111	8	94	94	NUM
bptjm-49	111	9	ptpn	ptpn	PROPN
bptjm-49	111	10	member	member	NOUN
bptjm-49	111	11	lung	lung	NOUN
bptjm-49	111	12	cancer	cancer	NOUN
bptjm-49	111	13	digestive	digestive	ADJ
bptjm-49	111	14	cancer	cancer	NOUN
bptjm-49	111	15	ptpn1	ptpn1	PROPN
bptjm-49	111	16	/	/	SYM
bptjm-49	111	17	ptp1b	ptp1b	PROPN
bptjm-49	111	18	biomarker	biomarker	NOUN
bptjm-49	111	19	:	:	PUNCT
bptjm-49	111	20	increased	increase	VERB
bptjm-49	111	21	levels	level	NOUN
bptjm-49	111	22	of	of	ADP
bptjm-49	111	23	ptp1b	ptp1b	NOUN
bptjm-49	111	24	in	in	ADP
bptjm-49	111	25	nsclc	nsclc	NOUN
bptjm-49	111	26	;	;	PUNCT
bptjm-49	111	27	decreased	decrease	VERB
bptjm-49	111	28	levels	level	NOUN
bptjm-49	111	29	of	of	ADP
bptjm-49	111	30	ptpn1	ptpn1	NOUN
bptjm-49	111	31	in	in	ADP
bptjm-49	111	32	luad	luad	PROPN
bptjm-49	111	33	therapeutic	therapeutic	ADJ
bptjm-49	111	34	:	:	PUNCT
bptjm-49	111	35	inhibition	inhibition	NOUN
bptjm-49	111	36	of	of	ADP
bptjm-49	111	37	ptp1b	ptp1b	NOUN
bptjm-49	111	38	in	in	ADP
bptjm-49	111	39	nsclc	nsclc	NOUN
bptjm-49	111	40	biomarker	biomarker	PROPN
bptjm-49	111	41	:	:	PUNCT
bptjm-49	111	42	increased	increase	VERB
bptjm-49	111	43	levels	level	NOUN
bptjm-49	111	44	of	of	ADP
bptjm-49	111	45	ptp1b	ptp1b	PROPN
bptjm-49	111	46	in	in	ADP
bptjm-49	111	47	crc	crc	PROPN
bptjm-49	111	48	,	,	PUNCT
bptjm-49	111	49	gastric	gastric	ADJ
bptjm-49	111	50	cancer	cancer	NOUN
bptjm-49	111	51	therapeutic	therapeutic	ADJ
bptjm-49	111	52	:	:	PUNCT
bptjm-49	111	53	inhibition	inhibition	NOUN
bptjm-49	111	54	of	of	ADP
bptjm-49	111	55	ptp1b	ptp1b	NOUN
bptjm-49	111	56	blocks	block	NOUN
bptjm-49	111	57	shc	shc	PROPN
bptjm-49	111	58	-	-	PUNCT
bptjm-49	111	59	grb2	grb2	PROPN
bptjm-49	111	60	-	-	PUNCT
bptjm-49	111	61	sos	sos	NOUN
bptjm-49	111	62	pathway	pathway	NOUN
bptjm-49	111	63	and	and	CCONJ
bptjm-49	111	64	mek	mek	PROPN
bptjm-49	111	65	/	/	SYM
bptjm-49	111	66	erk	erk	PROPN
bptjm-49	111	67	pathway	pathway	NOUN
bptjm-49	111	68	contrasting	contrasting	NOUN
bptjm-49	111	69	:	:	PUNCT
bptjm-49	111	70	tumor	tumor	NOUN
bptjm-49	111	71	suppressor	suppressor	NOUN
bptjm-49	111	72	qualities	quality	NOUN
bptjm-49	111	73	based	base	VERB
bptjm-49	111	74	on	on	ADP
bptjm-49	111	75	cellular	cellular	ADJ
bptjm-49	111	76	context	context	NOUN
bptjm-49	111	77	ptpn2	ptpn2	VERB
bptjm-49	111	78	insufficient	insufficient	ADJ
bptjm-49	111	79	research	research	NOUN
bptjm-49	111	80	biomarker	biomarker	NOUN
bptjm-49	111	81	:	:	PUNCT
bptjm-49	111	82	increased	increase	VERB
bptjm-49	111	83	levels	level	NOUN
bptjm-49	111	84	of	of	ADP
bptjm-49	111	85	ptpn2	ptpn2	VERB
bptjm-49	111	86	across	across	ADP
bptjm-49	111	87	all	all	DET
bptjm-49	111	88	stages	stage	NOUN
bptjm-49	111	89	of	of	ADP
bptjm-49	111	90	crc	crc	NOUN
bptjm-49	111	91	therapeutic	therapeutic	ADJ
bptjm-49	111	92	:	:	PUNCT
bptjm-49	111	93	inhibition	inhibition	NOUN
bptjm-49	111	94	of	of	ADP
bptjm-49	111	95	ptpn2	ptpn2	VERB
bptjm-49	111	96	which	which	PRON
bptjm-49	111	97	could	could	AUX
bptjm-49	111	98	increase	increase	VERB
bptjm-49	111	99	ifn	ifn	NOUN
bptjm-49	111	100	-	-	PUNCT
bptjm-49	111	101	γ	γ	NOUN
bptjm-49	111	102	signaling	signal	VERB
bptjm-49	111	103	pathway	pathway	NOUN
bptjm-49	111	104	and	and	CCONJ
bptjm-49	111	105	suppress	suppress	VERB
bptjm-49	111	106	krasmediated	krasmediated	ADJ
bptjm-49	111	107	mapk	mapk	NOUN
bptjm-49	111	108	pathway	pathway	NOUN
bptjm-49	111	109	ptpn3	ptpn3	PROPN
bptjm-49	111	110	biomarker	biomarker	PROPN
bptjm-49	111	111	:	:	PUNCT
bptjm-49	111	112	decreased	decrease	VERB
bptjm-49	111	113	levels	level	NOUN
bptjm-49	111	114	of	of	ADP
bptjm-49	111	115	ptpn3	ptpn3	PROPN
bptjm-49	111	116	in	in	ADP
bptjm-49	111	117	lung	lung	NOUN
bptjm-49	111	118	cancer	cancer	NOUN
bptjm-49	111	119	tissue	tissue	NOUN
bptjm-49	111	120	therapeutic	therapeutic	ADJ
bptjm-49	111	121	:	:	PUNCT
bptjm-49	111	122	upregulation	upregulation	NOUN
bptjm-49	111	123	of	of	ADP
bptjm-49	111	124	ptpn3	ptpn3	PROPN
bptjm-49	111	125	to	to	PART
bptjm-49	111	126	allow	allow	VERB
bptjm-49	111	127	for	for	ADP
bptjm-49	111	128	the	the	DET
bptjm-49	111	129	dephosphorylation	dephosphorylation	NOUN
bptjm-49	111	130	of	of	ADP
bptjm-49	111	131	src	src	NOUN
bptjm-49	111	132	and	and	CCONJ
bptjm-49	111	133	targeting	targeting	NOUN
bptjm-49	111	134	of	of	ADP
bptjm-49	111	135	egfr	egfr	NOUN
bptjm-49	111	136	for	for	ADP
bptjm-49	111	137	lysosomal	lysosomal	ADJ
bptjm-49	111	138	degradation	degradation	NOUN
bptjm-49	111	139	insufficient	insufficient	ADJ
bptjm-49	111	140	research	research	NOUN
bptjm-49	111	141	ptpn6	ptpn6	NOUN
bptjm-49	111	142	insufficient	insufficient	ADJ
bptjm-49	111	143	research	research	NOUN
bptjm-49	111	144	biomarker	biomarker	NOUN
bptjm-49	111	145	:	:	PUNCT
bptjm-49	111	146	increased	increase	VERB
bptjm-49	111	147	levels	level	NOUN
bptjm-49	111	148	of	of	ADP
bptjm-49	111	149	ptpn6	ptpn6	PROPN
bptjm-49	111	150	in	in	ADP
bptjm-49	111	151	crc	crc	PROPN
bptjm-49	111	152	therapeutic	therapeutic	ADJ
bptjm-49	111	153	:	:	PUNCT
bptjm-49	111	154	inhibition	inhibition	NOUN
bptjm-49	111	155	of	of	ADP
bptjm-49	111	156	ptpn6sp1	ptpn6sp1	NOUN
bptjm-49	111	157	-	-	PUNCT
bptjm-49	111	158	mapk	mapk	NOUN
bptjm-49	111	159	pathway	pathway	NOUN
bptjm-49	111	160	to	to	PART
bptjm-49	111	161	increase	increase	VERB
bptjm-49	111	162	chemosensitivity	chemosensitivity	NOUN
bptjm-49	111	163	of	of	ADP
bptjm-49	111	164	tumor	tumor	NOUN
bptjm-49	111	165	cells	cell	NOUN
bptjm-49	111	166	;	;	PUNCT
bptjm-49	111	167	inhibition	inhibition	NOUN
bptjm-49	111	168	of	of	ADP
bptjm-49	111	169	ptpn6	ptpn6	NOUN
bptjm-49	111	170	-	-	PUNCT
bptjm-49	111	171	egfr	egfr	NOUN
bptjm-49	111	172	complex	complex	ADJ
bptjm-49	111	173	berkeley	berkeley	PROPN
bptjm-49	111	174	pharma	pharma	PROPN
bptjm-49	111	175	tech	tech	NOUN
bptjm-49	111	176	journal	journal	NOUN
bptjm-49	111	177	of	of	ADP
bptjm-49	111	178	medicine	medicine	NOUN
bptjm-49	111	179	|	|	ADV
bptjm-49	111	180	95	95	NUM
bptjm-49	111	181	ptpn11	ptpn11	NOUN
bptjm-49	111	182	biomarker	biomarker	NOUN
bptjm-49	111	183	:	:	PUNCT
bptjm-49	111	184	increased	increase	VERB
bptjm-49	111	185	levels	level	NOUN
bptjm-49	111	186	of	of	ADP
bptjm-49	111	187	ptpn11	ptpn11	NOUN
bptjm-49	111	188	/	/	SYM
bptjm-49	111	189	shp2	shp2	NOUN
bptjm-49	111	190	in	in	ADP
bptjm-49	111	191	70	70	NUM
bptjm-49	111	192	%	%	NOUN
bptjm-49	111	193	of	of	ADP
bptjm-49	111	194	nsclc	nsclc	NOUN
bptjm-49	111	195	tissue	tissue	NOUN
bptjm-49	111	196	samples	sample	NOUN
bptjm-49	111	197	therapeutic	therapeutic	ADJ
bptjm-49	111	198	:	:	PUNCT
bptjm-49	111	199	small	small	ADJ
bptjm-49	111	200	molecule	molecule	NOUN
bptjm-49	111	201	inhibition	inhibition	NOUN
bptjm-49	111	202	of	of	ADP
bptjm-49	111	203	ptpn11	ptpn11	NOUN
bptjm-49	111	204	/	/	SYM
bptjm-49	111	205	shp2	shp2	NOUN
bptjm-49	111	206	which	which	PRON
bptjm-49	111	207	prevents	prevent	VERB
bptjm-49	111	208	shp2	shp2	NOUN
bptjm-49	111	209	mediated	mediate	VERB
bptjm-49	111	210	signal	signal	NOUN
bptjm-49	111	211	transduction	transduction	NOUN
bptjm-49	111	212	pathways	pathway	NOUN
bptjm-49	111	213	that	that	PRON
bptjm-49	111	214	are	be	AUX
bptjm-49	111	215	hyperactivated	hyperactivate	VERB
bptjm-49	111	216	biomarker	biomarker	NOUN
bptjm-49	111	217	:	:	PUNCT
bptjm-49	111	218	increased	increase	VERB
bptjm-49	111	219	levels	level	NOUN
bptjm-49	111	220	of	of	ADP
bptjm-49	111	221	ptpn11	ptpn11	NOUN
bptjm-49	111	222	/	/	SYM
bptjm-49	111	223	shp2	shp2	NOUN
bptjm-49	111	224	in	in	ADP
bptjm-49	111	225	60.78	60.78	NUM
bptjm-49	111	226	%	%	NOUN
bptjm-49	111	227	of	of	ADP
bptjm-49	111	228	gastric	gastric	ADJ
bptjm-49	111	229	cancers	cancer	NOUN
bptjm-49	111	230	therapeutic	therapeutic	ADJ
bptjm-49	111	231	:	:	PUNCT
bptjm-49	111	232	small	small	ADJ
bptjm-49	111	233	molecule	molecule	NOUN
bptjm-49	111	234	inhibition	inhibition	NOUN
bptjm-49	111	235	of	of	ADP
bptjm-49	111	236	ptpn11	ptpn11	NOUN
bptjm-49	111	237	/	/	SYM
bptjm-49	111	238	shp2	shp2	NOUN
bptjm-49	111	239	which	which	PRON
bptjm-49	111	240	prevents	prevent	VERB
bptjm-49	111	241	shp2	shp2	NOUN
bptjm-49	111	242	mediated	mediate	VERB
bptjm-49	111	243	signal	signal	NOUN
bptjm-49	111	244	transduction	transduction	NOUN
bptjm-49	111	245	pathways	pathway	NOUN
bptjm-49	111	246	that	that	PRON
bptjm-49	111	247	are	be	AUX
bptjm-49	111	248	hyperactivated	hyperactivate	VERB
bptjm-49	111	249	ptpn12	ptpn12	ADJ
bptjm-49	111	250	prognosis	prognosis	NOUN
bptjm-49	111	251	marker	marker	NOUN
bptjm-49	111	252	:	:	PUNCT
bptjm-49	111	253	increased	increase	VERB
bptjm-49	111	254	levels	level	NOUN
bptjm-49	111	255	of	of	ADP
bptjm-49	111	256	ptpn12	ptpn12	NOUN
bptjm-49	111	257	are	be	AUX
bptjm-49	111	258	associated	associate	VERB
bptjm-49	111	259	with	with	ADP
bptjm-49	111	260	higher	high	ADJ
bptjm-49	111	261	5year	5year	NUM
bptjm-49	111	262	survival	survival	NOUN
bptjm-49	111	263	rates	rate	NOUN
bptjm-49	111	264	in	in	ADP
bptjm-49	111	265	nsclc	nsclc	NOUN
bptjm-49	111	266	biomarker	biomarker	PROPN
bptjm-49	111	267	:	:	PUNCT
bptjm-49	111	268	increased	increase	VERB
bptjm-49	111	269	levels	level	NOUN
bptjm-49	111	270	of	of	ADP
bptjm-49	111	271	ptpn12	ptpn12	NOUN
bptjm-49	111	272	are	be	AUX
bptjm-49	111	273	correlated	correlate	VERB
bptjm-49	111	274	with	with	ADP
bptjm-49	111	275	incidences	incidence	NOUN
bptjm-49	111	276	of	of	ADP
bptjm-49	111	277	digestive	digestive	ADJ
bptjm-49	111	278	cancers	cancer	NOUN
bptjm-49	111	279	contrasting	contrasting	NOUN
bptjm-49	111	280	:	:	PUNCT
bptjm-49	111	281	other	other	ADJ
bptjm-49	111	282	research	research	NOUN
bptjm-49	111	283	has	have	AUX
bptjm-49	111	284	shown	show	VERB
bptjm-49	111	285	ptpn12	ptpn12	NOUN
bptjm-49	111	286	as	as	ADP
bptjm-49	111	287	a	a	DET
bptjm-49	111	288	tumor	tumor	NOUN
bptjm-49	111	289	suppressor	suppressor	NOUN
bptjm-49	111	290	that	that	PRON
bptjm-49	111	291	normally	normally	ADV
bptjm-49	111	292	has	have	VERB
bptjm-49	111	293	an	an	DET
bptjm-49	111	294	inhibitory	inhibitory	ADJ
bptjm-49	111	295	effect	effect	NOUN
bptjm-49	111	296	on	on	ADP
bptjm-49	111	297	the	the	DET
bptjm-49	111	298	ras	ras	PROPN
bptjm-49	111	299	/	/	SYM
bptjm-49	111	300	mek	mek	PROPN
bptjm-49	111	301	/	/	SYM
bptjm-49	111	302	erk	erk	PROPN
bptjm-49	111	303	signaling	signal	VERB
bptjm-49	111	304	by	by	ADP
bptjm-49	111	305	dephosphorylating	dephosphorylate	VERB
bptjm-49	111	306	the	the	DET
bptjm-49	111	307	protein	protein	NOUN
bptjm-49	111	308	shc	shc	PROPN
bptjm-49	111	309	ptpn13	ptpn13	PROPN
bptjm-49	111	310	biomarker	biomarker	PROPN
bptjm-49	111	311	:	:	PUNCT
bptjm-49	111	312	decreased	decrease	VERB
bptjm-49	111	313	levels	level	NOUN
bptjm-49	111	314	in	in	ADP
bptjm-49	111	315	nsclc	nsclc	NOUN
bptjm-49	111	316	therapeutic	therapeutic	ADJ
bptjm-49	111	317	:	:	PUNCT
bptjm-49	111	318	upregulation	upregulation	NOUN
bptjm-49	111	319	of	of	ADP
bptjm-49	111	320	ptpn13	ptpn13	NOUN
bptjm-49	111	321	to	to	PART
bptjm-49	111	322	inhibit	inhibit	VERB
bptjm-49	111	323	the	the	DET
bptjm-49	111	324	src	src	PROPN
bptjm-49	111	325	/	/	SYM
bptjm-49	111	326	erk	erk	PROPN
bptjm-49	111	327	/	/	SYM
bptjm-49	111	328	yap1	yap1	NOUN
bptjm-49	111	329	signaling	signal	VERB
bptjm-49	111	330	pathway	pathway	NOUN
bptjm-49	111	331	,	,	PUNCT
bptjm-49	111	332	counteract	counteract	VERB
bptjm-49	111	333	the	the	DET
bptjm-49	111	334	effects	effect	NOUN
bptjm-49	111	335	of	of	ADP
bptjm-49	111	336	mir-30e	mir-30e	NUM
bptjm-49	111	337	,	,	PUNCT
bptjm-49	111	338	and	and	CCONJ
bptjm-49	111	339	to	to	ADP
bptjm-49	111	340	downregulate	downregulate	PROPN
bptjm-49	111	341	her2	her2	PROPN
bptjm-49	111	342	activity	activity	NOUN
bptjm-49	111	343	insufficient	insufficient	ADJ
bptjm-49	111	344	research	research	NOUN
bptjm-49	111	345	figure	figure	NOUN
bptjm-49	111	346	5	5	NUM
bptjm-49	111	347	:	:	PUNCT
bptjm-49	111	348	summary	summary	NOUN
bptjm-49	111	349	of	of	ADP
bptjm-49	111	350	ptpn	ptpn	PROPN
bptjm-49	111	351	families	family	NOUN
bptjm-49	111	352	and	and	CCONJ
bptjm-49	111	353	their	their	PRON
bptjm-49	111	354	potential	potential	NOUN
bptjm-49	111	355	as	as	ADP
bptjm-49	111	356	a	a	DET
bptjm-49	111	357	biomarker	biomarker	NOUN
bptjm-49	111	358	,	,	PUNCT
bptjm-49	111	359	prognosis	prognosis	NOUN
bptjm-49	111	360	marker	marker	NOUN
bptjm-49	111	361	,	,	PUNCT
bptjm-49	111	362	and	and	CCONJ
bptjm-49	111	363	or/	or/	VERB
bptjm-49	111	364	therapeutic	therapeutic	ADJ
bptjm-49	111	365	target	target	NOUN
bptjm-49	111	366	in	in	ADP
bptjm-49	111	367	lung	lung	NOUN
bptjm-49	111	368	and	and	CCONJ
bptjm-49	111	369	digestive	digestive	ADJ
bptjm-49	111	370	cancer	cancer	NOUN
bptjm-49	111	371	.	.	PUNCT
bptjm-49	112	1	green	green	PROPN
bptjm-49	112	2	represents	represent	VERB
bptjm-49	112	3	ptpn	ptpn	NOUN
bptjm-49	112	4	as	as	ADP
bptjm-49	112	5	a	a	DET
bptjm-49	112	6	tumor	tumor	NOUN
bptjm-49	112	7	suppressor	suppressor	NOUN
bptjm-49	112	8	.	.	PUNCT
bptjm-49	113	1	red	red	PROPN
bptjm-49	113	2	represents	represent	VERB
bptjm-49	113	3	tumor	tumor	NOUN
bptjm-49	113	4	promoter	promoter	NOUN
bptjm-49	113	5	.	.	PUNCT
bptjm-49	114	1	orange	orange	PROPN
bptjm-49	114	2	represents	represent	VERB
bptjm-49	114	3	both	both	PRON
bptjm-49	114	4	tumor	tumor	NOUN
bptjm-49	114	5	suppressor	suppressor	NOUN
bptjm-49	114	6	and	and	CCONJ
bptjm-49	114	7	promoter	promoter	NOUN
bptjm-49	114	8	capabilities	capability	NOUN
bptjm-49	114	9	.	.	PUNCT
bptjm-49	115	1	“	"	PUNCT
bptjm-49	115	2	contrasting	contrasting	NOUN
bptjm-49	115	3	”	"	PUNCT
bptjm-49	115	4	refers	refer	VERB
bptjm-49	115	5	to	to	ADP
bptjm-49	115	6	conflicting	conflict	VERB
bptjm-49	115	7	research	research	NOUN
bptjm-49	115	8	regarding	regard	VERB
bptjm-49	115	9	the	the	DET
bptjm-49	115	10	role	role	NOUN
bptjm-49	115	11	of	of	ADP
bptjm-49	115	12	the	the	DET
bptjm-49	115	13	ptpn	ptpn	NOUN
bptjm-49	115	14	.	.	PUNCT
bptjm-49	116	1	“	"	PUNCT
bptjm-49	116	2	insufficient	insufficient	ADJ
bptjm-49	116	3	research	research	NOUN
bptjm-49	116	4	”	"	PUNCT
bptjm-49	116	5	refers	refer	VERB
bptjm-49	116	6	to	to	ADP
bptjm-49	116	7	not	not	PART
bptjm-49	116	8	enough	enough	ADJ
bptjm-49	116	9	publications	publication	NOUN
bptjm-49	116	10	on	on	ADP
bptjm-49	116	11	the	the	DET
bptjm-49	116	12	topic	topic	NOUN
bptjm-49	116	13	to	to	PART
bptjm-49	116	14	include	include	VERB
bptjm-49	116	15	in	in	ADP
bptjm-49	116	16	the	the	DET
bptjm-49	116	17	review	review	NOUN
bptjm-49	116	18	.	.	PUNCT
bptjm-49	117	1	references	reference	NOUN
bptjm-49	117	2	1	1	NUM
bptjm-49	117	3	.	.	PUNCT
bptjm-49	117	4	lung	lung	NOUN
bptjm-49	117	5	cancer	cancer	NOUN
bptjm-49	117	6	statistics	statistic	NOUN
bptjm-49	117	7	:	:	PUNCT
bptjm-49	117	8	how	how	SCONJ
bptjm-49	117	9	common	common	ADJ
bptjm-49	117	10	is	be	AUX
bptjm-49	117	11	lung	lung	NOUN
bptjm-49	117	12	cancer	cancer	NOUN
bptjm-49	117	13	?	?	PUNCT
bptjm-49	118	1	lung	lung	NOUN
bptjm-49	118	2	cancer	cancer	NOUN
bptjm-49	118	3	statistics	statistic	NOUN
bptjm-49	118	4	|	|	ADV
bptjm-49	118	5	how	how	SCONJ
bptjm-49	118	6	common	common	ADJ
bptjm-49	118	7	is	be	AUX
bptjm-49	118	8	lung	lung	NOUN
bptjm-49	118	9	cancer	cancer	NOUN
bptjm-49	118	10	?	?	PUNCT
bptjm-49	119	1	(	(	PUNCT
bptjm-49	119	2	n.d	n.d	PROPN
bptjm-49	119	3	.	.	PROPN
bptjm-49	119	4	)	)	PUNCT
bptjm-49	119	5	.	.	PUNCT
bptjm-49	120	1	retrieved	retrieve	VERB
bptjm-49	120	2	march	march	PROPN
bptjm-49	120	3	22	22	NUM
bptjm-49	120	4	,	,	PUNCT
bptjm-49	120	5	2023	2023	NUM
bptjm-49	120	6	,	,	PUNCT
bptjm-49	120	7	from	from	ADP
bptjm-49	120	8	https://www.cancer.org/cancer/lung-cancer/ab	https://www.cancer.org/cancer/lung-cancer/ab	NOUN
bptjm-49	120	9	out	out	ADP
bptjm-49	120	10	/	/	SYM
bptjm-49	120	11	key	key	NOUN
bptjm-49	120	12	-	-	PUNCT
bptjm-49	120	13	statistics.html	statistics.html	NUM
bptjm-49	120	14	2	2	NUM
bptjm-49	120	15	.	.	PUNCT
bptjm-49	121	1	sung	sung	PROPN
bptjm-49	121	2	,	,	PUNCT
bptjm-49	121	3	h.	h.	PROPN
bptjm-49	121	4	,	,	PUNCT
bptjm-49	121	5	ferlay	ferlay	PROPN
bptjm-49	121	6	,	,	PUNCT
bptjm-49	121	7	j.	j.	PROPN
bptjm-49	121	8	,	,	PUNCT
bptjm-49	121	9	siegel	siegel	PROPN
bptjm-49	121	10	,	,	PUNCT
bptjm-49	121	11	r.	r.	PROPN
bptjm-49	121	12	l.	l.	PROPN
bptjm-49	121	13	,	,	PUNCT
bptjm-49	121	14	laversanne	laversanne	PROPN
bptjm-49	121	15	,	,	PUNCT
bptjm-49	121	16	m.	m.	NOUN
bptjm-49	121	17	,	,	PUNCT
bptjm-49	121	18	soerjomataram	soerjomataram	PROPN
bptjm-49	121	19	,	,	PUNCT
bptjm-49	121	20	i.	i.	NOUN
bptjm-49	121	21	,	,	PUNCT
bptjm-49	121	22	jemal	jemal	PROPN
bptjm-49	121	23	,	,	PUNCT
bptjm-49	121	24	a.	a.	NOUN
bptjm-49	121	25	,	,	PUNCT
bptjm-49	121	26	&	&	CCONJ
bptjm-49	121	27	bray	bray	PROPN
bptjm-49	121	28	,	,	PUNCT
bptjm-49	121	29	f.	f.	PROPN
bptjm-49	121	30	(	(	PUNCT
bptjm-49	121	31	2021	2021	NUM
bptjm-49	121	32	)	)	PUNCT
bptjm-49	121	33	.	.	PUNCT
bptjm-49	122	1	global	global	ADJ
bptjm-49	122	2	cancer	cancer	NOUN
bptjm-49	122	3	statistics	statistic	NOUN
bptjm-49	122	4	2020	2020	NUM
bptjm-49	122	5	:	:	PUNCT
bptjm-49	122	6	globocan	globocan	PROPN
bptjm-49	122	7	estimates	estimate	NOUN
bptjm-49	122	8	of	of	ADP
bptjm-49	122	9	incidence	incidence	NOUN
bptjm-49	122	10	and	and	CCONJ
bptjm-49	122	11	mortality	mortality	NOUN
bptjm-49	122	12	worldwide	worldwide	ADV
bptjm-49	122	13	for	for	ADP
bptjm-49	122	14	36	36	NUM
bptjm-49	122	15	cancers	cancer	NOUN
bptjm-49	122	16	in	in	ADP
bptjm-49	122	17	185	185	NUM
bptjm-49	122	18	countries	country	NOUN
bptjm-49	122	19	.	.	PUNCT
bptjm-49	123	1	ca	can	AUX
bptjm-49	123	2	:	:	PUNCT
bptjm-49	123	3	a	a	DET
bptjm-49	123	4	cancer	cancer	NOUN
bptjm-49	123	5	journal	journal	NOUN
bptjm-49	123	6	for	for	ADP
bptjm-49	123	7	clinicians	clinician	NOUN
bptjm-49	123	8	,	,	PUNCT
bptjm-49	123	9	71(3	71(3	NUM
bptjm-49	123	10	)	)	PUNCT
bptjm-49	123	11	,	,	PUNCT
bptjm-49	123	12	209–249	209–249	NUM
bptjm-49	123	13	.	.	PUNCT
bptjm-49	124	1	https://doi.org/10.3322/caac.21660	https://doi.org/10.3322/caac.21660	X
bptjm-49	124	2	3	3	X
bptjm-49	124	3	.	.	NOUN
bptjm-49	124	4	stomach	stomach	NOUN
bptjm-49	124	5	cancer	cancer	NOUN
bptjm-49	124	6	statistics	statistic	NOUN
bptjm-49	124	7	.	.	PUNCT
bptjm-49	125	1	cancer.net	cancer.net	NOUN
bptjm-49	125	2	.	.	PUNCT
bptjm-49	126	1	(	(	PUNCT
bptjm-49	126	2	2022	2022	NUM
bptjm-49	126	3	,	,	PUNCT
bptjm-49	126	4	august	august	PROPN
bptjm-49	126	5	18	18	NUM
bptjm-49	126	6	)	)	PUNCT
bptjm-49	126	7	.	.	PUNCT
bptjm-49	127	1	retrievedmarch	retrievedmarch	PROPN
bptjm-49	127	2	22	22	NUM
bptjm-49	127	3	,	,	PUNCT
bptjm-49	127	4	2023	2023	NUM
bptjm-49	127	5	,	,	PUNCT
bptjm-49	127	6	from	from	ADP
bptjm-49	127	7	https://www.cancer.net/cancer-types/stomach-ca	https://www.cancer.net/cancer-types/stomach-ca	NUM
bptjm-49	127	8	ncer	ncer	NOUN
bptjm-49	127	9	/	/	SYM
bptjm-49	127	10	statistics	statistic	NOUN
bptjm-49	127	11	4	4	NUM
bptjm-49	127	12	.	.	PUNCT
bptjm-49	127	13	centers	center	NOUN
bptjm-49	127	14	for	for	ADP
bptjm-49	127	15	disease	disease	NOUN
bptjm-49	127	16	control	control	NOUN
bptjm-49	127	17	and	and	CCONJ
bptjm-49	127	18	prevention	prevention	NOUN
bptjm-49	127	19	.	.	PUNCT
bptjm-49	128	1	(	(	PUNCT
bptjm-49	128	2	2022	2022	NUM
bptjm-49	128	3	,	,	PUNCT
bptjm-49	128	4	june	june	PROPN
bptjm-49	128	5	9	9	NUM
bptjm-49	128	6	)	)	PUNCT
bptjm-49	128	7	.	.	PUNCT
bptjm-49	129	1	cancer	cancer	NOUN
bptjm-49	129	2	treatments	treatment	NOUN
bptjm-49	129	3	.	.	PUNCT
bptjm-49	130	1	centers	center	NOUN
bptjm-49	130	2	for	for	ADP
bptjm-49	130	3	disease	disease	NOUN
bptjm-49	130	4	control	control	NOUN
bptjm-49	130	5	and	and	CCONJ
bptjm-49	130	6	prevention	prevention	NOUN
bptjm-49	130	7	.	.	PUNCT
bptjm-49	131	1	retrievedmarch	retrievedmarch	PROPN
bptjm-49	131	2	22	22	NUM
bptjm-49	131	3	,	,	PUNCT
bptjm-49	131	4	2023	2023	NUM
bptjm-49	131	5	,	,	PUNCT
bptjm-49	131	6	from	from	ADP
bptjm-49	131	7	https://www.cdc.gov/cancer/survivors/patient	https://www.cdc.gov/cancer/survivors/patient	PRON
bptjm-49	131	8	s	s	PART
bptjm-49	131	9	/	/	SYM
bptjm-49	131	10	treatments.htm#:~:text	treatments.htm#:~:text	ADJ
bptjm-49	131	11	=	=	SYM
bptjm-49	131	12	surgery%3a%20an	surgery%3a%20an	NOUN
bptjm-49	131	13	%	%	NOUN
bptjm-49	131	14	20operation%20where%20doctors	20operation%20where%20doctor	NOUN
bptjm-49	131	15	,	,	PUNCT
bptjm-49	131	16	hormone	hormone	NOUN
bptjm-49	131	17	s%20they%20need%20to%20grow	s%20they%20need%20to%20grow	NOUN
bptjm-49	131	18	.	.	PUNCT
bptjm-49	132	1	5	5	X
bptjm-49	132	2	.	.	NUM
bptjm-49	132	3	types	type	NOUN
bptjm-49	132	4	of	of	ADP
bptjm-49	132	5	cancer	cancer	NOUN
bptjm-49	132	6	treatment	treatment	NOUN
bptjm-49	132	7	.	.	PUNCT
bptjm-49	133	1	national	national	PROPN
bptjm-49	133	2	cancer	cancer	PROPN
bptjm-49	133	3	institute	institute	PROPN
bptjm-49	133	4	.	.	PUNCT
bptjm-49	134	1	(	(	PUNCT
bptjm-49	134	2	n.d	n.d	PROPN
bptjm-49	134	3	.	.	PROPN
bptjm-49	134	4	)	)	PUNCT
bptjm-49	134	5	.	.	PUNCT
bptjm-49	135	1	retrievedmarch	retrievedmarch	PROPN
bptjm-49	135	2	22	22	NUM
bptjm-49	135	3	,	,	PUNCT
bptjm-49	135	4	2023	2023	NUM
bptjm-49	135	5	,	,	PUNCT
bptjm-49	135	6	from	from	ADP
bptjm-49	135	7	https://www.cancer.gov/about-cancer/treatment	https://www.cancer.gov/about-cancer/treatment	ADJ
bptjm-49	135	8	/types	/types	PUNCT
bptjm-49	135	9	6	6	NUM
bptjm-49	135	10	.	.	X
bptjm-49	135	11	tang	tang	PROPN
bptjm-49	135	12	,	,	PUNCT
bptjm-49	135	13	x.	x.	PROPN
bptjm-49	135	14	,	,	PUNCT
bptjm-49	135	15	qi	qi	PROPN
bptjm-49	135	16	,	,	PUNCT
bptjm-49	135	17	c.	c.	PROPN
bptjm-49	135	18	,	,	PUNCT
bptjm-49	135	19	zhou	zhou	PROPN
bptjm-49	135	20	,	,	PUNCT
bptjm-49	135	21	h.	h.	PROPN
bptjm-49	135	22	,	,	PUNCT
bptjm-49	135	23	&	&	CCONJ
bptjm-49	135	24	liu	liu	PROPN
bptjm-49	135	25	,	,	PUNCT
bptjm-49	135	26	y.	y.	PROPN
bptjm-49	135	27	(	(	PUNCT
bptjm-49	135	28	2022	2022	NUM
bptjm-49	135	29	)	)	PUNCT
bptjm-49	135	30	.	.	PUNCT
bptjm-49	136	1	critical	critical	ADJ
bptjm-49	136	2	roles	role	NOUN
bptjm-49	136	3	of	of	ADP
bptjm-49	136	4	ptpn	ptpn	PROPN
bptjm-49	136	5	family	family	NOUN
bptjm-49	136	6	members	member	NOUN
bptjm-49	136	7	regulated	regulate	VERB
bptjm-49	136	8	by	by	ADP
bptjm-49	136	9	non	non	ADJ
bptjm-49	136	10	-	-	ADJ
bptjm-49	136	11	coding	coding	ADJ
bptjm-49	136	12	rnas	rna	NOUN
bptjm-49	136	13	in	in	ADP
bptjm-49	136	14	tumorigenesis	tumorigenesis	NOUN
bptjm-49	136	15	and	and	CCONJ
bptjm-49	136	16	immunotherapy	immunotherapy	NOUN
bptjm-49	136	17	.	.	PUNCT
bptjm-49	137	1	frontiers	frontier	NOUN
bptjm-49	137	2	in	in	ADP
bptjm-49	137	3	oncology	oncology	NOUN
bptjm-49	137	4	,	,	PUNCT
bptjm-49	137	5	12	12	NUM
bptjm-49	137	6	.	.	PUNCT
bptjm-49	138	1	https://doi.org/10.3389/fonc.2022.972906	https://doi.org/10.3389/fonc.2022.972906	PROPN
bptjm-49	138	2	7	7	NUM
bptjm-49	138	3	.	.	PUNCT
bptjm-49	138	4	xu	xu	PROPN
bptjm-49	138	5	,	,	PUNCT
bptjm-49	138	6	q.	q.	PROPN
bptjm-49	138	7	,	,	PUNCT
bptjm-49	138	8	wu	wu	PROPN
bptjm-49	138	9	,	,	PUNCT
bptjm-49	138	10	n.	n.	PROPN
bptjm-49	138	11	,	,	PUNCT
bptjm-49	138	12	li	li	PROPN
bptjm-49	138	13	,	,	PUNCT
bptjm-49	139	1	x.	x.	PROPN
bptjm-49	139	2	et	et	PROPN
bptjm-49	139	3	al	al	PROPN
bptjm-49	139	4	.	.	PROPN
bptjm-49	139	5	inhibition	inhibition	NOUN
bptjm-49	139	6	of	of	ADP
bptjm-49	139	7	ptp1b	ptp1b	NOUN
bptjm-49	139	8	blocks	block	NOUN
bptjm-49	139	9	pancreatic	pancreatic	ADJ
bptjm-49	139	10	cancer	cancer	NOUN
bptjm-49	139	11	progression	progression	NOUN
bptjm-49	139	12	by	by	ADP
bptjm-49	139	13	targeting	target	VERB
bptjm-49	139	14	the	the	DET
bptjm-49	139	15	pkm2	pkm2	PROPN
bptjm-49	139	16	/	/	SYM
bptjm-49	139	17	ampk	ampk	NOUN
bptjm-49	139	18	/	/	SYM
bptjm-49	139	19	mtoc1	mtoc1	NOUN
bptjm-49	139	20	pathway	pathway	NOUN
bptjm-49	139	21	.	.	PUNCT
bptjm-49	140	1	cell	cell	NOUN
bptjm-49	140	2	death	death	NOUN
bptjm-49	140	3	dis	dis	PROPN
bptjm-49	140	4	10	10	NUM
bptjm-49	140	5	,	,	PUNCT
bptjm-49	140	6	874	874	NUM
bptjm-49	140	7	(	(	PUNCT
bptjm-49	140	8	2019	2019	NUM
bptjm-49	140	9	)	)	PUNCT
bptjm-49	140	10	.	.	PUNCT
bptjm-49	141	1	https://doi.org/10.1038/s41419-019-2073-4	https://doi.org/10.1038/s41419-019-2073-4	NUM
bptjm-49	141	2	8	8	NUM
bptjm-49	141	3	.	.	PUNCT
bptjm-49	142	1	hoekstra	hoekstra	PROPN
bptjm-49	142	2	e	e	PROPN
bptjm-49	142	3	,	,	PUNCT
bptjm-49	142	4	das	das	PROPN
bptjm-49	142	5	am	be	AUX
bptjm-49	142	6	,	,	PUNCT
bptjm-49	142	7	swets	swet	VERB
bptjm-49	142	8	m	m	PRON
bptjm-49	142	9	,	,	PUNCT
bptjm-49	142	10	et	et	PROPN
bptjm-49	142	11	al	al	PROPN
bptjm-49	142	12	.	.	PROPN
bptjm-49	142	13	increased	increase	VERB
bptjm-49	142	14	ptp1b	ptp1b	NOUN
bptjm-49	142	15	expression	expression	NOUN
bptjm-49	142	16	and	and	CCONJ
bptjm-49	142	17	phosphatase	phosphatase	NOUN
bptjm-49	142	18	activity	activity	NOUN
bptjm-49	142	19	in	in	ADP
bptjm-49	142	20	colorectal	colorectal	ADJ
bptjm-49	142	21	cancer	cancer	NOUN
bptjm-49	142	22	results	result	NOUN
bptjm-49	142	23	in	in	ADP
bptjm-49	142	24	a	a	DET
bptjm-49	142	25	more	more	ADV
bptjm-49	142	26	invasive	invasive	ADJ
bptjm-49	142	27	phenotype	phenotype	NOUN
bptjm-49	142	28	and	and	CCONJ
bptjm-49	142	29	worse	bad	ADJ
bptjm-49	142	30	patient	patient	ADJ
bptjm-49	142	31	outcome.oncotarget	outcome.oncotarget	NOUN
bptjm-49	142	32	.	.	PUNCT
bptjm-49	143	1	2016;7(16):21922	2016;7(16):21922	PROPN
bptjm-49	143	2	-	-	SYM
bptjm-49	143	3	21938	21938	NUM
bptjm-49	143	4	.	.	PUNCT
bptjm-49	144	1	doi:10.18632	doi:10.18632	PROPN
bptjm-49	144	2	/	/	SYM
bptjm-49	144	3	oncotarget.7829	oncotarget.7829	PROPN
bptjm-49	144	4	9	9	NUM
bptjm-49	144	5	.	.	PUNCT
bptjm-49	145	1	zhou	zhou	PROPN
bptjm-49	145	2	j	j	PROPN
bptjm-49	145	3	,	,	PUNCT
bptjm-49	145	4	guo	guo	PROPN
bptjm-49	145	5	h	h	PROPN
bptjm-49	145	6	,	,	PUNCT
bptjm-49	145	7	zhang	zhang	PROPN
bptjm-49	145	8	y	y	PROPN
bptjm-49	145	9	,	,	PUNCT
bptjm-49	145	10	liu	liu	PROPN
bptjm-49	145	11	h	h	PROPN
bptjm-49	145	12	,	,	PUNCT
bptjm-49	145	13	dou	dou	PROPN
bptjm-49	145	14	q.	q.	NOUN
bptjm-49	145	15	the	the	DET
bptjm-49	145	16	role	role	NOUN
bptjm-49	145	17	of	of	ADP
bptjm-49	145	18	ptp1b	ptp1b	PROPN
bptjm-49	145	19	(	(	PUNCT
bptjm-49	145	20	ptpn1	ptpn1	PROPN
bptjm-49	145	21	)	)	PUNCT
bptjm-49	145	22	in	in	ADP
bptjm-49	145	23	the	the	DET
bptjm-49	145	24	prognosis	prognosis	NOUN
bptjm-49	145	25	of	of	ADP
bptjm-49	145	26	solid	solid	ADJ
bptjm-49	145	27	tumors	tumor	NOUN
bptjm-49	145	28	:	:	PUNCT
bptjm-49	145	29	a	a	DET
bptjm-49	145	30	meta-analysis.medicine	meta-analysis.medicine	ADJ
bptjm-49	145	31	(	(	PUNCT
bptjm-49	145	32	baltimore	baltimore	PROPN
bptjm-49	145	33	)	)	PUNCT
bptjm-49	145	34	.	.	PUNCT
bptjm-49	146	1	2022;101(40):e30826	2022;101(40):e30826	NUM
bptjm-49	146	2	.	.	PUNCT
bptjm-49	147	1	doi:10.1097	doi:10.1097	PROPN
bptjm-49	147	2	/	/	SYM
bptjm-49	148	1	md.0000000000030826	md.0000000000030826	PROPN
bptjm-49	148	2	10	10	NUM
bptjm-49	148	3	.	.	PUNCT
bptjm-49	149	1	wang	wang	PROPN
bptjm-49	149	2	n	n	CCONJ
bptjm-49	149	3	,	,	PUNCT
bptjm-49	149	4	she	she	PRON
bptjm-49	149	5	j	j	PROPN
bptjm-49	149	6	,	,	PUNCT
bptjm-49	149	7	liuw	liuw	NOUN
bptjm-49	149	8	,	,	PUNCT
bptjm-49	149	9	et	et	PROPN
bptjm-49	149	10	al	al	PROPN
bptjm-49	149	11	.	.	PUNCT
bptjm-49	150	1	frequent	frequent	ADJ
bptjm-49	150	2	ampli	ampli	NOUN
bptjm-49	150	3	�	�	NOUN
bptjm-49	150	4	cation	cation	NOUN
bptjm-49	150	5	of	of	ADP
bptjm-49	150	6	ptp1b	ptp1b	PROPN
bptjm-49	150	7	is	be	AUX
bptjm-49	150	8	associated	associate	VERB
bptjm-49	150	9	with	with	ADP
bptjm-49	150	10	poor	poor	ADJ
bptjm-49	150	11	survival	survival	NOUN
bptjm-49	150	12	of	of	ADP
bptjm-49	150	13	gastric	gastric	ADJ
bptjm-49	150	14	cancer	cancer	NOUN
bptjm-49	150	15	patients	patient	NOUN
bptjm-49	150	16	.	.	PUNCT
bptjm-49	151	1	cell	cell	NOUN
bptjm-49	151	2	cycle	cycle	NOUN
bptjm-49	151	3	.	.	PUNCT
bptjm-49	152	1	2015;14(5):732	2015;14(5):732	NUM
bptjm-49	152	2	-	-	SYM
bptjm-49	152	3	743	743	NUM
bptjm-49	152	4	.	.	PUNCT
bptjm-49	153	1	doi:10.1080/15384101.2014.998047	doi:10.1080/15384101.2014.998047	PROPN
bptjm-49	153	2	11	11	NUM
bptjm-49	153	3	.	.	PUNCT
bptjm-49	154	1	wang	wang	PROPN
bptjm-49	154	2	j	j	PROPN
bptjm-49	154	3	,	,	PUNCT
bptjm-49	154	4	chen	chen	PROPN
bptjm-49	154	5	x	x	PROPN
bptjm-49	154	6	,	,	PUNCT
bptjm-49	154	7	liu	liu	PROPN
bptjm-49	154	8	b	b	PROPN
bptjm-49	154	9	,	,	PUNCT
bptjm-49	154	10	zhu	zhu	PROPN
bptjm-49	154	11	z.	z.	PROPN
bptjm-49	154	12	suppression	suppression	NOUN
bptjm-49	154	13	of	of	ADP
bptjm-49	154	14	ptp1b	ptp1b	NOUN
bptjm-49	154	15	in	in	ADP
bptjm-49	154	16	gastric	gastric	ADJ
bptjm-49	154	17	cancer	cancer	NOUN
bptjm-49	154	18	cells	cell	NOUN
bptjm-49	154	19	in	in	ADP
bptjm-49	154	20	vitro	vitro	X
bptjm-49	154	21	induces	induce	VERB
bptjm-49	154	22	a	a	DET
bptjm-49	154	23	change	change	NOUN
bptjm-49	154	24	in	in	ADP
bptjm-49	154	25	the	the	DET
bptjm-49	154	26	genome	genome	NOUN
bptjm-49	154	27	-	-	PUNCT
bptjm-49	154	28	wide	wide	ADJ
bptjm-49	154	29	expression	expression	NOUN
bptjm-49	154	30	pro	pro	X
bptjm-49	154	31	�	�	VERB
bptjm-49	154	32	le	le	X
bptjm-49	154	33	and	and	CCONJ
bptjm-49	154	34	inhibits	inhibit	VERB
bptjm-49	154	35	gastric	gastric	ADJ
bptjm-49	154	36	cancer	cancer	NOUN
bptjm-49	154	37	cell	cell	NOUN
bptjm-49	154	38	growth	growth	NOUN
bptjm-49	154	39	.	.	PUNCT
bptjm-49	155	1	cell	cell	NOUN
bptjm-49	155	2	biol	biol	PROPN
bptjm-49	155	3	int	int	NOUN
bptjm-49	155	4	.	.	PUNCT
bptjm-49	156	1	2010;34(7):747	2010;34(7):747	NUM
bptjm-49	156	2	-	-	SYM
bptjm-49	156	3	753	753	NUM
bptjm-49	156	4	.	.	PUNCT
bptjm-49	157	1	doi:10.1042	doi:10.1042	PROPN
bptjm-49	157	2	/	/	SYM
bptjm-49	157	3	cbi20090447	cbi20090447	PROPN
bptjm-49	157	4	12	12	NUM
bptjm-49	157	5	.	.	PUNCT
bptjm-49	158	1	lessard	lessard	PROPN
bptjm-49	158	2	l	l	PROPN
bptjm-49	158	3	,	,	PUNCT
bptjm-49	158	4	stuible	stuible	ADJ
bptjm-49	158	5	m	m	PROPN
bptjm-49	158	6	,	,	PUNCT
bptjm-49	158	7	tremblay	tremblay	VERB
bptjm-49	158	8	ml	ml	VERB
bptjm-49	158	9	.	.	PUNCT
bptjm-49	159	1	the	the	DET
bptjm-49	159	2	two	two	NUM
bptjm-49	159	3	faces	face	NOUN
bptjm-49	159	4	of	of	ADP
bptjm-49	159	5	ptp1b	ptp1b	NOUN
bptjm-49	159	6	in	in	ADP
bptjm-49	159	7	cancer	cancer	NOUN
bptjm-49	159	8	.	.	PUNCT
bptjm-49	160	1	biochim	biochim	PROPN
bptjm-49	160	2	biophys	biophy	NOUN
bptjm-49	160	3	acta	acta	PROPN
bptjm-49	160	4	.	.	PUNCT
bptjm-49	161	1	2010;1804(3):613	2010;1804(3):613	NUM
bptjm-49	161	2	-	-	SYM
bptjm-49	161	3	619	619	NUM
bptjm-49	161	4	.	.	PUNCT
bptjm-49	162	1	doi:10.1016	doi:10.1016	PROPN
bptjm-49	162	2	/	/	SYM
bptjm-49	162	3	j.bbapap.2009.09.018	j.bbapap.2009.09.018	NOUN
bptjm-49	162	4	13	13	NUM
bptjm-49	162	5	.	.	PUNCT
bptjm-49	163	1	harmer	harmer	PROPN
bptjm-49	163	2	sl	sl	PROPN
bptjm-49	163	3	,	,	PUNCT
bptjm-49	163	4	defranco	defranco	PROPN
bptjm-49	163	5	al	al	PROPN
bptjm-49	163	6	.	.	PUNCT
bptjm-49	164	1	shc	shc	PROPN
bptjm-49	164	2	contains	contain	VERB
bptjm-49	164	3	two	two	NUM
bptjm-49	164	4	grb2	grb2	NOUN
bptjm-49	164	5	binding	bind	VERB
bptjm-49	164	6	sites	site	NOUN
bptjm-49	164	7	needed	need	VERB
bptjm-49	164	8	for	for	ADP
bptjm-49	164	9	...	...	PUNCT
bptjm-49	164	10	researchgate	researchgate	NOUN
bptjm-49	164	11	.	.	PUNCT
bptjm-49	165	1	researchgate	researchgate	NOUN
bptjm-49	165	2	.	.	PUNCT
bptjm-49	166	1	https://www.researchgate.net/pro�le/anthony-d	https://www.researchgate.net/pro�le/anthony-d	PROPN
bptjm-49	166	2	berkeley	berkeley	PROPN
bptjm-49	166	3	pharma	pharma	PROPN
bptjm-49	166	4	tech	tech	NOUN
bptjm-49	166	5	journal	journal	NOUN
bptjm-49	166	6	of	of	ADP
bptjm-49	166	7	medicine	medicine	NOUN
bptjm-49	166	8	|	|	ADV
bptjm-49	166	9	96	96	NUM
bptjm-49	166	10	efranco	efranco	NOUN
bptjm-49	166	11	/	/	SYM
bptjm-49	166	12	publication/14020657_shc_contains_tw	publication/14020657_shc_contains_tw	PROPN
bptjm-49	166	13	o_grb2_binding_sites_needed_for_e	o_grb2_binding_sites_needed_for_e	PROPN
bptjm-49	166	14	�	�	PROPN
bptjm-49	166	15	cient_for	cient_for	ADP
bptjm-49	166	16	mation_of_complexes_with_sos_in_b_lympho	mation_of_complexes_with_sos_in_b_lympho	NOUN
bptjm-49	166	17	cytes	cyte	VERB
bptjm-49	166	18	/	/	SYM
bptjm-49	166	19	links/00b49517194a617a09000000	links/00b49517194a617a09000000	PROPN
bptjm-49	166	20	/	/	SYM
bptjm-49	166	21	shc	shc	PROPN
bptjm-49	166	22	-	-	PUNCT
bptjm-49	166	23	co	co	NOUN
bptjm-49	166	24	ntains	ntains	PROPN
bptjm-49	166	25	-	-	PUNCT
bptjm-49	166	26	two	two	NUM
bptjm-49	166	27	-	-	PUNCT
bptjm-49	166	28	grb2	grb2	NOUN
bptjm-49	166	29	-	-	PUNCT
bptjm-49	166	30	binding	bind	VERB
bptjm-49	166	31	-	-	PUNCT
bptjm-49	166	32	sites	site	NOUN
bptjm-49	166	33	-	-	PUNCT
bptjm-49	166	34	needed	need	VERB
bptjm-49	166	35	-	-	PUNCT
bptjm-49	166	36	for	for	ADP
bptjm-49	166	37	-	-	PUNCT
bptjm-49	166	38	e	e	NOUN
bptjm-49	166	39	�	�	NOUN
bptjm-49	166	40	cien	cien	NOUN
bptjm-49	166	41	t	t	NOUN
bptjm-49	166	42	-	-	PUNCT
bptjm-49	166	43	formation	formation	NOUN
bptjm-49	166	44	-	-	PUNCT
bptjm-49	166	45	of	of	ADP
bptjm-49	166	46	-	-	PUNCT
bptjm-49	166	47	complexes	complex	NOUN
bptjm-49	166	48	-	-	PUNCT
bptjm-49	166	49	with	with	ADP
bptjm-49	166	50	-	-	PUNCT
bptjm-49	166	51	sos	sos	NOUN
bptjm-49	166	52	-	-	PUNCT
bptjm-49	166	53	in	in	ADP
bptjm-49	166	54	-	-	PUNCT
bptjm-49	166	55	b	b	NOUN
bptjm-49	166	56	-	-	PUNCT
bptjm-49	166	57	lympho	lympho	ADJ
bptjm-49	166	58	cytes.pdf	cytes.pdf	PROPN
bptjm-49	166	59	.	.	PUNCT
bptjm-49	167	1	published	publish	VERB
bptjm-49	167	2	august	august	PROPN
bptjm-49	167	3	1997	1997	NUM
bptjm-49	167	4	.	.	PUNCT
bptjm-49	168	1	accessedmay	accessedmay	VERB
bptjm-49	168	2	5	5	NUM
bptjm-49	168	3	,	,	PUNCT
bptjm-49	168	4	2023	2023	NUM
bptjm-49	168	5	.	.	PUNCT
bptjm-49	169	1	14	14	NUM
bptjm-49	169	2	.	.	PUNCT
bptjm-49	170	1	liu	liu	PROPN
bptjm-49	170	2	h	h	PROPN
bptjm-49	170	3	,	,	PUNCT
bptjm-49	170	4	wu	wu	PROPN
bptjm-49	170	5	y	y	PROPN
bptjm-49	170	6	,	,	PUNCT
bptjm-49	170	7	zhu	zhu	PROPN
bptjm-49	170	8	s	s	PART
bptjm-49	170	9	,	,	PUNCT
bptjm-49	170	10	et	et	PROPN
bptjm-49	170	11	al	al	PROPN
bptjm-49	170	12	.	.	PUNCT
bptjm-49	170	13	ptp1b	ptp1b	PROPN
bptjm-49	170	14	promotes	promote	VERB
bptjm-49	170	15	cell	cell	NOUN
bptjm-49	170	16	proliferation	proliferation	NOUN
bptjm-49	170	17	and	and	CCONJ
bptjm-49	170	18	metastasis	metastasis	NOUN
bptjm-49	170	19	through	through	ADP
bptjm-49	170	20	activating	activate	VERB
bptjm-49	170	21	src	src	NOUN
bptjm-49	170	22	and	and	CCONJ
bptjm-49	170	23	erk1/2	erk1/2	PROPN
bptjm-49	170	24	in	in	ADP
bptjm-49	170	25	non	non	ADJ
bptjm-49	170	26	-	-	ADJ
bptjm-49	170	27	small	small	ADJ
bptjm-49	170	28	cell	cell	NOUN
bptjm-49	170	29	lung	lung	NOUN
bptjm-49	170	30	cancer	cancer	NOUN
bptjm-49	170	31	.	.	PUNCT
bptjm-49	171	1	cancer	cancer	NOUN
bptjm-49	171	2	lett	lett	PROPN
bptjm-49	171	3	.	.	PUNCT
bptjm-49	172	1	2015;359(2):218	2015;359(2):218	NUM
bptjm-49	172	2	-	-	SYM
bptjm-49	172	3	225	225	NUM
bptjm-49	172	4	.	.	PUNCT
bptjm-49	173	1	doi:10.1016	doi:10.1016	PROPN
bptjm-49	173	2	/	/	SYM
bptjm-49	173	3	j.canlet.2015.01.020	j.canlet.2015.01.020	PROPN
bptjm-49	173	4	15	15	NUM
bptjm-49	173	5	.	.	PUNCT
bptjm-49	174	1	wang	wang	PROPN
bptjm-49	174	2	c	c	PROPN
bptjm-49	174	3	-	-	PUNCT
bptjm-49	174	4	c	c	NOUN
bptjm-49	174	5	,	,	PUNCT
bptjm-49	174	6	shenw	shenw	ADJ
bptjm-49	174	7	-	-	PUNCT
bptjm-49	174	8	j	j	NOUN
bptjm-49	174	9	,	,	PUNCT
bptjm-49	174	10	anuraga	anuraga	PROPN
bptjm-49	174	11	g	g	PROPN
bptjm-49	174	12	,	,	PUNCT
bptjm-49	174	13	khoa	khoa	NOUN
bptjm-49	174	14	ta	ta	PROPN
bptjm-49	174	15	hd	hd	PROPN
bptjm-49	174	16	,	,	PUNCT
bptjm-49	174	17	xuan	xuan	PROPN
bptjm-49	174	18	dtm	dtm	PROPN
bptjm-49	174	19	,	,	PUNCT
bptjm-49	174	20	chen	chen	PROPN
bptjm-49	174	21	s	s	PROPN
bptjm-49	174	22	-	-	PUNCT
bptjm-49	174	23	t	t	PROPN
bptjm-49	174	24	,	,	PUNCT
bptjm-49	174	25	shen	shen	PROPN
bptjm-49	175	1	c	c	PROPN
bptjm-49	175	2	-	-	PUNCT
bptjm-49	175	3	f	f	PROPN
bptjm-49	175	4	,	,	PUNCT
bptjm-49	175	5	jiang	jiang	PROPN
bptjm-49	175	6	j	j	PROPN
bptjm-49	175	7	-	-	PROPN
bptjm-49	175	8	z	z	PROPN
bptjm-49	175	9	,	,	PUNCT
bptjm-49	175	10	sun	sun	PROPN
bptjm-49	175	11	z	z	PROPN
bptjm-49	175	12	,	,	PUNCT
bptjm-49	175	13	wang	wang	PROPN
bptjm-49	175	14	c	c	PROPN
bptjm-49	175	15	-	-	PUNCT
bptjm-49	175	16	y	y	PROPN
bptjm-49	175	17	,	,	PUNCT
bptjm-49	175	18	wangw	wangw	NOUN
bptjm-49	175	19	-	-	PUNCT
bptjm-49	175	20	j.	j.	PROPN
bptjm-49	175	21	novel	novel	ADJ
bptjm-49	175	22	potential	potential	ADJ
bptjm-49	175	23	therapeutic	therapeutic	ADJ
bptjm-49	175	24	targets	target	NOUN
bptjm-49	175	25	of	of	ADP
bptjm-49	175	26	ptpn	ptpn	ADJ
bptjm-49	175	27	families	family	NOUN
bptjm-49	175	28	for	for	ADP
bptjm-49	175	29	lung	lung	NOUN
bptjm-49	175	30	cancer	cancer	NOUN
bptjm-49	175	31	.	.	PUNCT
bptjm-49	176	1	journal	journal	PROPN
bptjm-49	176	2	of	of	ADP
bptjm-49	176	3	personalizedmedicine	personalizedmedicine	NOUN
bptjm-49	176	4	.	.	PUNCT
bptjm-49	177	1	2022	2022	NUM
bptjm-49	177	2	;	;	PUNCT
bptjm-49	177	3	12(12):1947	12(12):1947	NUM
bptjm-49	177	4	.	.	PUNCT
bptjm-49	178	1	https://doi.org/10.3390/jpm12121947	https://doi.org/10.3390/jpm12121947	PROPN
bptjm-49	178	2	16	16	NUM
bptjm-49	178	3	.	.	PUNCT
bptjm-49	179	1	katkeviciute	katkeviciute	PROPN
bptjm-49	179	2	,	,	PUNCT
bptjm-49	179	3	e.	e.	PROPN
bptjm-49	179	4	,	,	PUNCT
bptjm-49	179	5	hering	hering	PROPN
bptjm-49	179	6	,	,	PUNCT
bptjm-49	179	7	l.	l.	PROPN
bptjm-49	179	8	,	,	PUNCT
bptjm-49	179	9	montalban	montalban	PROPN
bptjm-49	179	10	-	-	PUNCT
bptjm-49	179	11	arques	arques	PROPN
bptjm-49	179	12	,	,	PUNCT
bptjm-49	179	13	a.	a.	NOUN
bptjm-49	179	14	,	,	PUNCT
bptjm-49	179	15	busenhart	busenhart	NOUN
bptjm-49	179	16	,	,	PUNCT
bptjm-49	179	17	p.	p.	PROPN
bptjm-49	179	18	,	,	PUNCT
bptjm-49	179	19	schwarz	schwarz	PROPN
bptjm-49	179	20	�	�	PROPN
bptjm-49	179	21	scher	scher	PROPN
bptjm-49	179	22	,	,	PUNCT
bptjm-49	179	23	m.	m.	NOUN
bptjm-49	179	24	,	,	PUNCT
bptjm-49	179	25	manzini	manzini	PROPN
bptjm-49	179	26	,	,	PUNCT
bptjm-49	179	27	r.	r.	PROPN
bptjm-49	179	28	,	,	PUNCT
bptjm-49	179	29	conde	conde	PROPN
bptjm-49	179	30	,	,	PUNCT
bptjm-49	179	31	j.	j.	PROPN
bptjm-49	179	32	,	,	PUNCT
bptjm-49	179	33	atrott	atrott	PROPN
bptjm-49	179	34	,	,	PUNCT
bptjm-49	179	35	k.	k.	PROPN
bptjm-49	179	36	,	,	PUNCT
bptjm-49	179	37	lang	lang	PROPN
bptjm-49	179	38	,	,	PUNCT
bptjm-49	179	39	s.	s.	PROPN
bptjm-49	179	40	,	,	PUNCT
bptjm-49	179	41	rogler	rogler	PROPN
bptjm-49	179	42	,	,	PUNCT
bptjm-49	179	43	g.	g.	PROPN
bptjm-49	179	44	,	,	PUNCT
bptjm-49	179	45	naschberger	naschberger	PROPN
bptjm-49	179	46	,	,	PUNCT
bptjm-49	179	47	e.	e.	PROPN
bptjm-49	179	48	,	,	PUNCT
bptjm-49	179	49	schellerer	schellerer	NOUN
bptjm-49	179	50	,	,	PUNCT
bptjm-49	179	51	v.	v.	PROPN
bptjm-49	179	52	s.	s.	PROPN
bptjm-49	179	53	,	,	PUNCT
bptjm-49	179	54	stürzl	stürzl	PROPN
bptjm-49	179	55	,	,	PUNCT
bptjm-49	179	56	m.	m.	NOUN
bptjm-49	179	57	,	,	PUNCT
bptjm-49	179	58	rickenbacher	rickenbacher	PROPN
bptjm-49	179	59	,	,	PUNCT
bptjm-49	179	60	a.	a.	NOUN
bptjm-49	179	61	,	,	PUNCT
bptjm-49	179	62	turina	turina	ADV
bptjm-49	179	63	,	,	PUNCT
bptjm-49	179	64	m.	m.	NOUN
bptjm-49	179	65	,	,	PUNCT
bptjm-49	179	66	weber	weber	PROPN
bptjm-49	179	67	,	,	PUNCT
bptjm-49	179	68	a.	a.	PROPN
bptjm-49	179	69	,	,	PUNCT
bptjm-49	179	70	leibl	leibl	PROPN
bptjm-49	179	71	,	,	PUNCT
bptjm-49	179	72	s.	s.	PROPN
bptjm-49	179	73	,	,	PUNCT
bptjm-49	179	74	leventhal	leventhal	PROPN
bptjm-49	179	75	,	,	PUNCT
bptjm-49	179	76	g.	g.	PROPN
bptjm-49	179	77	e.	e.	PROPN
bptjm-49	179	78	,	,	PUNCT
bptjm-49	179	79	levesque	levesque	PROPN
bptjm-49	179	80	,	,	PUNCT
bptjm-49	179	81	m.	m.	NOUN
bptjm-49	179	82	,	,	PUNCT
bptjm-49	179	83	spalinger	spalinger	NOUN
bptjm-49	179	84	,	,	PUNCT
bptjm-49	179	85	m.	m.	NOUN
bptjm-49	179	86	r.	r.	PROPN
bptjm-49	179	87	(	(	PUNCT
bptjm-49	179	88	2021	2021	NUM
bptjm-49	179	89	)	)	PUNCT
bptjm-49	179	90	.	.	PUNCT
bptjm-49	180	1	protein	protein	NOUN
bptjm-49	180	2	tyrosine	tyrosine	NOUN
bptjm-49	180	3	phosphatase	phosphatase	NOUN
bptjm-49	180	4	nonreceptor	nonreceptor	ADJ
bptjm-49	180	5	type	type	NOUN
bptjm-49	180	6	2	2	NUM
bptjm-49	180	7	controls	control	VERB
bptjm-49	180	8	colorectal	colorectal	ADJ
bptjm-49	180	9	cancer	cancer	NOUN
bptjm-49	180	10	development	development	NOUN
bptjm-49	180	11	.	.	PUNCT
bptjm-49	181	1	journal	journal	PROPN
bptjm-49	181	2	of	of	ADP
bptjm-49	181	3	clinical	clinical	ADJ
bptjm-49	181	4	investigation	investigation	NOUN
bptjm-49	181	5	,	,	PUNCT
bptjm-49	181	6	131(1	131(1	NUM
bptjm-49	181	7	)	)	PUNCT
bptjm-49	181	8	.	.	PUNCT
bptjm-49	182	1	https://doi.org/10.1172/jci140281	https://doi.org/10.1172/jci140281	PROPN
bptjm-49	182	2	17	17	NUM
bptjm-49	182	3	.	.	PUNCT
bptjm-49	183	1	ivashkiv	ivashkiv	PROPN
bptjm-49	183	2	,	,	PUNCT
bptjm-49	183	3	l.	l.	PROPN
bptjm-49	183	4	b.	b.	PROPN
bptjm-49	183	5	(	(	PUNCT
bptjm-49	183	6	2018	2018	NUM
bptjm-49	183	7	)	)	PUNCT
bptjm-49	183	8	.	.	PUNCT
bptjm-49	184	1	ifnγ	ifnγ	NOUN
bptjm-49	184	2	:	:	PUNCT
bptjm-49	184	3	signalling	signal	VERB
bptjm-49	184	4	,	,	PUNCT
bptjm-49	184	5	epigenetics	epigenetic	NOUN
bptjm-49	184	6	and	and	CCONJ
bptjm-49	184	7	roles	role	NOUN
bptjm-49	184	8	in	in	ADP
bptjm-49	184	9	immunity	immunity	NOUN
bptjm-49	184	10	,	,	PUNCT
bptjm-49	184	11	metabolism	metabolism	NOUN
bptjm-49	184	12	,	,	PUNCT
bptjm-49	184	13	disease	disease	NOUN
bptjm-49	184	14	and	and	CCONJ
bptjm-49	184	15	cancer	cancer	NOUN
bptjm-49	184	16	immunotherapy.nature	immunotherapy.nature	PROPN
bptjm-49	184	17	reviews	review	VERB
bptjm-49	184	18	immunology	immunology	NOUN
bptjm-49	184	19	.	.	PUNCT
bptjm-49	185	1	18(9	18(9	NOUN
bptjm-49	185	2	)	)	PUNCT
bptjm-49	185	3	,	,	PUNCT
bptjm-49	186	1	545–558	545–558	NUM
bptjm-49	186	2	.	.	PUNCT
bptjm-49	187	1	https://doi.org/10.1038/s41577-018-0029-z	https://doi.org/10.1038/s41577-018-0029-z	PROPN
bptjm-49	187	2	18	18	NUM
bptjm-49	187	3	.	.	PUNCT
bptjm-49	188	1	liu	liu	PROPN
bptjm-49	188	2	,	,	PUNCT
bptjm-49	188	3	x.	x.	PROPN
bptjm-49	188	4	,	,	PUNCT
bptjm-49	188	5	ye	ye	PROPN
bptjm-49	188	6	,	,	PUNCT
bptjm-49	188	7	l.	l.	PROPN
bptjm-49	188	8	,	,	PUNCT
bptjm-49	188	9	bai	bai	PROPN
bptjm-49	188	10	,	,	PUNCT
bptjm-49	188	11	y.	y.	PROPN
bptjm-49	188	12	,	,	PUNCT
bptjm-49	188	13	mojidi	mojidi	PROPN
bptjm-49	188	14	,	,	PUNCT
bptjm-49	188	15	h.	h.	PROPN
bptjm-49	188	16	,	,	PUNCT
bptjm-49	188	17	simister	simister	PROPN
bptjm-49	188	18	,	,	PUNCT
bptjm-49	188	19	n.	n.	PROPN
bptjm-49	188	20	e.	e.	PROPN
bptjm-49	188	21	,	,	PUNCT
bptjm-49	188	22	&	&	CCONJ
bptjm-49	188	23	zhu	zhu	PROPN
bptjm-49	188	24	,	,	PUNCT
bptjm-49	188	25	x.	x.	NOUN
bptjm-49	188	26	(	(	PUNCT
bptjm-49	188	27	2008	2008	NUM
bptjm-49	188	28	)	)	PUNCT
bptjm-49	188	29	.	.	PUNCT
bptjm-49	189	1	activation	activation	NOUN
bptjm-49	189	2	of	of	ADP
bptjm-49	189	3	the	the	DET
bptjm-49	189	4	jak	jak	PROPN
bptjm-49	189	5	/	/	SYM
bptjm-49	189	6	stat-1	stat-1	NUM
bptjm-49	189	7	signaling	signal	VERB
bptjm-49	189	8	pathway	pathway	NOUN
bptjm-49	189	9	by	by	ADP
bptjm-49	189	10	ifn	ifn	PROPN
bptjm-49	189	11	-	-	PUNCT
bptjm-49	189	12	γ	γ	X
bptjm-49	189	13	can	can	AUX
bptjm-49	189	14	down	down	ADV
bptjm-49	189	15	-	-	PUNCT
bptjm-49	189	16	regulate	regulate	VERB
bptjm-49	189	17	functional	functional	ADJ
bptjm-49	189	18	expression	expression	NOUN
bptjm-49	189	19	of	of	ADP
bptjm-49	189	20	the	the	DET
bptjm-49	189	21	mhc	mhc	PROPN
bptjm-49	189	22	class	class	PROPN
bptjm-49	189	23	i	i	NOUN
bptjm-49	189	24	-	-	PUNCT
bptjm-49	189	25	related	relate	VERB
bptjm-49	189	26	neonatal	neonatal	ADJ
bptjm-49	189	27	fc	fc	NOUN
bptjm-49	189	28	receptor	receptor	NOUN
bptjm-49	189	29	for	for	ADP
bptjm-49	189	30	igg	igg	PROPN
bptjm-49	189	31	.	.	PUNCT
bptjm-49	190	1	the	the	DET
bptjm-49	190	2	journal	journal	NOUN
bptjm-49	190	3	of	of	ADP
bptjm-49	190	4	immunology	immunology	NOUN
bptjm-49	190	5	,	,	PUNCT
bptjm-49	190	6	181(1	181(1	NUM
bptjm-49	190	7	)	)	PUNCT
bptjm-49	190	8	,	,	PUNCT
bptjm-49	190	9	449–463	449–463	NUM
bptjm-49	190	10	.	.	PUNCT
bptjm-49	190	11	https://doi.org/10.4049/jimmunol.181.1.449	https://doi.org/10.4049/jimmunol.181.1.449	PROPN
bptjm-49	190	12	19	19	NUM
bptjm-49	190	13	.	.	PUNCT
bptjm-49	191	1	zhu	zhu	PROPN
bptjm-49	191	2	,	,	PUNCT
bptjm-49	191	3	z.	z.	PROPN
bptjm-49	191	4	,	,	PUNCT
bptjm-49	191	5	tang	tang	PROPN
bptjm-49	191	6	,	,	PUNCT
bptjm-49	191	7	r.	r.	PROPN
bptjm-49	191	8	,	,	PUNCT
bptjm-49	191	9	hu	hu	PROPN
bptjm-49	191	10	�	�	PROPN
bptjm-49	191	11	,	,	PUNCT
bptjm-49	191	12	s.	s.	PROPN
bptjm-49	191	13	,	,	PUNCT
bptjm-49	191	14	kummetha	kummetha	PROPN
bptjm-49	191	15	,	,	PUNCT
bptjm-49	191	16	i.	i.	PROPN
bptjm-49	191	17	r.	r.	PROPN
bptjm-49	191	18	,	,	PUNCT
bptjm-49	191	19	wang	wang	PROPN
bptjm-49	191	20	,	,	PUNCT
bptjm-49	191	21	l.	l.	PROPN
bptjm-49	191	22	,	,	PUNCT
bptjm-49	191	23	li	li	PROPN
bptjm-49	191	24	,	,	PUNCT
bptjm-49	191	25	n.	n.	NOUN
bptjm-49	191	26	,	,	PUNCT
bptjm-49	191	27	&	&	CCONJ
bptjm-49	191	28	rana	rana	PROPN
bptjm-49	191	29	,	,	PUNCT
bptjm-49	191	30	t.	t.	PROPN
bptjm-49	191	31	m.	m.	NOUN
bptjm-49	191	32	(	(	PUNCT
bptjm-49	191	33	2023	2023	NUM
bptjm-49	191	34	)	)	PUNCT
bptjm-49	191	35	.	.	PUNCT
bptjm-49	192	1	small	small	ADJ
bptjm-49	192	2	-	-	PUNCT
bptjm-49	192	3	molecule	molecule	NOUN
bptjm-49	192	4	ptpn2	ptpn2	VERB
bptjm-49	192	5	inhibitors	inhibitor	NOUN
bptjm-49	192	6	sensitize	sensitize	VERB
bptjm-49	192	7	resistant	resistant	ADJ
bptjm-49	192	8	melanoma	melanoma	NOUN
bptjm-49	192	9	to	to	ADP
bptjm-49	192	10	anti	anti	ADJ
bptjm-49	192	11	-	-	ADJ
bptjm-49	192	12	pd-1	pd-1	ADJ
bptjm-49	192	13	immunotherapy	immunotherapy	NOUN
bptjm-49	192	14	.	.	PUNCT
bptjm-49	193	1	cancer	cancer	NOUN
bptjm-49	193	2	research	research	NOUN
bptjm-49	193	3	communications	communication	NOUN
bptjm-49	193	4	,	,	PUNCT
bptjm-49	193	5	3(1	3(1	NUM
bptjm-49	193	6	)	)	PUNCT
bptjm-49	193	7	,	,	PUNCT
bptjm-49	193	8	119–129	119–129	NUM
bptjm-49	193	9	.	.	PUNCT
bptjm-49	194	1	https://doi.org/10.1158/2767-9764.crc-21-0186	https://doi.org/10.1158/2767-9764.crc-21-0186	PROPN
bptjm-49	195	1	20	20	NUM
bptjm-49	195	2	.	.	PUNCT
bptjm-49	196	1	zhu	zhu	PROPN
bptjm-49	196	2	,	,	PUNCT
bptjm-49	196	3	g.	g.	PROPN
bptjm-49	196	4	,	,	PUNCT
bptjm-49	196	5	pei	pei	PROPN
bptjm-49	196	6	,	,	PUNCT
bptjm-49	196	7	l.	l.	PROPN
bptjm-49	196	8	,	,	PUNCT
bptjm-49	196	9	xia	xia	PROPN
bptjm-49	196	10	,	,	PUNCT
bptjm-49	196	11	h.	h.	PROPN
bptjm-49	196	12	,	,	PUNCT
bptjm-49	196	13	tang	tang	PROPN
bptjm-49	196	14	,	,	PUNCT
bptjm-49	196	15	q.	q.	PROPN
bptjm-49	196	16	,	,	PUNCT
bptjm-49	196	17	&	&	CCONJ
bptjm-49	196	18	bi	bi	PROPN
bptjm-49	196	19	,	,	PUNCT
bptjm-49	196	20	f.	f.	PROPN
bptjm-49	196	21	(	(	PUNCT
bptjm-49	196	22	2021	2021	NUM
bptjm-49	196	23	)	)	PUNCT
bptjm-49	196	24	.	.	PUNCT
bptjm-49	197	1	role	role	NOUN
bptjm-49	197	2	of	of	ADP
bptjm-49	197	3	oncogenic	oncogenic	ADJ
bptjm-49	197	4	kras	kra	NOUN
bptjm-49	197	5	in	in	ADP
bptjm-49	197	6	the	the	DET
bptjm-49	197	7	prognosis	prognosis	NOUN
bptjm-49	197	8	,	,	PUNCT
bptjm-49	197	9	diagnosis	diagnosis	NOUN
bptjm-49	197	10	and	and	CCONJ
bptjm-49	197	11	treatment	treatment	NOUN
bptjm-49	197	12	of	of	ADP
bptjm-49	197	13	colorectal	colorectal	ADJ
bptjm-49	197	14	cancer	cancer	NOUN
bptjm-49	197	15	.	.	PUNCT
bptjm-49	198	1	molecular	molecular	ADJ
bptjm-49	198	2	cancer	cancer	NOUN
bptjm-49	198	3	,	,	PUNCT
bptjm-49	198	4	20(1	20(1	NUM
bptjm-49	198	5	)	)	PUNCT
bptjm-49	198	6	.	.	PUNCT
bptjm-49	199	1	https://doi.org/10.1186/s12943-021-01441-4	https://doi.org/10.1186/s12943-021-01441-4	NUM
bptjm-49	200	1	21.huang	21.huang	PROPN
bptjm-49	200	2	,	,	PUNCT
bptjm-49	200	3	l.	l.	PROPN
bptjm-49	200	4	,	,	PUNCT
bptjm-49	200	5	guo	guo	PROPN
bptjm-49	200	6	,	,	PUNCT
bptjm-49	200	7	z.	z.	PROPN
bptjm-49	200	8	,	,	PUNCT
bptjm-49	200	9	wang	wang	PROPN
bptjm-49	200	10	,	,	PUNCT
bptjm-49	200	11	f.	f.	PROPN
bptjm-49	200	12	,	,	PUNCT
bptjm-49	200	13	&	&	CCONJ
bptjm-49	200	14	fu	fu	PROPN
bptjm-49	200	15	,	,	PUNCT
bptjm-49	200	16	l.	l.	PROPN
bptjm-49	200	17	(	(	PUNCT
bptjm-49	200	18	2021	2021	NUM
bptjm-49	200	19	)	)	PUNCT
bptjm-49	200	20	.	.	PUNCT
bptjm-49	201	1	kras	kras	PROPN
bptjm-49	201	2	mutation	mutation	PROPN
bptjm-49	201	3	:	:	PUNCT
bptjm-49	201	4	from	from	ADP
bptjm-49	201	5	undruggable	undruggable	ADJ
bptjm-49	201	6	to	to	PART
bptjm-49	201	7	druggable	druggable	VERB
bptjm-49	201	8	in	in	ADP
bptjm-49	201	9	cancer	cancer	NOUN
bptjm-49	201	10	.	.	PUNCT
bptjm-49	202	1	signal	signal	ADJ
bptjm-49	202	2	transduction	transduction	NOUN
bptjm-49	202	3	and	and	CCONJ
bptjm-49	202	4	targeted	target	VERB
bptjm-49	202	5	therapy	therapy	NOUN
bptjm-49	202	6	,	,	PUNCT
bptjm-49	202	7	6(1	6(1	NUM
bptjm-49	202	8	)	)	PUNCT
bptjm-49	202	9	.	.	PUNCT
bptjm-49	203	1	https://doi.org/10.1038/s41392-021-00780-4	https://doi.org/10.1038/s41392-021-00780-4	NUM
bptjm-49	203	2	22	22	NUM
bptjm-49	203	3	.	.	PUNCT
bptjm-49	204	1	huang	huang	PROPN
bptjm-49	204	2	,	,	PUNCT
bptjm-49	204	3	z.	z.	PROPN
bptjm-49	204	4	,	,	PUNCT
bptjm-49	204	5	liu	liu	PROPN
bptjm-49	204	6	,	,	PUNCT
bptjm-49	204	7	m.	m.	NOUN
bptjm-49	204	8	,	,	PUNCT
bptjm-49	204	9	li	li	PROPN
bptjm-49	204	10	,	,	PUNCT
bptjm-49	204	11	d.	d.	PROPN
bptjm-49	204	12	,	,	PUNCT
bptjm-49	204	13	tan	tan	PROPN
bptjm-49	204	14	,	,	PUNCT
bptjm-49	204	15	y.	y.	PROPN
bptjm-49	204	16	,	,	PUNCT
bptjm-49	204	17	zhang	zhang	PROPN
bptjm-49	204	18	,	,	PUNCT
bptjm-49	204	19	r.	r.	PROPN
bptjm-49	204	20	,	,	PUNCT
bptjm-49	204	21	xia	xia	PROPN
bptjm-49	204	22	,	,	PUNCT
bptjm-49	204	23	z.	z.	PROPN
bptjm-49	204	24	,	,	PUNCT
bptjm-49	204	25	wang	wang	PROPN
bptjm-49	204	26	,	,	PUNCT
bptjm-49	204	27	p.	p.	PROPN
bptjm-49	204	28	,	,	PUNCT
bptjm-49	204	29	jiao	jiao	PROPN
bptjm-49	204	30	,	,	PUNCT
bptjm-49	204	31	b.	b.	PROPN
bptjm-49	204	32	,	,	PUNCT
bptjm-49	204	33	liu	liu	PROPN
bptjm-49	204	34	,	,	PUNCT
bptjm-49	204	35	p.	p.	PROPN
bptjm-49	204	36	,	,	PUNCT
bptjm-49	204	37	&	&	CCONJ
bptjm-49	204	38	ren	ren	PROPN
bptjm-49	204	39	,	,	PUNCT
bptjm-49	204	40	r.	r.	PROPN
bptjm-49	204	41	(	(	PUNCT
bptjm-49	204	42	2020	2020	NUM
bptjm-49	204	43	)	)	PUNCT
bptjm-49	204	44	.	.	PUNCT
bptjm-49	205	1	ptpn2	ptpn2	VERB
bptjm-49	205	2	regulates	regulate	VERB
bptjm-49	205	3	the	the	DET
bptjm-49	205	4	activation	activation	NOUN
bptjm-49	205	5	of	of	ADP
bptjm-49	205	6	kras	kra	NOUN
bptjm-49	205	7	and	and	CCONJ
bptjm-49	205	8	plays	play	VERB
bptjm-49	205	9	a	a	DET
bptjm-49	205	10	critical	critical	ADJ
bptjm-49	205	11	role	role	NOUN
bptjm-49	205	12	in	in	ADP
bptjm-49	205	13	proliferation	proliferation	NOUN
bptjm-49	205	14	and	and	CCONJ
bptjm-49	205	15	survival	survival	NOUN
bptjm-49	205	16	of	of	ADP
bptjm-49	205	17	kras	kras	PROPN
bptjm-49	205	18	-	-	PUNCT
bptjm-49	205	19	driven	drive	VERB
bptjm-49	205	20	cancer	cancer	NOUN
bptjm-49	205	21	cells	cell	NOUN
bptjm-49	205	22	.	.	PUNCT
bptjm-49	206	1	journal	journal	NOUN
bptjm-49	206	2	of	of	ADP
bptjm-49	206	3	biological	biological	ADJ
bptjm-49	206	4	chemistry	chemistry	NOUN
bptjm-49	206	5	,	,	PUNCT
bptjm-49	206	6	295(52	295(52	NUM
bptjm-49	206	7	)	)	PUNCT
bptjm-49	206	8	,	,	PUNCT
bptjm-49	206	9	18343–18354	18343–18354	NUM
bptjm-49	206	10	.	.	PUNCT
bptjm-49	206	11	https://doi.org/10.1074/jbc.ra119.011060	https://doi.org/10.1074/jbc.ra119.011060	NOUN
bptjm-49	206	12	23	23	NUM
bptjm-49	206	13	.	.	PUNCT
bptjm-49	207	1	jung	jung	PROPN
bptjm-49	207	2	,	,	PUNCT
bptjm-49	207	3	y.	y.	PROPN
bptjm-49	207	4	,	,	PUNCT
bptjm-49	207	5	kim	kim	PROPN
bptjm-49	207	6	,	,	PUNCT
bptjm-49	207	7	p.	p.	PROPN
bptjm-49	207	8	,	,	PUNCT
bptjm-49	207	9	jung	jung	PROPN
bptjm-49	207	10	,	,	PUNCT
bptjm-49	207	11	y.	y.	PROPN
bptjm-49	207	12	,	,	PUNCT
bptjm-49	207	13	keum	keum	PROPN
bptjm-49	207	14	,	,	PUNCT
bptjm-49	207	15	j.	j.	PROPN
bptjm-49	207	16	,	,	PUNCT
bptjm-49	207	17	kim	kim	PROPN
bptjm-49	207	18	,	,	PUNCT
bptjm-49	207	19	s.-n	s.-n	PROPN
bptjm-49	207	20	.	.	PROPN
bptjm-49	207	21	,	,	PUNCT
bptjm-49	207	22	choi	choi	NOUN
bptjm-49	207	23	,	,	PUNCT
bptjm-49	207	24	y.	y.	PROPN
bptjm-49	207	25	s.	s.	PROPN
bptjm-49	207	26	,	,	PUNCT
bptjm-49	207	27	do	do	VERB
bptjm-49	207	28	,	,	PUNCT
bptjm-49	207	29	i.-g	i.-g	PROPN
bptjm-49	207	30	.	.	PROPN
bptjm-49	207	31	,	,	PUNCT
bptjm-49	207	32	lee	lee	PROPN
bptjm-49	207	33	,	,	PUNCT
bptjm-49	207	34	j.	j.	PROPN
bptjm-49	207	35	,	,	PUNCT
bptjm-49	207	36	choi	choi	NOUN
bptjm-49	207	37	,	,	PUNCT
bptjm-49	207	38	s.-j	s.-j	PROPN
bptjm-49	207	39	.	.	PROPN
bptjm-49	207	40	,	,	PUNCT
bptjm-49	207	41	kim	kim	PROPN
bptjm-49	207	42	,	,	PUNCT
bptjm-49	207	43	s.	s.	PROPN
bptjm-49	207	44	,	,	PUNCT
bptjm-49	207	45	lee	lee	PROPN
bptjm-49	207	46	,	,	PUNCT
bptjm-49	207	47	j.-e	j.-e	PROPN
bptjm-49	207	48	.	.	PUNCT
bptjm-49	207	49	,	,	PUNCT
bptjm-49	207	50	kim	kim	PROPN
bptjm-49	207	51	,	,	PUNCT
bptjm-49	207	52	j.	j.	PROPN
bptjm-49	207	53	,	,	PUNCT
bptjm-49	207	54	lee	lee	PROPN
bptjm-49	207	55	,	,	PUNCT
bptjm-49	207	56	s.	s.	PROPN
bptjm-49	207	57	,	,	PUNCT
bptjm-49	207	58	&	&	CCONJ
bptjm-49	207	59	kim	kim	PROPN
bptjm-49	207	60	,	,	PUNCT
bptjm-49	207	61	j.	j.	PROPN
bptjm-49	207	62	(	(	PUNCT
bptjm-49	207	63	2012	2012	NUM
bptjm-49	207	64	)	)	PUNCT
bptjm-49	207	65	.	.	PUNCT
bptjm-49	208	1	discovery	discovery	NOUN
bptjm-49	208	2	of	of	ADP
bptjm-49	208	3	alk	alk	PROPN
bptjm-49	208	4	-	-	PUNCT
bptjm-49	208	5	ptpn3	ptpn3	NOUN
bptjm-49	208	6	gene	gene	NOUN
bptjm-49	208	7	fusion	fusion	NOUN
bptjm-49	208	8	from	from	ADP
bptjm-49	208	9	human	human	ADJ
bptjm-49	208	10	non	non	ADJ
bptjm-49	208	11	-	-	ADJ
bptjm-49	208	12	small	small	ADJ
bptjm-49	208	13	cell	cell	NOUN
bptjm-49	208	14	lung	lung	NOUN
bptjm-49	208	15	carcinoma	carcinoma	NOUN
bptjm-49	208	16	cell	cell	NOUN
bptjm-49	208	17	line	line	NOUN
bptjm-49	208	18	using	use	VERB
bptjm-49	208	19	next	next	ADJ
bptjm-49	208	20	generation	generation	NOUN
bptjm-49	208	21	rna	rna	NOUN
bptjm-49	208	22	sequencing	sequencing	NOUN
bptjm-49	208	23	.	.	PUNCT
bptjm-49	209	1	genes	gene	NOUN
bptjm-49	209	2	,	,	PUNCT
bptjm-49	209	3	chromosomes	chromosome	NOUN
bptjm-49	209	4	and	and	CCONJ
bptjm-49	209	5	cancer	cancer	NOUN
bptjm-49	209	6	,	,	PUNCT
bptjm-49	209	7	51(6	51(6	NOUN
bptjm-49	209	8	)	)	PUNCT
bptjm-49	209	9	,	,	PUNCT
bptjm-49	209	10	590–597	590–597	NUM
bptjm-49	209	11	.	.	PUNCT
bptjm-49	210	1	https://doi.org/10.1002/gcc.21945	https://doi.org/10.1002/gcc.21945	PROPN
bptjm-49	210	2	berkeley	berkeley	PROPN
bptjm-49	210	3	pharma	pharma	PROPN
bptjm-49	210	4	tech	tech	NOUN
bptjm-49	210	5	journal	journal	NOUN
bptjm-49	210	6	of	of	ADP
bptjm-49	210	7	medicine	medicine	NOUN
bptjm-49	210	8	|	|	ADV
bptjm-49	210	9	97	97	NUM
bptjm-49	210	10	24	24	NUM
bptjm-49	210	11	.	.	PUNCT
bptjm-49	211	1	li	li	PROPN
bptjm-49	211	2	,	,	PUNCT
bptjm-49	211	3	m.-y	m.-y	PROPN
bptjm-49	211	4	.	.	PUNCT
bptjm-49	211	5	,	,	PUNCT
bptjm-49	211	6	peng	peng	PROPN
bptjm-49	211	7	,	,	PUNCT
bptjm-49	211	8	w.-h	w.-h	NOUN
bptjm-49	211	9	.	.	PUNCT
bptjm-49	211	10	,	,	PUNCT
bptjm-49	211	11	wu	wu	PROPN
bptjm-49	211	12	,	,	PUNCT
bptjm-49	211	13	c.-h	c.-h	PROPN
bptjm-49	211	14	.	.	PROPN
bptjm-49	211	15	,	,	PUNCT
bptjm-49	211	16	chang	chang	PROPN
bptjm-49	211	17	,	,	PUNCT
bptjm-49	211	18	y.-m	y.-m	PROPN
bptjm-49	211	19	.	.	PROPN
bptjm-49	211	20	,	,	PUNCT
bptjm-49	211	21	lin	lin	PROPN
bptjm-49	211	22	,	,	PUNCT
bptjm-49	211	23	y.-l	y.-l	NOUN
bptjm-49	211	24	.	.	PUNCT
bptjm-49	211	25	,	,	PUNCT
bptjm-49	211	26	chang	chang	PROPN
bptjm-49	211	27	,	,	PUNCT
bptjm-49	211	28	g.-d	g.-d	PROPN
bptjm-49	211	29	.	.	PUNCT
bptjm-49	211	30	,	,	PUNCT
bptjm-49	211	31	wu	wu	PROPN
bptjm-49	211	32	,	,	PUNCT
bptjm-49	211	33	h.-c	h.-c	PROPN
bptjm-49	211	34	.	.	PUNCT
bptjm-49	211	35	,	,	PUNCT
bptjm-49	211	36	&	&	CCONJ
bptjm-49	211	37	chen	chen	PROPN
bptjm-49	211	38	,	,	PUNCT
bptjm-49	211	39	g.-c	g.-c	PROPN
bptjm-49	211	40	.	.	PUNCT
bptjm-49	212	1	(	(	PUNCT
bptjm-49	212	2	2019	2019	NUM
bptjm-49	212	3	)	)	PUNCT
bptjm-49	212	4	.	.	PUNCT
bptjm-49	213	1	ptpn3	ptpn3	PROPN
bptjm-49	213	2	suppresses	suppress	VERB
bptjm-49	213	3	lung	lung	NOUN
bptjm-49	213	4	cancer	cancer	NOUN
bptjm-49	213	5	cell	cell	NOUN
bptjm-49	213	6	invasiveness	invasiveness	NOUN
bptjm-49	213	7	by	by	ADP
bptjm-49	213	8	counteracting	counteract	VERB
bptjm-49	213	9	src	src	NOUN
bptjm-49	213	10	-	-	PUNCT
bptjm-49	213	11	mediated	mediate	VERB
bptjm-49	213	12	daam1	daam1	NOUN
bptjm-49	213	13	activation	activation	NOUN
bptjm-49	213	14	and	and	CCONJ
bptjm-49	213	15	actin	actin	NOUN
bptjm-49	213	16	polymerization.oncogene	polymerization.oncogene	NOUN
bptjm-49	213	17	,	,	PUNCT
bptjm-49	213	18	38(44	38(44	NUM
bptjm-49	213	19	)	)	PUNCT
bptjm-49	213	20	,	,	PUNCT
bptjm-49	213	21	7002–7016	7002–7016	NUM
bptjm-49	213	22	.	.	PUNCT
bptjm-49	214	1	https://doi.org/10.1038/s41388-019-0948-6	https://doi.org/10.1038/s41388-019-0948-6	PROPN
bptjm-49	214	2	25	25	NUM
bptjm-49	214	3	.	.	PUNCT
bptjm-49	215	1	li	li	PROPN
bptjm-49	215	2	,	,	PUNCT
bptjm-49	215	3	m.-y	m.-y	PROPN
bptjm-49	215	4	.	.	PUNCT
bptjm-49	215	5	,	,	PUNCT
bptjm-49	215	6	lai	lai	PROPN
bptjm-49	215	7	,	,	PUNCT
bptjm-49	215	8	p.-l	p.-l	PROPN
bptjm-49	215	9	.	.	PUNCT
bptjm-49	215	10	,	,	PUNCT
bptjm-49	215	11	chou	chou	NOUN
bptjm-49	215	12	,	,	PUNCT
bptjm-49	215	13	y.-t	y.-t	NOUN
bptjm-49	215	14	.	.	PUNCT
bptjm-49	215	15	,	,	PUNCT
bptjm-49	215	16	chi	chi	PROPN
bptjm-49	215	17	,	,	PUNCT
bptjm-49	215	18	a.-p	a.-p	PROPN
bptjm-49	215	19	.	.	PROPN
bptjm-49	215	20	,	,	PUNCT
bptjm-49	215	21	mi	mi	PROPN
bptjm-49	215	22	,	,	PUNCT
bptjm-49	215	23	y.-z	y.-z	PROPN
bptjm-49	215	24	.	.	PUNCT
bptjm-49	215	25	,	,	PUNCT
bptjm-49	215	26	khoo	khoo	PROPN
bptjm-49	215	27	,	,	PUNCT
bptjm-49	215	28	k.-h	k.-h	PROPN
bptjm-49	215	29	.	.	PROPN
bptjm-49	215	30	,	,	PUNCT
bptjm-49	215	31	chang	chang	PROPN
bptjm-49	215	32	,	,	PUNCT
bptjm-49	215	33	g.-d	g.-d	PROPN
bptjm-49	215	34	.	.	PUNCT
bptjm-49	215	35	,	,	PUNCT
bptjm-49	215	36	wu	wu	PROPN
bptjm-49	215	37	,	,	PUNCT
bptjm-49	215	38	c.-w	c.-w	PROPN
bptjm-49	215	39	.	.	PROPN
bptjm-49	215	40	,	,	PUNCT
bptjm-49	216	1	meng	meng	PROPN
bptjm-49	216	2	,	,	PUNCT
bptjm-49	216	3	t.-c	t.-c	PROPN
bptjm-49	216	4	.	.	PROPN
bptjm-49	216	5	,	,	PUNCT
bptjm-49	216	6	&	&	CCONJ
bptjm-49	216	7	chen	chen	PROPN
bptjm-49	216	8	,	,	PUNCT
bptjm-49	216	9	g.-c	g.-c	PROPN
bptjm-49	216	10	.	.	PUNCT
bptjm-49	217	1	(	(	PUNCT
bptjm-49	217	2	2014	2014	NUM
bptjm-49	217	3	)	)	PUNCT
bptjm-49	217	4	.	.	PUNCT
bptjm-49	218	1	protein	protein	NOUN
bptjm-49	218	2	tyrosine	tyrosine	NOUN
bptjm-49	218	3	phosphatase	phosphatase	NOUN
bptjm-49	218	4	ptpn3	ptpn3	PROPN
bptjm-49	218	5	inhibits	inhibit	VERB
bptjm-49	218	6	lung	lung	NOUN
bptjm-49	218	7	cancer	cancer	NOUN
bptjm-49	218	8	cell	cell	NOUN
bptjm-49	218	9	proliferation	proliferation	NOUN
bptjm-49	218	10	and	and	CCONJ
bptjm-49	218	11	migration	migration	NOUN
bptjm-49	218	12	by	by	ADP
bptjm-49	218	13	promoting	promote	VERB
bptjm-49	218	14	egfr	egfr	ADJ
bptjm-49	218	15	endocytic	endocytic	ADJ
bptjm-49	218	16	degradation	degradation	NOUN
bptjm-49	218	17	.	.	PUNCT
bptjm-49	219	1	oncogene	oncogene	NOUN
bptjm-49	219	2	,	,	PUNCT
bptjm-49	219	3	34(29	34(29	NUM
bptjm-49	219	4	)	)	PUNCT
bptjm-49	219	5	,	,	PUNCT
bptjm-49	219	6	3791–3803	3791–3803	NUM
bptjm-49	219	7	.	.	PUNCT
bptjm-49	220	1	https://doi.org/10.1038/onc.2014.312	https://doi.org/10.1038/onc.2014.312	PROPN
bptjm-49	220	2	26	26	NUM
bptjm-49	220	3	.	.	PUNCT
bptjm-49	221	1	liu	liu	PROPN
bptjm-49	221	2	g	g	PROPN
bptjm-49	221	3	,	,	PUNCT
bptjm-49	221	4	zhang	zhang	PROPN
bptjm-49	221	5	y	y	PROPN
bptjm-49	221	6	,	,	PUNCT
bptjm-49	221	7	huang	huang	PROPN
bptjm-49	221	8	y	y	PROPN
bptjm-49	221	9	,	,	PUNCT
bptjm-49	221	10	yuan	yuan	PROPN
bptjm-49	221	11	x	x	SYM
bptjm-49	221	12	,	,	PUNCT
bptjm-49	221	13	cao	cao	PROPN
bptjm-49	221	14	z	z	PROPN
bptjm-49	221	15	,	,	PUNCT
bptjm-49	221	16	zhao	zhao	PROPN
bptjm-49	221	17	z.	z.	PROPN
bptjm-49	221	18	ptpn6	ptpn6	NOUN
bptjm-49	221	19	-	-	PUNCT
bptjm-49	221	20	egfr	egfr	NOUN
bptjm-49	221	21	protein	protein	NOUN
bptjm-49	221	22	complex	complex	NOUN
bptjm-49	221	23	:	:	PUNCT
bptjm-49	221	24	a	a	DET
bptjm-49	221	25	novel	novel	ADJ
bptjm-49	221	26	target	target	NOUN
bptjm-49	221	27	for	for	ADP
bptjm-49	221	28	colon	colon	NOUN
bptjm-49	221	29	cancer	cancer	NOUN
bptjm-49	221	30	metastasis	metastasis	NOUN
bptjm-49	221	31	.	.	PUNCT
bptjm-49	222	1	j	j	PROPN
bptjm-49	222	2	oncol	oncol	ADJ
bptjm-49	222	3	.	.	PUNCT
bptjm-49	223	1	2022;2022:7391069	2022;2022:7391069	NUM
bptjm-49	223	2	.	.	PUNCT
bptjm-49	223	3	published	publish	VERB
bptjm-49	223	4	2022	2022	NUM
bptjm-49	223	5	feb	feb	NOUN
bptjm-49	223	6	11	11	NUM
bptjm-49	223	7	.	.	PUNCT
bptjm-49	224	1	doi:10.1155/2022/7391069	doi:10.1155/2022/7391069	NUM
bptjm-49	224	2	27	27	NUM
bptjm-49	224	3	.	.	PUNCT
bptjm-49	225	1	fang	fang	PROPN
bptjm-49	225	2	h	h	PROPN
bptjm-49	225	3	,	,	PUNCT
bptjm-49	225	4	maw	maw	NOUN
bptjm-49	225	5	,	,	PUNCT
bptjm-49	225	6	guo	guo	PROPN
bptjm-49	225	7	x	x	PROPN
bptjm-49	225	8	,	,	PUNCT
bptjm-49	225	9	wang	wang	PROPN
bptjm-49	225	10	j.	j.	PROPN
bptjm-49	225	11	ptpn6	ptpn6	PROPN
bptjm-49	225	12	promotes	promote	VERB
bptjm-49	225	13	chemosensitivity	chemosensitivity	NOUN
bptjm-49	225	14	of	of	ADP
bptjm-49	225	15	colorectal	colorectal	ADJ
bptjm-49	225	16	cancer	cancer	NOUN
bptjm-49	225	17	cells	cell	NOUN
bptjm-49	225	18	via	via	ADP
bptjm-49	225	19	inhibiting	inhibit	VERB
bptjm-49	225	20	the	the	DET
bptjm-49	225	21	sp1	sp1	NOUN
bptjm-49	225	22	/	/	SYM
bptjm-49	225	23	mapk	mapk	NOUN
bptjm-49	225	24	signalling	signal	VERB
bptjm-49	225	25	pathway	pathway	NOUN
bptjm-49	225	26	.	.	PUNCT
bptjm-49	226	1	cell	cell	NOUN
bptjm-49	226	2	biochem	biochem	PROPN
bptjm-49	226	3	funct	funct	NOUN
bptjm-49	226	4	.	.	PUNCT
bptjm-49	227	1	2021;39(3):392	2021;39(3):392	PROPN
bptjm-49	227	2	-	-	SYM
bptjm-49	227	3	400	400	NUM
bptjm-49	227	4	.	.	PUNCT
bptjm-49	228	1	doi:10.1002	doi:10.1002	NOUN
bptjm-49	228	2	/	/	SYM
bptjm-49	228	3	cbf.3604	cbf.3604	SYM
bptjm-49	228	4	28	28	NUM
bptjm-49	228	5	.	.	PUNCT
bptjm-49	229	1	chan	chan	PROPN
bptjm-49	229	2	,	,	PUNCT
bptjm-49	229	3	g.	g.	PROPN
bptjm-49	229	4	,	,	PUNCT
bptjm-49	229	5	&	&	CCONJ
bptjm-49	229	6	neel	neel	PROPN
bptjm-49	229	7	,	,	PUNCT
bptjm-49	229	8	b.	b.	PROPN
bptjm-49	229	9	g.	g.	PROPN
bptjm-49	229	10	(	(	PUNCT
bptjm-49	229	11	2016	2016	NUM
bptjm-49	229	12	)	)	PUNCT
bptjm-49	229	13	.	.	PUNCT
bptjm-49	230	1	role	role	NOUN
bptjm-49	230	2	of	of	ADP
bptjm-49	230	3	ptpn11	ptpn11	NOUN
bptjm-49	230	4	(	(	PUNCT
bptjm-49	230	5	shp2	shp2	NOUN
bptjm-49	230	6	)	)	PUNCT
bptjm-49	230	7	in	in	ADP
bptjm-49	230	8	cancer	cancer	NOUN
bptjm-49	230	9	.	.	PUNCT
bptjm-49	231	1	protein	protein	NOUN
bptjm-49	231	2	tyrosine	tyrosine	NOUN
bptjm-49	231	3	phosphatases	phosphatase	NOUN
bptjm-49	231	4	in	in	ADP
bptjm-49	231	5	cancer	cancer	NOUN
bptjm-49	231	6	,	,	PUNCT
bptjm-49	231	7	115–143	115–143	NUM
bptjm-49	231	8	.	.	PUNCT
bptjm-49	232	1	https://doi.org/10.1007/978-1-4939-3649-6_4	https://doi.org/10.1007/978-1-4939-3649-6_4	PROPN
bptjm-49	232	2	29	29	NUM
bptjm-49	232	3	.	.	PUNCT
bptjm-49	233	1	li	li	PROPN
bptjm-49	233	2	,	,	PUNCT
bptjm-49	233	3	s.	s.	PROPN
bptjm-49	233	4	,	,	PUNCT
bptjm-49	233	5	wang	wang	PROPN
bptjm-49	233	6	,	,	PUNCT
bptjm-49	233	7	x.	x.	PROPN
bptjm-49	233	8	,	,	PUNCT
bptjm-49	233	9	li	li	PROPN
bptjm-49	233	10	,	,	PUNCT
bptjm-49	233	11	q.	q.	PROPN
bptjm-49	233	12	,	,	PUNCT
bptjm-49	233	13	&	&	CCONJ
bptjm-49	233	14	li	li	PROPN
bptjm-49	233	15	,	,	PUNCT
bptjm-49	233	16	c.	c.	PROPN
bptjm-49	233	17	(	(	PUNCT
bptjm-49	233	18	2022	2022	NUM
bptjm-49	233	19	)	)	PUNCT
bptjm-49	233	20	.	.	PUNCT
bptjm-49	234	1	role	role	NOUN
bptjm-49	234	2	of	of	ADP
bptjm-49	234	3	shp2	shp2	NOUN
bptjm-49	234	4	/	/	SYM
bptjm-49	234	5	ptpn11	ptpn11	NOUN
bptjm-49	234	6	in	in	ADP
bptjm-49	234	7	the	the	DET
bptjm-49	234	8	occurrence	occurrence	NOUN
bptjm-49	234	9	and	and	CCONJ
bptjm-49	234	10	prognosis	prognosis	NOUN
bptjm-49	234	11	of	of	ADP
bptjm-49	234	12	cancer	cancer	NOUN
bptjm-49	234	13	:	:	PUNCT
bptjm-49	234	14	a	a	DET
bptjm-49	234	15	systematic	systematic	ADJ
bptjm-49	234	16	review	review	NOUN
bptjm-49	234	17	and	and	CCONJ
bptjm-49	234	18	meta‑analysis.oncology	meta‑analysis.oncology	NOUN
bptjm-49	234	19	letters	letter	NOUN
bptjm-49	234	20	,	,	PUNCT
bptjm-49	234	21	25(1	25(1	NUM
bptjm-49	234	22	)	)	PUNCT
bptjm-49	234	23	.	.	PUNCT
bptjm-49	235	1	https://doi.org/10.3892/ol.2022.13605	https://doi.org/10.3892/ol.2022.13605	PROPN
bptjm-49	235	2	30	30	NUM
bptjm-49	235	3	.	.	PUNCT
bptjm-49	236	1	goto	goto	NOUN
bptjm-49	236	2	,	,	PUNCT
bptjm-49	236	3	y.	y.	PROPN
bptjm-49	236	4	,	,	PUNCT
bptjm-49	236	5	ando	ando	PROPN
bptjm-49	236	6	,	,	PUNCT
bptjm-49	236	7	t.	t.	PROPN
bptjm-49	236	8	,	,	PUNCT
bptjm-49	236	9	yamamoto	yamamoto	PROPN
bptjm-49	236	10	,	,	PUNCT
bptjm-49	236	11	k.	k.	PROPN
bptjm-49	236	12	,	,	PUNCT
bptjm-49	236	13	tamakoshi	tamakoshi	PROPN
bptjm-49	236	14	,	,	PUNCT
bptjm-49	236	15	a.	a.	NOUN
bptjm-49	236	16	,	,	PUNCT
bptjm-49	236	17	el	el	PROPN
bptjm-49	236	18	-	-	PUNCT
bptjm-49	236	19	omar	omar	PROPN
bptjm-49	236	20	,	,	PUNCT
bptjm-49	236	21	e.	e.	PROPN
bptjm-49	236	22	,	,	PUNCT
bptjm-49	236	23	goto	goto	NOUN
bptjm-49	236	24	,	,	PUNCT
bptjm-49	236	25	h.	h.	PROPN
bptjm-49	236	26	,	,	PUNCT
bptjm-49	236	27	&	&	CCONJ
bptjm-49	236	28	hamajima	hamajima	PROPN
bptjm-49	236	29	,	,	PUNCT
bptjm-49	236	30	n.	n.	NOUN
bptjm-49	236	31	(	(	PUNCT
bptjm-49	236	32	2005	2005	NUM
bptjm-49	236	33	)	)	PUNCT
bptjm-49	236	34	.	.	PUNCT
bptjm-49	237	1	association	association	NOUN
bptjm-49	237	2	between	between	ADP
bptjm-49	237	3	serum	serum	NOUN
bptjm-49	237	4	pepsinogens	pepsinogen	NOUN
bptjm-49	237	5	and	and	CCONJ
bptjm-49	237	6	polymorphismofptpn11	polymorphismofptpn11	ADV
bptjm-49	237	7	encoding	encode	VERB
bptjm-49	237	8	shp-2	shp-2	VERB
bptjm-49	237	9	amonghelicobacter	amonghelicobacter	NOUN
bptjm-49	237	10	pylori	pylori	NOUN
bptjm-49	237	11	seropositive	seropositive	ADJ
bptjm-49	237	12	japanese	japanese	PROPN
bptjm-49	237	13	.	.	PUNCT
bptjm-49	238	1	international	international	ADJ
bptjm-49	238	2	journal	journal	PROPN
bptjm-49	238	3	of	of	ADP
bptjm-49	238	4	cancer	cancer	NOUN
bptjm-49	238	5	,	,	PUNCT
bptjm-49	238	6	118(1	118(1	NUM
bptjm-49	238	7	)	)	PUNCT
bptjm-49	238	8	,	,	PUNCT
bptjm-49	238	9	203–208	203–208	NUM
bptjm-49	238	10	.	.	PUNCT
bptjm-49	239	1	https://doi.org/10.1002/ijc.21338	https://doi.org/10.1002/ijc.21338	NOUN
bptjm-49	239	2	31	31	NUM
bptjm-49	239	3	.	.	PUNCT
bptjm-49	240	1	nian	nian	ADJ
bptjm-49	240	2	,	,	PUNCT
bptjm-49	240	3	q.	q.	PROPN
bptjm-49	240	4	,	,	PUNCT
bptjm-49	240	5	zeng	zeng	PROPN
bptjm-49	240	6	,	,	PUNCT
bptjm-49	240	7	j.	j.	PROPN
bptjm-49	240	8	,	,	PUNCT
bptjm-49	240	9	he	he	PRON
bptjm-49	240	10	,	,	PUNCT
bptjm-49	240	11	l.	l.	PROPN
bptjm-49	240	12	,	,	PUNCT
bptjm-49	240	13	chen	chen	PROPN
bptjm-49	240	14	,	,	PUNCT
bptjm-49	240	15	y.	y.	PROPN
bptjm-49	240	16	,	,	PUNCT
bptjm-49	240	17	zhang	zhang	PROPN
bptjm-49	240	18	,	,	PUNCT
bptjm-49	240	19	z.	z.	PROPN
bptjm-49	240	20	,	,	PUNCT
bptjm-49	240	21	rodrigues	rodrigues	PROPN
bptjm-49	240	22	-	-	PUNCT
bptjm-49	240	23	lima	lima	PROPN
bptjm-49	240	24	,	,	PUNCT
bptjm-49	240	25	f.	f.	PROPN
bptjm-49	240	26	,	,	PUNCT
bptjm-49	240	27	zhao	zhao	PROPN
bptjm-49	240	28	,	,	PUNCT
bptjm-49	240	29	l.	l.	PROPN
bptjm-49	240	30	,	,	PUNCT
bptjm-49	240	31	feng	feng	PROPN
bptjm-49	240	32	,	,	PUNCT
bptjm-49	240	33	x.	x.	PROPN
bptjm-49	240	34	,	,	PUNCT
bptjm-49	240	35	&	&	CCONJ
bptjm-49	240	36	shi	shi	PROPN
bptjm-49	240	37	,	,	PUNCT
bptjm-49	240	38	j.	j.	PROPN
bptjm-49	240	39	(	(	PUNCT
bptjm-49	240	40	2021	2021	NUM
bptjm-49	240	41	)	)	PUNCT
bptjm-49	240	42	.	.	PUNCT
bptjm-49	241	1	a	a	DET
bptjm-49	241	2	small	small	ADJ
bptjm-49	241	3	molecule	molecule	NOUN
bptjm-49	241	4	inhibitor	inhibitor	NOUN
bptjm-49	241	5	targeting	target	VERB
bptjm-49	241	6	shp2	shp2	NOUN
bptjm-49	241	7	mutations	mutation	NOUN
bptjm-49	241	8	for	for	ADP
bptjm-49	241	9	the	the	DET
bptjm-49	241	10	lung	lung	NOUN
bptjm-49	241	11	carcinoma	carcinoma	NOUN
bptjm-49	241	12	.	.	PUNCT
bptjm-49	242	1	chinese	chinese	ADJ
bptjm-49	242	2	chemical	chemical	PROPN
bptjm-49	242	3	letters	letter	NOUN
bptjm-49	242	4	,	,	PUNCT
bptjm-49	242	5	32(5	32(5	NOUN
bptjm-49	242	6	)	)	PUNCT
bptjm-49	242	7	,	,	PUNCT
bptjm-49	242	8	1645–1652	1645–1652	NUM
bptjm-49	242	9	.	.	PUNCT
bptjm-49	243	1	https://doi.org/10.1016/j.cclet.2021.01.002	https://doi.org/10.1016/j.cclet.2021.01.002	NOUN
bptjm-49	243	2	32	32	NUM
bptjm-49	243	3	.	.	PUNCT
bptjm-49	244	1	huo	huo	NOUN
bptjm-49	244	2	,	,	PUNCT
bptjm-49	244	3	y.-hu	y.-hu	PROPN
bptjm-49	244	4	,	,	PUNCT
bptjm-49	244	5	wang	wang	PROPN
bptjm-49	244	6	,	,	PUNCT
bptjm-49	244	7	y.-ni	y.-ni	PROPN
bptjm-49	244	8	,	,	PUNCT
bptjm-49	244	9	meng	meng	PROPN
bptjm-49	244	10	,	,	PUNCT
bptjm-49	244	11	l.-bing	l.-bing	PROPN
bptjm-49	244	12	,	,	PUNCT
bptjm-49	244	13	zhang	zhang	PROPN
bptjm-49	244	14	,	,	PUNCT
bptjm-49	244	15	a.-li	a.-li	PROPN
bptjm-49	244	16	,	,	PUNCT
bptjm-49	244	17	&	&	CCONJ
bptjm-49	244	18	liu	liu	PROPN
bptjm-49	244	19	,	,	PUNCT
bptjm-49	244	20	b.	b.	PROPN
bptjm-49	244	21	(	(	PUNCT
bptjm-49	244	22	2020	2020	NUM
bptjm-49	244	23	)	)	PUNCT
bptjm-49	244	24	.	.	PUNCT
bptjm-49	245	1	progress	progress	NOUN
bptjm-49	245	2	in	in	ADP
bptjm-49	245	3	the	the	DET
bptjm-49	245	4	correlation	correlation	NOUN
bptjm-49	245	5	between	between	ADP
bptjm-49	245	6	ptpn12	ptpn12	ADJ
bptjm-49	245	7	gene	gene	NOUN
bptjm-49	245	8	expression	expression	NOUN
bptjm-49	245	9	and	and	CCONJ
bptjm-49	245	10	human	human	NOUN
bptjm-49	245	11	tumors.medicine	tumors.medicine	NOUN
bptjm-49	245	12	,	,	PUNCT
bptjm-49	245	13	99(24	99(24	NUM
bptjm-49	245	14	)	)	PUNCT
bptjm-49	245	15	.	.	PUNCT
bptjm-49	246	1	https://doi.org/10.1097/md.00000000000204	https://doi.org/10.1097/md.00000000000204	PROPN
bptjm-49	246	2	45	45	NUM
bptjm-49	246	3	33	33	NUM
bptjm-49	246	4	.	.	PUNCT
bptjm-49	247	1	shen	shen	PROPN
bptjm-49	247	2	,	,	PUNCT
bptjm-49	247	3	n.	n.	PROPN
bptjm-49	247	4	,	,	PUNCT
bptjm-49	247	5	li	li	PROPN
bptjm-49	247	6	,	,	PUNCT
bptjm-49	247	7	l.	l.	PROPN
bptjm-49	247	8	,	,	PUNCT
bptjm-49	247	9	xu	xu	PROPN
bptjm-49	247	10	,	,	PUNCT
bptjm-49	247	11	w.	w.	PROPN
bptjm-49	247	12	,	,	PUNCT
bptjm-49	247	13	tian	tian	PROPN
bptjm-49	247	14	,	,	PUNCT
bptjm-49	247	15	j.	j.	PROPN
bptjm-49	247	16	,	,	PUNCT
bptjm-49	247	17	yang	yang	PROPN
bptjm-49	247	18	,	,	PUNCT
bptjm-49	247	19	y.	y.	PROPN
bptjm-49	247	20	,	,	PUNCT
bptjm-49	247	21	zhu	zhu	PROPN
bptjm-49	247	22	,	,	PUNCT
bptjm-49	247	23	y.	y.	PROPN
bptjm-49	247	24	,	,	PUNCT
bptjm-49	247	25	gong	gong	PROPN
bptjm-49	247	26	,	,	PUNCT
bptjm-49	247	27	y.	y.	PROPN
bptjm-49	247	28	,	,	PUNCT
bptjm-49	247	29	ke	ke	PROPN
bptjm-49	247	30	,	,	PUNCT
bptjm-49	247	31	j.	j.	PROPN
bptjm-49	247	32	,	,	PUNCT
bptjm-49	247	33	gong	gong	PROPN
bptjm-49	247	34	,	,	PUNCT
bptjm-49	247	35	j.	j.	PROPN
bptjm-49	247	36	,	,	PUNCT
bptjm-49	247	37	chang	chang	PROPN
bptjm-49	247	38	,	,	PUNCT
bptjm-49	247	39	j.	j.	PROPN
bptjm-49	247	40	,	,	PUNCT
bptjm-49	247	41	zhong	zhong	PROPN
bptjm-49	247	42	,	,	PUNCT
bptjm-49	247	43	r.	r.	PROPN
bptjm-49	247	44	,	,	PUNCT
bptjm-49	247	45	&	&	CCONJ
bptjm-49	247	46	miao	miao	NOUN
bptjm-49	247	47	,	,	PUNCT
bptjm-49	247	48	x.	x.	NOUN
bptjm-49	247	49	(	(	PUNCT
bptjm-49	247	50	2019	2019	NUM
bptjm-49	247	51	)	)	PUNCT
bptjm-49	247	52	.	.	PUNCT
bptjm-49	248	1	a	a	DET
bptjm-49	248	2	missense	missense	NOUN
bptjm-49	248	3	variant	variant	NOUN
bptjm-49	248	4	in	in	ADP
bptjm-49	248	5	ptpn12	ptpn12	NOUN
bptjm-49	248	6	associated	associate	VERB
bptjm-49	248	7	with	with	ADP
bptjm-49	248	8	the	the	DET
bptjm-49	248	9	risk	risk	NOUN
bptjm-49	248	10	of	of	ADP
bptjm-49	248	11	colorectal	colorectal	ADJ
bptjm-49	248	12	cancer	cancer	NOUN
bptjm-49	248	13	by	by	ADP
bptjm-49	248	14	modifying	modify	VERB
bptjm-49	248	15	ras	ras	PROPN
bptjm-49	248	16	/	/	SYM
bptjm-49	248	17	mek	mek	PROPN
bptjm-49	248	18	/	/	SYM
bptjm-49	248	19	erk	erk	PROPN
bptjm-49	248	20	signaling	signal	VERB
bptjm-49	248	21	.	.	PUNCT
bptjm-49	249	1	cancer	cancer	NOUN
bptjm-49	249	2	epidemiology	epidemiology	NOUN
bptjm-49	249	3	,	,	PUNCT
bptjm-49	249	4	59	59	NUM
bptjm-49	249	5	,	,	PUNCT
bptjm-49	249	6	109–114	109–114	NUM
bptjm-49	249	7	.	.	PUNCT
bptjm-49	250	1	https://doi.org/10.1016/j.canep.2019.01.013	https://doi.org/10.1016/j.canep.2019.01.013	NOUN
bptjm-49	250	2	34	34	NUM
bptjm-49	250	3	.	.	PUNCT
bptjm-49	251	1	chen	chen	PROPN
bptjm-49	251	2	,	,	PUNCT
bptjm-49	251	3	j.	j.	PROPN
bptjm-49	251	4	,	,	PUNCT
bptjm-49	251	5	zhao	zhao	PROPN
bptjm-49	251	6	,	,	PUNCT
bptjm-49	251	7	x.	x.	NOUN
bptjm-49	251	8	,	,	PUNCT
bptjm-49	251	9	yuan	yuan	PROPN
bptjm-49	251	10	,	,	PUNCT
bptjm-49	251	11	y.	y.	PROPN
bptjm-49	251	12	,	,	PUNCT
bptjm-49	251	13	&	&	CCONJ
bptjm-49	251	14	jing	jing	PROPN
bptjm-49	251	15	,	,	PUNCT
bptjm-49	251	16	j.-jing	j.-je	VERB
bptjm-49	251	17	.	.	PUNCT
bptjm-49	252	1	(	(	PUNCT
bptjm-49	252	2	2020	2020	NUM
bptjm-49	252	3	)	)	PUNCT
bptjm-49	252	4	.	.	PUNCT
bptjm-49	253	1	the	the	DET
bptjm-49	253	2	expression	expression	NOUN
bptjm-49	253	3	patterns	pattern	NOUN
bptjm-49	253	4	and	and	CCONJ
bptjm-49	253	5	the	the	DET
bptjm-49	253	6	prognostic	prognostic	ADJ
bptjm-49	253	7	roles	role	NOUN
bptjm-49	253	8	of	of	ADP
bptjm-49	253	9	ptpn	ptpn	PROPN
bptjm-49	253	10	family	family	NOUN
bptjm-49	253	11	members	member	NOUN
bptjm-49	253	12	in	in	ADP
bptjm-49	253	13	digestive	digestive	ADJ
bptjm-49	253	14	tract	tract	NOUN
bptjm-49	253	15	cancers	cancer	NOUN
bptjm-49	253	16	.	.	PUNCT
bptjm-49	254	1	https://doi.org/10.21203/rs.3.rs-19689/v1	https://doi.org/10.21203/rs.3.rs-19689/v1	PROPN
bptjm-49	255	1	35	35	NUM
bptjm-49	255	2	.	.	PUNCT
bptjm-49	256	1	cao	cao	PROPN
bptjm-49	256	2	,	,	PUNCT
bptjm-49	256	3	x.	x.	PROPN
bptjm-49	256	4	,	,	PUNCT
bptjm-49	256	5	chen	chen	PROPN
bptjm-49	256	6	,	,	PUNCT
bptjm-49	256	7	y.-z	y.-z	PROPN
bptjm-49	256	8	.	.	PUNCT
bptjm-49	256	9	,	,	PUNCT
bptjm-49	256	10	luo	luo	PROPN
bptjm-49	256	11	,	,	PUNCT
bptjm-49	256	12	r.-z	r.-z	PROPN
bptjm-49	256	13	.	.	PUNCT
bptjm-49	256	14	,	,	PUNCT
bptjm-49	256	15	zhang	zhang	PROPN
bptjm-49	256	16	,	,	PUNCT
bptjm-49	256	17	l.	l.	PROPN
bptjm-49	256	18	,	,	PUNCT
bptjm-49	256	19	zhang	zhang	PROPN
bptjm-49	256	20	,	,	PUNCT
bptjm-49	256	21	s.-l	s.-l	PROPN
bptjm-49	256	22	.	.	PUNCT
bptjm-49	256	23	,	,	PUNCT
bptjm-49	256	24	zeng	zeng	PROPN
bptjm-49	256	25	,	,	PUNCT
bptjm-49	256	26	j.	j.	PROPN
bptjm-49	256	27	,	,	PUNCT
bptjm-49	256	28	jiang	jiang	PROPN
bptjm-49	256	29	,	,	PUNCT
bptjm-49	256	30	y.-c	y.-c	PROPN
bptjm-49	256	31	.	.	PROPN
bptjm-49	256	32	,	,	PUNCT
bptjm-49	256	33	han	han	PROPN
bptjm-49	256	34	,	,	PUNCT
bptjm-49	256	35	y.-j	y.-j	PROPN
bptjm-49	256	36	.	.	PROPN
bptjm-49	256	37	,	,	PUNCT
bptjm-49	256	38	&	&	CCONJ
bptjm-49	256	39	wen	wen	PROPN
bptjm-49	256	40	,	,	PUNCT
bptjm-49	256	41	z.-s	z.-s	PROPN
bptjm-49	256	42	.	.	PUNCT
bptjm-49	257	1	(	(	PUNCT
bptjm-49	257	2	2015	2015	NUM
bptjm-49	257	3	)	)	PUNCT
bptjm-49	257	4	.	.	PUNCT
bptjm-49	258	1	tyrosine	tyrosine	NOUN
bptjm-49	258	2	-	-	PUNCT
bptjm-49	258	3	protein	protein	NOUN
bptjm-49	258	4	phosphatase	phosphatase	NOUN
bptjm-49	258	5	non	non	ADJ
bptjm-49	258	6	-	-	ADJ
bptjm-49	258	7	receptor	receptor	ADJ
bptjm-49	258	8	type	type	NOUN
bptjm-49	258	9	12	12	NUM
bptjm-49	258	10	expression	expression	NOUN
bptjm-49	258	11	is	be	AUX
bptjm-49	258	12	a	a	DET
bptjm-49	258	13	good	good	ADJ
bptjm-49	258	14	prognostic	prognostic	ADJ
bptjm-49	258	15	factor	factor	NOUN
bptjm-49	258	16	in	in	ADP
bptjm-49	258	17	resectable	resectable	ADJ
bptjm-49	258	18	non	non	ADJ
bptjm-49	258	19	-	-	ADJ
bptjm-49	258	20	small	small	ADJ
bptjm-49	258	21	cell	cell	NOUN
bptjm-49	258	22	lung	lung	NOUN
bptjm-49	258	23	cancer.oncotarget	cancer.oncotarget	NOUN
bptjm-49	258	24	,	,	PUNCT
bptjm-49	258	25	6(13	6(13	NUM
bptjm-49	258	26	)	)	PUNCT
bptjm-49	258	27	,	,	PUNCT
bptjm-49	258	28	berkeley	berkeley	PROPN
bptjm-49	258	29	pharma	pharma	PROPN
bptjm-49	258	30	tech	tech	NOUN
bptjm-49	258	31	journal	journal	NOUN
bptjm-49	258	32	of	of	ADP
bptjm-49	258	33	medicine	medicine	NOUN
bptjm-49	258	34	|	|	ADV
bptjm-49	258	35	98	98	NUM
bptjm-49	258	36	11704–11713	11704–11713	NUM
bptjm-49	258	37	.	.	PUNCT
bptjm-49	258	38	https://doi.org/10.18632/oncotarget.3588	https://doi.org/10.18632/oncotarget.3588	PROPN
bptjm-49	259	1	36	36	NUM
bptjm-49	259	2	.	.	PUNCT
bptjm-49	260	1	mcheik	mcheik	PROPN
bptjm-49	260	2	,	,	PUNCT
bptjm-49	260	3	s.	s.	PROPN
bptjm-49	260	4	,	,	PUNCT
bptjm-49	260	5	aptecar	aptecar	PROPN
bptjm-49	260	6	,	,	PUNCT
bptjm-49	260	7	l.	l.	PROPN
bptjm-49	260	8	,	,	PUNCT
bptjm-49	260	9	coopman	coopman	PROPN
bptjm-49	260	10	,	,	PUNCT
bptjm-49	260	11	p.	p.	NOUN
bptjm-49	260	12	,	,	PUNCT
bptjm-49	260	13	d’hondt	d’hondt	PROPN
bptjm-49	260	14	,	,	PUNCT
bptjm-49	260	15	v.	v.	ADV
bptjm-49	260	16	,	,	PUNCT
bptjm-49	260	17	&	&	CCONJ
bptjm-49	260	18	freiss	freiss	NOUN
bptjm-49	260	19	,	,	PUNCT
bptjm-49	260	20	g.	g.	PROPN
bptjm-49	260	21	(	(	PUNCT
bptjm-49	260	22	2020	2020	NUM
bptjm-49	260	23	)	)	PUNCT
bptjm-49	260	24	.	.	PUNCT
bptjm-49	261	1	dual	dual	ADJ
bptjm-49	261	2	role	role	NOUN
bptjm-49	261	3	of	of	ADP
bptjm-49	261	4	the	the	DET
bptjm-49	261	5	ptpn13	ptpn13	ADJ
bptjm-49	261	6	tyrosine	tyrosine	NOUN
bptjm-49	261	7	phosphatase	phosphatase	NOUN
bptjm-49	261	8	in	in	ADP
bptjm-49	261	9	cancer	cancer	NOUN
bptjm-49	261	10	.	.	PUNCT
bptjm-49	262	1	biomolecules	biomolecule	NOUN
bptjm-49	262	2	,	,	PUNCT
bptjm-49	262	3	10(12	10(12	NUM
bptjm-49	262	4	)	)	PUNCT
bptjm-49	262	5	,	,	PUNCT
bptjm-49	262	6	1659	1659	NUM
bptjm-49	262	7	.	.	PUNCT
bptjm-49	263	1	https://doi.org/10.3390/biom10121659	https://doi.org/10.3390/biom10121659	PROPN
bptjm-49	263	2	37	37	NUM
bptjm-49	263	3	.	.	PUNCT
bptjm-49	264	1	hamyeh	hamyeh	PROPN
bptjm-49	264	2	,	,	PUNCT
bptjm-49	264	3	m.	m.	NOUN
bptjm-49	264	4	,	,	PUNCT
bptjm-49	264	5	bernex	bernex	PROPN
bptjm-49	264	6	,	,	PUNCT
bptjm-49	264	7	f.	f.	PROPN
bptjm-49	264	8	,	,	PUNCT
bptjm-49	264	9	larive	larive	PROPN
bptjm-49	264	10	,	,	PUNCT
bptjm-49	264	11	r.	r.	PROPN
bptjm-49	264	12	m.	m.	PROPN
bptjm-49	264	13	,	,	PUNCT
bptjm-49	264	14	naldi	naldi	PROPN
bptjm-49	264	15	,	,	PUNCT
bptjm-49	264	16	a.	a.	NOUN
bptjm-49	264	17	,	,	PUNCT
bptjm-49	264	18	urbach	urbach	PROPN
bptjm-49	264	19	,	,	PUNCT
bptjm-49	264	20	s.	s.	PROPN
bptjm-49	264	21	,	,	PUNCT
bptjm-49	264	22	simony	simony	NOUN
bptjm-49	264	23	-	-	PUNCT
bptjm-49	264	24	lafontaine	lafontaine	NOUN
bptjm-49	264	25	,	,	PUNCT
bptjm-49	264	26	j.	j.	PROPN
bptjm-49	264	27	,	,	PUNCT
bptjm-49	264	28	puech	puech	PROPN
bptjm-49	264	29	,	,	PUNCT
bptjm-49	264	30	c.	c.	PROPN
bptjm-49	264	31	,	,	PUNCT
bptjm-49	264	32	bakhache	bakhache	PROPN
bptjm-49	264	33	,	,	PUNCT
bptjm-49	264	34	w.	w.	PROPN
bptjm-49	264	35	,	,	PUNCT
bptjm-49	264	36	solassol	solassol	VERB
bptjm-49	264	37	,	,	PUNCT
bptjm-49	264	38	j.	j.	PROPN
bptjm-49	264	39	,	,	PUNCT
bptjm-49	264	40	coopman	coopman	PROPN
bptjm-49	264	41	,	,	PUNCT
bptjm-49	264	42	p.	p.	PROPN
bptjm-49	264	43	j.	j.	PROPN
bptjm-49	264	44	,	,	PUNCT
bptjm-49	264	45	hendriks	hendriks	PROPN
bptjm-49	264	46	,	,	PUNCT
bptjm-49	264	47	w.	w.	PROPN
bptjm-49	264	48	j.	j.	PROPN
bptjm-49	264	49	a.	a.	PROPN
bptjm-49	264	50	j.	j.	PROPN
bptjm-49	264	51	,	,	PUNCT
bptjm-49	264	52	&	&	CCONJ
bptjm-49	264	53	freiss	freiss	PROPN
bptjm-49	264	54	,	,	PUNCT
bptjm-49	264	55	g.	g.	PROPN
bptjm-49	264	56	(	(	PUNCT
bptjm-49	264	57	2020	2020	NUM
bptjm-49	264	58	)	)	PUNCT
bptjm-49	264	59	.	.	PUNCT
bptjm-49	265	1	ptpn13	ptpn13	NOUN
bptjm-49	265	2	induces	induce	VERB
bptjm-49	265	3	cell	cell	NOUN
bptjm-49	265	4	junction	junction	NOUN
bptjm-49	265	5	stabilization	stabilization	NOUN
bptjm-49	265	6	and	and	CCONJ
bptjm-49	265	7	inhibits	inhibit	VERB
bptjm-49	265	8	mammary	mammary	ADJ
bptjm-49	265	9	tumor	tumor	NOUN
bptjm-49	265	10	invasiveness	invasiveness	NOUN
bptjm-49	265	11	.	.	PUNCT
bptjm-49	266	1	theranostics	theranostic	NOUN
bptjm-49	266	2	,	,	PUNCT
bptjm-49	266	3	10(3	10(3	NUM
bptjm-49	266	4	)	)	PUNCT
bptjm-49	266	5	,	,	PUNCT
bptjm-49	266	6	1016–1032	1016–1032	NUM
bptjm-49	266	7	.	.	PUNCT
bptjm-49	266	8	https://doi.org/10.7150/thno.38537	https://doi.org/10.7150/thno.38537	NOUN
bptjm-49	266	9	38	38	NUM
bptjm-49	266	10	.	.	PUNCT
bptjm-49	267	1	d’hondt	d’hondt	PROPN
bptjm-49	267	2	,	,	PUNCT
bptjm-49	267	3	v.	v.	CCONJ
bptjm-49	267	4	,	,	PUNCT
bptjm-49	267	5	lacroix	lacroix	NOUN
bptjm-49	267	6	-	-	PUNCT
bptjm-49	267	7	triki	triki	PROPN
bptjm-49	267	8	,	,	PUNCT
bptjm-49	267	9	m.	m.	NOUN
bptjm-49	267	10	,	,	PUNCT
bptjm-49	267	11	jarlier	jarlier	NOUN
bptjm-49	267	12	,	,	PUNCT
bptjm-49	267	13	m.	m.	NOUN
bptjm-49	267	14	,	,	PUNCT
bptjm-49	267	15	boissiere	boissiere	NOUN
bptjm-49	267	16	-	-	PUNCT
bptjm-49	267	17	michot	michot	NOUN
bptjm-49	267	18	,	,	PUNCT
bptjm-49	267	19	f.	f.	PROPN
bptjm-49	267	20	,	,	PUNCT
bptjm-49	267	21	puech	puech	NOUN
bptjm-49	267	22	,	,	PUNCT
bptjm-49	267	23	c.	c.	PROPN
bptjm-49	267	24	,	,	PUNCT
bptjm-49	267	25	coopman	coopman	NOUN
bptjm-49	267	26	,	,	PUNCT
bptjm-49	267	27	p.	p.	PROPN
bptjm-49	267	28	,	,	PUNCT
bptjm-49	267	29	katsaros	katsaros	PROPN
bptjm-49	267	30	,	,	PUNCT
bptjm-49	267	31	d.	d.	PROPN
bptjm-49	267	32	,	,	PUNCT
bptjm-49	267	33	&	&	CCONJ
bptjm-49	267	34	freiss	freiss	PROPN
bptjm-49	267	35	,	,	PUNCT
bptjm-49	267	36	g.	g.	PROPN
bptjm-49	267	37	(	(	PUNCT
bptjm-49	267	38	2017	2017	NUM
bptjm-49	267	39	)	)	PUNCT
bptjm-49	267	40	.	.	PUNCT
bptjm-49	268	1	high	high	ADJ
bptjm-49	268	2	ptpn13	ptpn13	NOUN
bptjm-49	268	3	expression	expression	NOUN
bptjm-49	268	4	in	in	ADP
bptjm-49	268	5	high	high	ADJ
bptjm-49	268	6	grade	grade	NOUN
bptjm-49	268	7	serous	serous	ADJ
bptjm-49	268	8	ovarian	ovarian	ADJ
bptjm-49	268	9	carcinoma	carcinoma	NOUN
bptjm-49	268	10	is	be	AUX
bptjm-49	268	11	associated	associate	VERB
bptjm-49	268	12	with	with	ADP
bptjm-49	268	13	a	a	DET
bptjm-49	268	14	better	well	ADJ
bptjm-49	268	15	patient	patient	ADJ
bptjm-49	268	16	outcome.oncotarget	outcome.oncotarget	NOUN
bptjm-49	268	17	,	,	PUNCT
bptjm-49	268	18	8(56	8(56	NUM
bptjm-49	268	19	)	)	PUNCT
bptjm-49	268	20	,	,	PUNCT
bptjm-49	268	21	95662–95673	95662–95673	NUM
bptjm-49	268	22	.	.	PUNCT
bptjm-49	269	1	https://doi.org/10.18632/oncotarget.21175	https://doi.org/10.18632/oncotarget.21175	PROPN
bptjm-49	270	1	39	39	NUM
bptjm-49	270	2	.	.	PUNCT
bptjm-49	271	1	zhuang	zhuang	PROPN
bptjm-49	271	2	,	,	PUNCT
bptjm-49	271	3	l.	l.	PROPN
bptjm-49	271	4	,	,	PUNCT
bptjm-49	271	5	shou	shou	PROPN
bptjm-49	271	6	,	,	PUNCT
bptjm-49	271	7	t.	t.	PROPN
bptjm-49	271	8	,	,	PUNCT
bptjm-49	271	9	li	li	PROPN
bptjm-49	271	10	,	,	PUNCT
bptjm-49	271	11	k.	k.	PROPN
bptjm-49	271	12	,	,	PUNCT
bptjm-49	271	13	gao	gao	PROPN
bptjm-49	271	14	,	,	PUNCT
bptjm-49	271	15	c.-l	c.-l	PROPN
bptjm-49	271	16	.	.	PUNCT
bptjm-49	271	17	,	,	PUNCT
bptjm-49	271	18	duan	duan	PROPN
bptjm-49	271	19	,	,	PUNCT
bptjm-49	271	20	l.-c	l.-c	PROPN
bptjm-49	271	21	.	.	PUNCT
bptjm-49	271	22	,	,	PUNCT
bptjm-49	271	23	fang	fang	PROPN
bptjm-49	271	24	,	,	PUNCT
bptjm-49	271	25	l.-z	l.-z	PROPN
bptjm-49	271	26	.	.	PUNCT
bptjm-49	271	27	,	,	PUNCT
bptjm-49	271	28	zhang	zhang	PROPN
bptjm-49	271	29	,	,	PUNCT
bptjm-49	271	30	q.-y	q.-y	NOUN
bptjm-49	271	31	.	.	PUNCT
bptjm-49	271	32	,	,	PUNCT
bptjm-49	271	33	chen	chen	PROPN
bptjm-49	271	34	,	,	PUNCT
bptjm-49	271	35	z.-n	z.-n	PROPN
bptjm-49	271	36	.	.	PROPN
bptjm-49	271	37	,	,	PUNCT
bptjm-49	271	38	zhang	zhang	PROPN
bptjm-49	271	39	,	,	PUNCT
bptjm-49	271	40	c.	c.	PROPN
bptjm-49	271	41	,	,	PUNCT
bptjm-49	271	42	yang	yang	PROPN
bptjm-49	271	43	,	,	PUNCT
bptjm-49	271	44	s.-t	s.-t	PROPN
bptjm-49	271	45	.	.	PUNCT
bptjm-49	271	46	,	,	PUNCT
bptjm-49	271	47	&	&	CCONJ
bptjm-49	271	48	li	li	PROPN
bptjm-49	271	49	,	,	PUNCT
bptjm-49	271	50	g.-f	g.-f	NOUN
bptjm-49	271	51	.	.	PUNCT
bptjm-49	272	1	(	(	PUNCT
bptjm-49	272	2	2017	2017	NUM
bptjm-49	272	3	)	)	PUNCT
bptjm-49	272	4	.	.	PUNCT
bptjm-49	273	1	microrna-30e-5p	microrna-30e-5p	PROPN
bptjm-49	273	2	promotes	promote	VERB
bptjm-49	273	3	cell	cell	NOUN
bptjm-49	273	4	growth	growth	NOUN
bptjm-49	273	5	by	by	ADP
bptjm-49	273	6	targeting	target	VERB
bptjm-49	273	7	ptpn	ptpn	NOUN
bptjm-49	273	8	13	13	NUM
bptjm-49	273	9	and	and	CCONJ
bptjm-49	273	10	indicates	indicate	VERB
bptjm-49	273	11	poor	poor	ADJ
bptjm-49	273	12	survival	survival	NOUN
bptjm-49	273	13	and	and	CCONJ
bptjm-49	273	14	recurrence	recurrence	NOUN
bptjm-49	273	15	in	in	ADP
bptjm-49	273	16	lung	lung	NOUN
bptjm-49	273	17	adenocarcinoma	adenocarcinoma	NOUN
bptjm-49	273	18	.	.	PUNCT
bptjm-49	274	1	journal	journal	NOUN
bptjm-49	274	2	of	of	ADP
bptjm-49	274	3	cellular	cellular	ADJ
bptjm-49	274	4	and	and	CCONJ
bptjm-49	274	5	molecularmedicine	molecularmedicine	NOUN
bptjm-49	274	6	,	,	PUNCT
bptjm-49	274	7	21(11	21(11	NUM
bptjm-49	274	8	)	)	PUNCT
bptjm-49	274	9	,	,	PUNCT
bptjm-49	274	10	2852–2862	2852–2862	NUM
bptjm-49	274	11	.	.	PUNCT
bptjm-49	275	1	https://doi.org/10.1111/jcmm.13198	https://doi.org/10.1111/jcmm.13198	ADJ
bptjm-49	275	2	40	40	NUM
bptjm-49	275	3	.	.	PUNCT
bptjm-49	276	1	scrima	scrima	PROPN
bptjm-49	276	2	,	,	PUNCT
bptjm-49	276	3	m.	m.	NOUN
bptjm-49	276	4	,	,	PUNCT
bptjm-49	276	5	demarco	demarco	PROPN
bptjm-49	276	6	,	,	PUNCT
bptjm-49	276	7	c.	c.	PROPN
bptjm-49	276	8	,	,	PUNCT
bptjm-49	276	9	de	de	X
bptjm-49	276	10	vita	vita	PROPN
bptjm-49	276	11	,	,	PUNCT
bptjm-49	276	12	f.	f.	PROPN
bptjm-49	276	13	,	,	PUNCT
bptjm-49	276	14	fabiani	fabiani	PROPN
bptjm-49	276	15	,	,	PUNCT
bptjm-49	276	16	f.	f.	PROPN
bptjm-49	276	17	,	,	PUNCT
bptjm-49	276	18	franco	franco	PROPN
bptjm-49	276	19	,	,	PUNCT
bptjm-49	276	20	r.	r.	PROPN
bptjm-49	276	21	,	,	PUNCT
bptjm-49	276	22	pirozzi	pirozzi	ADV
bptjm-49	276	23	,	,	PUNCT
bptjm-49	276	24	g.	g.	PROPN
bptjm-49	276	25	,	,	PUNCT
bptjm-49	276	26	rocco	rocco	NOUN
bptjm-49	276	27	,	,	PUNCT
bptjm-49	276	28	g.	g.	NOUN
bptjm-49	276	29	,	,	PUNCT
bptjm-49	276	30	malanga	malanga	PROPN
bptjm-49	276	31	,	,	PUNCT
bptjm-49	276	32	d.	d.	PROPN
bptjm-49	276	33	,	,	PUNCT
bptjm-49	276	34	&	&	CCONJ
bptjm-49	276	35	viglietto	viglietto	NOUN
bptjm-49	276	36	,	,	PUNCT
bptjm-49	276	37	g.	g.	PROPN
bptjm-49	276	38	(	(	PUNCT
bptjm-49	276	39	2012	2012	NUM
bptjm-49	276	40	)	)	PUNCT
bptjm-49	276	41	.	.	PUNCT
bptjm-49	277	1	the	the	DET
bptjm-49	277	2	nonreceptor	nonreceptor	ADJ
bptjm-49	277	3	-	-	PUNCT
bptjm-49	277	4	type	type	NOUN
bptjm-49	277	5	tyrosine	tyrosine	NOUN
bptjm-49	277	6	phosphatase	phosphatase	NOUN
bptjm-49	277	7	ptpn13	ptpn13	NOUN
bptjm-49	277	8	is	be	AUX
bptjm-49	277	9	a	a	DET
bptjm-49	277	10	tumor	tumor	NOUN
bptjm-49	277	11	suppressor	suppressor	NOUN
bptjm-49	277	12	gene	gene	NOUN
bptjm-49	277	13	in	in	ADP
bptjm-49	277	14	non	non	ADJ
bptjm-49	277	15	–	–	ADJ
bptjm-49	277	16	small	small	ADJ
bptjm-49	277	17	cell	cell	NOUN
bptjm-49	277	18	lung	lung	NOUN
bptjm-49	277	19	cancer	cancer	NOUN
bptjm-49	277	20	.	.	PUNCT
bptjm-49	278	1	the	the	DET
bptjm-49	278	2	american	american	PROPN
bptjm-49	278	3	journal	journal	PROPN
bptjm-49	278	4	of	of	ADP
bptjm-49	278	5	pathology	pathology	PROPN
bptjm-49	278	6	,	,	PUNCT
bptjm-49	278	7	180(3	180(3	NUM
bptjm-49	278	8	)	)	PUNCT
bptjm-49	278	9	,	,	PUNCT
bptjm-49	278	10	1202–1214	1202–1214	NUM
bptjm-49	278	11	.	.	PUNCT
bptjm-49	279	1	https://doi.org/10.1016/j.ajpath.2011.11.03	https://doi.org/10.1016/j.ajpath.2011.11.03	ADJ
bptjm-49	279	2	8	8	NUM
bptjm-49	279	3	41	41	NUM
bptjm-49	279	4	.	.	PUNCT
bptjm-49	280	1	zhu	zhu	PROPN
bptjm-49	280	2	,	,	PUNCT
bptjm-49	280	3	j.-h	j.-h	PROPN
bptjm-49	280	4	.	.	PUNCT
bptjm-49	280	5	,	,	PUNCT
bptjm-49	280	6	chen	chen	PROPN
bptjm-49	280	7	,	,	PUNCT
bptjm-49	280	8	r.	r.	PROPN
bptjm-49	280	9	,	,	PUNCT
bptjm-49	280	10	yi	yi	PROPN
bptjm-49	280	11	,	,	PUNCT
bptjm-49	280	12	w.	w.	PROPN
bptjm-49	280	13	,	,	PUNCT
bptjm-49	280	14	cantin	cantin	NOUN
bptjm-49	280	15	,	,	PUNCT
bptjm-49	280	16	g.	g.	PROPN
bptjm-49	280	17	t.	t.	PROPN
bptjm-49	280	18	,	,	PUNCT
bptjm-49	280	19	fearns	fearn	NOUN
bptjm-49	280	20	,	,	PUNCT
bptjm-49	280	21	c.	c.	PROPN
bptjm-49	280	22	,	,	PUNCT
bptjm-49	280	23	yang	yang	PROPN
bptjm-49	280	24	,	,	PUNCT
bptjm-49	280	25	y.	y.	PROPN
bptjm-49	280	26	,	,	PUNCT
bptjm-49	280	27	yates	yates	PROPN
bptjm-49	280	28	,	,	PUNCT
bptjm-49	280	29	j.	j.	PROPN
bptjm-49	280	30	r.	r.	PROPN
bptjm-49	280	31	,	,	PUNCT
bptjm-49	280	32	&	&	CCONJ
bptjm-49	280	33	lee	lee	PROPN
bptjm-49	280	34	,	,	PUNCT
bptjm-49	280	35	j.-d	j.-d	PROPN
bptjm-49	280	36	.	.	PUNCT
bptjm-49	281	1	(	(	PUNCT
bptjm-49	281	2	2007	2007	NUM
bptjm-49	281	3	)	)	PUNCT
bptjm-49	281	4	.	.	PUNCT
bptjm-49	282	1	protein	protein	NOUN
bptjm-49	282	2	tyrosine	tyrosine	NOUN
bptjm-49	282	3	phosphatase	phosphatase	PROPN
bptjm-49	282	4	ptpn13	ptpn13	PROPN
bptjm-49	282	5	negatively	negatively	ADV
bptjm-49	282	6	regulates	regulate	VERB
bptjm-49	282	7	her2	her2	PROPN
bptjm-49	282	8	/	/	SYM
bptjm-49	282	9	erbb2	erbb2	PROPN
bptjm-49	282	10	malignant	malignant	ADJ
bptjm-49	282	11	signaling.oncogene	signaling.oncogene	NOUN
bptjm-49	282	12	,	,	PUNCT
bptjm-49	282	13	27(18	27(18	NUM
bptjm-49	282	14	)	)	PUNCT
bptjm-49	282	15	,	,	PUNCT
bptjm-49	282	16	2525–2531	2525–2531	NUM
bptjm-49	282	17	.	.	NUM
bptjm-49	282	18	https://doi.org/10.1038/sj.onc.1210922	https://doi.org/10.1038/sj.onc.1210922	NOUN
bptjm-49	282	19	42	42	NUM
bptjm-49	282	20	.	.	PUNCT
bptjm-49	283	1	wang	wang	PROPN
bptjm-49	283	2	,	,	PUNCT
bptjm-49	283	3	j.	j.	PROPN
bptjm-49	283	4	,	,	PUNCT
bptjm-49	283	5	li	li	PROPN
bptjm-49	283	6	,	,	PUNCT
bptjm-49	283	7	s.	s.	PROPN
bptjm-49	283	8	,	,	PUNCT
bptjm-49	283	9	zhang	zhang	PROPN
bptjm-49	283	10	,	,	PUNCT
bptjm-49	283	11	x.	x.	PROPN
bptjm-49	283	12	,	,	PUNCT
bptjm-49	283	13	zhu	zhu	PROPN
bptjm-49	283	14	,	,	PUNCT
bptjm-49	283	15	n.	n.	NOUN
bptjm-49	283	16	,	,	PUNCT
bptjm-49	283	17	yiminniyaze	yiminniyaze	NOUN
bptjm-49	283	18	,	,	PUNCT
bptjm-49	283	19	r.	r.	PROPN
bptjm-49	283	20	,	,	PUNCT
bptjm-49	283	21	dong	dong	PROPN
bptjm-49	283	22	,	,	PUNCT
bptjm-49	283	23	l.	l.	PROPN
bptjm-49	283	24	,	,	PUNCT
bptjm-49	283	25	li	li	PROPN
bptjm-49	283	26	,	,	PUNCT
bptjm-49	283	27	c.	c.	PROPN
bptjm-49	283	28	,	,	PUNCT
bptjm-49	283	29	gulinuer	gulinuer	PROPN
bptjm-49	283	30	,	,	PUNCT
bptjm-49	283	31	w.	w.	PROPN
bptjm-49	283	32	,	,	PUNCT
bptjm-49	283	33	xia	xia	PROPN
bptjm-49	283	34	,	,	PUNCT
bptjm-49	283	35	j.	j.	PROPN
bptjm-49	283	36	,	,	PUNCT
bptjm-49	283	37	li	li	PROPN
bptjm-49	283	38	,	,	PUNCT
bptjm-49	283	39	j.	j.	PROPN
bptjm-49	283	40	,	,	PUNCT
bptjm-49	283	41	zhou	zhou	PROPN
bptjm-49	283	42	,	,	PUNCT
bptjm-49	283	43	d.	d.	PROPN
bptjm-49	283	44	,	,	PUNCT
bptjm-49	283	45	liu	liu	PROPN
bptjm-49	283	46	,	,	PUNCT
bptjm-49	283	47	x.	x.	PROPN
bptjm-49	283	48	,	,	PUNCT
bptjm-49	283	49	zhang	zhang	PROPN
bptjm-49	283	50	,	,	PUNCT
bptjm-49	283	51	y.	y.	PROPN
bptjm-49	283	52	,	,	PUNCT
bptjm-49	283	53	zhang	zhang	PROPN
bptjm-49	283	54	,	,	PUNCT
bptjm-49	283	55	y.	y.	PROPN
bptjm-49	283	56	,	,	PUNCT
bptjm-49	283	57	&	&	CCONJ
bptjm-49	283	58	li	li	PROPN
bptjm-49	283	59	,	,	PUNCT
bptjm-49	283	60	s.	s.	PROPN
bptjm-49	283	61	(	(	PUNCT
bptjm-49	283	62	2022	2022	NUM
bptjm-49	283	63	)	)	PUNCT
bptjm-49	283	64	.	.	PUNCT
bptjm-49	284	1	protein	protein	NOUN
bptjm-49	284	2	tyrosine	tyrosine	NOUN
bptjm-49	284	3	phosphatase	phosphatase	NOUN
bptjm-49	284	4	ptpl1	ptpl1	NOUN
bptjm-49	284	5	suppresses	suppress	VERB
bptjm-49	284	6	lung	lung	NOUN
bptjm-49	284	7	cancer	cancer	NOUN
bptjm-49	284	8	through	through	ADP
bptjm-49	284	9	src	src	PROPN
bptjm-49	284	10	/	/	SYM
bptjm-49	284	11	erk	erk	PROPN
bptjm-49	284	12	/	/	SYM
bptjm-49	284	13	yap1	yap1	NOUN
bptjm-49	284	14	signaling	signaling	ADJ
bptjm-49	284	15	.	.	PUNCT
bptjm-49	284	16	thoracic	thoracic	NOUN
bptjm-49	284	17	cancer	cancer	NOUN
bptjm-49	284	18	,	,	PUNCT
bptjm-49	284	19	13(21	13(21	NUM
bptjm-49	284	20	)	)	PUNCT
bptjm-49	284	21	,	,	PUNCT
bptjm-49	284	22	3042–3051	3042–3051	NUM
bptjm-49	284	23	.	.	PUNCT
bptjm-49	285	1	https://doi.org/10.1111/1759-7714.14657	https://doi.org/10.1111/1759-7714.14657	PROPN
bptjm-49	285	2	43	43	NUM
bptjm-49	285	3	.	.	PUNCT
bptjm-49	286	1	chen	chen	PROPN
bptjm-49	286	2	,	,	PUNCT
bptjm-49	286	3	w.	w.	PROPN
bptjm-49	286	4	,	,	PUNCT
bptjm-49	286	5	wang	wang	PROPN
bptjm-49	286	6	,	,	PUNCT
bptjm-49	286	7	j.	j.	PROPN
bptjm-49	286	8	,	,	PUNCT
bptjm-49	286	9	liu	liu	PROPN
bptjm-49	286	10	,	,	PUNCT
bptjm-49	286	11	s.	s.	PROPN
bptjm-49	286	12	,	,	PUNCT
bptjm-49	286	13	wang	wang	PROPN
bptjm-49	286	14	,	,	PUNCT
bptjm-49	286	15	s.	s.	PROPN
bptjm-49	286	16	,	,	PUNCT
bptjm-49	286	17	cheng	cheng	PROPN
bptjm-49	286	18	,	,	PUNCT
bptjm-49	286	19	y.	y.	PROPN
bptjm-49	286	20	,	,	PUNCT
bptjm-49	286	21	zhou	zhou	PROPN
bptjm-49	286	22	,	,	PUNCT
bptjm-49	286	23	w.	w.	PROPN
bptjm-49	286	24	,	,	PUNCT
bptjm-49	286	25	duan	duan	PROPN
bptjm-49	286	26	,	,	PUNCT
bptjm-49	286	27	c.	c.	PROPN
bptjm-49	286	28	,	,	PUNCT
bptjm-49	286	29	&	&	CCONJ
bptjm-49	286	30	zhang	zhang	PROPN
bptjm-49	286	31	,	,	PUNCT
bptjm-49	286	32	c.	c.	PROPN
bptjm-49	286	33	(	(	PUNCT
bptjm-49	286	34	2016	2016	NUM
bptjm-49	286	35	)	)	PUNCT
bptjm-49	286	36	.	.	PUNCT
bptjm-49	287	1	microrna-361	microrna-361	NOUN
bptjm-49	287	2	-	-	PUNCT
bptjm-49	287	3	3p	3p	NUM
bptjm-49	287	4	suppresses	suppress	VERB
bptjm-49	287	5	tumor	tumor	NOUN
bptjm-49	287	6	cell	cell	NOUN
bptjm-49	287	7	proliferation	proliferation	NOUN
bptjm-49	287	8	and	and	CCONJ
bptjm-49	287	9	metastasis	metastasis	NOUN
bptjm-49	287	10	by	by	ADP
bptjm-49	287	11	directly	directly	ADV
bptjm-49	287	12	targeting	target	VERB
bptjm-49	287	13	sh2b1	sh2b1	PROPN
bptjm-49	287	14	in	in	ADP
bptjm-49	287	15	nsclc	nsclc	NOUN
bptjm-49	287	16	.	.	PUNCT
bptjm-49	288	1	journal	journal	NOUN
bptjm-49	288	2	of	of	ADP
bptjm-49	288	3	experimental	experimental	PROPN
bptjm-49	288	4	&	&	CCONJ
bptjm-49	288	5	clinical	clinical	ADJ
bptjm-49	288	6	cancer	cancer	NOUN
bptjm-49	288	7	research	research	NOUN
bptjm-49	288	8	,	,	PUNCT
bptjm-49	288	9	35(1	35(1	NUM
bptjm-49	288	10	)	)	PUNCT
bptjm-49	288	11	.	.	PUNCT
bptjm-49	289	1	https://doi.org/10.1186/s13046-016-0357-4	https://doi.org/10.1186/s13046-016-0357-4	NUM
bptjm-49	289	2	44	44	NUM
bptjm-49	289	3	.	.	PUNCT
bptjm-49	290	1	fernandez	fernandez	PROPN
bptjm-49	290	2	,	,	PUNCT
bptjm-49	290	3	s.	s.	PROPN
bptjm-49	290	4	,	,	PUNCT
bptjm-49	290	5	risolino	risolino	NOUN
bptjm-49	290	6	,	,	PUNCT
bptjm-49	290	7	m.	m.	NOUN
bptjm-49	290	8	,	,	PUNCT
bptjm-49	290	9	mandia	mandia	PROPN
bptjm-49	290	10	,	,	PUNCT
bptjm-49	290	11	n.	n.	NOUN
bptjm-49	290	12	,	,	PUNCT
bptjm-49	290	13	talotta	talotta	PROPN
bptjm-49	290	14	,	,	PUNCT
bptjm-49	290	15	f.	f.	PROPN
bptjm-49	290	16	,	,	PUNCT
bptjm-49	290	17	soini	soini	PROPN
bptjm-49	290	18	,	,	PUNCT
bptjm-49	290	19	y.	y.	PROPN
bptjm-49	290	20	,	,	PUNCT
bptjm-49	290	21	incoronato	incoronato	PROPN
bptjm-49	290	22	,	,	PUNCT
bptjm-49	290	23	m.	m.	NOUN
bptjm-49	290	24	,	,	PUNCT
bptjm-49	290	25	condorelli	condorelli	PROPN
bptjm-49	290	26	,	,	PUNCT
bptjm-49	290	27	g.	g.	PROPN
bptjm-49	290	28	,	,	PUNCT
bptjm-49	290	29	ban	ban	PROPN
bptjm-49	290	30	�	�	PROPN
bptjm-49	290	31	,	,	PUNCT
bptjm-49	290	32	s.	s.	PROPN
bptjm-49	290	33	,	,	PUNCT
bptjm-49	290	34	&	&	CCONJ
bptjm-49	290	35	verde	verde	PROPN
bptjm-49	290	36	,	,	PUNCT
bptjm-49	290	37	p.	p.	NOUN
bptjm-49	290	38	(	(	PUNCT
bptjm-49	290	39	2014	2014	NUM
bptjm-49	290	40	)	)	PUNCT
bptjm-49	290	41	.	.	PUNCT
bptjm-49	291	1	mir-340	mir-340	NOUN
bptjm-49	291	2	inhibits	inhibit	VERB
bptjm-49	291	3	tumor	tumor	NOUN
bptjm-49	291	4	cell	cell	NOUN
bptjm-49	291	5	proliferation	proliferation	NOUN
bptjm-49	291	6	and	and	CCONJ
bptjm-49	291	7	induces	induce	VERB
bptjm-49	291	8	apoptosis	apoptosis	NOUN
bptjm-49	291	9	by	by	ADP
bptjm-49	291	10	targeting	target	VERB
bptjm-49	291	11	multiple	multiple	ADJ
bptjm-49	291	12	negative	negative	ADJ
bptjm-49	291	13	regulators	regulator	NOUN
bptjm-49	291	14	of	of	ADP
bptjm-49	291	15	p27	p27	NOUN
bptjm-49	291	16	in	in	ADP
bptjm-49	291	17	non	non	ADJ
bptjm-49	291	18	-	-	ADJ
bptjm-49	291	19	small	small	ADJ
bptjm-49	291	20	cell	cell	NOUN
bptjm-49	291	21	lung	lung	NOUN
bptjm-49	291	22	cancer.oncogene	cancer.oncogene	PROPN
bptjm-49	291	23	,	,	PUNCT
bptjm-49	291	24	34(25	34(25	PROPN
bptjm-49	291	25	)	)	PUNCT
bptjm-49	291	26	,	,	PUNCT
bptjm-49	291	27	3240–3250	3240–3250	NUM
bptjm-49	291	28	.	.	PUNCT
bptjm-49	292	1	https://doi.org/10.1038/onc.2014.267	https://doi.org/10.1038/onc.2014.267	PROPN
bptjm-49	292	2	45	45	NUM
bptjm-49	292	3	.	.	PUNCT
bptjm-49	293	1	song	song	PROPN
bptjm-49	293	2	,	,	PUNCT
bptjm-49	293	3	q.	q.	PROPN
bptjm-49	293	4	,	,	PUNCT
bptjm-49	293	5	xu	xu	PROPN
bptjm-49	293	6	,	,	PUNCT
bptjm-49	293	7	y.	y.	PROPN
bptjm-49	293	8	,	,	PUNCT
bptjm-49	293	9	yang	yang	PROPN
bptjm-49	293	10	,	,	PUNCT
bptjm-49	293	11	c.	c.	PROPN
bptjm-49	293	12	,	,	PUNCT
bptjm-49	293	13	chen	chen	PROPN
bptjm-49	293	14	,	,	PUNCT
bptjm-49	293	15	z.	z.	PROPN
bptjm-49	293	16	,	,	PUNCT
bptjm-49	293	17	jia	jia	PROPN
bptjm-49	293	18	,	,	PUNCT
bptjm-49	293	19	c.	c.	PROPN
bptjm-49	293	20	,	,	PUNCT
bptjm-49	293	21	chen	chen	PROPN
bptjm-49	293	22	,	,	PUNCT
bptjm-49	293	23	j.	j.	PROPN
bptjm-49	293	24	,	,	PUNCT
bptjm-49	293	25	zhang	zhang	PROPN
bptjm-49	293	26	,	,	PUNCT
bptjm-49	293	27	y.	y.	PROPN
bptjm-49	293	28	,	,	PUNCT
bptjm-49	293	29	lai	lai	PROPN
bptjm-49	293	30	,	,	PUNCT
bptjm-49	293	31	p.	p.	PROPN
bptjm-49	293	32	,	,	PUNCT
bptjm-49	293	33	fan	fan	PROPN
bptjm-49	293	34	,	,	PUNCT
bptjm-49	293	35	x.	x.	PROPN
bptjm-49	293	36	,	,	PUNCT
bptjm-49	293	37	zhou	zhou	PROPN
bptjm-49	293	38	,	,	PUNCT
bptjm-49	293	39	x.	x.	PROPN
bptjm-49	293	40	,	,	PUNCT
bptjm-49	293	41	lin	lin	PROPN
bptjm-49	293	42	,	,	PUNCT
bptjm-49	293	43	j.	j.	PROPN
bptjm-49	293	44	,	,	PUNCT
bptjm-49	293	45	li	li	PROPN
bptjm-49	293	46	,	,	PUNCT
bptjm-49	293	47	m.	m.	NOUN
bptjm-49	293	48	,	,	PUNCT
bptjm-49	293	49	ma	ma	PROPN
bptjm-49	293	50	,	,	PUNCT
bptjm-49	293	51	w.	w.	PROPN
bptjm-49	293	52	,	,	PUNCT
bptjm-49	293	53	luo	luo	PROPN
bptjm-49	293	54	,	,	PUNCT
bptjm-49	293	55	s.	s.	PROPN
bptjm-49	293	56	,	,	PUNCT
bptjm-49	293	57	&	&	CCONJ
bptjm-49	293	58	bai	bai	PROPN
bptjm-49	293	59	,	,	PUNCT
bptjm-49	293	60	x.	x.	NOUN
bptjm-49	293	61	(	(	PUNCT
bptjm-49	293	62	2014	2014	NUM
bptjm-49	293	63	)	)	PUNCT
bptjm-49	293	64	.	.	PUNCT
bptjm-49	294	1	mir-483	mir-483	PROPN
bptjm-49	294	2	-	-	PUNCT
bptjm-49	294	3	5p	5p	PROPN
bptjm-49	294	4	promotes	promote	VERB
bptjm-49	294	5	invasion	invasion	NOUN
bptjm-49	294	6	and	and	CCONJ
bptjm-49	294	7	metastasis	metastasis	NOUN
bptjm-49	294	8	of	of	ADP
bptjm-49	294	9	lung	lung	NOUN
bptjm-49	294	10	adenocarcinoma	adenocarcinoma	NOUN
bptjm-49	294	11	by	by	ADP
bptjm-49	294	12	targeting	target	VERB
bptjm-49	294	13	rhogdi1	rhogdi1	NOUN
bptjm-49	294	14	and	and	CCONJ
bptjm-49	294	15	berkeley	berkeley	PROPN
bptjm-49	294	16	pharma	pharma	PROPN
bptjm-49	294	17	tech	tech	NOUN
bptjm-49	294	18	journal	journal	NOUN
bptjm-49	294	19	of	of	ADP
bptjm-49	294	20	medicine	medicine	NOUN
bptjm-49	294	21	|	|	ADV
bptjm-49	294	22	99	99	NUM
bptjm-49	294	23	alcam	alcam	NOUN
bptjm-49	294	24	.	.	PUNCT
bptjm-49	295	1	cancer	cancer	NOUN
bptjm-49	295	2	research	research	NOUN
bptjm-49	295	3	,	,	PUNCT
bptjm-49	295	4	74(11	74(11	NUM
bptjm-49	295	5	)	)	PUNCT
bptjm-49	295	6	,	,	PUNCT
bptjm-49	295	7	3031–3042	3031–3042	NUM
bptjm-49	295	8	.	.	PUNCT
bptjm-49	296	1	https://doi.org/10.1158/0008-5472.can-13-2193	https://doi.org/10.1158/0008-5472.can-13-2193	PROPN
bptjm-49	296	2	46	46	NUM
bptjm-49	296	3	.	.	PUNCT
bptjm-49	297	1	cui	cui	PROPN
bptjm-49	297	2	,	,	PUNCT
bptjm-49	297	3	r.	r.	PROPN
bptjm-49	297	4	,	,	PUNCT
bptjm-49	297	5	meng	meng	PROPN
bptjm-49	297	6	,	,	PUNCT
bptjm-49	297	7	w.	w.	PROPN
bptjm-49	297	8	,	,	PUNCT
bptjm-49	297	9	sun	sun	NOUN
bptjm-49	297	10	,	,	PUNCT
bptjm-49	297	11	h.-l	h.-l	PROPN
bptjm-49	297	12	.	.	PUNCT
bptjm-49	297	13	,	,	PUNCT
bptjm-49	297	14	kim	kim	PROPN
bptjm-49	297	15	,	,	PUNCT
bptjm-49	297	16	t.	t.	PROPN
bptjm-49	297	17	,	,	PUNCT
bptjm-49	297	18	ye	ye	PROPN
bptjm-49	297	19	,	,	PUNCT
bptjm-49	297	20	z.	z.	PROPN
bptjm-49	297	21	,	,	PUNCT
bptjm-49	297	22	fassan	fassan	ADJ
bptjm-49	297	23	,	,	PUNCT
bptjm-49	297	24	m.	m.	NOUN
bptjm-49	297	25	,	,	PUNCT
bptjm-49	297	26	jeon	jeon	PROPN
bptjm-49	297	27	,	,	PUNCT
bptjm-49	297	28	y.-j	y.-j	PROPN
bptjm-49	297	29	.	.	PROPN
bptjm-49	297	30	,	,	PUNCT
bptjm-49	297	31	li	li	PROPN
bptjm-49	297	32	,	,	PUNCT
bptjm-49	297	33	b.	b.	PROPN
bptjm-49	297	34	,	,	PUNCT
bptjm-49	297	35	vicentini	vicentini	PROPN
bptjm-49	297	36	,	,	PUNCT
bptjm-49	297	37	c.	c.	PROPN
bptjm-49	297	38	,	,	PUNCT
bptjm-49	297	39	peng	peng	PROPN
bptjm-49	297	40	,	,	PUNCT
bptjm-49	297	41	y.	y.	PROPN
bptjm-49	297	42	,	,	PUNCT
bptjm-49	297	43	lee	lee	PROPN
bptjm-49	297	44	,	,	PUNCT
bptjm-49	297	45	t.	t.	PROPN
bptjm-49	297	46	j.	j.	PROPN
bptjm-49	297	47	,	,	PUNCT
bptjm-49	297	48	luo	luo	PROPN
bptjm-49	297	49	,	,	PUNCT
bptjm-49	297	50	z.	z.	PROPN
bptjm-49	297	51	,	,	PUNCT
bptjm-49	297	52	liu	liu	PROPN
bptjm-49	297	53	,	,	PUNCT
bptjm-49	297	54	l.	l.	PROPN
bptjm-49	297	55	,	,	PUNCT
bptjm-49	297	56	xu	xu	PROPN
bptjm-49	297	57	,	,	PUNCT
bptjm-49	297	58	d.	d.	PROPN
bptjm-49	297	59	,	,	PUNCT
bptjm-49	297	60	tili	tili	PROPN
bptjm-49	297	61	,	,	PUNCT
bptjm-49	297	62	e.	e.	PROPN
bptjm-49	297	63	,	,	PUNCT
bptjm-49	297	64	jin	jin	PROPN
bptjm-49	297	65	,	,	PUNCT
bptjm-49	297	66	v.	v.	PROPN
bptjm-49	297	67	,	,	PUNCT
bptjm-49	297	68	middleton	middleton	PROPN
bptjm-49	297	69	,	,	PUNCT
bptjm-49	297	70	j.	j.	PROPN
bptjm-49	297	71	,	,	PUNCT
bptjm-49	297	72	chakravarti	chakravarti	PROPN
bptjm-49	297	73	,	,	PUNCT
bptjm-49	297	74	a.	a.	NOUN
bptjm-49	297	75	,	,	PUNCT
bptjm-49	297	76	lautenschlaeger	lautenschlaeger	NOUN
bptjm-49	297	77	,	,	PUNCT
bptjm-49	297	78	t.	t.	PROPN
bptjm-49	297	79	,	,	PUNCT
bptjm-49	297	80	&	&	CCONJ
bptjm-49	297	81	croce	croce	PROPN
bptjm-49	297	82	,	,	PUNCT
bptjm-49	297	83	c.	c.	PROPN
bptjm-49	297	84	m.	m.	NOUN
bptjm-49	297	85	(	(	PUNCT
bptjm-49	297	86	2015	2015	NUM
bptjm-49	297	87	)	)	PUNCT
bptjm-49	297	88	.	.	PUNCT
bptjm-49	298	1	microrna-224	microrna-224	PROPN
bptjm-49	298	2	promotes	promote	VERB
bptjm-49	298	3	tumor	tumor	NOUN
bptjm-49	298	4	progression	progression	NOUN
bptjm-49	298	5	in	in	ADP
bptjm-49	298	6	nonsmall	nonsmall	NOUN
bptjm-49	298	7	cell	cell	NOUN
bptjm-49	298	8	lung	lung	NOUN
bptjm-49	298	9	cancer	cancer	NOUN
bptjm-49	298	10	.	.	PUNCT
bptjm-49	299	1	proceedings	proceeding	NOUN
bptjm-49	299	2	of	of	ADP
bptjm-49	299	3	the	the	DET
bptjm-49	299	4	national	national	PROPN
bptjm-49	299	5	academy	academy	PROPN
bptjm-49	299	6	of	of	ADP
bptjm-49	299	7	sciences	sciences	PROPN
bptjm-49	299	8	,	,	PUNCT
bptjm-49	299	9	112(31	112(31	NUM
bptjm-49	299	10	)	)	PUNCT
bptjm-49	299	11	.	.	PUNCT
bptjm-49	300	1	https://doi.org/10.1073/pnas.1502068112	https://doi.org/10.1073/pnas.1502068112	PROPN
bptjm-49	301	1	47	47	NUM
bptjm-49	301	2	.	.	PUNCT
bptjm-49	302	1	vichas	vichas	PROPN
bptjm-49	302	2	,	,	PUNCT
bptjm-49	302	3	a.	a.	PROPN
bptjm-49	302	4	,	,	PUNCT
bptjm-49	302	5	riley	riley	PROPN
bptjm-49	302	6	,	,	PUNCT
bptjm-49	302	7	a.	a.	PROPN
bptjm-49	302	8	k.	k.	PROPN
bptjm-49	302	9	,	,	PUNCT
bptjm-49	302	10	nkinsi	nkinsi	PROPN
bptjm-49	302	11	,	,	PUNCT
bptjm-49	302	12	n.	n.	PROPN
bptjm-49	302	13	t.	t.	PROPN
bptjm-49	302	14	,	,	PUNCT
bptjm-49	302	15	kamlapurkar	kamlapurkar	PROPN
bptjm-49	302	16	,	,	PUNCT
bptjm-49	302	17	s.	s.	PROPN
bptjm-49	302	18	,	,	PUNCT
bptjm-49	302	19	parrish	parrish	PROPN
bptjm-49	302	20	,	,	PUNCT
bptjm-49	302	21	p.	p.	PROPN
bptjm-49	302	22	c.	c.	PROPN
bptjm-49	302	23	,	,	PUNCT
bptjm-49	302	24	lo	lo	PROPN
bptjm-49	302	25	,	,	PUNCT
bptjm-49	302	26	a.	a.	PROPN
bptjm-49	302	27	,	,	PUNCT
bptjm-49	302	28	duke	duke	PROPN
bptjm-49	302	29	,	,	PUNCT
bptjm-49	302	30	f.	f.	PROPN
bptjm-49	302	31	,	,	PUNCT
bptjm-49	302	32	chen	chen	PROPN
bptjm-49	302	33	,	,	PUNCT
bptjm-49	302	34	j.	j.	PROPN
bptjm-49	302	35	,	,	PUNCT
bptjm-49	302	36	fung	fung	PROPN
bptjm-49	302	37	,	,	PUNCT
bptjm-49	302	38	i.	i.	PROPN
bptjm-49	302	39	,	,	PUNCT
bptjm-49	302	40	watson	watson	PROPN
bptjm-49	302	41	,	,	PUNCT
bptjm-49	302	42	j.	j.	PROPN
bptjm-49	302	43	,	,	PUNCT
bptjm-49	302	44	rees	rees	PROPN
bptjm-49	302	45	,	,	PUNCT
bptjm-49	302	46	m.	m.	NOUN
bptjm-49	302	47	,	,	PUNCT
bptjm-49	302	48	gabel	gabel	NOUN
bptjm-49	302	49	,	,	PUNCT
bptjm-49	302	50	a.	a.	NOUN
bptjm-49	302	51	m.	m.	NOUN
bptjm-49	302	52	,	,	PUNCT
bptjm-49	302	53	thomas	thomas	PROPN
bptjm-49	302	54	,	,	PUNCT
bptjm-49	302	55	j.	j.	PROPN
bptjm-49	302	56	d.	d.	PROPN
bptjm-49	302	57	,	,	PUNCT
bptjm-49	302	58	bradley	bradley	PROPN
bptjm-49	302	59	,	,	PUNCT
bptjm-49	302	60	r.	r.	PROPN
bptjm-49	302	61	k.	k.	PROPN
bptjm-49	302	62	,	,	PUNCT
bptjm-49	302	63	lee	lee	PROPN
bptjm-49	302	64	,	,	PUNCT
bptjm-49	302	65	j.	j.	PROPN
bptjm-49	302	66	k.	k.	PROPN
bptjm-49	302	67	,	,	PUNCT
bptjm-49	302	68	hatch	hatch	PROPN
bptjm-49	302	69	,	,	PUNCT
bptjm-49	302	70	e.	e.	PROPN
bptjm-49	302	71	m.	m.	PROPN
bptjm-49	302	72	,	,	PUNCT
bptjm-49	302	73	baine	baine	PROPN
bptjm-49	302	74	,	,	PUNCT
bptjm-49	302	75	m.	m.	PROPN
bptjm-49	302	76	k.	k.	PROPN
bptjm-49	302	77	,	,	PUNCT
bptjm-49	302	78	rekhtman	rekhtman	PROPN
bptjm-49	302	79	,	,	PUNCT
bptjm-49	302	80	n.	n.	NOUN
bptjm-49	302	81	,	,	PUNCT
bptjm-49	302	82	ladanyi	ladanyi	PROPN
bptjm-49	302	83	,	,	PUNCT
bptjm-49	302	84	m.	m.	NOUN
bptjm-49	302	85	,	,	PUNCT
bptjm-49	302	86	…	…	PUNCT
bptjm-49	302	87	berger	berger	PROPN
bptjm-49	302	88	,	,	PUNCT
bptjm-49	302	89	a.	a.	PROPN
bptjm-49	302	90	h.	h.	PROPN
bptjm-49	302	91	(	(	PUNCT
bptjm-49	302	92	2021	2021	NUM
bptjm-49	302	93	)	)	PUNCT
bptjm-49	302	94	.	.	PUNCT
bptjm-49	303	1	integrative	integrative	ADJ
bptjm-49	303	2	oncogene	oncogene	NOUN
bptjm-49	303	3	-	-	PUNCT
bptjm-49	303	4	dependency	dependency	NOUN
bptjm-49	303	5	mapping	mapping	NOUN
bptjm-49	303	6	identi	identi	NOUN
bptjm-49	303	7	�	�	PROPN
bptjm-49	303	8	es	es	ADJ
bptjm-49	303	9	rit1	rit1	NOUN
bptjm-49	303	10	vulnerabilities	vulnerability	NOUN
bptjm-49	303	11	and	and	CCONJ
bptjm-49	303	12	synergies	synergy	NOUN
bptjm-49	303	13	in	in	ADP
bptjm-49	303	14	lung	lung	NOUN
bptjm-49	303	15	cancer.nature	cancer.nature	PROPN
bptjm-49	303	16	communications	communication	NOUN
bptjm-49	303	17	,	,	PUNCT
bptjm-49	303	18	12(1	12(1	NUM
bptjm-49	303	19	)	)	PUNCT
bptjm-49	303	20	.	.	PUNCT
bptjm-49	304	1	https://doi.org/10.1038/s41467-021-24841-y	https://doi.org/10.1038/s41467-021-24841-y	PROPN
bptjm-49	304	2	48	48	NUM
bptjm-49	304	3	.	.	PUNCT
bptjm-49	305	1	zhang	zhang	PROPN
bptjm-49	305	2	,	,	PUNCT
bptjm-49	305	3	y.	y.	PROPN
bptjm-49	305	4	,	,	PUNCT
bptjm-49	305	5	wang	wang	PROPN
bptjm-49	305	6	,	,	PUNCT
bptjm-49	305	7	y.	y.	PROPN
bptjm-49	305	8	,	,	PUNCT
bptjm-49	305	9	zhou	zhou	PROPN
bptjm-49	305	10	,	,	PUNCT
bptjm-49	305	11	d.	d.	PROPN
bptjm-49	305	12	,	,	PUNCT
bptjm-49	305	13	wang	wang	PROPN
bptjm-49	305	14	,	,	PUNCT
bptjm-49	305	15	k.	k.	PROPN
bptjm-49	305	16	,	,	PUNCT
bptjm-49	305	17	wang	wang	PROPN
bptjm-49	305	18	,	,	PUNCT
bptjm-49	305	19	x.	x.	PROPN
bptjm-49	305	20	,	,	PUNCT
bptjm-49	305	21	wang	wang	PROPN
bptjm-49	305	22	,	,	PUNCT
bptjm-49	305	23	x.	x.	PROPN
bptjm-49	305	24	,	,	PUNCT
bptjm-49	305	25	jiang	jiang	PROPN
bptjm-49	305	26	,	,	PUNCT
bptjm-49	305	27	y.	y.	PROPN
bptjm-49	305	28	,	,	PUNCT
bptjm-49	305	29	zhao	zhao	PROPN
bptjm-49	305	30	,	,	PUNCT
bptjm-49	305	31	m.	m.	NOUN
bptjm-49	305	32	,	,	PUNCT
bptjm-49	305	33	yu	yu	PROPN
bptjm-49	305	34	,	,	PUNCT
bptjm-49	305	35	r.	r.	PROPN
bptjm-49	305	36	,	,	PUNCT
bptjm-49	305	37	&	&	CCONJ
bptjm-49	305	38	zhou	zhou	PROPN
bptjm-49	305	39	,	,	PUNCT
bptjm-49	305	40	x.	x.	NOUN
bptjm-49	305	41	(	(	PUNCT
bptjm-49	305	42	2021	2021	NUM
bptjm-49	305	43	)	)	PUNCT
bptjm-49	305	44	.	.	PUNCT
bptjm-49	306	1	radiation	radiation	NOUN
bptjm-49	306	2	-	-	PUNCT
bptjm-49	306	3	induced	induce	VERB
bptjm-49	306	4	yap	yap	NOUN
bptjm-49	306	5	activation	activation	NOUN
bptjm-49	306	6	confers	confer	NOUN
bptjm-49	306	7	glioma	glioma	NOUN
bptjm-49	306	8	radioresistance	radioresistance	NOUN
bptjm-49	306	9	via	via	ADP
bptjm-49	306	10	promoting	promote	VERB
bptjm-49	306	11	fgf2	fgf2	ADJ
bptjm-49	306	12	transcription	transcription	NOUN
bptjm-49	306	13	and	and	CCONJ
bptjm-49	306	14	dna	dna	NOUN
bptjm-49	306	15	damage	damage	NOUN
bptjm-49	306	16	repair.oncogene	repair.oncogene	NOUN
bptjm-49	306	17	,	,	PUNCT
bptjm-49	306	18	40(27	40(27	NUM
bptjm-49	306	19	)	)	PUNCT
bptjm-49	306	20	,	,	PUNCT
bptjm-49	306	21	4580–4591	4580–4591	NUM
bptjm-49	306	22	.	.	PUNCT
bptjm-49	307	1	https://doi.org/10.1038/s41388-021-01878-3	https://doi.org/10.1038/s41388-021-01878-3	PROPN
bptjm-49	307	2	49	49	NUM
bptjm-49	307	3	.	.	PUNCT
bptjm-49	308	1	a	a	DET
bptjm-49	308	2	�	�	PROPN
bptjm-49	308	3	rst	rst	VERB
bptjm-49	308	4	-	-	PUNCT
bptjm-49	308	5	in	in	ADP
bptjm-49	308	6	-	-	PUNCT
bptjm-49	308	7	human	human	ADJ
bptjm-49	308	8	study	study	NOUN
bptjm-49	308	9	of	of	ADP
bptjm-49	308	10	jab-3068	jab-3068	NOUN
bptjm-49	308	11	(	(	PUNCT
bptjm-49	308	12	shp2	shp2	NOUN
bptjm-49	308	13	inhibitor	inhibitor	NOUN
bptjm-49	308	14	)	)	PUNCT
bptjm-49	308	15	in	in	ADP
bptjm-49	308	16	adult	adult	NOUN
bptjm-49	308	17	patients	patient	NOUN
bptjm-49	308	18	with	with	ADP
bptjm-49	308	19	advanced	advanced	ADJ
bptjm-49	308	20	solid	solid	ADJ
bptjm-49	308	21	tumors	tumor	NOUN
bptjm-49	308	22	in	in	ADP
bptjm-49	308	23	china	china	PROPN
bptjm-49	308	24	full	full	ADJ
bptjm-49	308	25	text	text	NOUN
bptjm-49	308	26	view	view	NOUN
bptjm-49	308	27	.	.	PUNCT
bptjm-49	309	1	full	full	ADJ
bptjm-49	309	2	text	text	NOUN
bptjm-49	309	3	view	view	NOUN
bptjm-49	309	4	clinicaltrials.gov	clinicaltrials.gov	X
bptjm-49	309	5	.	.	PUNCT
bptjm-49	309	6	(	(	PUNCT
bptjm-49	309	7	n.d	n.d	PROPN
bptjm-49	309	8	.	.	PROPN
bptjm-49	309	9	)	)	PUNCT
bptjm-49	309	10	.	.	PUNCT
bptjm-49	310	1	retrievedmarch	retrievedmarch	PROPN
bptjm-49	310	2	24	24	NUM
bptjm-49	310	3	,	,	PUNCT
bptjm-49	310	4	2023	2023	NUM
bptjm-49	310	5	,	,	PUNCT
bptjm-49	310	6	from	from	ADP
bptjm-49	310	7	https://clinicaltrials.gov/ct2/show/nct03565003	https://clinicaltrials.gov/ct2/show/nct03565003	PRON
bptjm-49	310	8	?	?	NOUN
bptjm-49	310	9	term	term	NOUN
bptjm-49	310	10	=	=	SYM
bptjm-49	310	11	ptpn11&cond	ptpn11&cond	NUM
bptjm-49	310	12	=	=	SYM
bptjm-49	310	13	non	non	NOUN
bptjm-49	310	14	-	-	NOUN
bptjm-49	310	15	small%2bcell%2bl	small%2bcell%2bl	ADV
bptjm-49	310	16	ung%2bcancer&draw=2&rank=3	ung%2bcancer&draw=2&rank=3	ADJ
bptjm-49	310	17	50	50	NUM
bptjm-49	310	18	.	.	PUNCT
bptjm-49	311	1	a	a	DET
bptjm-49	311	2	�	�	PROPN
bptjm-49	311	3	rst	rst	VERB
bptjm-49	311	4	-	-	PUNCT
bptjm-49	311	5	in	in	ADP
bptjm-49	311	6	-	-	PUNCT
bptjm-49	311	7	human	human	ADJ
bptjm-49	311	8	,	,	PUNCT
bptjm-49	311	9	phase	phase	NOUN
bptjm-49	311	10	1	1	NUM
bptjm-49	311	11	study	study	NOUN
bptjm-49	311	12	of	of	ADP
bptjm-49	311	13	jab-3312	jab-3312	NOUN
bptjm-49	311	14	in	in	ADP
bptjm-49	311	15	adult	adult	NOUN
bptjm-49	311	16	patients	patient	NOUN
bptjm-49	311	17	with	with	ADP
bptjm-49	311	18	advanced	advanced	ADJ
bptjm-49	311	19	solid	solid	ADJ
bptjm-49	311	20	tumors	tumor	NOUN
bptjm-49	311	21	full	full	ADJ
bptjm-49	311	22	text	text	NOUN
bptjm-49	311	23	view	view	NOUN
bptjm-49	311	24	.	.	PUNCT
bptjm-49	312	1	full	full	ADJ
bptjm-49	312	2	text	text	NOUN
bptjm-49	312	3	view	view	NOUN
bptjm-49	312	4	clinicaltrials.gov	clinicaltrials.gov	X
bptjm-49	312	5	.	.	PUNCT
bptjm-49	312	6	(	(	PUNCT
bptjm-49	312	7	n.d	n.d	PROPN
bptjm-49	312	8	.	.	PROPN
bptjm-49	312	9	)	)	PUNCT
bptjm-49	312	10	.	.	PUNCT
bptjm-49	313	1	retrievedmarch	retrievedmarch	PROPN
bptjm-49	313	2	24	24	NUM
bptjm-49	313	3	,	,	PUNCT
bptjm-49	313	4	2023	2023	NUM
bptjm-49	313	5	,	,	PUNCT
bptjm-49	313	6	from	from	ADP
bptjm-49	313	7	https://clinicaltrials.gov/ct2/show/nct0404	https://clinicaltrials.gov/ct2/show/nct0404	X
bptjm-49	313	8	5496?term	5496?term	NUM
bptjm-49	313	9	=	=	SYM
bptjm-49	313	10	ptpn11&cond	ptpn11&cond	NUM
bptjm-49	313	11	=	=	SYM
bptjm-49	313	12	non	non	ADJ
bptjm-49	313	13	-	-	ADJ
bptjm-49	313	14	small%2b	small%2b	ADJ
bptjm-49	313	15	cell%2blung%2bcancer&draw=2	cell%2blung%2bcancer&draw=2	PROPN
bptjm-49	313	16	51	51	NUM
bptjm-49	313	17	.	.	PUNCT
bptjm-49	314	1	a	a	DET
bptjm-49	314	2	study	study	NOUN
bptjm-49	314	3	evaluating	evaluate	VERB
bptjm-49	314	4	the	the	DET
bptjm-49	314	5	activity	activity	NOUN
bptjm-49	314	6	of	of	ADP
bptjm-49	314	7	anti	anti	ADJ
bptjm-49	314	8	-	-	ADJ
bptjm-49	314	9	cancer	cancer	ADJ
bptjm-49	314	10	treatments	treatment	NOUN
bptjm-49	314	11	targeting	target	VERB
bptjm-49	314	12	tumormolecular	tumormolecular	ADJ
bptjm-49	314	13	alterations	alteration	NOUN
bptjm-49	314	14	/	/	SYM
bptjm-49	314	15	characteristics	characteristic	NOUN
bptjm-49	314	16	in	in	ADP
bptjm-49	314	17	advanced	advanced	ADJ
bptjm-49	314	18	/	/	SYM
bptjm-49	314	19	metastatic	metastatic	ADJ
bptjm-49	314	20	tumors	tumor	NOUN
bptjm-49	314	21	.	.	PUNCT
bptjm-49	315	1	(	(	PUNCT
bptjm-49	315	2	megamost	megamost	ADJ
bptjm-49	315	3	)	)	PUNCT
bptjm-49	315	4	full	full	ADJ
bptjm-49	315	5	text	text	NOUN
bptjm-49	315	6	view	view	NOUN
bptjm-49	315	7	.	.	PUNCT
bptjm-49	316	1	full	full	ADJ
bptjm-49	316	2	text	text	NOUN
bptjm-49	316	3	view	view	NOUN
bptjm-49	316	4	clinicaltrials.gov	clinicaltrials.gov	X
bptjm-49	316	5	.	.	PUNCT
bptjm-49	316	6	(	(	PUNCT
bptjm-49	316	7	n.d	n.d	PROPN
bptjm-49	316	8	.	.	PROPN
bptjm-49	316	9	)	)	PUNCT
bptjm-49	316	10	.	.	PUNCT
bptjm-49	317	1	retrievedmarch	retrievedmarch	PROPN
bptjm-49	317	2	24	24	NUM
bptjm-49	317	3	,	,	PUNCT
bptjm-49	317	4	2023	2023	NUM
bptjm-49	317	5	,	,	PUNCT
bptjm-49	317	6	from	from	ADP
bptjm-49	317	7	https://clinicaltrials.gov/ct2/show/study/nct041	https://clinicaltrials.gov/ct2/show/study/nct041	NOUN
bptjm-49	317	8	16541?term	16541?term	NUM
bptjm-49	317	9	=	=	SYM
bptjm-49	317	10	protein+tyrosine+phosphatases+non	protein+tyrosine+phosphatases+non	NOUN
bptjm-49	317	11	-receptor+type&draw=2&rank=2	-receptor+type&draw=2&rank=2	PROPN
bptjm-49	317	12	berkeley	berkeley	PROPN
bptjm-49	317	13	pharma	pharma	PROPN
bptjm-49	317	14	tech	tech	NOUN
bptjm-49	317	15	journal	journal	NOUN
bptjm-49	317	16	of	of	ADP
bptjm-49	317	17	medicine	medicine	NOUN
bptjm-49	317	18	|	|	ADV
bptjm-49	317	19	100	100	NUM